
<html lang="en"     class="pb-page"  data-request-id="f2718250-279d-406e-9fee-8f8f32b37925"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b01093;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-7;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Battle against Vancomycin-Resistant Bacteria: Recent Developments in Chemical Strategies" /></meta><meta name="dc.Creator" content="Geetika  Dhanda" /></meta><meta name="dc.Creator" content="Paramita  Sarkar" /></meta><meta name="dc.Creator" content="Sandip  Samaddar" /></meta><meta name="dc.Creator" content="Jayanta  Haldar" /></meta><meta name="dc.Description" content="Vancomycin, a natural glycopeptide antibiotic, was used as the antibiotic of last resort for the treatment of multidrug-resistant Gram-positive bacterial infections. However, almost 30 years after ..." /></meta><meta name="Description" content="Vancomycin, a natural glycopeptide antibiotic, was used as the antibiotic of last resort for the treatment of multidrug-resistant Gram-positive bacterial infections. However, almost 30 years after ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 7, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01093" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01093" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01093" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01093" /></link>
        
    
    

<title>Battle against Vancomycin-Resistant Bacteria: Recent Developments in Chemical Strategies | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01093" /></meta><meta property="og:title" content="Battle against Vancomycin-Resistant Bacteria: Recent Developments in Chemical Strategies" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0015.jpeg" /></meta><meta property="og:description" content="Vancomycin, a natural glycopeptide antibiotic, was used as the antibiotic of last resort for the treatment of multidrug-resistant Gram-positive bacterial infections. However, almost 30 years after its use, resistance to vancomycin was first reported in 1986 in France. This became a major health concern, and alternative treatment strategies were urgently needed. New classes of molecules, including semisynthetic antibacterial compounds and newer generations of the previously used antibiotics, were developed. Semisynthetic derivatives of vancomycin with enhanced binding affinity, membrane disruption ability, and lipid binding properties have exhibited promising results against both Gram-positive and Gram-negative bacteria. Various successful approaches developed to overcome the acquired resistance in Gram-positive bacteria, intrinsic resistance in Gram-negative bacteria, and other forms of noninherited resistance to vancomycin have been discussed in this Perspective." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01093"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01093">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01093&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01093&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01093&amp;href=/doi/10.1021/acs.jmedchem.8b01093" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3184-3205</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00189" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.8b01361" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Battle against Vancomycin-Resistant Bacteria: Recent Developments in Chemical Strategies</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Geetika Dhanda</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Geetika Dhanda</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Antimicrobial Research Laboratory, New Chemistry Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Jakkur, Bengaluru 560064, Karnataka, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Geetika++Dhanda">Geetika Dhanda</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Paramita Sarkar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paramita Sarkar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Antimicrobial Research Laboratory, New Chemistry Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Jakkur, Bengaluru 560064, Karnataka, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paramita++Sarkar">Paramita Sarkar</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Sandip Samaddar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sandip Samaddar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Antimicrobial Research Laboratory, New Chemistry Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Jakkur, Bengaluru 560064, Karnataka, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sandip++Samaddar">Sandip Samaddar</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Jayanta Haldar</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jayanta Haldar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Antimicrobial Research Laboratory, New Chemistry Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Jakkur, Bengaluru 560064, Karnataka, India</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (+91) 80-2208-2565. Fax: (+91) 80-2208-2627. E-mail: <a href="/cdn-cgi/l/email-protection#8ee4eff7efe0faefcee4e0edeffdfca0efeda0e7e0"><span class="__cf_email__" data-cfemail="f49e958d959a8095b49e9a97958786da9597da9d9a">[emailÂ protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jayanta++Haldar">Jayanta Haldar</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8068-1015" title="Orcid link">http://orcid.org/0000-0002-8068-1015</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01093&amp;href=/doi/10.1021%2Facs.jmedchem.8b01093" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3184â3205</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 7, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 July 2018</li><li><span class="item_label"><b>Published</b> online</span>7 November 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 April 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01093" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01093</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3184%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGeetika%2BDhanda%252C%2BParamita%2BSarkar%252C%2BSandip%2BSamaddar%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D7%26contentID%3Dacs.jmedchem.8b01093%26title%3DBattle%2Bagainst%2BVancomycin-Resistant%2BBacteria%253A%2BRecent%2BDevelopments%2Bin%2BChemical%2BStrategies%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3205%26publicationDate%3DApril%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01093"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2905</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">30</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01093" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Battle against Vancomycin-Resistant Bacteria: Recent Developments in Chemical Strategies&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Geetika&quot;,&quot;last_name&quot;:&quot;Dhanda&quot;},{&quot;first_name&quot;:&quot;Paramita&quot;,&quot;last_name&quot;:&quot;Sarkar&quot;},{&quot;first_name&quot;:&quot;Sandip&quot;,&quot;last_name&quot;:&quot;Samaddar&quot;},{&quot;first_name&quot;:&quot;Jayanta&quot;,&quot;last_name&quot;:&quot;Haldar&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;3184-3205&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01093&quot;},&quot;abstract&quot;:&quot;Vancomycin, a natural glycopeptide antibiotic, was used as the antibiotic of last resort for the treatment of multidrug-resistant Gram-positive bacterial infections. However, almost 30 years after its use, resistance to vancomycin was first reported in 1986 in France. This became a major health concern, and alternative treatment strategies were urgently needed. New classes of molecules, including semisynthetic antibacterial compounds and newer generations of the previously used antibiotics, were developed. Semisynthetic derivatives of vancomycin with enhanced binding affinity, membrane disruption ability, and lipid binding properties have exhibited promising results against both Gram-positive and Gram-negative bacteria. Various successful approaches developed to overcome the acquired resistance in Gram-positive bacteria, intrinsic resistance in Gram-negative bacteria, and other forms of noninherited resistance to vancomycin have been discussed in this Perspective.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01093&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01093" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01093&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01093" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01093&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01093" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01093&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01093&amp;href=/doi/10.1021/acs.jmedchem.8b01093" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01093" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01093" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (13 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01093%26sid%3Dliteratum%253Aachs%26pmid%3D30404451%26genre%3Darticle%26aulast%3DDhanda%26date%3D2019%26atitle%3DBattle%2Bagainst%2BVancomycin-Resistant%2BBacteria%253A%2BRecent%2BDevelopments%2Bin%2BChemical%2BStrategies%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D7%26spage%3D3184%26epage%3D3205%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291214" title="Bacteria">Bacteria</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/jmcmar.2019.62.issue-7/20190411/jmcmar.2019.62.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Vancomycin, a natural glycopeptide antibiotic, was used as the antibiotic of last resort for the treatment of multidrug-resistant Gram-positive bacterial infections. However, almost 30 years after its use, resistance to vancomycin was first reported in 1986 in France. This became a major health concern, and alternative treatment strategies were urgently needed. New classes of molecules, including semisynthetic antibacterial compounds and newer generations of the previously used antibiotics, were developed. Semisynthetic derivatives of vancomycin with enhanced binding affinity, membrane disruption ability, and lipid binding properties have exhibited promising results against both Gram-positive and Gram-negative bacteria. Various successful approaches developed to overcome the acquired resistance in Gram-positive bacteria, intrinsic resistance in Gram-negative bacteria, and other forms of noninherited resistance to vancomycin have been discussed in this Perspective.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The emergence and spread of antimicrobial resistance (AMR) globally poses a major threat to the management of infectious diseases, resulting in high morbidity and mortality.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The World Health Organizationâs (WHO) Global Antimicrobial Surveillance System (GLASS) revealed high levels of resistance in a number of serious bacterial infections worldwide. Resistance in bacteria such as <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i>, <i>Staphylococcus aureus</i>, and <i>Streptococcus pneumoniae</i>, followed by <i>Salmonella</i> spp. are among the most commonly reported.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> To tackle the rapid emergence of antimicrobial resistance, initiatives were taken by various health organizations and governments, which resulted in the approval of several new antibiotics. Five new classes of antibiotics, lipopeptides (daptomycin), oxazolidinones (linezolid), pleuromutilin (retapamulin), macrocyclic antibiotics (fidaxomicin), and diarylquinoline (bedaquiline), were introduced into the market. The other new antibiotics, which were modifications of the previously existing antibiotics, had limited usefulness due to the pan-class mechanisms of resistance in bacteria. This lack of novel scaffolds from target-based or phenotypic-screening methods had resulted in the withdrawal of pharmaceutical companies from antibiotic research.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> This further aggravated the problem of AMR. Another aspect of bacterial infection that had been given little attention to earlier is the phenomenon of ânoninheritedâ resistance to antibiotics. In this case, bacteria that are inherently susceptible to antibiotics are often phenotypically resistant to them.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The ability of bacteria to cause intracellular infections, form biofilms, and go into a metabolically inactive state contributes to this phenotypic ânoninheritedâ resistance. This noninherited resistance causes an additional burden to AMR and makes treatment more challenging.</div><div class="NLM_p">Among all the classes of approved antibiotics, the glycopeptide antibiotics had the highest longevity in the clinic. The advantage of this class of antibiotics was that they worked by binding to the substrate for peptidoglycan synthesis instead of an enzyme, which is prone to mutations, thereby leading to a decreased propensity of resistance. Vancomycin was reserved as an antibiotic of last resort for the treatment of complicated infections caused by multidrug-resistant Gram-positive bacteria which prevented the widespread development of resistance to it. It was not until almost three decades from vancomycinâs introduction in the clinic that resistance to it was observed. The emergence of resistance to this antibiotic raised alarms in the clinic and in the scientific community, calling for immediate measures to curb resistance. According to the list of priority pathogens published by WHO in 2017, vancomycin-resistant <i>Enterococcus faecium</i> and vancomycin-intermediate and resistant <i>S. aureus</i> (VISA and VRSA) come under the high priority category because the number of options for the treatment of vancomycin-resistant bacteria still remain limited.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p last">This perspective provides an overview of the current treatment options for vancomycin-resistant bacterial infections. Various approaches that have been developed to overcome acquired and noninherited resistance to vancomycin in bacteria have also been highlighted. Additionally, the strategies to increase the spectrum of activity of vancomycin against Gram-negative bacteria have been discussed.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Glycopeptide Progenitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36620" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36620" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Glycopeptide antibiotics constitute an important class of cell-wall biosynthesis inhibitors. They are glycosylated heptapeptides produced by a group of soil actinomycetes and are composed of a tricyclic or tetracyclic nonribosomal peptide core. The glycopeptides are categorized into five different structural subclasses, IâV, based on the amino acid residues for amino acids 1 and 3 in the heptapeptide. Vancomycin, actinoidin A, ristocetin A, teicoplanin, and complestatin are some molecules belonging to these subclasses, respectively.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Vancomycin (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) is the first molecule from this class of antibiotics, which was isolated by Eli Lilly in 1953 and introduced in clinic in 1958.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Teicoplanin is another clinically relevant molecule which was first reported in 1978 and approved for clinical use in 1988 in Europe.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Vancomycin contains five aromatic amino acids and two aliphatic amino acids, thus belonging to subclass I of glycopeptide antibiotics. Teicoplanin (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) contains seven aromatic amino acids and a long fatty acid chain linked to the glucosamine sugar, thus being a lipoglycopeptide. Clinically employed teicoplanin is a mixture consisting of teicoplanin A2-1 to A2-5, with A2-2 being the major component. These drugs, especially vancomycin, are mainstays in the treatment of life-threatening infections due to methicillin resistant <i>S. aureus</i> (MRSA).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Vancomycin has been recommended intravenously as a treatment for complicated skin structure infections, endocarditis, and bloodstream infections caused by MRSA. Despite the advantages of vancomycin, there were initially many side effects associated with its intravenous administration, including nephrotoxicity, red-man syndrome, and ototoxicity, which have now been resolved due to better purification techniques. It was associated with relatively poor pharmacokinetic (half-life = 4â11 h) and tissue penetrating properties as compared to other glycopeptide antibiotics. Sometimes, teicoplanin is preferred over vancomycin due to its better potency against various clinical isolates belonging to <i>Enterococcus</i>, <i>Staphylococcus</i>, and <i>Streptococcus</i> genera and its better tolerability.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> It has better pharmacokinetic properties (half-life = 30 h) and may be administered intravenously or intramuscularly.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Glycopeptide progenitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">3.  Mechanism of Action</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62367" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62367" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The glycopeptide antibiotics inhibit cell-wall biosynthesis by binding to the <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Ala moiety of the peptidoglycan precursors (lipid II and immature peptidoglycan), thus averting transglycosylation and transpeptidation in the later extracytoplasmic stages of cell wall biosynthesis (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). This complex of glycopeptide antibiotics with the <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Ala terminus is stabilized via five hydrogen bonds, hydrophobic forces, and van der Waals forces. Vancomycin is known to form back to back dimers in solution, which results in an improved binding affinity to the substrate. The binding constant of vancomycin with the <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Ala terminus is 4.4 Ã 10<sup>5</sup> M<sup>â1</sup>.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> However, unlike vancomycin, teicoplanin does not form dimers. Additional membrane-anchoring properties are imparted by the lipophilic moiety of teicoplanin which improves association and thus binding affinity with the substrate. This mechanism of action makes the glycopeptide antibiotics less susceptible to resistance as compared to the enzyme-targeting antibiotics, which are easily rendered ineffective due to genetic alterations. It was due to this unique mechanism of action that vancomycin enjoyed decades of resistance-free use.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Mechanism of action of vancomycin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">4.  Resistance Development</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83383" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83383" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The first instance of vancomycin resistance occurred in <i>Enterococcus faecium</i> in France in 1986.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In the USA, the rise of vancomycin-resistant Enterococci (VRE), a prolific colonizer, gained pace due to the ever-increasing use of vancomycin in hospital settings. In Europe, it happened in communities, probably due to overuse of avoparcin (another glycopeptide antibiotic, used as a growth promoter in livestock).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Later, in 1996, <i>S. aureus</i> with decreased susceptibility to vancomycin was first isolated from an infant patient admitted in a hospital in Japan.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> This vancomycin intermediate <i>S. aureus</i> (VISA) strain (Mu50) has been serving as a typical VISA strain with vancomycin minimum inhibitory concentration (MIC) of 8 Î¼g mL<sup>â1</sup> since isolation.</div><div class="NLM_p">The first report of high vancomycin resistance in <i>S. aureus</i>, which is known as vancomycin resistant <i>S. aureus</i> (VRSA), came in 2002 as a clinical isolate with MIC > 32 Î¼g mL<sup>â1</sup> accompanied by VRE (<i>vanA</i> positive, vancomycin resistance gene cluster), which was identified from a catheter-related infection of a hospitalized patient in USA.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> A strain of <i>S. aureus</i> is considered to be a hetero-VISA (hVISA) strain if it contains subpopulations of cells that grow on the <4 Î¼g mL<sup>â1</sup> vancomycin-containing BHI agar plate, whereas for VISA and VRSA, the MICs are 4â8 and 16 Î¼g mL<sup>â1</sup> in broth dilution, respectively.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The following section covers the details of the mechanisms of resistance to vancomycin, including the intrinsic resistance seen in Gram-negative bacteria.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">4.1.  Acquired Resistance</h3><div class="NLM_p">Acquired resistance to vancomycin is due to production of peptidoglycan precursors ending with <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Lac and <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Ser instead of <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Ala, which bind to vancomycin with highly diminished affinity (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). To date, 11 gene clusters that confer resistance to vancomycin in enterococci have been identified. The <i>vanA</i>, <i>vanB</i>, <i>vanD</i>, <i>vanF</i>, <i>vanI</i>, and <i>vanM</i> encode <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Lac, whereas clusters <i>vanC</i>, <i>vanE</i>, <i>vanG</i>, <i>vanL</i>, and <i>vanN</i> are linked to <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Ser resistance. The <i>vanA</i> and <i>vanB</i> gene clusters are the most commonly encountered genes.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> The production of these peptidoglycan precursors leads to a 1000-fold loss in binding affinity of vancomycin to the target peptide with association constant of the order of 10<sup>2</sup> M<sup>â1</sup>.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Acquired resistance to vancomycin; VSSA = vancomycin-susceptible <i>S. aureus</i>, VISA = vancomycin intermediate <i>S. aureus</i>, hVISA = heterovancomycin intermediate <i>S. aureus</i>, VRSA = vancomycin-resistant <i>S. aureus</i>, VRE = vancomycin-resistant Enterococci.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The <i>vanA</i> and <i>vanB</i> gene clusters comprise variants of three resistance genes namely <i>vanH</i>, <i>vanX</i>, and <i>vanA</i> and homologues which are essential for <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Lac mediated resistance.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The presence of vancomycin, teicoplanin, or other compounds that cause perturbation of cell wall precursors causes the VanS protein (a membrane-associated sensor kinase) to autophosphorylate. This, in turn induces phosphorylation of the VanR protein, a cytoplasmic response regulator and transcriptional activator. The VanR increases the expression of the <i>vanR</i> and <i>vanS</i> genes, binds to the <i>vanHAX</i> core, and regulates the expression of the resistance genes of the <i>vanA</i> and <i>vanB</i> clusters.<a onclick="showRef(event, 'ref17 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref19">(17,19)</a> The <i>vanH</i> genes encode a <span class="smallcaps smallerCapital">d</span>-lactate dehydrogenase that reduces pyruvate into <span class="smallcaps smallerCapital">d</span>-Lac and <i>vanX</i> encodes a <span class="smallcaps smallerCapital">d</span>,<span class="smallcaps smallerCapital">d</span>-dipeptidase that hydrolyzes <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Ala. <i>VanA</i> and its homologues encode a ligase that synthesizes <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Lac.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Additionally, <i>vanY</i>, encoding for a <span class="smallcaps smallerCapital">d</span>,<span class="smallcaps smallerCapital">d</span>-carboxypeptidase, is also present in the <i>vanA</i> and <i>vanB</i> clusters. It cleaves the <span class="smallcaps smallerCapital">d</span>-Ala at the <i>C</i>-terminus of late membrane-bound peptidoglycan precursors.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In <i>vanA</i> and <i>vanB</i> clusters, another gene <i>vanZ</i> encodes for a protein that confers low-level teicoplanin resistance.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In recent years, vancomycin-resistant bacteria have evolved to produce a single VanXY enzyme which is able to mediate both the activities of <span class="smallcaps smallerCapital">d</span>,<span class="smallcaps smallerCapital">d</span>-dipeptidase and <span class="smallcaps smallerCapital">d</span>,<span class="smallcaps smallerCapital">d</span>-pentapeptidase.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a></div><div class="NLM_p">Vancomycin-resistance in VISA results from the thickening of the bacterial cell wall. In most cases, the relevant mutated genes (<i>walkR</i> system, <i>yvqF/vraSR</i> system) appear to be directly or indirectly involved with the biosynthesis or metabolism of the two-component sensory regulatory systems that control transcription of genes in cell wall biosynthesis.<a onclick="showRef(event, 'ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28">(25â28)</a> However, mutations in the RNA polymerase gene <i>rpoB</i> were also detected in VISA isolates.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Apart from these genes, genes encoding Î²-lactamase have been shown to take part in the VISA phenotype.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> VISA isolates share properties such as excess of cell wall material, aberrant separation of daughter cells after cell division, and diminished rates of autolysis.<a onclick="showRef(event, 'ref32 ref33 ref34 ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34 ref35 ref36 ref37 ref38">(32â38)</a> The molecular mechanisms behind these altered phenomena still remain to be explained. VISA isolates are notable for the abnormally high quantities of synthesized peptidoglycan that result in irregularly shaped and thickened cell walls (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). A recent study on VISA strains (Mu50 lineage) suggested that activated arginine catabolism under regulation of two-component regulatory systems, VraSR and GraRS, is responsible for providing adenosine triphosphate (ATP) molecules and ammonia to compensate for increased cell wall biosynthesis in VISA.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Further investigations are necessary to attribute this phenomenon globally to VISA strains of different lineages.</div><div class="NLM_p">Additionally, in the thickened cell wall, decreased cross-linking of peptidoglycan strands were detected, which results in an increase of non-cross-linked <span class="smallcaps smallerCapital">d</span>-alanylâ<span class="smallcaps smallerCapital">d</span>-alanine side chains.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> Sieradzki et al. had shown that when vancomycin is added to the culture medium of VISA/VRSA laboratory mutant strains, it completely disappears. The bound vancomycin to <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Ala acts as a barrier to rest of the free vancomycin molecules to reach further inside.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a></div><div class="NLM_p last">Genotypic analysis of VRSA indicated that its resistance genes were acquired from VRE.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> In some strains of VRSA, resistance was found to be due to both cell wall thickening as well as modified pentapeptide termini (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">4.2.  Intrinsic Resistance in Gram-Negative Bacteria</h3><div class="NLM_p last">Gram-negative bacteria possess an additional outer membrane, which acts as a barrier for entry of hydrophilic molecules like the glycopeptides. Further, their high molecular weight and size prevents their permeation through porins in the outer membrane to reach the cell wall region. This results in the intrinsic resistance of Gram-negative bacteria to glycopeptides.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">5.  Current Therapeutics in the Clinic to Treat Vancomycin-Resistant Infections</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50335" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50335" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Currently, linezolid (Zyvox) and combination of quinupristin and dalfopristin (Synercid) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) are the antibiotics which have been approved for the treatment of infections caused by vancomycin-resistant <i>E. faecium</i>.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> They exhibit in vitro activity against vancomycin-resistant <i>E. faecalis</i> as well and have been employed for clinical studies.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Linezolid is an oxazolidinone antibiotic which was approved by the Food and Drug Administration (FDA) of the United States in 2000. It inhibits the formation of the initiation complex formed between the mRNA, <i>N</i>-formylmethionine tRNA (fMet-tRNA), and the 30S ribosomal subunit, thus inhibiting protein synthesis in bacteria. It has close to 100% bioavailability with slight toxicity in the form of myelosuppression, serotonin syndrome, neuropathy, and lactic acidosis.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Linezolid has been approved in the US for vancomycin-resistant <i>E. faecium</i> infections, including bacteremia, nosocomial and community-associated pneumonia (CAP) caused by methicillin-susceptible and resistant <i>S. aureus</i> (MSSA and MRSA), or multidrug-resistant <i>Streptococcus pneumoniae</i> and complicated and uncomplicated skin and skin structure infections (SSSi).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Quinupristin and dalfopristin belong to the streptogramin class of antibiotics and were approved as a combination therapy by the FDA in 1998. They work by inhibition of bacterial protein synthesis in the elongation phase. The combination therapy is provided as a 30:70 ratio of quinupristin (pristinamycin I A, a group B streptogramin) and dalfopristin (pristinamycin II A, a group A streptogramin). This combination received approval for use in adults for the treatment of infections caused by vancomycin-resistant <i>E. faecium</i> and for the treatment of complicated skin and skin structure infections (cSSSi) caused by MSSA or <i>Streptococcus pyogenes</i>. This combination is rarely employed for treatment due to its high toxicity.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Clinically approved antibiotics for the treatment of vancomycin-resistant bacteria.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In addition to these antibiotics, daptomycin (Cubicin), tedizolid (Silvextro), and tigecycline (Tygacil) have shown promising in vitro activity and good clinical results against vancomycin-resistant bacteria, although they have not been approved for use against these infections.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> They have been employed for the treatment of vancomycin-resistant infections off-label. Reduced susceptibility of vancomycin-resistant strains to linezolid and daptomycin was reported within a few years of their introduction.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> Considering the limited number of options for the treatment of infections caused by vancomycin-resistant bacteria, there is an urgent need for new antibacterial agents to fill in the clinical void.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">6.  Clinically Approved Semisynthetic Glycopeptides</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58838" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58838" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The next generation glycopeptides are semisynthetic derivatives of the naturally occurring glycopeptides, which show enhanced antibacterial activity against vancomycin-sensitive as well as vancomycin-resistant strains. Telavancin (Vibativ), dalbavancin (Dalvance), and oritavancin (Orbactiv) are the clinically approved semisynthetic glycopeptides (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). These are lipoglycopeptides which have lipophilic moieties linked to the core structure, just like teicoplanin. The long lipophilic moieties help with membrane-anchoring, which enhances binding affinity to the substrate, thus making them more potent than the naturally occurring glycopeptides. By virtue of their lipophilic character, they demonstrate better pharmacodynamic and pharmacokinetic properties.<a onclick="showRef(event, 'ref7 ref8 ref51'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref51">(7,8,51)</a> Telavancin consists of a (phosphomethyl) aminomethyl moiety substituted at the para position of the aromatic ring of the dihydroxyphenylglycine residue, to increase solubility and a decylaminoethyl moiety conjugated to the vancosamine sugar of vancomycin to impart membrane-anchoring function. It has enhanced bactericidal properties due to its membrane-disruptive mechanism of action and improved tissue distribution due to the (phosphomethyl) aminomethyl moiety with a terminal half-life of about 8 h.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52,53)</a> In 2009, it was approved by the FDA for the treatment of cSSSi and, later, in 2013, for treatment of hospital-acquired and ventilator-associated pneumonia caused by <i>S. aureus</i>. Dalbavancin is a semisynthetic variant of the teicoplanin family member, A40926. It has a terminally branched dodecyl chain, linked via an amide bond to the glucosamine of the parent drug. This mimics the fatty acyl moiety of teicoplanin which is important to impart membrane anchoring properties. It is also modified through the amidation of the <i>C</i>-terminus carboxyl with an <i>N</i>,<i>N</i>-dimethylpropylamine group. It shows an MIC of 0.1 Î¼g mL<sup>â1</sup> against VRE (VanB phenotype).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Dalbavancin was approved by the FDA in 2014 for the treatment of acute skin and skin-structure infections caused by MSSA and MRSA, vancomycin susceptible <i>E. faecalis</i>, and <i>Streptococci</i>. Its half-life ranges from 149 to 250 h.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Oritavancin is the <i>N</i>-aryl derivative of the natural product chloroeromomycin. Here, the chlorophenyl-benzyl group is attached to the parent glycopeptide by imine bond formation and subsequent reduction between the corresponding aldehyde and epivancosamine of chloroeremomycin. The chlorophenyl-benzyl group serves to be a good replacement for the fatty acyl groups present in the natural glycopeptides and confers good activity against VRE. In addition to the <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Ala terminus, oritavancin binds to the pentaglycyl bridging segment of the peptidoglycan of Enterococci, thus significantly inhibiting transpeptidation. Oritavancin exhibits MICs of <1 Î¼g mL<sup>â1</sup> against MRSA and vancomycin-resistant pathogens.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> It was approved by the FDA in 2014 for the treatment of infections caused by MSSA, MRSA, vancomycin-susceptible <i>E. faecalis</i>, and Streptococci.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Its half-life is 393 h.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Although these semisynthetic glycopeptides have been approved by the FDA, they are yet to be approved for the treatment of vancomycin-resistant infections.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Clinically approved semisynthetic glycopeptides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">7.  Recent Developments to Tackle Acquired Resistance</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33185" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33185" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">With growing resistance to vancomycin manifested in the form of VRE, VISA, and VRSA, there is an urgent need to develop novel antibiotics. Resistance to vancomycin can be tackled by either developing semisynthetic derivatives of the natural glycopeptide antibiotics to increase their potency or synthesizing and isolating novel antibacterial agents. Semisynthetic approaches involve structural modifications that could lead to an additional mechanism of action, which could result in improved efficacy and low propensity of resistance development. Antibacterial compounds with novel mechanisms of action are advantageous as they are not subject to cross-resistance with glycopeptides. The subsequent sections focus on the recent developments to combat vancomycin resistance through the semisynthesis and synthesis of novel vancomycin type antibiotics. Further, a brief account of other antibacterial agents which have shown activity against vancomycin-resistant bacteria has been given. Developments to tackle Gram-negative pathogens, remedy intracellular infections, and biofilm formation have also been focused upon.</div><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">7.1.  Modifications of Vancomycin</h3><div class="NLM_p">Vancomycin has many sites whose modification would not compromise its ability to bind to the target. This allows tailoring of the basic structure to incorporate moieties that enhance binding affinity or anchor and disrupt the membrane, thereby overcoming resistance. Thus, various functionalities like amino, hydroxyl, carboxyl, and the chloro substituents of the triaryl biether backbone have been exploited for modifications.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> In this section, we have focused on the strategies that have proved to be successful in tackling vancomycin-resistant bacteria (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Strategies to Overcome Acquired Resistance of Gram-Positive Bacteria to Vancomycin</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">strategy</th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">chemical modifications</th><th class="colsep0 rowsep0" align="center">activity (MIC)</th><th class="colsep0 rowsep0" align="center">refs</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(A) increasing binding affinity to the target peptide</td><td class="colsep0 rowsep0" align="left">âcore modifications</td><td class="colsep0 rowsep0" align="left">â¢[Î¨[CH<sub>2</sub>NH]Tpg<sup>4</sup>] vancomycin</td><td class="colsep0 rowsep0" align="left">VRE-VanA (31 Î¼g mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢[Î¨[C(âNH)NH]Tpg<sup>4</sup>] vancomycin (<b>2a</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanA (0.5 Î¼g mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢CBP derivative of [Î¨[C(âNH)NH]Tpg<sup>4</sup>] vancomycin (<b>2b</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanA (0.005 Î¼g mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢[Î¨[C(âS)NH]Tpg<sup>4</sup>] vancomycin</td><td class="colsep0 rowsep0" align="left">>32 Î¼g mL<sup>â1</sup></td><td class="colsep0 rowsep0" align="center">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢CBP derivative of [Î¨[C(âS)NH]Tpg<sup>4</sup>] vancomycin (<b>2c</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanB (2 Î¼g mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">âperipheral modifications</td><td class="colsep0 rowsep0" align="left">â¢cyclic and acyclic sugars conjugated with the <i>C</i>-terminus of vancomycin, e.g., lactobionic acidâvancomycin conjugate (<b>3</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanA (36 Î¼M)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢lipophilic lactobionic acidâvancomycin conjugate for membrane-anchoring properties, e.g., lactobionic acidâvancomycin conjugate with decyl moiety at the vancosamine (<b>4</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanA (0.7Â Î¼M)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">âhomomeric multivalent analogues</td><td class="colsep0 rowsep0" align="left">â¢Bis (vancomycin) carboxamides (<b>5a</b>â<b>5c</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanA (11 Î¼M)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢trivalent vancomycin derivatives using amide coupling at <i>C</i>-terminus (<b>6</b>)</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢multivalent vancomycin derivatives using ROMP (<b>7</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanB (2 Î¼g mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢dimers by bridging the saccharide domains of vancomycin in a back-to-back fashion using disulfide and olefin tether (<b>8</b>)</td><td class="colsep0 rowsep0" align="left">VRE (1â2 Î¼g mL<sup>â1</sup>) VISA (1 Î¼g mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢[Pt(en)<sub>2</sub>(vancomycin)<sub>2</sub>]<sup>2+</sup> (to impart structural rigidity and minimize loss in conformational entropy) (<b>9</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanA (0.8 Î¼g mL<sup>â1</sup>) VRE-VanB (0.28 Î¼g mL<sup>â1</sup>) VRE-VanC (0.03 Î¼g mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢vancomycin aglycon dimer containing two permanent positive charges in the linker (<b>10</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanA (48 Î¼M) VISA (0.1 Î¼M)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢lipophilic vancomycin aglycon dimer with an octyl chain (for membrane-anchoring properties) (<b>11</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanA (2.5 Î¼M) VISA (0.6 Î¼M)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢vancomycin homodimers and heterodimers by linking azide-functionalized <i>C</i>-terminus vancomycin derivatives with alkyne-functionalized <i>C</i>-terminus vancomycin derivatives (<b>12a</b>â<b>12c</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanB (0.8 Î¼g mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="left">â¯â¯â¯â¯â¯</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(B) incorporation of membrane-disruptive properties</td><td class="colsep0 rowsep0" align="left">âlipidation</td><td class="colsep0 rowsep0" align="left">â¢methyl ether derivatives of vancomycin aglycon by completely or partially methylating the aryl hydroxyl groups, e.g., tetramethyl ether analogue of vancomycin aglycon, also esterified at the <i>C</i>-terminus (<b>13</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanB (1.6 Î¼g mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢replacement of chloro groups of vancomycin with carbon substituents using SuzukiâMiyaura cross-coupling, e.g., vancomycin derivative by replacement of chloro group of residue-2 with styryl group (<b>14</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanB (2 Î¼g mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢positional isomers of lipidated/acylated vancomycin at hydroxyl groups prepared using Ï (methyl) histidine (Pmh)-based catalysts (<b>15</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanB (0.25â1 Î¼g mL<sup>â1</sup>) VRE-VanS (0.25â0.5 Î¼g mL<sup>â1</sup>) VRE-VanA (16 Î¼g mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢lipophilic vancomycinâsugar conjugates with lipophilic substitutions at the vancosamine and sugar moieties on the phenyl ring of the seventh amino acid (<b>16</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanA (1â2Â Î¼gÂ mL<sup>â1</sup>) VRE-VanB (â¤0.06 Î¼g mL<sup>â1</sup>) VISA (0.12Â Î¼gÂ mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">âconjugation of lipophilic moieties with a permanent positive charge</td><td class="colsep0 rowsep0" align="left">â¢attachment of lipophilic quaternary ammonium groups with alkyl chains (octyl and tetradecyl-best derivatives) (<b>17a</b>, <b>17b</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanA (0.7 Î¼M) VISA (0.36 Î¼M)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref81 ref82">(81,82)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢lipophilic vancomycinâsugar conjugates (membrane-disruptive properties and enhanced binding affinity) (<b>17c</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanA (0.09 Î¼M) VISA (0.10 Î¼M)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">âmodifications in the [Î¨[CH<sub>2</sub>NH]Tpg<sup>4</sup> vancomycin to confer multiple synergistic mechanisms of action</td><td class="colsep0 rowsep0" align="left">attachment of CBP group and peripheral quaternary ammonium salt to [Î¨[CH<sub>2</sub>NH]Tpg<sup>4</sup>] (<b>18</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanA (0.01â0.005 Î¼g mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">âvancomycinâpeptide conjugates</td><td class="colsep0 rowsep0" align="left">conjugation of vancomycin with moieties consisting of electrostatic effector peptide sequence (EEPS) and a hydrophobic membrane-insertive element (MIE) (<b>19a</b>â<b>19d</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanA (0.125 Î¼g mL<sup>â1</sup>) VRSA (0.05 Î¼g mL<sup>â1</sup>) VISA (0.03 Î¼g mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="left">â¯â¯â¯â¯â¯</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(C) conjugation of groups to enhance interactions with other components of the bacterial membrane and cell wall</td><td class="colsep0 rowsep0" align="left">âtargeting the pyrophosphate of the C<sub>55</sub>âlipid (bactoprenol)</td><td class="colsep0 rowsep0" align="left">conjugation of dipicolyl-1,6-hexadiamine (Dipi) to the <i>C</i>-terminus of vancomycin (<b>20</b>)</td><td class="colsep0 rowsep0" align="left">VRE-VanB (1.5 Î¼M) VISA (1 Î¼M) VRE-VanA (2 Î¼M)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">âtargeting saccharides of the cell wall</td><td class="colsep0 rowsep0" align="left">tethering benzoxaborole group to vancomycin (<b>21</b>)</td><td class="colsep0 rowsep0" align="left">VISA (1â2Â Î¼M)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></td></tr></tbody></table></div></div><div id="sec7_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13">7.1.1.  Increasing Binding Affinity to the Target Peptides</h4><div class="NLM_p">Approaches to enhance the binding affinity of vancomycin to the target peptide (<span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Ala and <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Lac) include modifications to the peptide backbone and periphery to increase hydrogen-bonding interactions and the development of homomeric multivalent analogues of the drug. All approaches exhibited promising results.</div><div id="sec7_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i14" class="anchor-spacer"></div><h5 class="article-section__title" id="_i14">7.1.1.1.  Modifications of the Peptide Core</h5><div class="NLM_p">Modifications at different amino-acid residues of vancomycin have been made in order to make up for the lost binding affinity. These include modifications of residue-1 (<span class="smallcaps smallerCapital">l</span>-leucine), residue-3 (<span class="smallcaps smallerCapital">l</span>-aspargine), and residue-4 (dihydroxyphenylglycine), to name a few.<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a> These strategies rely on total synthesis of the compounds rather than small manipulations in the parent compound, thus presenting significant synthetic challenges.</div><div class="NLM_p">In the past, it had been established that lone pairâlone pair repulsions between vancomycin and the mutated target peptide, <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Lac (100-fold contribution), and loss in H-bonding between vancomycin and the mutated target peptide (10-fold contribution) are both responsible for the lost binding affinity. This indicated that the designs that emphasize on eliminating the destabilizing lone pair repulsion between the vancomycin residue-4 carbonyl and the <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Lac ester oxygen would significantly increase the binding affinity.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Therefore, vancomycin analogues with residue-4 pocket modifications were developed by Boger and co-workers thereafter (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Initially, an analogue, [Î¨[CH<sub>2</sub>NH]Tpg<sup>4</sup>] vancomycin aglycon (<b>1a</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) containing a methylene group instead of the residue-4 amide carbonyl was developed.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Although this design relied on the strength of only four hydrogen bonds, it retained activity against the vancomycin-sensitive strains. This analogue demonstrated a 40-fold increase in affinity for <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Lac and a 35-fold reduction in affinity for <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Ala as compared to vancomycin.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Enhancement of binding affinity through core modifications.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Subsequently, the group engineered a reverse hydrogen bonding group by introducing an amidine group in place of the carbonyl at residue-4 of vancomycin.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> This [Î¨[C(âNH)NH]Tpg<sup>4</sup>] vancomycin aglycon (<b>1b</b>) binds to both <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Ala and the mutated ligand <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Lac with high affinity.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> A thioamide analogue of the vancomycin aglycon was also synthesized (<b>1c</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). To incorporate both enhanced binding affinity and sufficient hydrophobicity in the same molecule, Bogerâs group developed the (4-chlorobiphenyl) methyl (CBP) derivative of <b>2a</b> (<b>2b</b>).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Furthermore, the corresponding CBP derivative of the thioamide analogue, [Î¨[C(âS)NH]Tpg<sup>4</sup>] vancomycin was also prepared (<b>2c</b>).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> The binding constant of <b>1c</b> was determined which clearly suggested an alternative mechanism of action conferred by the CBP group in <b>2c</b>. The antibacterial efficacies of the above-mentioned vancomycin analogues are given in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>. The results indicate a synergistic effect between the pocket and peripheral modifications in vancomycin. The CBP group inhibits transglycosylation and thus cell wall biosynthesis, independent of <span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Ala/<span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Lac binding.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div></div><div id="sec7_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i15" class="anchor-spacer"></div><h5 class="article-section__title" id="_i15">7.1.1.2.  Increasing the Scope of H-Bonding with the Pentapeptide by Peripheral Modifications</h5><div class="NLM_p">A water molecule bridges the H-bonding interaction between the <i>C</i>-terminus of vancomycin and the peptide nitrogen atom of the ligand.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> It was thus conjectured that modification of the <i>C</i>-terminus with moieties that can form direct hydrogen bonds with the N atom of the target peptide, also present in the mutated pentapeptide terminus, could stabilize the vancomycinâligand complex. This would further enhance the binding affinity. In a strategy developed in our group, cyclic, acyclic, and cyclicâacyclic sugars were conjugated to the <i>C</i>-terminus of vancomycin.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The sugars provide additional H-bond interactions and thus enhance the binding affinity to the mutated target peptide while retaining affinity with the sensitive terminus. Among the synthesized compounds, the derivatives with lactobionic acid and gluconic acid conjugated to the carboxylic acid group of vancomycin exhibited highest affinity to the mutated pentapeptide terminus. The optimized compound, lactobionic acid-vancomycin conjugate (<b>3</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) showed 170-fold higher affinity for the model peptide <i>N</i>,<i>N</i>-diacetyl-Lysâ<span class="smallcaps smallerCapital">d</span>-Alaâ<span class="smallcaps smallerCapital">d</span>-Lac than vancomycin.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Enhancement of binding affinity through peripheral modifications.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To further improve the activity, alkyl chains were appended to the amino group of vancosamine in the optimized vancomycinâlactobionic acid conjugate to yield the lipophilic sugarâvancomycin conjugates.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> This was expected to confer additional membrane-anchoring properties as seen in teicoplanin and the second-generation glycopeptides. The derivative with a decyl chain was selected as the optimized compound (<b>4</b>). MICs for this compound can be referred to in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>. The 1000-fold increase in activity of the lipophilic vancomycinâsugar conjugate highlights the importance of synergism shown by additional hydrogen bonding to the substrate and membrane-anchoring properties. This strategy paves a way for a rational approach in the development of novel glycopeptide antibiotics.</div></div><div id="sec7_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i16" class="anchor-spacer"></div><h5 class="article-section__title" id="_i16">7.1.1.3.  Development of Homomeric Multivalent Analogues</h5><div class="NLM_p">Except for teicoplanin, glycopeptide antibiotics are known to form dimers through hydrogen bonding and hydrophobic interactions.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Vancomycin dimerizes through four amideâamide hydrogen bonds. This noncovalent dimerization is co-operative with ligand binding and results in stronger binding than the monomers. The self-association of vancomycin in solution is weak (<i>K</i><sub>dim</sub> = 700 M<sup>â1</sup>), suggesting that noncovalent self-association might not play a significant role in its biological action.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Employing this information to increase the binding affinity of vancomycin to the mutated target peptide, scientists developed various multivalent homomeric analogues to increase the binding affinity. This strategy was one of the first in addressing the problem of vancomycin resistance seen in bacteria. The various designs have been explained in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and illustrated in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>.<a onclick="showRef(event, 'ref66 ref67 ref68 ref69 ref70 ref71 ref72 ref73 ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref66 ref67 ref68 ref69 ref70 ref71 ref72 ref73 ref74 ref75">(66â75)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0009.jpeg" id="GRAPHIC-d7e1819-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Enhancement of binding affinity through development of multivalent homomeric analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0008.jpeg jm-2018-01093n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec7_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17">7.1.2.  Incorporation of Membrane-Disruptive Properties</h4><div class="NLM_p">Teicoplanin and second-generation glycopeptides highlighted the importance of membrane-anchoring properties served by hydrophobic chains. In the previous section, we have already seen glimpses of lipophilic vancomycinâsugar conjugates and lipophilic vancomycin dimers to impart membrane-anchoring properties. Taking a cue from these, numerous lipo-vancomycin derivatives were developed by various groups, although their membrane-disruptive properties were not investigated (<b>13</b>â<b>16</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).<a onclick="showRef(event, 'ref76 ref77 ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref76 ref77 ref78 ref79">(76â79)</a> Reports on the introduction of lipophilic moieties to glycopeptides are well documented in literature.<a onclick="showRef(event, 'ref58 ref80'); return false;" href="javascript:void(0);" class="ref ref58 ref80">(58,80)</a> Molecules containing lipophilic moieties with a permanent positive charge have been known to show antibacterial properties through enhanced interactions with the negatively charged bacterial membrane. Incorporating this idea into glycopeptide antibiotics, membrane-disrupting lipophilic cationic vancomycin derivatives were developed (<b>17</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).<a onclick="showRef(event, 'ref81 ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref81 ref82 ref83">(81â83)</a> This strategy was coupled with other strategies that enhance binding affinity for the target peptide to develop highly potent vancomycin derivatives by Bogerâs group and Haldarâs group (<b>17c</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>; <b>18</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>). Bogerâs group recently incorporated two peripheral modifications into the previously synthesized [Î¨[CH<sub>2</sub>NH]Tpg<sup>4</sup>] vancomycin (<b>18</b>).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The two peripheral modifications involved the introduction of a CBP group to the pendant disaccharide and a membrane-active component to the <i>C</i>-terminus through amidation reaction. The first modification could inhibit transglycosylation and thus cell wall biosynthesis more effectively. The second modification conferred membrane-active properties to the glycopeptide. Both modifications were coupled in [Î¨[CH<sub>2</sub>NH]Tpg<sup>4</sup>] vancomycin to yield the final compound with a CBP group and a peripheral quaternary ammonium salt, which showed activity against VRE-Van A (<b>18</b>). The compound was >10-fold more potent than the CBP derivative alone, >1000-fold more potent than the [Î¨[CH<sub>2</sub>NH]Tpg<sup>4</sup>] vancomycin pocket analogue, and a striking >10000-fold more potent than vancomycin itself. Recently, in another design, vancapticins were developed by Blaskovich et al. wherein vancomycin was conjugated with moieties that incorporate membrane-disruptive properties. The membrane-interactive moiety consisted of an electrostatic effector peptide sequence (EEPS) and a hydrophobic membrane-insertive element (MIE) (<b>19</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> The details of the various derivatives which exhibited activity against vancomycin-resistant strains using this strategy have been covered in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>, and <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Lipidation without investigation of membrane-interaction properties (<b>13</b>â<b>16</b>) and incorporation of membrane-disruptive properties (<b>17</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Incorporation of membrane-disruptive properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">7.1.3.  Conjugation of Groups to Enhance Interactions with Other Components of the Bacterial Membrane and Cell Wall</h4><div class="NLM_p">Various other components of the bacterial cell membrane can be targeted to inhibit the process of cell-wall biosynthesis. The phosphate group of the C<sub>55</sub>-lipid (bactoprenol) in the bacterial membrane helps in the transport of the precursor <i>N</i>-acetylglucosamine-<i>N</i>-acetylmuramic acid pentapeptide (GlcNAc-MurNAc pp) from the cytoplasm to the exterior of the cell membrane to further the formation of the peptidoglycan chain. Because the target for vancomycin lies in the vicinity of the membrane, conjugating moieties that can bind to the other components of the membrane is an interesting strategy to enhance activity. In an effort to restore the activity of vancomycin in resistant strains, a Zn<sup>2+</sup> binding ligand, dipicolyl-1,6-hexadiamine (Dipi) was conjugated to the <i>C</i>-terminus of vancomycin (Dipi-van) in our lab (<b>20</b>, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A).<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> The idea was that the dipicolyl amine moiety would capture zinc ions (Zn<sup>2+</sup>), which could be released from apoptotic cells at the site of bacterial infection with high selectivity. The Dipi-van-Zn<sup>2+</sup> could then complex with the pyrophosphate of the cell membrane lipids (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>B). The enhanced inhibition of cell-wall biosynthesis was confirmed by the intracellular accumulation of the precursor, UDP-<i>N</i>-acetylmuramyl-pentadepsipeptide (UDPMurNAc-pp) (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>C). Dipi-van exhibited a 375-fold and 160-fold increase in activity against VRE<sub>m</sub> (VanA phenotype, <i>E. faecium</i>) and VRE<sub>s</sub> (VanB phenotype, <i>E. faecalis</i>) as compared to vancomycin, respectively (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A). Further, this compound reduced the bacterial burden in mice in VRE kidney infection (5 log CFU g<sup>â1</sup> reduction). It did not show any increase in MIC when bacteria were subjected to serial passages of the compound indicating no susceptibility to resistance development.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A) Structure of Dipi-van. (B) Complex formation of Dipi-van-Zn<sup>2+</sup> with geranyl pyrophosphate which was identified through mass spectrometry. (C) Identification of intracellular UDPMurNAc-pp in the presence of Dipi-van by monitoring absorbance at Î» = 260 nm. Parts B and C reproduced with permission from ref <a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a>. Copyright 2016 John Wiley and Sons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Furthermore, components of the cell wall like the saccharides can also be targeted to enhance the activity of the drug. In another approach to enhance activity by targeting other components of the cell wall, Zhang et al. tethered a benzoxaborole group to the <i>C</i>-terminus of vancomycin, eremomycin, and teicoplanin aglycons, as well as to vancomycin, or to the <i>N</i>-terminus of vancomycin and teicoplanin aglycon, or to the amine of vancosamine and <i>N</i>-terminus of vancomycin.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> The rationale behind this was that the benzoxaborole group would form additional interactions with the 1,2- and 1,3-diols of saccharides coating the cell surface and therefore enhance the efficacy of the drugs (<b>21</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>).</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Conjugation of groups to enhance interactions with cell-wall components (<b>21</b>) and vancomycinânisin hybrid for multiple-target binding (<b>22</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">7.2.  Glycopeptide Hybrids with Other Antibacterials</h3><div class="NLM_p last">Antibiotic hybrids provide an interesting approach toward tackling resistance development as they combine the mechanisms of action of different antibiotics. Such hybrids could delay resistance development as genetic alterations in two biological targets are less feasible. In one report, vancomycinânisin conjugates were developed by linking the <i>C</i>-terminus or <i>N</i>-terminus of vancomycin to the <i>C</i>-terminus of nisin through variable linkers using click chemistry. Nisin is an antimicrobial peptide whose <i>N</i>-terminus is known to bind to the pyrophosphate of lipid II. It was conjectured that through the combination of both moieties in a single molecule, simultaneous lipid II binding of the two parts could lead to increased affinity through bivalency or chelate effect and reinstate the activity of vancomycin to the resistant strains. One of the developed conjugates showed a 40-fold increase in activity against VRE (<b>22</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>).<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Similarly, it was speculated that conjugating a glycopeptide with a Î²-lactam would result in enhanced antibacterial activity due to the combined mode of action of Î²-lactams and glycopeptides for cell wall biosynthesis inhibition. With this concept, Theravance Biopharma, Inc., developed vancomycinâcephalosporin hybrids. Out of these, TD-1607 is currently in phase II clinical trials.<a onclick="showRef(event, 'ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref88 ref89">(88,89)</a> Another such hybrid, Cefilavancin (TD-1792) was reported to enter phase III clinical trials in 2015 but no development has been reported thereafter. These derivatives exhibited enhanced bactericidal activity but were not effective against vancomycin-resistant strains.</div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">8.  Tackling Infections Caused by Gram-Negative Bacteria</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23144" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23144" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Gram-negative bacteria are intrinsically resistant to vancomycin due to the presence of an additional outer membrane composed of lipopolysaccharide. According to the list of priority pathogens published by the WHO in 2017, all the highly critical pathogens are Gram-negative bacteria. Given the dearth of antibiotics to treat infections caused by Gram-negative bacteria, new strategies have to be devised. Various strategies have been employed to extend the spectrum of activity of vancomycin to treat such infections (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Such strategies are welcome as they would provide a new approach to tackle Gram-negative bacteria. This section gives an overview of these strategies.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Strategies To Tackle Intrinsic Resistance of Gram-Negative Bacteria to Vancomycin</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">strategy</th><th class="colsep0 rowsep0" align="center">examples</th><th class="colsep0 rowsep0" align="center">activity</th><th class="colsep0 rowsep0" align="center">refs</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(A) incorporation of membrane-active properties</td><td class="colsep0 rowsep0" align="left">cationic lipophilic derivative of vancomycin (<b>17b</b>)</td><td class="colsep0 rowsep0" align="left"><i>A. baumannii</i>-R4942 (MICÂ =Â 3 Î¼M) <i>E. cloacae</i>: NDM-1 (MICÂ =Â 12.5Â Î¼M) <i>P. aeruginosa</i>-R590 (MICÂ =Â 6.1Â Î¼M)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">â¯â¯â¯â¯â¯</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(B) adjuvant therapy</td><td class="colsep0 rowsep0" align="left">â¢employment of silver (Ag<sup>+</sup>) as an adjuvant with vancomycin</td><td class="colsep0 rowsep0" align="left">90% survival of mice in an acute mouse peritonitis <i>E. coli</i> infection model</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢polymyxinâtobramycin hybrids as adjuvant with vancomycin</td><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i> (MIC of vancomycin reduced to 0.5Â Î¼gÂ mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢colistin as an adjuvant with teicoplanin</td><td class="colsep0 rowsep0" align="left"><i>A. baumannii</i> (MIC of teicoplanin â¤2Â Î¼gÂ mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢colistin as an adjuvant with telavancin</td><td class="colsep0 rowsep0" align="left">MIC of telavancin <1 Î¼g mL<sup>â1</sup> against clinical isolates</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢nitrofurantoin as an adjuvant with vancomycin</td><td class="colsep0 rowsep0" align="left"><i>E. coli</i> (MIC of vancomycinÂ =Â 12.5 Î¼g mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢trimethoprim as an adjuvant with vancomycin</td><td class="colsep0 rowsep0" align="left"><i>E. coli</i> (MIC of vancomycinÂ =Â 6.25 Î¼g mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">â¯â¯â¯â¯â¯</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(C) vancomycin derivative as metallo-Î²-lactamase inhibitor</td><td class="colsep0 rowsep0" align="left">Zn<sup>2+</sup> binding Dipi-van as a metallo-Î²-lactamase inhibitor used in combination with Meropenem (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>A)</td><td class="colsep0 rowsep0" align="left">MIC of Meropenem reduced to 3.15 Î¼g mL<sup>â1</sup> against NDM-1 producing Gram-negative pathogens</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">â¯â¯â¯â¯â¯</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(D) other approaches</td><td class="colsep0 rowsep0" align="left">â¢loading vancomycin into fusogenic liposomes composed of phospholipidâcholesterol hemisuccinate mixture</td><td class="colsep0 rowsep0" align="left"><i>E. coli</i> and <i>A. baumannii</i> (MICÂ =Â 6 Î¼gÂ mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">â¢conjugation of vancomycin with gold nanoparticles</td><td class="colsep0 rowsep0" align="left"><i>E. coli</i> (8Â Î¼gÂ mL<sup>â1</sup>)</td><td class="colsep0 rowsep0" align="center"><a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a></td></tr></tbody></table></div></div><div id="sec8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">8.1.  Membrane-Active Semisynthetic Derivatives of Vancomycin</h3><div class="NLM_p last">The cationic lipophilic analogue of vancomycin (<b>17b</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) displayed remarkable activity against Gram-negative pathogens, including carbapenem-resistant clinical isolates with MICs ranging from 1.2 to 6.1 Î¼M.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> It could permeabilize and depolarize the outer and inner cell membranes of <i>E. coli</i>, proving that the compounds compromised the cell membrane integrity. Compound <b>17b</b> did not induce resistance in <i>A. baumannii</i>, although the currently used antibiotic, colistin showed an increase in MIC from the fifth passage of antibiotic exposure itself. It exhibited good in vivo antibacterial activity against <i>A. baumannii</i> in mouse thigh infection model (3 log CFU g<sup>â1</sup> reduction in bacterial load). Thus, conjugation of cationic lipophilic moieties with a permanent positive charge was proved to be effective even in clinically relevant Gram-negative pathogens due to an additional membrane-disruptive mechanism of action.</div></div><div id="sec8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">8.2.  Adjuvant Therapy</h3><div class="NLM_p last">Another approach to tackle resistance against vancomycin is through âadjuvant therapyâ or âcombination therapyâ. An adjuvant is an agent that modifies the effect of other agents at comparatively lower concentrations. Small molecules and nanoparticles have been used as adjuvants to potentiate the activity of vancomycin or other glycopeptides against the resistant strains of bacteria. Silver has been known to exhibit antibacterial activity through permeabilization of the bacterial membrane. Induced membrane permeability could sensitize various intrinsically resistant strains of bacteria including Gram-negative pathogens to vancomycin. Collinsâ group reported in 2013 that on using silver as an adjuvant, Gram-negative bacteria were sensitized to vancomycin in vitro.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> They demonstrated that Ag<sup>+</sup> potentiated vancomycin against <i>E. coli</i> in a mouse peritonitis model. More recently, polymyxinâtobramycin antimicrobial hybrids, which show potent antibacterial activity (MIC of 2â16 Î¼g mL<sup>â1</sup> or 0.7â5.7 Î¼M) against multidrug resistant/extensively drug resistant (MDR/XDR) <i>P. aeruginosa</i> strains have also been demonstrated to act as an adjuvant with various antibiotics against <i>P. aeruginosa</i>.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> The individual components of the hybrid were conjugated through copper-catalyzed alkyne azide click reaction (CuAAC), a 1,3-dipolar cycloaddition followed by removal of the protecting groups. Vancomycin, which is ineffective against Gram-negative bacteria due to the impermeability of the outer membrane, was potentiated in <i>P. aeruginosa</i> strains due to the synergistic membrane-disruptive activity of the antimicrobial hybrid. The synergistic mechanism was proposed due to fractional inhibitory concentration index (FICI) value of <0.5 in the case of vancomycin. For one of the <i>P. aeruginosa</i> strains, activity of vancomycin improved by 1024-fold (MIC = 0.5 Î¼g mL<sup>â1</sup>) on using the hybrid as an adjuvant. It has also been reported that Zn (II) mediates vancomycin polymerization and is able to potentiate its activity against vancomycin-resistant bacteria.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Glycopeptides have also been used with other antibiotics in combination therapies. In one of these reports, the in vitro activity of teicoplanin in combination with colistin against multidrug-resistant strains of <i>A. baumannii</i> has been proved.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> The combination of teicoplanin and colistin was found to be bactericidal. FICIs of <0.5 indicated significant in vitro synergy. Using the ETest method, it was observed that the MIC of teicoplanin fell from 256 to â¤2 Î¼g mL<sup>â1</sup> at subinhibitory concentrations of colistin. In another report, combination of the lipoglycopeptide, telavancin, with colistin exhibited good activity against Gram-negative bacterial pathogens.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> The in vitro combination was tested against 66 clinical isolates of Gram-negative pathogens and displayed noticeable synergy with an FICI value of <0.5 against the majority of colistin-susceptible enterobacteria. However, against <i>P. aeruginosa</i> and strains with colistin resistance, only limited effects were seen. Using an Etest assay, it was found that the activity of telavancin was enhanced from >32 to <1 Î¼g mL<sup>â1</sup> for 35% of the clinical isolates by relatively low concentrations of colistin (0.25â0.75 Î¼g mL<sup>â1</sup>). In another study, vancomycin exhibited strong synergistic interactions with nitrofurantoin and trimethoprim against <i>E. coli</i> with vancomycin concentrations as low as 12.5 Î¼g mL<sup>â1</sup> in the presence of 3.5 Î¼g mL<sup>â1</sup> of nitrofurantoin and 6.25 Î¼g mL<sup>â1</sup> in the presence of 0.2 Î¼g mL<sup>â1</sup> of trimethoprim.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></div></div><div id="sec8_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24">8.3.  Vancomycin Derivative as Metallo-Î²-lactamase Inhibitor</h3><div class="NLM_p">One of the reasons why antibiotics are rendered ineffective in resistant bacteria is inactivating enzymes. New-Delhi-Î²-lactamase-1 (NDM-1) producing Gram-negative bacteria are resistant to Î²-lactams including carbapenems. The metallo-Î²-lactamase enzyme is responsible for the inactivation of Î²-lactams. In our lab, we have developed a semisynthetic vancomycin derivative, Dipi-van (<b>20</b>, <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>A), which is able to penetrate the outer membrane of Gram-negative bacteria and inactivate the metallo-Î²-lactamase enzyme by depleting zinc ions (Zn<sup>2+</sup>) from the active site of the enzyme. As a result of this, the derivative at a concentration of 28.7 Î¼g mL<sup>â1</sup> was able to resensitize NDM-1 producing Gram-negative pathogens to Meropenem at a concentration of 3.1 Î¼g mL<sup>â1</sup> (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>B). The dipicolyl moiety was responsible for depletion of the zinc ions and inhibition of the NDM-1 enzyme activity (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>C). The synergistic effect of the combination was tested against NDM-1 positive <i>K. pneumoniae</i> in a sepsis infection model. The combination reduced the bacterial burden by 3â4 Log CFU g<sup>â1</sup> in the liver, lungs, kidneys, and spleen.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Thus, vancomycin derivatives like Dipi-van can act as resistance breakers and restore the activity of obsolete drugs against resistant bacteria, including NDM-1 producing bacteria.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. (A) Combination of NDM-1 inhibitor (Dipi-van) and Î²-lactam antibiotic (Meropenem). (B) Antibacterial activity of combination of Meropenem and Dipi-van and (C) NDM-1 enzyme inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec8_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">8.4.  Other Approaches</h3><div class="NLM_p last">In addition to the aforementioned membrane-active approaches and adjuvant therapy, liposomal formulations of vancomycin have shown promising results against Gram-negative pathogens. It was found that upon loading vancomycin into fusogenic liposomes composed of phospholipidâcholesterol hemisuccinate mixture, MIC values as low as 6 Î¼g mL<sup>â1</sup> were obtained against clinical isolates of <i>E. coli</i> and <i>A. baumannii</i>.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> In another instance, vancomycin was conjugated to gold nanoparticles to yield a polyvalent inhibitor. These Auâvancomycin conjugates were found to exhibit some activity against <i>E. coli</i> with an MIC of 8 Î¼g mL<sup>â1</sup>.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a></div></div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">9.  Treatment of Intracellular Infections, Stationary-Phase Bacteria, and Disruption of Biofilms</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Bacteria are known to establish mature biofilms on medical implants and host tissue, which is an important factor in the persistence of chronic infections. The formation of a biofilm reduces the susceptibility to antimicrobials, thus making treatment difficult. Lipophilic semisynthetic derivatives of vancomycin and other glycopeptides have exhibited good outcomes against stationary-phase and biofilms of <i>S. aureus</i>. Oritavancin induced membrane depolarization, increased membrane permeability, and caused defects in stationary-phase MSSA. Furthermore, oritavancin was successful in sterilizing biofilms of MSSA, MRSA, and VRSA at minimal biofilm eradication concentrations (MBECs) between 0.5 and 8 Î¼g mL<sup>â1</sup>.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Telavancin was also found to be active against <i>Staphylococcus</i> and <i>Enterococcus</i> strains of bacteria embedded in biofilms. MBEC was found to be 0.125â2 Î¼g mL<sup>â1</sup>. It inhibited biofilm growth at concentrations below its MIC.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> On the contrary, vancomycin did not demonstrate the same activity (MBEC > 512 Î¼g mL<sup>â1</sup>) against <i>S. aureus</i> and <i>E. faecalis</i>. In fact, there are reports wherein vancomycin has been shown to promote biofilm formation in Staphylococci at sublethal doses.</div><div class="NLM_p">The lipophilic vancomycin conjugates and lipophilic vancomycinâsugar conjugates synthesized in our lab have already been discussed in this Perspective. As a highlight of this report, the optimized lipophilic derivative, <b>17b</b>, and the lipophilic vancomycinâsugar conjugate <b>17c</b> were found to disrupt bacterial biofilms of MRSA (>5 log CFU mL<sup>â1</sup> reduction of cell viability in preformed biofilms at 5 Î¼M).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> These results demonstrate a significant activity of oritavancin, telavancin, and membrane-active derivatives of vancomycin against <i>S. aureus</i> in phases of growth that exhibit noninherited resistance to other antimicrobial agents.</div><div class="NLM_p last">Osteomyelitis and endocarditis are intracellular infections caused by <i>S. aureus</i>. These infections are difficult to eradicate as intracellular localization allows bacteria to be protected from the host immune defenses as well as from the action of many antimicrobials. Oritavancin has been able to show intracellular bactericidal effects (2 log reduction in bacterial load) against <i>S. aureus</i> in a model of THP-1 macrophages.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Telavancin, another lipoglycopeptide, has exhibited better cellular pharmacokinetics in mouse macrophages and rat embryonic fibroblasts, as compared to vancomycin.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> More recently, the intracellular activity of the cationic lipophilic vancomycin derivative, <b>17a</b> (<b>17</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>) was tested against MRSA in RAW macrophages.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> This compound exhibited bactericidal activity against intracellular MRSA in a time- and concentration-dependent manner. The intracellular activity was found to be significantly higher than that of vancomycin and linezolid. These findings suggest that lipoglycopeptides are more potent against intracellular infections caused by <i>S. aureus</i> and MRSA in comparison to vancomycin. In addition to these, a novel antibodyâantibiotic conjugate (AAC) was able to eliminate intracellular MRSA.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> The conjugate consisted of an anti-<i>S. aureus</i> antibody (THIOMAB) directed against the wall-techoic acids (anionic glycomers connected to the peptidoglycan of Gram-positive bacteria), covalently linked to a rifalogue (rifamycin derivative) through a cathepsin-cleavable linker. The Î²-<i>N</i>-acetylglucosamine cell wall techoic acid (Î²-GlcNAc-WTA) antibody is an attractive candidate for designing an AAC as its antigen is highly abundant in <i>S. aureus</i> during infection and is absent in mammalian cells.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> The AAC acts like a prodrug which upon opsonizing extracellular <i>S. aureus</i> followed by internalization by cells leads to killing of intracellular <i>S. aureus</i> by active release of the antibiotic. The antibiotic was activated only in the proteolytic environment of the phagolysosome and was superior to vancomycin in the treatment of intracellular MRSA. The THIOMAB AAC was found to be stable in in vivo mice models.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Although considerable progress is seen in the approaches to treat such complicated infections, more research still needs to be dedicated toward these aspects.</div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">10.  Other Classes of Molecules That Can Solve the Problem</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46500" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46500" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Another approach adopted by researchers is to design or identify new antibacterials with different mechanisms of action to fight the battle against drug-resistant bacteria. Compounds with new mechanisms of action can be exploited without any combination or attachment to glycopeptides, thus avoiding cross-resistance. This section covers few of the recent advances in new antibacterial compounds to treat vancomycin-resistant bacteria. Only some of these compounds have been discussed as a detailed literature survey on this topic is beyond the scope of this Perspective.</div><div class="NLM_p last">Teixobactin is a new antibacterial depsipeptide which is a potential clinical candidate for the treatment of vancomycin-resistant bacteria. It is a cyclic undeca depsipeptide which was isolated by the cultivation of <i>Eleftheria terrae</i> (Aquabacteria) in their natural environment in the presence of certain special growth factors via the use of iChip culturing technology.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> It was identified as a potential antibiotic against various resistant strains of Gram-positive bacteria in 2015.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Teixobactin shows good activity against vancomycin-resistant <i>Enterococcus faecalis</i> and vancomycin-resistant <i>E. faecium</i> (MIC = 0.5 Î¼g mL<sup>â1</sup>). It was found to be superior to vancomycin in killing late exponential phase populations of <i>S. aureus</i>. It also retained bactericidal activity against VISA.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Teixobactin is an example of a novel peptidoglycan inhibitor known to inhibit cell wall biosynthesis and techoic acid biosynthesis by binding to lipid I, lipid II, and lipid III (precursor for wall techoic acid biosynthesis). This suggests that it would be less susceptible to resistance development. Nitrofuranyl benzimidazoles have also exhibited good antimicrobial activity against VRE, with MICs as low as 1 Î¼g mL<sup>â1</sup>.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Moreover, cephalosporins have also shown good activity against vancomycin-resistant strains with MICs as low as <0.5 and 1 Î¼g mL<sup>â1</sup> against VRE and VRSA, respectively.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Oxadiazoles, another class of antibacterials, have displayed efficacy against VRE (MICs = 1â4 Î¼g mL<sup>â1</sup>).<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Another class of molecules that holds promise are antimicrobial peptides (AMPs), which are known to kill bacteria through membrane disruption. In 2004, Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide, showed decent antibacterial activity against vancomycin-resistant <i>E. faecium</i> (MIC = 2â16 Î¼g mL<sup>â1</sup>). More recently, other antimicrobial peptides have been reported. For example, a novel bacteriocin from 478 <i>E. faecalis</i> strain, isolated from human feces, has demonstrated high antibacterial activity against several multidrug-resistant enterococci (MDRE) and vancomycin-resistant enterococci (VRE) strains.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Among 68 clinical isolates of MDRE and VRE, this bacteriocin was able to inhibit 28 (41.1%). Another antimicrobial peptide that has shown promising results against vancomycin-resistant bacteria is Lugdunin, a novel thiazolidine-containing cyclic peptide antibiotic. It is a nonribosomally synthesized biologically active compound which is produced by nasal <i>Staphylococcus lugdunensis</i> strains, a human-associated bacterium. It shows decent antibacterial activity against <i>E. faecium</i> BK463 (MIC = 3 Î¼g mL<sup>â1</sup>) and <i>E. faecalis</i> VRE366 (MIC = 12 Î¼g mL<sup>â1</sup>).<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Taking inspiration from this peptide, researchers might think of exploring the human microbiota further as a source of novel antibiotics. In another recent report, two short AMPs, WR12 and D-IK8, have been documented to show good activity for treating drug-resistant and intracellular infections caused by <i>S. aureus</i>.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> The two peptides have shown good antibacterial activity against VISA (MICs 1 and 8 Î¼g mL<sup>â1</sup>, respectively) and VRSA (MICs ranging from 4 to 8 Î¼g mL<sup>â1</sup> and 8â16 Î¼g mL<sup>â1</sup>, respectively). Moreover, both peptides significantly disrupted the 24 h mature biofilms of <i>S. aureus</i> at a concentration four times the MIC, reducing biofilm mass by 50%. Higher concentrations of vancomycin and linezolid were required (16 Ã MIC) to reduce the same percentage of biofilm mass. This proves the greater efficacy of the two AMPs in treating biofilms of <i>S. aureus</i>. Some synthetic AMP mimics have exhibited promising activity against vancomycin-resistant bacteria.<a onclick="showRef(event, 'ref114 ref115 ref116 ref117 ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref114 ref115 ref116 ref117 ref118 ref119">(114â119)</a> These examples elicit the potential of AMPs and AMP mimics as agents for treating infections caused by vancomycin-resistant bacteria. In addition to this, another class of compounds, caprazamycins and carbacaprazamycins (chemically stable analogues of caprazamycins), have been known to show good antibacterial activity against VRE. Caprazamycins (CPZs) are members of a class of naturally occurring 6â²-<i>N</i>-alkyl-5â²-Î²-<i>O</i>-aminoribosylglycyluridine antibiotics and have previously exhibited good antimycobacterial activity. CPZs are inhibitors of the phospho-MurNAc-pentapeptide translocase (MraY), which is responsible for the formation of lipid I during peptidoglycan biosynthesis. In the report, the activity of the optimized carbacaprazamycin was found to be 8 Î¼g mL<sup>â1</sup> against <i>E. faecalis</i> SR7914 (VRE) and <i>E. faecium</i> SR7917 (VRE) in comparison to 2 and 1 Î¼g mL<sup>â1</sup> with palmitoylzaprazole, which is the less stable congener of caprazamycin.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> In another report, novel inhibitors of staphyloxanthin virulence factor were designed which showed good activity against VISA infections in vivo.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> It is considered to be an important virulence factor with antioxidant properties.<a onclick="showRef(event, 'ref122 ref123 ref124'); return false;" href="javascript:void(0);" class="ref ref122 ref123 ref124">(122â124)</a> Staphyloxanthin (STX) is distributed in <i>S. aureus</i> and contains numerous conjugated double bonds to resist the reactive oxygen species (ROS) produced by neutrophils and macrophages. Therefore, blocking the STX biosynthetic pathway is an effective therapeutic strategy for complicated <i>S. aureus</i> infections. In the above study, chroman and coumaran derivatives were addressed as novel inhibitors. Two derivatives showed good in vivo activity against VISA Mu50. Various lantibiotics (polycyclic peptide antibiotics containing lanthionine and methyllanthionine residues) and their semisynthetic derivatives have exhibited good antimicrobial activity against vancomycin-resistant strains.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> Semisynthetic derivatives of nisin were synthesized, which comprised of the <i>N</i>-terminus A/B ring region of the original lantibiotic and lipid amines. The semisynthetic lipopeptides retained lipid II binding and the best derivative showed an MIC of 4 Î¼g mL<sup>â1</sup>.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Another lantibiotic, microbisporicin exhibited MIC of 2 and 0.5â2 Î¼g mL<sup>â1</sup> against VISA and VRE (VanA) strains, respectively.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Moreover, undecaprenyl pyrophosphate synthase inhibitors were screened for activity against different strains of bacteria. Two 4-oxo-2-thioxo-1,3-thiazolidine based inhibitors displayed MIC of 1â8 and 4 Î¼g mL<sup>â1</sup> against VRE, respectively.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> These compounds are just a few examples of the recent advances in the identification, isolation, and synthesis of novel chemical scaffolds that can be exploited to combat the epidemic of vancomycin resistance. It is expected that in the coming years, more compounds will find their way into the antibacterial armamentarium.</div></div><div id="sec11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">11.  Summary and Outlook</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13480" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13480" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">WHO had listed vancomycin as a high priority antibiotic in human medicine. Resistance to glycopeptides removes one class of antibiotics from the antibacterial armamentarium for the treatment of serious infections. Numerous initiatives have been taken to overcome this acquired resistance, and this Perspective provides an overview of the chemical strategies that have been used to overcome and treat vancomycin-resistant bacteria. The successful strategies involved modifications to enhance binding affinity to the mutated target peptide, membrane disruption ability, and lipid binding properties. Modifications to afford membrane-disruptive properties into the parent glycopeptide is a promising approach given the low propensity for resistance of these molecules. Molecules with multimodal mechanisms of action may be the way forward because bacteria would then need to devise multiple strategies to develop resistance. Because there is a lack of antibiotics for the treatment of MDR Gram-negative bacteria, the extension of the use of glycopeptides to Gram-negative bacteria would be a welcome strategy. Although this aspect is underexplored, the use of membrane-destabilizing agents in combination with glycopeptides has yielded interesting results. A combination of glycopeptide derivatives with other antibiotics must be thoroughly investigated in order to generate a new therapeutic field, especially for the treatment of Gram-negative pathogens. This would help in employing vancomycin derivatives as inhibitors or resistance breakers in inhibitor/drug combinations. Developing antibiotics or adjuvants that could also overcome the ânoninheritedâ resistance due to intracellular and biofilm-associated infections is an important requirement for the effective treatment of multidrug-resistant infections. The lipophilic semisynthetic glycopeptides have been successful in addressing this problem. This must be kept in mind while designing new strategies. Combination of glycopeptides with known quorum sensing (QS) inhibitors can also be a potential strategy to address the problem of vancomycin resistance. QS refers to bacterial communication, and hence its inhibitors can be advantageous against biofilms of <i>S. aureus</i> whose formation is guided through QS. Further, different classes of compounds other than glycopeptides must be explored thoroughly. Novel chemical scaffolds have an advantage to avoid cross-resistance with glycopeptides.</div><div class="NLM_p last">Although a lot of work has been done with respect to modification of glycopeptide antibiotics, these compounds are yet to find their way into the clinical pipeline. Challenges in purification and large-scale production of semisynthetic glycopeptides impede the process of drug discovery. Only one semisynthetic glycopeptide, TD-1607, is currently in phase II, but it is not effective against vancomycin-resistant bacteria. Linezolid, which is used as the antibiotic of last resort for the treatment of vancomycin-resistant bacteria, possesses a high propensity of resistance and it is thus imperative to develop new antibiotics and devise new strategies to treat infections caused by multidrug-resistant bacteria. The current clinical pipeline is not sufficient to cope with the increasing cases of resistance in bacteria and the need for new classes of antibiotics remains.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01093" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62707" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62707" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jayanta Haldar</span> - <span class="hlFld-Affiliation affiliation">Antimicrobial Research Laboratory,
New Chemistry Unit, Jawaharlal Nehru Centre
for Advanced Scientific Research, Jakkur, Bengaluru 560064, Karnataka, India</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8068-1015" title="Orcid link">http://orcid.org/0000-0002-8068-1015</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a4cec5ddc5cad0c5e4cecac7c5d7d68ac5c78acdca"><span class="__cf_email__" data-cfemail="4228233b232c362302282c212331306c23216c2b2c">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Geetika Dhanda</span> - <span class="hlFld-Affiliation affiliation">Antimicrobial Research Laboratory,
New Chemistry Unit, Jawaharlal Nehru Centre
for Advanced Scientific Research, Jakkur, Bengaluru 560064, Karnataka, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paramita Sarkar</span> - <span class="hlFld-Affiliation affiliation">Antimicrobial Research Laboratory,
New Chemistry Unit, Jawaharlal Nehru Centre
for Advanced Scientific Research, Jakkur, Bengaluru 560064, Karnataka, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandip Samaddar</span> - <span class="hlFld-Affiliation affiliation">Antimicrobial Research Laboratory,
New Chemistry Unit, Jawaharlal Nehru Centre
for Advanced Scientific Research, Jakkur, Bengaluru 560064, Karnataka, India</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73274" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73274" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Geetika Dhanda</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=BIO-d7e2846-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Geetika Dhanda</b> received her bachelorâs degree in chemistry from Miranda House, University of Delhi. She joined the New Chemistry Unit at Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) as an Integrated Ph.D. student and is currently pursuing her Masterâs project under the supervision of Prof. Jayanta Haldar. Her current research focuses on the development of synthetic mimics of antimicrobial peptides to overcome acquired and intrinsic resistance in bacteria.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Paramita Sarkar</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=BIO-d7e2851-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Paramita Sarkar</b> received her bachelorâs degree in chemistry from St. Xavierâs College, Kolkata. She subsequently joined the New Chemistry Unit at JNCASR as an Integrated Ph.D. student and is currently pursuing her Ph.D. under the supervision of Prof. Jayanta Haldar. Her current research focuses on the development of semisynthetic antibiotics to overcome acquired resistance in bacteria.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Sandip Samaddar</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=BIO-d7e2856-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Sandip Samaddar</b> received his bachelorâs and masterâs degrees in microbiology from University of Calcutta. He did his Ph.D. in biochemistry in the Department of Biochemistry at University of Calcutta and subsequently joined Prof. Haldarâs laboratory as a Research Associate. His current research focuses on finding efficacy and specificity of chemically synthesized molecules on various multidrug resistant pathogens.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Jayanta Haldar</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=BIO-d7e2861-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jayanta Haldar</b> received his doctoral degree from the Indian Institute of Science in Bangalore. After completing postdoctoral research at the Massachusetts Institute of Technology, he joined the New Chemistry Unit, JNCASR as an assistant professor. He is currently an associate professor at the institute. His groupâs research focuses on the development of innovative chemical and nanotechnology-based strategies towards the prevention and treatment of infectious diseases.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86475" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86475" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Prof. C. N. R. Rao (JNCASR) for his constant support and encouragement. J.H. acknowledges Sheikh Saqr Career Award Fellowship.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AMR</td><td class="NLM_def"><p class="first last">antimicrobial resistance</p></td></tr><tr><td class="NLM_term">WHO</td><td class="NLM_def"><p class="first last">World Health Organization</p></td></tr><tr><td class="NLM_term">GLASS</td><td class="NLM_def"><p class="first last">Global Antimicrobial Surveillance System</p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimum inhibitory concentration</p></td></tr><tr><td class="NLM_term">MSSA</td><td class="NLM_def"><p class="first last">methicillin-susceptible <i>S. aureus</i></p></td></tr><tr><td class="NLM_term">VRE</td><td class="NLM_def"><p class="first last">vancomycin-resistant Enterococci</p></td></tr><tr><td class="NLM_term">VISA</td><td class="NLM_def"><p class="first last">vancomycin-intermediate <i>S. aureus</i></p></td></tr><tr><td class="NLM_term">VRSA</td><td class="NLM_def"><p class="first last">vancomycin-resistant <i>S. aureus</i></p></td></tr><tr><td class="NLM_term">MRSA</td><td class="NLM_def"><p class="first last">methicillin resistant <i>S. aureus</i></p></td></tr><tr><td class="NLM_term">hVISA</td><td class="NLM_def"><p class="first last">heterovancomycin intermediate <i>S. aureus</i></p></td></tr><tr><td class="NLM_term">VSSA</td><td class="NLM_def"><p class="first last">vancomycin-susceptible <i>S. aureus</i></p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">mRNA</td><td class="NLM_def"><p class="first last">messenger ribonucleic acid</p></td></tr><tr><td class="NLM_term">fmet-tRNA</td><td class="NLM_def"><p class="first last"><i>N</i>-formylmethionine transfer ribonucleic acid</p></td></tr><tr><td class="NLM_term">CAP</td><td class="NLM_def"><p class="first last">community associated pneumonia</p></td></tr><tr><td class="NLM_term">SSSi</td><td class="NLM_def"><p class="first last">skin and skin structure infections</p></td></tr><tr><td class="NLM_term">cSSSi</td><td class="NLM_def"><p class="first last">complicated skin and skin-structure infections</p></td></tr><tr><td class="NLM_term">CBP</td><td class="NLM_def"><p class="first last">(4-chlorobiphenyl) methyl</p></td></tr><tr><td class="NLM_term">EEPS</td><td class="NLM_def"><p class="first last">electrostatic effector peptide sequence</p></td></tr><tr><td class="NLM_term">MIE</td><td class="NLM_def"><p class="first last">membrane insertive element</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistant</p></td></tr><tr><td class="NLM_term">XDR</td><td class="NLM_def"><p class="first last">extensively drug resistant</p></td></tr><tr><td class="NLM_term">CuAAC</td><td class="NLM_def"><p class="first last">copper-catalyzed alkyne azide click reaction</p></td></tr><tr><td class="NLM_term">FICI</td><td class="NLM_def"><p class="first last">fractional inhibitory concentration index</p></td></tr><tr><td class="NLM_term">NDM-1</td><td class="NLM_def"><p class="first last">New-Delhi-Î²-lactamase-1</p></td></tr><tr><td class="NLM_term">MBEC</td><td class="NLM_def"><p class="first last">minimal biofilm eradication concentration</p></td></tr><tr><td class="NLM_term">AAC</td><td class="NLM_def"><p class="first last">antibodyâantibiotic conjugate</p></td></tr><tr><td class="NLM_term">AMP</td><td class="NLM_def"><p class="first last">antimicrobial peptide</p></td></tr><tr><td class="NLM_term">MDRE</td><td class="NLM_def"><p class="first last">multidrug-resistant Enterococci</p></td></tr><tr><td class="NLM_term">CPZs</td><td class="NLM_def"><p class="first last">caprazamycins</p></td></tr><tr><td class="NLM_term">STX</td><td class="NLM_def"><p class="first last">staphyloxanthin</p></td></tr><tr><td class="NLM_term">CFU</td><td class="NLM_def"><p class="first last">colony forming units</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34633" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34633" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 128 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">OâNeill, J.</span></span> <span> </span><span class="NLM_article-title">Tackling Drug-Resistant Infections Globally: Final Report and Recommendations</span>.  <i>Review on Antimicrobial Resistance</i>; <span class="NLM_publisher-name">Wellcome Trust</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+O%E2%80%99Neill&title=Tackling+Drug-Resistant+Infections+Globally%3A+Final+Report+and+Recommendations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%26atitle%3DTackling%2520Drug-Resistant%2520Infections%2520Globally%253A%2520Final%2520Report%2520and%2520Recommendations%26jtitle%3DReview%2520on%2520Antimicrobial%2520Resistance%26pub%3DWellcome%2520Trust%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span> <i>High Levels of Antibiotic Resistance Found Worldwide, New Data Shows</i>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, January 28, <span class="NLM_year">2018</span>; <a href="http://www.who.int/mediacentre/news/releases/2018/antibiotic-resistance-found/en/" class="extLink">http://www.who.int/mediacentre/news/releases/2018/antibiotic-resistance-found/en/</a> (accessed March 20, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+High+Levels+of+Antibiotic+Resistance+Found+Worldwide%2C+New+Data+Shows%3B+World+Health+Organization%3A+Geneva%2C+January+28%2C+2018%3B+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Fnews%2Freleases%2F2018%2Fantibiotic-resistance-found%2Fen%2F+%28accessed+March+20%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DHigh%2520Levels%2520of%2520Antibiotic%2520Resistance%2520Found%2520Worldwide%252C%2520New%2520Data%2520Shows%26pub%3DWorld%2520Health%2520Organization%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tommasi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkup, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manchester, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. A.</span></span> <span> </span><span class="NLM_article-title">ESKAPEing the labyrinth of antibacterial discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">529</span>â <span class="NLM_lpage">542</span>, <span class="refDoi">Â DOI: 10.1038/nrd4572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fnrd4572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=26139286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyks77M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=529-542&author=R.+Tommasiauthor=D.+G.+Brownauthor=G.+K.+Walkupauthor=J.+I.+Manchesterauthor=A.+A.+Miller&title=ESKAPEing+the+labyrinth+of+antibacterial+discovery&doi=10.1038%2Fnrd4572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">ESKAPEing the labyrinth of antibacterial discovery</span></div><div class="casAuthors">Tommasi, Ruben; Brown, Dean G.; Walkup, Grant K.; Manchester, John I.; Miller, Alita A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">529-542</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antimicrobial drug resistance is a growing threat to global public health.  Multidrug resistance among the 'ESKAPE' organisms - encompassing Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. - is of particular concern because they are responsible for many serious infections in hospitals.  Although some promising agents are in the pipeline, there is an urgent need for new antibiotic scaffolds.  However, antibacterial researchers have struggled to identify new small mols. with meaningful cellular activity, esp. those effective against multidrug-resistant Gram-neg. pathogens.  This difficulty ultimately stems from an incomplete understanding of efflux systems and compd. permeation through bacterial membranes.  This Opinion article describes findings from target-based and phenotypic screening efforts carried out at AstraZeneca over the past decade, discusses some of the subsequent chem. challenges and concludes with a description of new approaches comprising a combination of computational modeling and advanced biol. tools which may pave the way towards the discovery of new antibacterial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolJg6HXnn7BLVg90H21EOLACvtfcHk0liT7-C6pSor0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyks77M&md5=0d3159250e27926ab280c305ea5fb9ef</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd4572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4572%26sid%3Dliteratum%253Aachs%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DWalkup%26aufirst%3DG.%2BK.%26aulast%3DManchester%26aufirst%3DJ.%2BI.%26aulast%3DMiller%26aufirst%3DA.%2BA.%26atitle%3DESKAPEing%2520the%2520labyrinth%2520of%2520antibacterial%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D529%26epage%3D542%26doi%3D10.1038%2Fnrd4572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levin, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozen, D. E.</span></span> <span> </span><span class="NLM_article-title">Non-inherited antibiotic resistance</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">556</span>â <span class="NLM_lpage">562</span>, <span class="refDoi">Â DOI: 10.1038/nrmicro1445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fnrmicro1445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=16778840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvVGlurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=556-562&author=B.+R.+Levinauthor=D.+E.+Rozen&title=Non-inherited+antibiotic+resistance&doi=10.1038%2Fnrmicro1445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Non-inherited antibiotic resistance</span></div><div class="casAuthors">Levin, Bruce R.; Rozen, Daniel E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">556-562</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In addn. to their impressive, well-publicized and well-researched propensity to evolve and acquire genetically detd. mechanisms for resistance to antibiotics, bacteria that are inherently susceptible to these drugs can also be phenotypically refractory to their action.  This phenomenon of non-inherited resistance to antibiotics was known since the beginning of the antibiotic era but, relative to inherited resistance, it was given little attention.  Here, the authors review the in vitro and in vivo evidence for the different forms of non-inherited resistance and the mechanisms responsible.  With the aid of a simple math. model and computer simulations, the authors show how non-inherited resistance could extend the duration of antibiotic treatment, cause treatment failure and promote the generation and ascent of inherited resistance in treated patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO0moi9krOQbVg90H21EOLACvtfcHk0lieV4TOeAGJtg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvVGlurw%253D&md5=22a627ccfd1443eca63dde7c8e0f3b2a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1445%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DB.%2BR.%26aulast%3DRozen%26aufirst%3DD.%2BE.%26atitle%3DNon-inherited%2520antibiotic%2520resistance%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2006%26volume%3D4%26spage%3D556%26epage%3D562%26doi%3D10.1038%2Fnrmicro1445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span> <i>Global Priority List of Antibiotic-Resistant Bacteria
To Guide Research,
Discovery, and Development of New Antibiotics</i>;  <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2018</span>; <a href="https://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/" class="extLink">https://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/</a> (accessed April 3, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Global+Priority+List+of+Antibiotic-Resistant+Bacteria%0ATo+Guide+Research%2C%0ADiscovery%2C+and+Development+of+New+Antibiotics%3B+World+Health+Organization%3A+Geneva%2C+2018%3B+https%3A%2F%2Fwww.who.int%2Fmedicines%2Fpublications%2Fglobal-priority-list-antibiotic-resistant-bacteria%2Fen%2F+%28accessed+April+3%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%2520Priority%2520List%2520of%2520Antibiotic-Resistant%2520Bacteria%250ATo%2520Guide%2520Research%252C%250ADiscovery%252C%2520and%2520Development%2520of%2520New%2520Antibiotics%26pub%3DWorld%2520Health%2520Organization%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicolaou, K.
C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boddy, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brase, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winssinger, N.</span></span> <span> </span><span class="NLM_article-title">Chemistry, biology, and medicine of the glycopeptide antibiotics</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2096</span>â <span class="NLM_lpage">2152</span>, <span class="refDoi">Â DOI: 10.1002/(SICI)1521-3773(19990802)38:15<2096::AID-ANIE2096>3.0.CO;2-F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1002%2F%28SICI%291521-3773%2819990802%2938%3A15%3C2096%3A%3AAID-ANIE2096%3E3.0.CO%3B2-F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10425471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BC2sbgslCrsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=2096-2152&author=K.%0AC.+Nicolaouauthor=C.+N.+Boddyauthor=S.+Braseauthor=N.+Winssinger&title=Chemistry%2C+biology%2C+and+medicine+of+the+glycopeptide+antibiotics&doi=10.1002%2F%28SICI%291521-3773%2819990802%2938%3A15%3C2096%3A%3AAID-ANIE2096%3E3.0.CO%3B2-F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry, Biology, and Medicine of the Glycopeptide Antibiotics</span></div><div class="casAuthors">Nicolaou; Boddy; Brase; Winssinger</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2096-2152</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The war against infectious bacteria is not over! Although vancomycin and glycopeptide antibiotics have provided a strong last line of defence against many drug-resistant bacteria, their overuse has given rise to more dangerous strains of bacteria.  An understanding of the chemistry and biology of these highly complex glycopeptides are destined to play a crucial role in the discovery of new antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHXUM29xIhol1C8OJBvdfbfW6udTcc2eYCqlZM86OVCrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbgslCrsA%253D%253D&md5=522c0e94fef28bd6457bc310e1be341a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819990802%2938%3A15%3C2096%3A%3AAID-ANIE2096%3E3.0.CO%3B2-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819990802%252938%253A15%253C2096%253A%253AAID-ANIE2096%253E3.0.CO%253B2-F%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DK.%2BC.%26aulast%3DBoddy%26aufirst%3DC.%2BN.%26aulast%3DBrase%26aufirst%3DS.%26aulast%3DWinssinger%26aufirst%3DN.%26atitle%3DChemistry%252C%2520biology%252C%2520and%2520medicine%2520of%2520the%2520glycopeptide%2520antibiotics%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D2096%26epage%3D2152%26doi%3D10.1002%2F%28SICI%291521-3773%2819990802%2938%3A15%3C2096%3A%3AAID-ANIE2096%3E3.0.CO%3B2-F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kahne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, C.</span></span> <span> </span><span class="NLM_article-title">Glycopeptide and lipoglycopeptide antibiotics</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">425</span>â <span class="NLM_lpage">448</span>, <span class="refDoi">Â DOI: 10.1021/cr030103a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr030103a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVaksw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=425-448&author=D.+Kahneauthor=C.+Leimkuhlerauthor=W.+Luauthor=C.+Walsh&title=Glycopeptide+and+lipoglycopeptide+antibiotics&doi=10.1021%2Fcr030103a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Glycopeptide and Lipoglycopeptide Antibiotics</span></div><div class="casAuthors">Kahne, Dan; Leimkuhler, Catherine; Lu, Wei; Walsh, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">425-448</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on glycopeptide and lipoglycopeptide antibiotics.  Structural features, chem. synthesis, mechanism of action, resistance mechanisms and new directions for treating drug resistance are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBnRcMTFq_cbVg90H21EOLACvtfcHk0ljGONuFpOuzUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVaksw%253D%253D&md5=ef3f1a5f07faeacd22c0444d42637fd1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fcr030103a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr030103a%26sid%3Dliteratum%253Aachs%26aulast%3DKahne%26aufirst%3DD.%26aulast%3DLeimkuhler%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DWalsh%26aufirst%3DC.%26atitle%3DGlycopeptide%2520and%2520lipoglycopeptide%2520antibiotics%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D425%26epage%3D448%26doi%3D10.1021%2Fcr030103a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansford, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaskovich, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. A.</span></span> <span> </span><span class="NLM_article-title">Glycopeptide antibiotics: back to the future</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">631</span>â <span class="NLM_lpage">644</span>, <span class="refDoi">Â DOI: 10.1038/ja.2014.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fja.2014.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=25118105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ehsrvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2014&pages=631-644&author=M.+S.+Butlerauthor=K.+A.+Hansfordauthor=M.+A.+Blaskovichauthor=R.+Halaiauthor=M.+A.+Cooper&title=Glycopeptide+antibiotics%3A+back+to+the+future&doi=10.1038%2Fja.2014.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Glycopeptide antibiotics: Back to the future</span></div><div class="casAuthors">Butler, Mark S.; Hansford, Karl A.; Blaskovich, Mark A. T.; Halai, Reena; Cooper, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">631-644</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Glycopeptide antibiotics have been a key weapon in the fight against bacterial infections for over half a century, with the progenitors, vancomycin (1) and teicoplanin (2), still used extensively.  The increased occurrence of resistance and the effectiveness of these 'last resort' treatments for Gram-pos. infections has led to the discovery and clin. development of second generation, semisynthetic lipoglycopeptide derivs. such as telavancin (3), dalbavancin (4) and oritavancin (5), which all possess broader spectra of activity and improved pharmacokinetic properties.  Two of these new antibiotics, telavancin (3) and dalbavancin (4), were approved in the past 5 years and the third, oritavancin (5), is awaiting regulatory approval.  In this review, the discovery, development and assocd. resistance of vancomycin (1) and teicoplanin (2), and semi-synthetic glycopeptides, telavancin (3), dalbavancin (4) and oritavancin (5), are detailed.  The clin. implications of glycopeptide resistance, esp. vancomycin (1), as well as the future prospects for current glycopeptide drugs and the development of new glycopeptides are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBXjY3YHnypbVg90H21EOLACvtfcHk0ljGONuFpOuzUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ehsrvK&md5=04a3089be94990f1f3891cd6958ae79a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fja.2014.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2014.111%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DM.%2BS.%26aulast%3DHansford%26aufirst%3DK.%2BA.%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%26aulast%3DHalai%26aufirst%3DR.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26atitle%3DGlycopeptide%2520antibiotics%253A%2520back%2520to%2520the%2520future%26jtitle%3DJ.%2520Antibiot.%26date%3D2014%26volume%3D67%26spage%3D631%26epage%3D644%26doi%3D10.1038%2Fja.2014.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">516</span>â <span class="NLM_lpage">533</span>, <span class="refDoi">Â DOI: 10.1039/C6MD00585C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1039%2FC6MD00585C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=30108769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Wmt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=516-533&author=P.+Sarkarauthor=V.+Yarlagaddaauthor=C.+Ghoshauthor=J.+Haldar&title=A+review+on+cell+wall+synthesis+inhibitors+with+an+emphasis+on+glycopeptide+antibiotics&doi=10.1039%2FC6MD00585C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics</span></div><div class="casAuthors">Sarkar, Paramita; Yarlagadda, Venkateswarlu; Ghosh, Chandradhish; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">516-533</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cell wall biosynthesis inhibitors (CBIs) have historically been one of the most effective classes of antibiotics.  They are the most extensively used class of antibiotics and their importance is exemplified by the Î²-lactams and glycopeptide antibiotics.  However, this class of antibiotics has not received impunity from resistance development.  In the wake of this predicament, this review presents the progress of CBIs, esp. glycopeptide derivs. as antibiotics to confront antibacterial resistance.  The various strategies used for the development of CBIs, their clin. status and possible directions in which this field can evolve have also been discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroG-nR7J34fLVg90H21EOLACvtfcHk0ljGONuFpOuzUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Wmt7w%253D&md5=3ae2916276ca7fc960f137788705c555</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1039%2FC6MD00585C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00585C%26sid%3Dliteratum%253Aachs%26aulast%3DSarkar%26aufirst%3DP.%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DC.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DA%2520review%2520on%2520cell%2520wall%2520synthesis%2520inhibitors%2520with%2520an%2520emphasis%2520on%2520glycopeptide%2520antibiotics%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26spage%3D516%26epage%3D533%26doi%3D10.1039%2FC6MD00585C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McComas, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">9314</span>â <span class="NLM_lpage">9315</span>, <span class="refDoi">Â DOI: 10.1021/ja035901x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja035901x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltlCksbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=9314-9315&author=C.+C.+McComasauthor=B.+M.+Crowleyauthor=D.+L.+Boger&title=Partitioning+the+loss+in+vancomycin+binding+affinity+for+D-Ala-D-Lac+into+lost+H-bond+and+repulsive+lone+pair+contributions&doi=10.1021%2Fja035901x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Partitioning the Loss in Vancomycin Binding Affinity for D-Ala-D-Lac into Lost H-Bond and Repulsive Lone Pair Contributions</span></div><div class="casAuthors">McComas, Casey C.; Crowley, Brendan M.; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">9314-9315</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The binding affinity of AcNH(CH2)4CH(AcNH)C:ONHCH(CH3)C:OCH2CH(CH3)CO2H (I), which incorporates a methylene (CH2) in place of the key linking amide of Ac2-L-Lys-D-Ala-D-Ala, for vancomycin was compared with that of Ac2-L-Lys-D-Ala-D-Ala and Ac2-L-Lys-D-Ala-D-Lac.  The vancomycin affinity for I was approx. 10-fold less than that of Ac2-L-Lys-D-Ala-D-Ala, but 100-fold greater than that of Ac2-L-Lys-D-Ala-D-Lac.  This suggests that the reduced binding affinity of Ac2-L-Lys-D-Ala-D-Lac (4.1 kcal/mol) may be attributed to both the loss of a key H-bond (1.5 kcal/mol) and a destabilizing lone pair/lone pair electrostatic interaction introduced with the ester oxygen of Ac2-L-Lys-D-Ala-D-Lac (2.6 kcal/mol) with the latter, not the H-bond, being responsible for the largest share of the 1000-fold redn.  These observations have significant ramifications in the reengineering of the vancomycin structure to bind D-Ala-D-Lac and thus overcoming bacterial resistance to vancomycin in its binding to precursor peptidoglycan in cell wall biosynthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb8pKB_Ped6rVg90H21EOLACvtfcHk0ljGONuFpOuzUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltlCksbs%253D&md5=322f71e8dfe940e24a7b7ec360a417b6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fja035901x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja035901x%26sid%3Dliteratum%253Aachs%26aulast%3DMcComas%26aufirst%3DC.%2BC.%26aulast%3DCrowley%26aufirst%3DB.%2BM.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DPartitioning%2520the%2520loss%2520in%2520vancomycin%2520binding%2520affinity%2520for%2520D-Ala-D-Lac%2520into%2520lost%2520H-bond%2520and%2520repulsive%2520lone%2520pair%2520contributions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D9314%26epage%3D9315%26doi%3D10.1021%2Fja035901x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uttley, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidoo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, R. C.</span></span> <span> </span><span class="NLM_article-title">Vancomycin-resistant enterococci</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>331</i></span>,  <span class="NLM_fpage">57</span>â <span class="NLM_lpage">58</span>, <span class="refDoi">Â DOI: 10.1016/S0140-6736(88)91037-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2FS0140-6736%2888%2991037-9" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1988&pages=57-58&author=A.+H.+Uttleyauthor=C.+H.+Collinsauthor=J.+Naidooauthor=R.+C.+George&title=Vancomycin-resistant+enterococci&doi=10.1016%2FS0140-6736%2888%2991037-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2888%2991037-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252888%252991037-9%26sid%3Dliteratum%253Aachs%26aulast%3DUttley%26aufirst%3DA.%2BH.%26aulast%3DCollins%26aufirst%3DC.%2BH.%26aulast%3DNaidoo%26aufirst%3DJ.%26aulast%3DGeorge%26aufirst%3DR.%2BC.%26atitle%3DVancomycin-resistant%2520enterococci%26jtitle%3DLancet%26date%3D1988%26volume%3D331%26spage%3D57%26epage%3D58%26doi%3D10.1016%2FS0140-6736%2888%2991037-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Acar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casewell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, H.</span></span> <span> </span><span class="NLM_article-title">Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making</span>. <i>Clin. Microbiol. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">477</span>â <span class="NLM_lpage">482</span>, <span class="refDoi">Â DOI: 10.1046/j.1469-0691.2000.00128.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1046%2Fj.1469-0691.2000.00128.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=11168181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVGjtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=477-482&author=J.+Acarauthor=M.+Casewellauthor=J.+Freemanauthor=C.+Friisauthor=H.+Goossens&title=Avoparcin+and+virginiamycin+as+animal+growth+promoters%3A+a+plea+for+science+in+decision-making&doi=10.1046%2Fj.1469-0691.2000.00128.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making</span></div><div class="casAuthors">Acar, J.; Casewell, M.; Freeman, J.; Friis, C.; Goossens, H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology and Infection</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">477-482</span>CODEN:
                <span class="NLM_cas:coden">CMINFM</span>;
        ISSN:<span class="NLM_cas:issn">1198-743X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review with 51 refs.  There is a need to clarify the issue of gene transfer and bacterial population dynamics.  Specifically, several issues have to be answered: the extent to which growth promoters select for resistant organisms in animals; the prevalence of resistant enterococci in human populations; their ability to transfer resistance to other organisms; and the question on whether animal enterococci colonize humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCevqacSjIGbVg90H21EOLACvtfcHk0li0P0Cfy_xtHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVGjtb8%253D&md5=be20c45be4c01874c3454c1727fb8149</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1046%2Fj.1469-0691.2000.00128.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1469-0691.2000.00128.x%26sid%3Dliteratum%253Aachs%26aulast%3DAcar%26aufirst%3DJ.%26aulast%3DCasewell%26aufirst%3DM.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DFriis%26aufirst%3DC.%26aulast%3DGoossens%26aufirst%3DH.%26atitle%3DAvoparcin%2520and%2520virginiamycin%2520as%2520animal%2520growth%2520promoters%253A%2520a%2520plea%2520for%2520science%2520in%2520decision-making%26jtitle%3DClin.%2520Microbiol.%2520Infect.%26date%3D2000%26volume%3D6%26spage%3D477%26epage%3D482%26doi%3D10.1046%2Fj.1469-0691.2000.00128.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabuta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oguri, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenover, F. C.</span></span> <span> </span><span class="NLM_article-title">Methicillin-resistant <i>Staphylococcus aureus</i> clinical strain with reduced vancomycin susceptibility</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">135</span>â <span class="NLM_lpage">136</span>, <span class="refDoi">Â DOI: 10.1093/jac/40.1.135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1093%2Fjac%2F40.1.135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=9249217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK2sXltVCit7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=135-136&author=K.+Hiramatsuauthor=H.+Hanakiauthor=T.+Inoauthor=K.+Yabutaauthor=T.+Oguriauthor=F.+C.+Tenover&title=Methicillin-resistant+Staphylococcus+aureus+clinical+strain+with+reduced+vancomycin+susceptibility&doi=10.1093%2Fjac%2F40.1.135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility</span></div><div class="casAuthors">Hiramatsu, K.; Hanaki, H.; Ino, T.; Yabuta, K.; Oguri, T.; Tenover, F. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">135-136</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A clin. strain of methicillin-resistant S. aureus strain (Mu50) with reduced susceptibility to vancomycin (MIC = 8 mg/L) is described.  The strain did not carry vanA or van B genes, and the exact mechanism of reduced vancomycin susceptibility remains to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXrFXWdBg6c7Vg90H21EOLACvtfcHk0li0P0Cfy_xtHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXltVCit7w%253D&md5=d86e21c3e97d29df20cc1e2bd11c1dd2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F40.1.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F40.1.135%26sid%3Dliteratum%253Aachs%26aulast%3DHiramatsu%26aufirst%3DK.%26aulast%3DHanaki%26aufirst%3DH.%26aulast%3DIno%26aufirst%3DT.%26aulast%3DYabuta%26aufirst%3DK.%26aulast%3DOguri%26aufirst%3DT.%26aulast%3DTenover%26aufirst%3DF.%2BC.%26atitle%3DMethicillin-resistant%2520Staphylococcus%2520aureus%2520clinical%2520strain%2520with%2520reduced%2520vancomycin%2520susceptibility%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1997%26volume%3D40%26spage%3D135%26epage%3D136%26doi%3D10.1093%2Fjac%2F40.1.135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sievert, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hageman, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulton, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenover, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downes, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudrik, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pupp, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridkin, S. K.</span></span> <span> </span><span class="NLM_article-title">Infection with vancomycin-resistant <i>Staphylococcus aureus</i> containing the vanA resistance gene</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">1342</span>â <span class="NLM_lpage">1347</span>, <span class="refDoi">Â DOI: 10.1056/NEJMoa025025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1056%2FNEJMoa025025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=12672861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BD3s7lvVShsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=1342-1347&author=S.+Changauthor=D.+M.+Sievertauthor=J.+C.+Hagemanauthor=M.+L.+Boultonauthor=F.+C.+Tenoverauthor=F.+P.+Downesauthor=S.+Shahauthor=J.+T.+Rudrikauthor=G.+R.+Puppauthor=W.+J.+Brownauthor=D.+Cardoauthor=S.+K.+Fridkin&title=Infection+with+vancomycin-resistant+Staphylococcus+aureus+containing+the+vanA+resistance+gene&doi=10.1056%2FNEJMoa025025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene</span></div><div class="casAuthors">Chang Soju; Sievert Dawn M; Hageman Jeffrey C; Boulton Matthew L; Tenover Fred C; Downes Frances Pouch; Shah Sandip; Rudrik James T; Pupp Guy R; Brown William J; Cardo Denise; Fridkin Scott K</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1342-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcvhBy2uNOo0Gy1nwu7K2mfW6udTcc2eYhm44b1xIAq7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7lvVShsw%253D%253D&md5=2a58e80ddfe077d13d47d9ba059986c2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa025025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa025025%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DS.%26aulast%3DSievert%26aufirst%3DD.%2BM.%26aulast%3DHageman%26aufirst%3DJ.%2BC.%26aulast%3DBoulton%26aufirst%3DM.%2BL.%26aulast%3DTenover%26aufirst%3DF.%2BC.%26aulast%3DDownes%26aufirst%3DF.%2BP.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DRudrik%26aufirst%3DJ.%2BT.%26aulast%3DPupp%26aufirst%3DG.%2BR.%26aulast%3DBrown%26aufirst%3DW.%2BJ.%26aulast%3DCardo%26aufirst%3DD.%26aulast%3DFridkin%26aufirst%3DS.%2BK.%26atitle%3DInfection%2520with%2520vancomycin-resistant%2520Staphylococcus%2520aureus%2520containing%2520the%2520vanA%2520resistance%2520gene%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26spage%3D1342%26epage%3D1347%26doi%3D10.1056%2FNEJMoa025025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tenover, F. C.</span>; <span class="NLM_string-name">Biddle, J. W.</span>; <span class="NLM_string-name">Lancaster, M. V.</span></span> <span> </span><span class="NLM_article-title">Increasing Resistance to Vancomycin and Other Glycopeptides in <i>Staphylococcus aureus</i></span>.  <i>Emerging Infectious Diseases</i>; <span class="NLM_publisher-name">Centers for Disease Control and Prevention</span>: <span class="NLM_publisher-loc">Atlanta</span>, <span class="NLM_year">2012</span>; Vol.  <span class="NLM_volume">7</span> <a href="https://wwwnc.cdc.gov/eid/article/7/2/07-0327_article" class="extLink">https://wwwnc.cdc.gov/eid/article/7/2/07-0327_article</a> (accessed March 25, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=F.+C.+Tenover&author=J.+W.+Biddle&author=M.+V.+Lancaster&title=Increasing+Resistance+to+Vancomycin+and+Other+Glycopeptides+in+Staphylococcus+aureus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DTenover%26aufirst%3DF.%2BC.%26atitle%3DIncreasing%2520Resistance%2520to%2520Vancomycin%2520and%2520Other%2520Glycopeptides%2520in%2520Staphylococcus%2520aureus%26jtitle%3DEmerging%2520Infectious%2520Diseases%26pub%3DCenters%2520for%2520Disease%2520Control%2520and%2520Prevention%26date%3D2012%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bugg, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutka-Malen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courvalin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, C. T.</span></span> <span> </span><span class="NLM_article-title">Molecular basis for vancomycin resistance in <i>Enterococcus faecium</i> BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">10408</span>â <span class="NLM_lpage">10415</span>, <span class="refDoi">Â DOI: 10.1021/bi00107a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00107a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK3MXmtVeisbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1991&pages=10408-10415&author=T.+D.+Buggauthor=G.+D.+Wrightauthor=S.+Dutka-Malenauthor=M.+Arthurauthor=P.+Courvalinauthor=C.+T.+Walsh&title=Molecular+basis+for+vancomycin+resistance+in+Enterococcus+faecium+BM4147%3A+biosynthesis+of+a+depsipeptide+peptidoglycan+precursor+by+vancomycin+resistance+proteins+VanH+and+VanA&doi=10.1021%2Fbi00107a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis for vancomycin resistance in Enterococcus faecium BM4147:  biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA</span></div><div class="casAuthors">Bugg, Timothy D. H.; Wright, Gerard D.; Dutka-Malen, Sylvie; Arthur, Michel; Courvalin, Patrice; Walsh, Christopher T.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">10408-15</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">Vancomycin resistance in E. faecium BM4147 is mediated by vancomycin resistance proteins VanA and VanH.  VanA is a D-alanine:D-alanine ligase of altered substrate specificity, while the sequence of VanH is related to those of Î±-keto acid dehydrogenases.  VanH was purified to homogeneity, characterized as a D-specific Î±-keto acid dehydrogenase, and compared with D-lactate dehydrogenases from Leuconostoc mesenteroides and Lactobacillus leichmanii.  VanA was found to catalyze ester bond formation between D-alanine and the D-hydroxy acid products of VanH, the best substrate being D-2-hydroxybutyrate (Km = 0.60 mM).  The VanA product D-alanyl-D-2-hydroxybutyrate could then be incorporated into the UDPMurNac-pentapeptide peptidoglycan precursor by D-Ala-D-Ala adding enzyme from Escherichia coli or by crude ext. from E. faecium BM4147.  The vancomycin-binding const. of a synthetic modified peptidoglycan analog, N-acetyl-D-alanyl-D-2-hydroxybutyrate, (Kd > 73 mM) was >1000-fold higher than the binding const. for N-acetyl-D-alanyl-D-alanine (Kd = 54 Î¼M), partly due to the disruption of a H-bond in the vancomycin-target complex, thus providing a mol. rationale for high-level vancomycin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2uZ4SabTxLLVg90H21EOLACvtfcHk0lgHUL_rxZPzxA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmtVeisbw%253D&md5=39d58fd11f656b5f048551cd93604b16</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fbi00107a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00107a007%26sid%3Dliteratum%253Aachs%26aulast%3DBugg%26aufirst%3DT.%2BD.%26aulast%3DWright%26aufirst%3DG.%2BD.%26aulast%3DDutka-Malen%26aufirst%3DS.%26aulast%3DArthur%26aufirst%3DM.%26aulast%3DCourvalin%26aufirst%3DP.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26atitle%3DMolecular%2520basis%2520for%2520vancomycin%2520resistance%2520in%2520Enterococcus%2520faecium%2520BM4147%253A%2520biosynthesis%2520of%2520a%2520depsipeptide%2520peptidoglycan%2520precursor%2520by%2520vancomycin%2520resistance%2520proteins%2520VanH%2520and%2520VanA%26jtitle%3DBiochemistry%26date%3D1991%26volume%3D30%26spage%3D10408%26epage%3D10415%26doi%3D10.1021%2Fbi00107a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courvalin, P.</span></span> <span> </span><span class="NLM_article-title">Regulation of vanB-type vancomycin resistance gene expression by the vanS(B)-vanR (B) two-component regulatory system in <i>Enterococcus faecalis</i> V583</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">1302</span>â <span class="NLM_lpage">1309</span>, <span class="refDoi">Â DOI: 10.1128/jb.178.5.1302-1309.1996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2Fjb.178.5.1302-1309.1996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=8631706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK28XhsVSquro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=1996&pages=1302-1309&author=S.+Eversauthor=P.+Courvalin&title=Regulation+of+vanB-type+vancomycin+resistance+gene+expression+by+the+vanS%28B%29-vanR+%28B%29+two-component+regulatory+system+in+Enterococcus+faecalis+V583&doi=10.1128%2Fjb.178.5.1302-1309.1996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of VanB-type vancomycin resistance gene expression by the VanSB-VanRB two-component regulatory system in Enterococcus faecalis V583</span></div><div class="casAuthors">Evers, Stefan; Courvalin, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1302-9</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Acquired VanA- and VanB-type glycopeptide resistance in enterococci is due to synthesis of modified peptidoglycan precursors terminating in D-lactate.  As opposed to VanA-type strains which are resistant to both vancomycin and teicoplanin, VanB-type strains remain teicoplanin susceptible.  The authors have detd. the sequence of a 7,160-bp DNA fragment assocd. with VanB-type resistance in Enterococcus faecalis V583 that contains seven open reading frames.  The distal part encoded the VanHB, VanB, and VanXB proteins that are highly similar to the putative VanH, VanA, and VanX proteins responsible for VanA-type resistance.  Upstream from the structural genes for these proteins were the vanYB gene encoding a D,D-carboxypeptidase and an open reading frame vanW with an unknown function.  The proximal part of the gene cluster coded for the apparent VanSB-VanRB two-component regulatory system.  VanRB was related to response regulators of the OmpR subclass, and VanSB was related to membrane-assocd. histidine protein kinases.  Anal. of transcriptional fusions with a reporter gene and promoter mapping indicated that the VanRB-VanSB two-component regulatory system activates a promoter located immediately downstream from the vanSB gene.  Vancomycin, but not teicoplanin, was an inducer, which explains teicoplanin susceptibility of VanB-type enterococci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGvpda3GfjR7Vg90H21EOLACvtfcHk0lgHUL_rxZPzxA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhsVSquro%253D&md5=4765ba8d37c4c0eaa468542b6064dd80</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1128%2Fjb.178.5.1302-1309.1996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fjb.178.5.1302-1309.1996%26sid%3Dliteratum%253Aachs%26aulast%3DEvers%26aufirst%3DS.%26aulast%3DCourvalin%26aufirst%3DP.%26atitle%3DRegulation%2520of%2520vanB-type%2520vancomycin%2520resistance%2520gene%2520expression%2520by%2520the%2520vanS%2528B%2529-vanR%2520%2528B%2529%2520two-component%2520regulatory%2520system%2520in%2520Enterococcus%2520faecalis%2520V583%26jtitle%3DJ.%2520Bacteriol.%26date%3D1996%26volume%3D178%26spage%3D1302%26epage%3D1309%26doi%3D10.1128%2Fjb.178.5.1302-1309.1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintiliani, R.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Regulation of vanA- and vanB-type glycopeptide resistance in enterococci</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">375</span>â <span class="NLM_lpage">381</span>, <span class="refDoi">Â DOI: 10.1128/AAC.45.2.375-381.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.45.2.375-381.2001" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=375-381&author=M.+Arthurauthor=R.+Quintiliani&title=Regulation+of+vanA-+and+vanB-type+glycopeptide+resistance+in+enterococci&doi=10.1128%2FAAC.45.2.375-381.2001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1128%2FAAC.45.2.375-381.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.45.2.375-381.2001%26sid%3Dliteratum%253Aachs%26aulast%3DArthur%26aufirst%3DM.%26aulast%3DQuintiliani%26aufirst%3DR.%26atitle%3DRegulation%2520of%2520vanA-%2520and%2520vanB-type%2520glycopeptide%2520resistance%2520in%2520enterococci%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2001%26volume%3D45%26spage%3D375%26epage%3D381%26doi%3D10.1128%2FAAC.45.2.375-381.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courvalin, P.</span></span> <span> </span><span class="NLM_article-title">The vanS-vanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in <i>Enterococcus faecium</i> BM4147</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">2582</span>â <span class="NLM_lpage">2591</span>, <span class="refDoi">Â DOI: 10.1128/jb.174.8.2582-2591.1992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2Fjb.174.8.2582-2591.1992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1556077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK38XkvVCntrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=1992&pages=2582-2591&author=M.+Arthurauthor=C.+Molinasauthor=P.+Courvalin&title=The+vanS-vanR+two-component+regulatory+system+controls+synthesis+of+depsipeptide+peptidoglycan+precursors+in+Enterococcus+faecium+BM4147&doi=10.1128%2Fjb.174.8.2582-2591.1992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147</span></div><div class="casAuthors">Arthur, Michel; Molinas, Catherine; Courvalin, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2582-91</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    </div><div class="casAbstract">Plasmid pIP816 of E. faecium BM4147 confers inducible resistance to vancomycin and encodes the VanH dehydrogenase and the VanA ligase for synthesis of depsipeptide-contg. peptidoglycan precursors which bind the antibiotic with reduced affinity.  A cluster of 5 genes of pIP816 sufficient for peptidoglycan synthesis in the presence of vancomycin was characterized.  The distal part of the van cluster encodes VanH, VanA, and a third enzyme, VanX, all of which are necessary for resistance.  Synthesis of these enzymes was regulated at the transcriptional level by the VanS-VAnR two-component regulatory system encoded by the proximal part of the cluster.  VanR was a transcriptional activator related to response regulators of the OmpR subclass.  VanS stimulated VanR-dependent transcription and was related to membrane-assocd. histidine protein kinases which control the level of phosphorylation of response regulators.  Anal. of transcriptional fusions with a reporter gene and RNA mapping indicated that the VanR-VanS two-component regulatory system activates a promoter used for cotranscription of the vanH, vanA, and vanX resistance gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgG74tz2QKILVg90H21EOLACvtfcHk0ljCOdzE2Djapg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XkvVCntrw%253D&md5=2997551edb8792123273f06e9d17f5a8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2Fjb.174.8.2582-2591.1992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fjb.174.8.2582-2591.1992%26sid%3Dliteratum%253Aachs%26aulast%3DArthur%26aufirst%3DM.%26aulast%3DMolinas%26aufirst%3DC.%26aulast%3DCourvalin%26aufirst%3DP.%26atitle%3DThe%2520vanS-vanR%2520two-component%2520regulatory%2520system%2520controls%2520synthesis%2520of%2520depsipeptide%2520peptidoglycan%2520precursors%2520in%2520Enterococcus%2520faecium%2520BM4147%26jtitle%3DJ.%2520Bacteriol.%26date%3D1992%26volume%3D174%26spage%3D2582%26epage%3D2591%26doi%3D10.1128%2Fjb.174.8.2582-2591.1992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depardieu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courvalin, P.</span></span> <span> </span><span class="NLM_article-title">Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">33</span>â <span class="NLM_lpage">44</span>, <span class="refDoi">Â DOI: 10.1046/j.1365-2958.1996.00617.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1046%2Fj.1365-2958.1996.00617.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=8843432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK28Xks1Gjtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1996&pages=33-44&author=M.+Arthurauthor=F.+Depardieuauthor=P.+Reynoldsauthor=P.+Courvalin&title=Quantitative+analysis+of+the+metabolism+of+soluble+cytoplasmic+peptidoglycan+precursors+of+glycopeptide-resistant+enterococci&doi=10.1046%2Fj.1365-2958.1996.00617.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci</span></div><div class="casAuthors">Arthur, Michel; Depardieu, Florence; Reynolds, Peter; Courvalin, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-44</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">Transposon Tn1546 from Enterococcus faecium BM4147 mediates high-level resistance to the glycopeptide antibiotics vancomycin and teicoplanin.  Tn1546 encodes a dehydrogenase (VanH) and a ligase (VanA) that synthesize D-alanyl-D-lactate (D-Ala-D-Lac), a D,D-dipeptidase (VanX) that hydrolyses D-Ala-D-Ala, and a 2-component regulatory system (VanR-VanS) that controls transcription of the vanHAX operon.  Strains of Enterococcus faecalis harboring various copy nos. of the vanRSHAX cluster were tested to det. if there was a correlation between the levels of resistance to glycopeptides, the levels of expression of the corresponding resistance genes, and the relative proportions of the different cytoplasmic peptidoglycan precursors.  Increased transcription of the vanHAX operon was assocd. with increased incorporation of D-Ala-D-Lac into peptidoglycan precursors to the detriment of D-Ala-D-Ala, and with a gradual increase in the vancomycin-resistance levels.  More complete elimination of D-Ala-D-Ala-contg. precursors was required for teicoplanin resistance.  The VanY and VanZ proteins also encoded by Tn1546 were not effectors of the regulation of the vanHAX operon but contributed to vancomycin and teicoplanin resistance, resp.  Differences at the regulatory level accounted for phenotypic diversity in acquired glycopeptide resistance by prodn. of D-lac-ending precursors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9EnJW9ZatDrVg90H21EOLACvtfcHk0ljCOdzE2Djapg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xks1Gjtbs%253D&md5=199cb5bf66e27511f5e19cb9ce7eae32</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.1996.00617.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.1996.00617.x%26sid%3Dliteratum%253Aachs%26aulast%3DArthur%26aufirst%3DM.%26aulast%3DDepardieu%26aufirst%3DF.%26aulast%3DReynolds%26aufirst%3DP.%26aulast%3DCourvalin%26aufirst%3DP.%26atitle%3DQuantitative%2520analysis%2520of%2520the%2520metabolism%2520of%2520soluble%2520cytoplasmic%2520peptidoglycan%2520precursors%2520of%2520glycopeptide-resistant%2520enterococci%26jtitle%3DMol.%2520Microbiol.%26date%3D1996%26volume%3D21%26spage%3D33%26epage%3D44%26doi%3D10.1046%2Fj.1365-2958.1996.00617.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depardieu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabanie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courvalin, P.</span></span> <span> </span><span class="NLM_article-title">Requirement of the vanY and vanX D,D-peptidases for glycopeptide resistance in enterococci</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">819</span>â <span class="NLM_lpage">830</span>, <span class="refDoi">Â DOI: 10.1046/j.1365-2958.1998.01114.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1046%2Fj.1365-2958.1998.01114.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10094630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK1cXotVejs7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1998&pages=819-830&author=M.+Arthurauthor=F.+Depardieuauthor=L.+Cabanieauthor=P.+Reynoldsauthor=P.+Courvalin&title=Requirement+of+the+vanY+and+vanX+D%2CD-peptidases+for+glycopeptide+resistance+in+enterococci&doi=10.1046%2Fj.1365-2958.1998.01114.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of the VanY and VanX D,D-peptidases for glycopeptide resistance in enterococci</span></div><div class="casAuthors">Arthur, Michel; Depardieu, Florence; Cabanie, Lucien; Reynolds, Peter; Courvalin, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">819-830</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Transposon Tn1546 confers resistance to glycopeptide antibiotics in enterococci and encodes two D,D-peptidases (VanX and VanY) in addn. to the enzymes for the synthesis of D-alanyl-D-lactate (D-Ala-D-Lac).  VanY was produced in the baculovirus expression system and purified as a proteolytic fragment that lacked the putative N-terminal membrane anchor of the protein.  The enzyme was a Zn2+-dependent D,D-carboxypeptidase that cleaved the C-terminal residue of peptidoglycan precursors ending in R-D-Ala-D-Ala or R-D-Ala-D-Lac but not the dipeptide D-Ala-D-Ala.  The specificity consts. kcat/Km were 17- to 67-fold higher for substrates ending in the R-D-Ala-D-Ala target of glycopeptides.  In Enterococcus faecalis, VanY was present in membrane and cytoplasmic fractions, produced UDP-MurNAc-tetrapeptide from cytoplasmic peptidoglycan precursors and was required for high-level glycopeptide resistance in a medium supplemented with D-Ala.  The enzyme could not replace the VanX D,D-dipeptidase for the expression of glycopeptide resistance but a G237D substitution in the host D-Ala:D-Ala ligase restored resistance in a vanX null mutant.  Deletion of the membrane anchor of VanY led to an active D,D-carboxypeptidase exclusively located in the cytoplasmic fraction that did not contribute to glycopeptide resistance in a D-Ala-contg. medium.  Thus, VanX and VanY had non-overlapping functions involving the hydrolysis of D-Ala-D-Ala and the removal of D-Ala from membrane-bound lipid intermediates, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7KmmqClbHqrVg90H21EOLACvtfcHk0ljCOdzE2Djapg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVejs7w%253D&md5=9480d7d9cff343e85bfeee8b69525e3f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.1998.01114.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.1998.01114.x%26sid%3Dliteratum%253Aachs%26aulast%3DArthur%26aufirst%3DM.%26aulast%3DDepardieu%26aufirst%3DF.%26aulast%3DCabanie%26aufirst%3DL.%26aulast%3DReynolds%26aufirst%3DP.%26aulast%3DCourvalin%26aufirst%3DP.%26atitle%3DRequirement%2520of%2520the%2520vanY%2520and%2520vanX%2520D%252CD-peptidases%2520for%2520glycopeptide%2520resistance%2520in%2520enterococci%26jtitle%3DMol.%2520Microbiol.%26date%3D1998%26volume%3D30%26spage%3D819%26epage%3D830%26doi%3D10.1046%2Fj.1365-2958.1998.01114.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depardieu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courvalin, P.</span></span> <span> </span><span class="NLM_article-title">The vanZ gene of Tn1546 from <i>Enterococcus faecium</i> BM4147 confers resistance to teicoplanin</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">87</span>â <span class="NLM_lpage">92</span>, <span class="refDoi">Â DOI: 10.1016/0378-1119(94)00851-I</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2F0378-1119%2894%2900851-I" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=7867956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK2MXjvFyhsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=1995&pages=87-92&author=M.+Arthurauthor=F.+Depardieuauthor=C.+Molinasauthor=P.+Reynoldsauthor=P.+Courvalin&title=The+vanZ+gene+of+Tn1546+from+Enterococcus+faecium+BM4147+confers+resistance+to+teicoplanin&doi=10.1016%2F0378-1119%2894%2900851-I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin</span></div><div class="casAuthors">Arthur, Michel; Depardieu, Florence; Molinas, Catherine; Reynolds, Peter; Courvalin, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-92</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A 5-gene cluster from Tn1546 confers resistance to the glycopeptide antibiotics vancomycin (Vm) and teicoplanin (Te) by synthesis of pentadepsipeptide peptidoglycan precursors terminating in D-lactate, which replaces D-alanine in the same position of precursors utilized by susceptible enterococci.  Cloning and nucleotide sequencing indicated that Tn1546 contains an addnl. gene, designated vanZ, which confers low-level Te resistance, in the absence of the genes required for pentadepsipeptide synthesis.  Anal. of cytoplasmic peptidoglycan precursors, accumulated in the presence of ramoplanin, showed that VanZ-mediated Te resistance does not involve incorporation of a substituent of D-alanine into the precursors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7UxYWUpxqCLVg90H21EOLACvtfcHk0ljgWCKKDzIQ0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvFyhsr8%253D&md5=0d514e7d19547199011a5d061325255f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2F0378-1119%2894%2900851-I&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-1119%252894%252900851-I%26sid%3Dliteratum%253Aachs%26aulast%3DArthur%26aufirst%3DM.%26aulast%3DDepardieu%26aufirst%3DF.%26aulast%3DMolinas%26aufirst%3DC.%26aulast%3DReynolds%26aufirst%3DP.%26aulast%3DCourvalin%26aufirst%3DP.%26atitle%3DThe%2520vanZ%2520gene%2520of%2520Tn1546%2520from%2520Enterococcus%2520faecium%2520BM4147%2520confers%2520resistance%2520to%2520teicoplanin%26jtitle%3DGene%26date%3D1995%26volume%3D154%26spage%3D87%26epage%3D92%26doi%3D10.1016%2F0378-1119%2894%2900851-I" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arias, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courvalin, P.</span></span> <span> </span><span class="NLM_article-title">Gene vanXYC encodes D,D -dipeptidase (vanX) and D,D-carboxypeptidase (vanY) activities in vancomycin-resistant <i>Enterococcus gallinarum</i> BM4174</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">341</span>â <span class="NLM_lpage">349</span>, <span class="refDoi">Â DOI: 10.1046/j.1365-2958.1999.01604.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1046%2Fj.1365-2958.1999.01604.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10564477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK1MXntVSkt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1999&pages=341-349&author=P.+E.+Reynoldsauthor=C.+A.+Ariasauthor=P.+Courvalin&title=Gene+vanXYC+encodes+D%2CD+-dipeptidase+%28vanX%29+and+D%2CD-carboxypeptidase+%28vanY%29+activities+in+vancomycin-resistant+Enterococcus+gallinarum+BM4174&doi=10.1046%2Fj.1365-2958.1999.01604.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Gene vanXYC encodes D,D-dipeptidase (VanX) and D,D-carboxypeptidase (VanY) activities in vancomycin-resistant Enterococcus gallinarum BM4174</span></div><div class="casAuthors">Reynolds, Peter E.; Arias, Cesar A.; Courvalin, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">341-349</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">VanX and VanY have strict D,D-dipeptidase and D,D-carboxypeptidase activity, resp., that eliminates prodn. of peptidoglycan precursors ending in D-alanyl-D-alanine (D-Ala-D-Ala) in glycopeptide-resistant enterococci in which the C-terminal D-Ala residue has been replaced by D-lactate.  Enterococcus gallinarum BM4174 synthesizes peptidoglycan precursors ending in D-Ala-D-serine (D-Ala-D-Ser) essential for VanC-type vancomycin resistance.  Insertional inactivation of the vanC-1 gene encoding the ligase that catalyzes synthesis of D-Ala-D-Ser has a polar effect on both D,D-dipeptidase and D,D-carboxypeptidase activities.  The open reading frame downstream from vanC-1 encoded a sol. protein designated VanXYC (Mr22318), which had both of these activities.  It had 39% identity and 74% similarity to VanY in an overlap of 158 amino acids, and contained consensus sequences for binding zinc, stabilizing the binding of substrate and catalyzing hydrolysis that are present in both VanX- and VanY-type enzymes.  It had very low dipeptidase activity against D-Ala-D-Ser, unlike VanX, and no activity against UDP-MurNAc-pentapeptide[D-Ser], unlike VanY.  The introduction of plasmid pAT708(vanC-1,XYC) or pAT717(vanXYC) into vancomycin-susceptible Enterococcus faecalis JH2-2 conferred low-level vancomycin resistance only when D-Ser was present in the growth medium.  The peptidoglycan precursor profiles of E. faecalis JH2-2 and JH2-2(pAT708) and JH2-2(pAT717) indicated that the function of VanXYC was hydrolysis of D-Ala-D-Ala and removal of D-Ala from UDP-MurNAc-pentapeptide[D-Ala].  VanC-1 and VanXYC were essential, but not sufficient, for vancomycin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWCVngviwAn7Vg90H21EOLACvtfcHk0ljgWCKKDzIQ0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntVSkt74%253D&md5=e3ba1aba599cbaf0f59644a5ca65b0af</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.1999.01604.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.1999.01604.x%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DP.%2BE.%26aulast%3DArias%26aufirst%3DC.%2BA.%26aulast%3DCourvalin%26aufirst%3DP.%26atitle%3DGene%2520vanXYC%2520encodes%2520D%252CD%2520-dipeptidase%2520%2528vanX%2529%2520and%2520D%252CD-carboxypeptidase%2520%2528vanY%2529%2520activities%2520in%2520vancomycin-resistant%2520Enterococcus%2520gallinarum%2520BM4174%26jtitle%3DMol.%2520Microbiol.%26date%3D1999%26volume%3D34%26spage%3D341%26epage%3D349%26doi%3D10.1046%2Fj.1365-2958.1999.01604.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Podmore, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, P. E.</span></span> <span> </span><span class="NLM_article-title">Purification and characterization of vanXY(C), a D,D-dipeptidase/D,D-carboxypeptidase in vancomycin-resistant <i>Enterococcus gallinarum</i> BM4174</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>269</i></span>,  <span class="NLM_fpage">2740</span>â <span class="NLM_lpage">2746</span>, <span class="refDoi">Â DOI: 10.1046/j.1432-1033.2002.02946.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1046%2Fj.1432-1033.2002.02946.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=12047383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD38XkslWku7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=2002&pages=2740-2746&author=A.+H.+Podmoreauthor=P.+E.+Reynolds&title=Purification+and+characterization+of+vanXY%28C%29%2C+a+D%2CD-dipeptidase%2FD%2CD-carboxypeptidase+in+vancomycin-resistant+Enterococcus+gallinarum+BM4174&doi=10.1046%2Fj.1432-1033.2002.02946.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and characterization of VanXYC, a D,D-dipeptidase/D,D-carboxypeptidase in vancomycin-resistant Enterococcus gallinarum BM4174</span></div><div class="casAuthors">Podmore, Adrian H. B.; Reynolds, Peter E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2740-2746</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">VanXYC, a bifunctional enzyme from VanC-phenotype Enterococcus gallinarum BM4174 that catalyzes D,D-peptidase and D,D-carboxypeptidase activities, was purified as the native protein, as a maltose-binding protein fusion and with an N-terminal tag contg. six histidine residues.  The kinetic parameters of His6-VanXYC were measured for a variety of precursors of peptidoglycan synthesis involved in resistance: for D-Ala-D-Ala, the Km was 3.6 mM and kcat, 2.5 s-1; for UDP-MurNAc-L-Ala-D-Glu-L-Lys-D-Ala-D-Ala (UDP-MurNAc-pentapeptide[Ala]), Km was 18.8 mM and kcat 6.2 s-1; for D-Ala-D-Ser, Km was 15.5 mM and kcat 0.35 s-1.  His6-VanXYC was inactive against the peptidoglycan precursor UDP-MurNAc-L-Ala-D-Glu-L-Lys-D-Ala-D-Ser (UDP-MurNAc-pentapeptide[Ser]).  The rate of hydrolysis of the terminal D-Ala of UDP-MurNAc-pentapeptide[Ala] was inhibited 30% by 2 mM D-Ala-D-Ser or UDP-MurNAc-pentapeptide[Ser].  Therefore preferential hydrolysis of substrates terminating in D-Ala would occur during peptidoglycan synthesis in E. gallinarum BM4174, leaving precursors ending in D-Ser with a lower affinity for glycopeptides to be incorporated into peptidoglycan.  Mutation of an aspartate residue (Asp59) of His-tagged VanXYC corresponding to Asp68 in VanX to Ser or Ala, resulted in a 50% increase and 73% decrease, resp., of the specificity const. (kcat/Km) for D-Ala-D-Ala.  This situation is in contrast to VanX in which mutation of Asp68âAla produced a greater than 200 000-fold decrease in the substrate specificity const.  This suggests that Asp59, unlike Asp68 in VanX, does not have a pivotal role in catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_2UwQnL0qY7Vg90H21EOLACvtfcHk0ljgWCKKDzIQ0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkslWku7s%253D&md5=af2908e10604c0809612c7dc5b4c33a6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1033.2002.02946.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1033.2002.02946.x%26sid%3Dliteratum%253Aachs%26aulast%3DPodmore%26aufirst%3DA.%2BH.%26aulast%3DReynolds%26aufirst%3DP.%2BE.%26atitle%3DPurification%2520and%2520characterization%2520of%2520vanXY%2528C%2529%252C%2520a%2520D%252CD-dipeptidase%252FD%252CD-carboxypeptidase%2520in%2520vancomycin-resistant%2520Enterococcus%2520gallinarum%2520BM4174%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2002%26volume%3D269%26spage%3D2740%26epage%3D2746%26doi%3D10.1046%2Fj.1432-1033.2002.02946.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hafer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornblum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowy, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlemann, A. C.</span></span> <span> </span><span class="NLM_article-title">Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate <i>Staphylococcus aureus</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5845</span>â <span class="NLM_lpage">5851</span>, <span class="refDoi">Â DOI: 10.1128/AAC.01139-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.01139-12" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=5845-5851&author=C.+Haferauthor=Y.+Linauthor=J.+Kornblumauthor=F.+D.+Lowyauthor=A.+C.+Uhlemann&title=Contribution+of+selected+gene+mutations+to+resistance+in+clinical+isolates+of+vancomycin-intermediate+Staphylococcus+aureus&doi=10.1128%2FAAC.01139-12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FAAC.01139-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01139-12%26sid%3Dliteratum%253Aachs%26aulast%3DHafer%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DKornblum%26aufirst%3DJ.%26aulast%3DLowy%26aufirst%3DF.%2BD.%26aulast%3DUhlemann%26aufirst%3DA.%2BC.%26atitle%3DContribution%2520of%2520selected%2520gene%2520mutations%2520to%2520resistance%2520in%2520clinical%2520isolates%2520of%2520vancomycin-intermediate%2520Staphylococcus%2520aureus%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D5845%26epage%3D5851%26doi%3D10.1128%2FAAC.01139-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howden, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEvoy, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chua, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coombs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett-Wood, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robins-Browne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seemann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinear, T. P.</span></span> <span> </span><span class="NLM_article-title">Evolution of multidrug resistance during <i>Staphylococcus aureus</i> infection involves mutation of the essential two component regulator WalKR</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e1002359</span>, <span class="refDoi">Â DOI: 10.1371/journal.ppat.1002359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1371%2Fjournal.ppat.1002359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=22102812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFKqtLnI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=e1002359&author=B.+P.+Howdenauthor=C.+R.+McEvoyauthor=D.+L.+Allenauthor=K.+Chuaauthor=W.+Gaoauthor=P.+F.+Harrisonauthor=J.+Bellauthor=G.+Coombsauthor=V.+Bennett-Woodauthor=J.+L.+Porterauthor=R.+Robins-Browneauthor=J.+K.+Daviesauthor=T.+Seemannauthor=T.+P.+Stinear&title=Evolution+of+multidrug+resistance+during+Staphylococcus+aureus+infection+involves+mutation+of+the+essential+two+component+regulator+WalKR&doi=10.1371%2Fjournal.ppat.1002359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR</span></div><div class="casAuthors">Howden, Benjamin P.; McEvoy, Christopher R. E.; Allen, David L.; Chua, Kyra; Gao, Wei; Harrison, Paul F.; Bell, Jan; Coombs, Geoffrey; Bennett-Wood, Vicki; Porter, Jessica L.; Robins-Browne, Roy; Davies, John K.; Seemann, Torsten; Stinear, Timothy P.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e1002359</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Antimicrobial resistance in Staphylococcus aureus is a major public health threat, compounded by emergence of strains with resistance to vancomycin and daptomycin, both last line antimicrobials.  Here, the authors have performed high throughput DNA sequencing and comparative genomics for five clin. pairs of vancomycin-susceptible (VSSA) and vancomycin-intermediate ST239 S. aureus (VISA); each pair isolated before and after vancomycin treatment failure.  These comparisons revealed a frequent pattern of mutation among the VISA strains within the essential walKR two-component regulatory locus involved in control of cell wall metab.  The authors then conducted bi-directional allelic exchange expts. in the clin. VSSA and VISA strains and showed that single nucleotide substitutions within either walK or walR lead to co-resistance to vancomycin and daptomycin, and caused the typical cell wall thickening obsd. in resistant clin. isolates.  Ion Torrent genome sequencing confirmed no addnl. regulatory mutations had been introduced into either the walR or walK VISA mutants during the allelic exchange process.  However, two potential compensatory mutations were detected within putative transport genes for the walK mutant.  The minimal genetic changes in either walK or walR also attenuated virulence, reduced biofilm formation, and led to consistent transcriptional changes that suggest an important role for this regulator in control of central metab.  This study highlights the dramatic impacts of single mutations that arise during persistent S. aureus infections and demonstrates the role played by walKR to increase drug resistance, control metab. and alter the virulence potential of this pathogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTaLlZ4JNmRrVg90H21EOLACvtfcHk0li2XQB9L06OSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFKqtLnI&md5=7f90aed9bfbd12b36aebfa52b1fd99c0</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002359%26sid%3Dliteratum%253Aachs%26aulast%3DHowden%26aufirst%3DB.%2BP.%26aulast%3DMcEvoy%26aufirst%3DC.%2BR.%26aulast%3DAllen%26aufirst%3DD.%2BL.%26aulast%3DChua%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DHarrison%26aufirst%3DP.%2BF.%26aulast%3DBell%26aufirst%3DJ.%26aulast%3DCoombs%26aufirst%3DG.%26aulast%3DBennett-Wood%26aufirst%3DV.%26aulast%3DPorter%26aufirst%3DJ.%2BL.%26aulast%3DRobins-Browne%26aufirst%3DR.%26aulast%3DDavies%26aufirst%3DJ.%2BK.%26aulast%3DSeemann%26aufirst%3DT.%26aulast%3DStinear%26aufirst%3DT.%2BP.%26atitle%3DEvolution%2520of%2520multidrug%2520resistance%2520during%2520Staphylococcus%2520aureus%2520infection%2520involves%2520mutation%2520of%2520the%2520essential%2520two%2520component%2520regulator%2520WalKR%26jtitle%3DPLoS%2520Pathog.%26date%3D2011%26volume%3D7%26spage%3De1002359%26doi%3D10.1371%2Fjournal.ppat.1002359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howden, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinear, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J. K.</span></span> <span> </span><span class="NLM_article-title">Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical <i>Staphylococcus aureus</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3755</span>â <span class="NLM_lpage">3762</span>, <span class="refDoi">Â DOI: 10.1128/AAC.01613-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.01613-07" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3755-3762&author=B.+P.+Howdenauthor=T.+P.+Stinearauthor=D.+L.+Allenauthor=P.+D.+Johnsonauthor=P.+B.+Wardauthor=J.+K.+Davies&title=Genomic+analysis+reveals+a+point+mutation+in+the+two-component+sensor+gene+graS+that+leads+to+intermediate+vancomycin+resistance+in+clinical+Staphylococcus+aureus&doi=10.1128%2FAAC.01613-07"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1128%2FAAC.01613-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01613-07%26sid%3Dliteratum%253Aachs%26aulast%3DHowden%26aufirst%3DB.%2BP.%26aulast%3DStinear%26aufirst%3DT.%2BP.%26aulast%3DAllen%26aufirst%3DD.%2BL.%26aulast%3DJohnson%26aufirst%3DP.%2BD.%26aulast%3DWard%26aufirst%3DP.%2BB.%26aulast%3DDavies%26aufirst%3DJ.%2BK.%26atitle%3DGenomic%2520analysis%2520reveals%2520a%2520point%2520mutation%2520in%2520the%2520two-component%2520sensor%2520gene%2520graS%2520that%2520leads%2520to%2520intermediate%2520vancomycin%2520resistance%2520in%2520clinical%2520Staphylococcus%2520aureus%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3755%26epage%3D3762%26doi%3D10.1128%2FAAC.01613-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, K.</span></span> <span> </span><span class="NLM_article-title">Two-component system vraSR positively modulates the regulation of cell-wall biosynthesis pathway in <i>Staphylococcus aureus</i></span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">807</span>â <span class="NLM_lpage">821</span>, <span class="refDoi">Â DOI: 10.1046/j.1365-2958.2003.03599.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1046%2Fj.1365-2958.2003.03599.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=12864861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtFektb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2003&pages=807-821&author=M.+Kurodaauthor=H.+Kurodaauthor=T.+Oshimaauthor=F.+Takeuchiauthor=H.+Moriauthor=K.+Hiramatsu&title=Two-component+system+vraSR+positively+modulates+the+regulation+of+cell-wall+biosynthesis+pathway+in+Staphylococcus+aureus&doi=10.1046%2Fj.1365-2958.2003.03599.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus</span></div><div class="casAuthors">Kuroda, Makoto; Kuroda, Hiroko; Oshima, Taku; Takeuchi, Fumihiko; Mori, Hirotada; Hiramatsu, Keiichi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">807-821</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">DNA microarray covering the whole genome of Staphylococcus aureus strain N315 was prepd. to investigate transcription profiles.  The microarray analyses revealed that vancomycin induces transcription of 139 genes.  Forty-six genes among them failed to be induced in the vraSR null mutant KVR.  Part of the genes regulated by VraSR system is assocd. with cell-wall biosynthesis, such as PBP2, SgtB and MurZ.  Other cell-wall synthesis inhibitors also induced VraSR, suggesting that the sensor kinase VraS responds to the damage of cell-wall structure or inhibition of cell-wall biosynthesis.  Addnl., the vraSR null mutants derived from hetero- and homo-methicillin-resistant S. aureus showed significant decrease of resistance against teicoplanin, Î²-lactam, bacitracin and fosfomycin but not of D-cycloserine and levofloxacin.  The observation strongly indicates that VraSR constitutes a pos. regulator of cell-wall peptidoglycan synthesis, and that is deeply involved in the expression of Î²-lactam and glycopeptide resistance in S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqENYlaTCkTobVg90H21EOLACvtfcHk0liNxlRH6hT-hQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtFektb8%253D&md5=5313d2f39f127f0153fadde6335e9108</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2003.03599.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2003.03599.x%26sid%3Dliteratum%253Aachs%26aulast%3DKuroda%26aufirst%3DM.%26aulast%3DKuroda%26aufirst%3DH.%26aulast%3DOshima%26aufirst%3DT.%26aulast%3DTakeuchi%26aufirst%3DF.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DHiramatsu%26aufirst%3DK.%26atitle%3DTwo-component%2520system%2520vraSR%2520positively%2520modulates%2520the%2520regulation%2520of%2520cell-wall%2520biosynthesis%2520pathway%2520in%2520Staphylococcus%2520aureus%26jtitle%3DMol.%2520Microbiol.%26date%3D2003%26volume%3D49%26spage%3D807%26epage%3D821%26doi%3D10.1046%2Fj.1365-2958.2003.03599.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, K.</span></span> <span> </span><span class="NLM_article-title">Impact of rpoB mutations on reduced vancomycin susceptibility in <i>Staphylococcus aureus</i></span>. <i>J. Clin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">2680</span>â <span class="NLM_lpage">2684</span>, <span class="refDoi">Â DOI: 10.1128/JCM.02144-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FJCM.02144-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=21525224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BC3Mnks1Kgtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2011&pages=2680-2684&author=Y.+Watanabeauthor=L.+Cuiauthor=Y.+Katayamaauthor=K.+Kozueauthor=K.+Hiramatsu&title=Impact+of+rpoB+mutations+on+reduced+vancomycin+susceptibility+in+Staphylococcus+aureus&doi=10.1128%2FJCM.02144-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus</span></div><div class="casAuthors">Watanabe Yukiko; Cui Longzhu; Katayama Yuki; Kozue Kishii; Hiramatsu Keiichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical microbiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2680-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Of 38 vancomycin-intermediate Staphylococcus aureus (VISA) clinical strains, 27 (71%) possessed a mutation(s) in rpoB encoding the Î²-subunit of RNA polymerase.  Furthermore, 95.6% of the rifampin-resistant mutants obtained from 9 methicillin-resistant S. aureus (MRSA) clinical isolates showed decreased vancomycin susceptibilities.  These data indicate the involvement of an rpoB mutation in VISA phenotype expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTG4IaFRoMovpSWdIdmEou5fW6udTcc2eb_P92nZUBJErntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mnks1Kgtw%253D%253D&md5=bb1c2d8798ccb11e661d8623735daae6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1128%2FJCM.02144-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.02144-10%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DCui%26aufirst%3DL.%26aulast%3DKatayama%26aufirst%3DY.%26aulast%3DKozue%26aufirst%3DK.%26aulast%3DHiramatsu%26aufirst%3DK.%26atitle%3DImpact%2520of%2520rpoB%2520mutations%2520on%2520reduced%2520vancomycin%2520susceptibility%2520in%2520Staphylococcus%2520aureus%26jtitle%3DJ.%2520Clin.%2520Microbiol.%26date%3D2011%26volume%3D49%26spage%3D2680%26epage%3D2684%26doi%3D10.1128%2FJCM.02144-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiotsuka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, B. T.</span></span> <span> </span><span class="NLM_article-title">Presence of both heterogeneous vancomycin-intermediate resistance and Î²-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant <i>Staphylococcus aureus</i> bloodstream infection</span>. <i>Scand. J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">203</span>â <span class="NLM_lpage">212</span>, <span class="refDoi">Â DOI: 10.3109/00365548.2012.723221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.3109%2F00365548.2012.723221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=23113753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivFaqtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=203-212&author=T.+Takataauthor=M.+Miyazakiauthor=M.+Futoauthor=S.+Haraauthor=S.+Shiotsukaauthor=H.+Kamimuraauthor=H.+Yoshimuraauthor=A.+Matsunagaauthor=T.+Nishidaauthor=H.+Ishikuraauthor=T.+Ishikawaauthor=K.+Tamuraauthor=B.+T.+Tsuji&title=Presence+of+both+heterogeneous+vancomycin-intermediate+resistance+and+%CE%B2-lactam+antibiotic-induced+vancomycin+resistance+phenotypes+is+associated+with+the+outcome+in+methicillin-resistant+Staphylococcus+aureus+bloodstream+infection&doi=10.3109%2F00365548.2012.723221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Presence of both heterogeneous vancomycin-intermediate resistance and Î²-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection</span></div><div class="casAuthors">Takata, Tohru; Miyazaki, Motoyasu; Futo, Maki; Hara, Shuji; Shiotsuka, Shouichi; Kamimura, Hidetoshi; Yoshimura, Hisae; Matsunaga, Akira; Nishida, Takeshi; Ishikura, Hiroyasu; Ishikawa, Takahiko; Tamura, Kazuo; Tsuji, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-212</span>CODEN:
                <span class="NLM_cas:coden">SJIDB7</span>;
        ISSN:<span class="NLM_cas:issn">0036-5548</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Background: Although the individual expression of heterogeneous vancomycin-intermediate resistance (hVISA) and Î²-lactam antibiotic-induced vancomycin resistance (BIVR) phenotypes has been assocd. with treatment failure and recurrence in methicillin-resistant Staphylococcus aureus (MRSA) infections, the effect of the co-expression of these phenotypic profiles on clin. outcome has not been fully elucidated.  The aim of this study was to det. the impact of the combination of hVISA and BIVR phenotypes on the clin. outcome in MRSA bacteremia.  Methods: One hundred and sixty-two MRSA blood isolates from a 21-y period, 1987-2007, were randomly selected.  Screening for hVISA was done by the macromethod Etest and confirmed by population anal. profiles.  BIVR was identified using Mu3 agar contg. 4 Î¼g/mL of vancomycin.  Results: Thirty (18.5%) and 39 (24.1%) of the 162 MRSA blood isolates were pos. for the hVISA and BIVR phenotypes, resp.  Eighteen (11.1%) isolates possessed both hVISA and BIVR phenotypes (hVISA(+)/BIVR(+)).  In a subset of patients who received initial treatment with glycopeptides, only the patients whose isolates were hVISA(+)/BIVR(+) displayed a significantly higher mortality rate in comparison to those with non-hVISA(+)/BIVR(+) (80.0% vs 31.3%, p = 0.004).  The presence of both hVISA and BIVR phenotypes was a predictor of mortality using a logistic regression anal. (p = 0.025).  Conclusions: The combined phenotype of hVISA and BIVR was assocd. with a higher probability of mortality in patients with MRSA bacteremia.  Further prospective studies are warranted to delineate the clin. significance of the combined phenotype of hVISA and BIVR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNJtMhus8l8LVg90H21EOLACvtfcHk0liNxlRH6hT-hQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivFaqtb0%253D&md5=5bd39f50e516fc9b63b2c47d88f2b15c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3109%2F00365548.2012.723221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00365548.2012.723221%26sid%3Dliteratum%253Aachs%26aulast%3DTakata%26aufirst%3DT.%26aulast%3DMiyazaki%26aufirst%3DM.%26aulast%3DFuto%26aufirst%3DM.%26aulast%3DHara%26aufirst%3DS.%26aulast%3DShiotsuka%26aufirst%3DS.%26aulast%3DKamimura%26aufirst%3DH.%26aulast%3DYoshimura%26aufirst%3DH.%26aulast%3DMatsunaga%26aufirst%3DA.%26aulast%3DNishida%26aufirst%3DT.%26aulast%3DIshikura%26aufirst%3DH.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DTamura%26aufirst%3DK.%26aulast%3DTsuji%26aufirst%3DB.%2BT.%26atitle%3DPresence%2520of%2520both%2520heterogeneous%2520vancomycin-intermediate%2520resistance%2520and%2520%25CE%25B2-lactam%2520antibiotic-induced%2520vancomycin%2520resistance%2520phenotypes%2520is%2520associated%2520with%2520the%2520outcome%2520in%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520bloodstream%2520infection%26jtitle%3DScand.%2520J.%2520Infect.%2520Dis.%26date%3D2013%26volume%3D45%26spage%3D203%26epage%3D212%26doi%3D10.3109%2F00365548.2012.723221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda-Dantsuji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunakawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakae, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanaki, H.</span></span> <span> </span><span class="NLM_article-title">Low level ss-lactamase production in methicillin-resistant <i>Staphylococcus aureus</i> strains with ss-lactam antibiotics-induced vancomycin resistance</span>. <i>BMC Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">69</span>, <span class="refDoi">Â DOI: 10.1186/1471-2180-12-69</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1186%2F1471-2180-12-69" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=22568976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslWjtrrF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=69&author=Y.+Hiraoauthor=Y.+Ikeda-Dantsujiauthor=H.+Matsuiauthor=M.+Yoshidaauthor=S.+Horiauthor=K.+Sunakawaauthor=T.+Nakaeauthor=H.+Hanaki&title=Low+level+ss-lactamase+production+in+methicillin-resistant+Staphylococcus+aureus+strains+with+ss-lactam+antibiotics-induced+vancomycin+resistance&doi=10.1186%2F1471-2180-12-69"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Low level Î²-lactamase production in methicillin-resistant Staphylococcus aureus strains with Î²-lactam antibiotics-induced vancomycin resistance</span></div><div class="casAuthors">Hirao, Yuriko; Ikeda-Dantsuji, Yurika; Matsui, Hidehito; Yoshida, Masaki; Hori, Seiji; Sunakawa, Keisuke; Nakae, Taiji; Hanaki, Hideaki</div><div class="citationInfo"><span class="NLM_cas:title">BMC Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">69</span>CODEN:
                <span class="NLM_cas:coden">BMMIBC</span>;
        ISSN:<span class="NLM_cas:issn">1471-2180</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: A class of methicillin-resistant Staphylococcus aureus (MRSA) shows resistance to vancomycin only in the presence of Î²-lactam antibiotics (BIVR).  This type of vancomycin resistance is mainly attributable to the rapid depletion of free vancomycin in the presence of Î²-lactam antibiotics.  This means that Î²-lactam antibiotics remain active or intact in BIVR culture, although most MRSA cells are assumed to produce Î²-lactamase.  We hypothesised that the BIVR cells either did not harbor the Î²-lactamase gene, blaZ or the gene was quiescent.  We tested this hypothesis by detg. Î²-lactamase activity and conducting PCR amplification of blaZ.  Results: Five randomly selected lab. stock BIVR strains showed an undetectable level of Î²-lactamase activity and were blaZ-neg.  Five non-BIVR stock strains showed an av. Î²-lactamase activity of 2.59 Â± 0.35 U.  To test freshly isolated MRSA, 353 clin. isolates were collected from 11 regionally distant hospitals.  Among 25 BIVR strains, only 16% and 8% were blaZ pos. and Î²-lactamase-pos., resp.  In contrast, 95% and 61% of 328 non-BIVR strains had the blaZ gene and produced active Î²-lactamase, resp.  To know the mechanism of low Î²-lactamase activity in the BIVR cells, they were transformed with the plasmid carrying the blaZ gene.  The transformants still showed a low level of Î²-lactamase activity that was several orders of magnitude lower than that of blaZ-pos. non-BIVR cells.  Presence of the Î²-lactamase gene in the transformants was tested by PCR amplification of blaZ using 11 pairs of primers covering the entire blaZ sequence.  Yield of the PCR products was consistently low compared with that using blaZ-pos. non-BIVR cells.  Nucleotide sequencing of blaZ in one of the BIVR transformants revealed 10 amino acid substitutions.  Thus, it is likely that the Î²-lactamase gene was modified in the BIVR cells to downregulate active Î²-lactamase prodn.  Conclusions: We concluded that BIVR cells gain vancomycin resistance by the elimination or inactivation of Î²-lactamase prodn., thereby preserving Î²-lactam antibiotics in milieu, stimulating peptidoglycan metab. and depleting free vancomycin to a level below the min. inhibitory concn. of vancomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIQ5BvqHVvEbVg90H21EOLACvtfcHk0lgTmXI-Ez7p7w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslWjtrrF&md5=8be0228d6bc75191151d038ef4232aaf</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1186%2F1471-2180-12-69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2180-12-69%26sid%3Dliteratum%253Aachs%26aulast%3DHirao%26aufirst%3DY.%26aulast%3DIkeda-Dantsuji%26aufirst%3DY.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DHori%26aufirst%3DS.%26aulast%3DSunakawa%26aufirst%3DK.%26aulast%3DNakae%26aufirst%3DT.%26aulast%3DHanaki%26aufirst%3DH.%26atitle%3DLow%2520level%2520ss-lactamase%2520production%2520in%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520strains%2520with%2520ss-lactam%2520antibiotics-induced%2520vancomycin%2520resistance%26jtitle%3DBMC%2520Microbiol.%26date%3D2012%26volume%3D12%26spage%3D69%26doi%3D10.1186%2F1471-2180-12-69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howden, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinear, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayson, M. L.</span></span> <span> </span><span class="NLM_article-title">Reduced vancomycin susceptibility in <i>Staphylococcus aureus</i>, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">99</span>â <span class="NLM_lpage">139</span>, <span class="refDoi">Â DOI: 10.1128/CMR.00042-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FCMR.00042-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=20065327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3cXks1Sktb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=99-139&author=B.+P.+Howdenauthor=J.+K.+Daviesauthor=P.+D.+Johnsonauthor=T.+P.+Stinearauthor=M.+L.+Grayson&title=Reduced+vancomycin+susceptibility+in+Staphylococcus+aureus%2C+including+vancomycin-intermediate+and+heterogeneous+vancomycin-intermediate+strains%3A+resistance+mechanisms%2C+laboratory+detection%2C+and+clinical+implications&doi=10.1128%2FCMR.00042-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications</span></div><div class="casAuthors">Howden, Benjamin P.; Davies, John K.; Johnson, Paul D. R.; Stinear, Timothy P.; Grayson, M. Lindsay</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-139</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  The emergence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) over the past decade has provided a challenge to diagnostic microbiologists to detect these strains, clinicians treating patients with infections due to these strains, and researchers attempting to understand the resistance mechanisms.  Recent data show that these strains have been detected globally and in many cases are assocd. with glycopeptide treatment failure; however, more rigorous clin. studies are required to clearly define the contribution of hVISA to glycopeptide treatment outcomes.  It is now becoming clear that sequential point mutations in key global regulatory genes contribute to the hVISA and VISA phenotypes, which are assocd. predominately with cell wall thickening and restricted vancomycin access to its site of activity in the division septum; however, the phenotypic features of these strains can vary because the mutations leading to resistance can vary.  Interestingly, changes in the staphylococcal surface and expression of agr are likely to impact host-pathogen interactions in hVISA and VISA infections.  Given the subtleties of vancomycin susceptibility testing against S. aureus, it is imperative that diagnostic labs. use well-standardized methods and have a framework for detecting reduced vancomycin susceptibility in S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvAM9tPUh2GrVg90H21EOLACvtfcHk0lgTmXI-Ez7p7w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXks1Sktb8%253D&md5=d3c652cd4d82d78356e97e8f118524b0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1128%2FCMR.00042-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00042-09%26sid%3Dliteratum%253Aachs%26aulast%3DHowden%26aufirst%3DB.%2BP.%26aulast%3DDavies%26aufirst%3DJ.%2BK.%26aulast%3DJohnson%26aufirst%3DP.%2BD.%26aulast%3DStinear%26aufirst%3DT.%2BP.%26aulast%3DGrayson%26aufirst%3DM.%2BL.%26atitle%3DReduced%2520vancomycin%2520susceptibility%2520in%2520Staphylococcus%2520aureus%252C%2520including%2520vancomycin-intermediate%2520and%2520heterogeneous%2520vancomycin-intermediate%2520strains%253A%2520resistance%2520mechanisms%252C%2520laboratory%2520detection%252C%2520and%2520clinical%2520implications%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2010%26volume%3D23%26spage%3D99%26epage%3D139%26doi%3D10.1128%2FCMR.00042-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, K.</span></span> <span> </span><span class="NLM_article-title">Vancomycin-resistant <i>Staphylococcus aureus</i>: a new model of antibiotic resistance</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">147</span>â <span class="NLM_lpage">155</span>, <span class="refDoi">Â DOI: 10.1016/S1473-3099(01)00091-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2FS1473-3099%2801%2900091-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=11871491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVOnsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=147-155&author=K.+Hiramatsu&title=Vancomycin-resistant+Staphylococcus+aureus%3A+a+new+model+of+antibiotic+resistance&doi=10.1016%2FS1473-3099%2801%2900091-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance</span></div><div class="casAuthors">Hiramatsu, Keiichi</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">147-155</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Lancet Publishing Group</span>)
        </div><div class="casAbstract">A review.  A review.  Vancomycin was the most reliable therapeutic agent against infections caused by methicillin-resistant Staphylococcus aureus (MRSA).  However, in 1996 the first MRSA to acquire resistance to vancomycin, was isolated from a Japanese patient.  The patient had contracted a post-operative wound infection that was refractory to long-term vancomycin therapy.  Subsequent isolation of several vancomycin resistant S aureus (VRSA) strains from USA, France, Korea, South Africa, and Brazil has confirmed that emergence of vancomycin resistance in S aureus is a global issue.  A certain group of S aureus, designated hetero-VRSA, frequently generate VRSA upon exposure to vancomycin, and are assocd. with infections that are potentially refractory to vancomycin therapy.  Presence of hetero-VRSA may be an important indicator of the insidious decline of the clin. effectiveness of vancomycin in the hospitals.  Vancomycin resistance is acquired by mutation and thickening of cell wall due to accumulation of excess amts. of peptidoglycan.  This seems to be a common resistance mechanism for all VRSA strains isolated in the world so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowuaBZyorHErVg90H21EOLACvtfcHk0lgAHbk1xlu65Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVOnsbs%253D&md5=34781954f8fcb4be6b8d2624ef1a6ecd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2801%2900091-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252801%252900091-3%26sid%3Dliteratum%253Aachs%26aulast%3DHiramatsu%26aufirst%3DK.%26atitle%3DVancomycin-resistant%2520Staphylococcus%2520aureus%253A%2520a%2520new%2520model%2520of%2520antibiotic%2520resistance%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2001%26volume%3D1%26spage%3D147%26epage%3D155%26doi%3D10.1016%2FS1473-3099%2801%2900091-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howden, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peleg, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinear, T. P.</span></span> <span> </span><span class="NLM_article-title">The evolution of vancomycin intermediate <i>Staphylococcus aureus</i> (VISA) and heterogenous-VISA. <i>Infection, genetics and evolution</i></span>. <i>Infect., Genet. Evol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">575</span>â <span class="NLM_lpage">582</span>, <span class="refDoi">Â DOI: 10.1016/j.meegid.2013.03.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.meegid.2013.03.047" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=575-582&author=B.+P.+Howdenauthor=A.+Y.+Pelegauthor=T.+P.+Stinear&title=The+evolution+of+vancomycin+intermediate+Staphylococcus+aureus+%28VISA%29+and+heterogenous-VISA.+Infection%2C+genetics+and+evolution&doi=10.1016%2Fj.meegid.2013.03.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.meegid.2013.03.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.meegid.2013.03.047%26sid%3Dliteratum%253Aachs%26aulast%3DHowden%26aufirst%3DB.%2BP.%26aulast%3DPeleg%26aufirst%3DA.%2BY.%26aulast%3DStinear%26aufirst%3DT.%2BP.%26atitle%3DThe%2520evolution%2520of%2520vancomycin%2520intermediate%2520Staphylococcus%2520aureus%2520%2528VISA%2529%2520and%2520heterogenous-VISA.%2520Infection%252C%2520genetics%2520and%2520evolution%26jtitle%3DInfect.%252C%2520Genet.%2520Evol.%26date%3D2014%26volume%3D21%26spage%3D575%26epage%3D582%26doi%3D10.1016%2Fj.meegid.2013.03.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pfeltz, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, B. J.</span></span> <span> </span><span class="NLM_article-title">The escalating challenge of vancomycin resistance in <i>Staphylococcus aureus</i></span>. <i>Curr. Drug Targets: Infect. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">273</span>â <span class="NLM_lpage">294</span>, <span class="refDoi">Â DOI: 10.2174/1568005043340470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.2174%2F1568005043340470" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=15578969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVWgsrvF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=273-294&author=R.+F.+Pfeltzauthor=B.+J.+Wilkinson&title=The+escalating+challenge+of+vancomycin+resistance+in+Staphylococcus+aureus&doi=10.2174%2F1568005043340470"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The escalating challenge of vancomycin resistance in Staphylococcus aureus</span></div><div class="casAuthors">Pfeltz, R. F.; Wilkinson, B. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: Infectious Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">273-294</span>CODEN:
                <span class="NLM_cas:coden">CDTIAS</span>;
        ISSN:<span class="NLM_cas:issn">1568-0053</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The glycopeptide antibiotic vancomycin is considered indispensable for the treatment of multidrug-resistant Staphylococcus aureus infections, and so the acquisition by these organisms of transmissible glycopeptide resistance elements from enterococci had been anticipated with apprehension.  It was, therefore, a considerable surprise when vancomycin-intermediate S. aureus (VISA) clin. isolates were reported in 1997, with a novel, borderline-resistance phenotype acquired without genetic exchange.  Clin. vancomycin-resistant S. aureus (VRSA) were not reported until 2002, expressing high level, transmissible resistance by virtue of vanA resistance determinants within enterococcal transposable elements residing on staphylococcal plasmids.  This review provides an update on the frustratingly variable characteristics of the VISA phenotype, focus on the progress made in understanding the mol. basis of the VISA resistance mechanism from the viewpoint of genetic regulation and cell wall stress response, and summarize the information currently available on VRSA.  Finally, alternatives to vancomycin that are already available or nearing approval will be briefly reviewed, with attention to their limitations and potential for resistance development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZDY7SFW9WZ7Vg90H21EOLACvtfcHk0lgAHbk1xlu65Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVWgsrvF&md5=7983b6886bb7a69ed948846a4c6af723</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F1568005043340470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568005043340470%26sid%3Dliteratum%253Aachs%26aulast%3DPfeltz%26aufirst%3DR.%2BF.%26aulast%3DWilkinson%26aufirst%3DB.%2BJ.%26atitle%3DThe%2520escalating%2520challenge%2520of%2520vancomycin%2520resistance%2520in%2520Staphylococcus%2520aureus%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520Infect.%2520Disord.%26date%3D2004%26volume%3D4%26spage%3D273%26epage%3D294%26doi%3D10.2174%2F1568005043340470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, R. A.</span></span> <span> </span><span class="NLM_article-title">The prevalence and mechanisms of vancomycin resistance in <i>Staphylococcus aureus</i></span>. <i>Annu. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">657</span>â <span class="NLM_lpage">675</span>, <span class="refDoi">Â DOI: 10.1146/annurev.micro.56.012302.160806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1146%2Fannurev.micro.56.012302.160806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=12142482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD38Xos1Gisb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2002&pages=657-675&author=T.+R.+Walshauthor=R.+A.+Howe&title=The+prevalence+and+mechanisms+of+vancomycin+resistance+in+Staphylococcus+aureus&doi=10.1146%2Fannurev.micro.56.012302.160806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus</span></div><div class="casAuthors">Walsh, Timothy R.; Howe, Robin A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">657-675</span>CODEN:
                <span class="NLM_cas:coden">ARMIAZ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4227</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The emergence of Staphylococcus aureus resistant to vancomycin has caused considerable concern.  Such strains are currently rare, although they have been isolated from many areas of the world.  Considerable controversy surrounds strains of S. aureus displaying heterogeneous resistance to vancomycin regarding their definition and methods for detection.  This has led to considerable variance in ests. of prevalence (0-1.3%-20% in Japan) and has hindered efforts to define the clin. relevance of these strains.  The mechanism of resistance involves a complex reorganization of cell wall metab., leading to a grossly thickened cell wall with reduced peptidoglycan crosslinking.  There may be many different ways in which strains achieve this endpoint.  Current knowledge and theories are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3OfdZXD3KHbVg90H21EOLACvtfcHk0lgAHbk1xlu65Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xos1Gisb8%253D&md5=e04b7af25fc37d30801d10a0bdc90ad3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1146%2Fannurev.micro.56.012302.160806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.micro.56.012302.160806%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DT.%2BR.%26aulast%3DHowe%26aufirst%3DR.%2BA.%26atitle%3DThe%2520prevalence%2520and%2520mechanisms%2520of%2520vancomycin%2520resistance%2520in%2520Staphylococcus%2520aureus%26jtitle%3DAnnu.%2520Rev.%2520Microbiol.%26date%3D2002%26volume%3D56%26spage%3D657%26epage%3D675%26doi%3D10.1146%2Fannurev.micro.56.012302.160806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gardete, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mwangi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasz, A.</span></span> <span> </span><span class="NLM_article-title">Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant <i>Staphylococcus aureus</i> (MRSA) strain of clonal type USA300</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e1002505</span>, <span class="refDoi">Â DOI: 10.1371/journal.ppat.1002505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1371%2Fjournal.ppat.1002505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=22319446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFeqsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=e1002505&author=S.+Gardeteauthor=C.+Kimauthor=B.+M.+Hartmannauthor=M.+Mwangiauthor=C.+M.+Rouxauthor=P.+M.+Dunmanauthor=H.+F.+Chambersauthor=A.+Tomasz&title=Genetic+pathway+in+acquisition+and+loss+of+vancomycin+resistance+in+a+methicillin+resistant+Staphylococcus+aureus+%28MRSA%29+strain+of+clonal+type+USA300&doi=10.1371%2Fjournal.ppat.1002505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin-resistant Staphylococcus aureus (MRSA) strain of clonal type USA300</span></div><div class="casAuthors">Gardete, Susana; Kim, Choonkeun; Hartmann, Boris M.; Mwangi, Michael; Roux, Christelle M.; Dunman, Paul M.; Chambers, Henry F.; Tomasz, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e1002505</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">An isolate of the methicillin-resistant Staphylococcus aureus (MRSA) clone USA300 with reduced susceptibility to vancomycin (SG-R) (i.e., vancomycin-intermediate S. aureus, VISA) and its susceptible "parental" strain (SG-S) were recovered from a patient at the end and at the beginning of an unsuccessful vancomycin therapy.  The VISA phenotype was unstable in vitro generating a susceptible revertant strain (SG-rev).  The availability of these 3 isogenic strains allowed us to explore genetic correlates of antibiotic resistance as it emerged in vivo.  Compared to the susceptible isolate, both the VISA and revertant strains carried the same point mutations in yycH, vraG, yvqF and lspA genes and a substantial deletion within an intergenic region.  The revertant strain carried a single addnl. frameshift mutation in vraS which is part of two component regulatory system VraSR.  VISA isolate SG-R showed complex alterations in phenotype: decreased susceptibility to other antibiotics, slow autolysis, abnormal cell division and increased thickness of cell wall.  There was also altered expression of 239 genes including down-regulation of major virulence determinants.  All phenotypic properties and gene expression profile returned to parental levels in the revertant strain.  Introduction of wild-type yvqF on a multicopy plasmid into the VISA strain caused loss of resistance along with loss of all the assocd. phenotypic changes.  Introduction of the wild-type vraSR into the revertant strain caused recovery of VISA type resistance.  The yvqF/vraSR operon seems to function as an on/off switch: mutation in yvqF in strain SG-R turns on the vraSR system, which leads to increase in vancomycin resistance and down-regulation of virulence determinants.  Mutation in vraS in the revertant strain turns off this regulatory system accompanied by loss of resistance and normal expression of virulence genes.  Down-regulation of virulence genes may provide VISA strains with a "stealth" strategy to evade detection by the host immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXhBzsdiMdfLVg90H21EOLACvtfcHk0lhZJTBzwlK7LQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFeqsL8%253D&md5=01b164174dd56ff1cd9407cfc0c0b493</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002505%26sid%3Dliteratum%253Aachs%26aulast%3DGardete%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DHartmann%26aufirst%3DB.%2BM.%26aulast%3DMwangi%26aufirst%3DM.%26aulast%3DRoux%26aufirst%3DC.%2BM.%26aulast%3DDunman%26aufirst%3DP.%2BM.%26aulast%3DChambers%26aufirst%3DH.%2BF.%26aulast%3DTomasz%26aufirst%3DA.%26atitle%3DGenetic%2520pathway%2520in%2520acquisition%2520and%2520loss%2520of%2520vancomycin%2520resistance%2520in%2520a%2520methicillin%2520resistant%2520Staphylococcus%2520aureus%2520%2528MRSA%2529%2520strain%2520of%2520clonal%2520type%2520USA300%26jtitle%3DPLoS%2520Pathog.%26date%3D2012%26volume%3D8%26spage%3De1002505%26doi%3D10.1371%2Fjournal.ppat.1002505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sieradzki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasz, A.</span></span> <span> </span><span class="NLM_article-title">Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of <i>Staphylococcus aureus</i></span>. <i>Journal of bacteriology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">7103</span>â <span class="NLM_lpage">7110</span>, <span class="refDoi">Â DOI: 10.1128/JB.185.24.7103-7110.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FJB.185.24.7103-7110.2003" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2003&pages=7103-7110&author=K.+Sieradzkiauthor=A.+Tomasz&title=Alterations+of+cell+wall+structure+and+metabolism+accompany+reduced+susceptibility+to+vancomycin+in+an+isogenic+series+of+clinical+isolates+of+Staphylococcus+aureus&doi=10.1128%2FJB.185.24.7103-7110.2003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1128%2FJB.185.24.7103-7110.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.185.24.7103-7110.2003%26sid%3Dliteratum%253Aachs%26aulast%3DSieradzki%26aufirst%3DK.%26aulast%3DTomasz%26aufirst%3DA.%26atitle%3DAlterations%2520of%2520cell%2520wall%2520structure%2520and%2520metabolism%2520accompany%2520reduced%2520susceptibility%2520to%2520vancomycin%2520in%2520an%2520isogenic%2520series%2520of%2520clinical%2520isolates%2520of%2520Staphylococcus%2520aureus%26jtitle%3DJournal%2520of%2520bacteriology%26date%3D2003%26volume%3D185%26spage%3D7103%26epage%3D7110%26doi%3D10.1128%2FJB.185.24.7103-7110.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neoh, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Looi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamal, R.</span></span> <span> </span><span class="NLM_article-title">Activated ADI pathway: the initiator of intermediate vancomycin resistance in <i>Staphylococcus aureus</i></span>. <i>Can. J. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">260</span>â <span class="NLM_lpage">264</span>, <span class="refDoi">Â DOI: 10.1139/cjm-2016-0439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1139%2Fcjm-2016-0439" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2017&pages=260-264&author=X.+E.+Tanauthor=H.+M.+Neohauthor=M.+L.+Looiauthor=S.+F.+Chinauthor=L.+Cuiauthor=K.+Hiramatsuauthor=S.+Hussinauthor=R.+Jamal&title=Activated+ADI+pathway%3A+the+initiator+of+intermediate+vancomycin+resistance+in+Staphylococcus+aureus&doi=10.1139%2Fcjm-2016-0439"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1139%2Fcjm-2016-0439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fcjm-2016-0439%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DX.%2BE.%26aulast%3DNeoh%26aufirst%3DH.%2BM.%26aulast%3DLooi%26aufirst%3DM.%2BL.%26aulast%3DChin%26aufirst%3DS.%2BF.%26aulast%3DCui%26aufirst%3DL.%26aulast%3DHiramatsu%26aufirst%3DK.%26aulast%3DHussin%26aufirst%3DS.%26aulast%3DJamal%26aufirst%3DR.%26atitle%3DActivated%2520ADI%2520pathway%253A%2520the%2520initiator%2520of%2520intermediate%2520vancomycin%2520resistance%2520in%2520Staphylococcus%2520aureus%26jtitle%3DCan.%2520J.%2520Microbiol.%26date%3D2017%26volume%3D63%26spage%3D260%26epage%3D264%26doi%3D10.1139%2Fcjm-2016-0439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labischinski, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inaba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, K.</span></span> <span> </span><span class="NLM_article-title">Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant <i>Staphylococcus aureus</i> strain Mu50</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">315</span>â <span class="NLM_lpage">320</span>, <span class="refDoi">Â DOI: 10.1093/jac/42.3.315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1093%2Fjac%2F42.3.315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=9786471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlGiu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=315-320&author=H.+Hanakiauthor=H.+Labischinskiauthor=Y.+Inabaauthor=N.+Kondoauthor=H.+Murakamiauthor=K.+Hiramatsu&title=Increase+in+glutamine-non-amidated+muropeptides+in+the+peptidoglycan+of+vancomycin-resistant+Staphylococcus+aureus+strain+Mu50&doi=10.1093%2Fjac%2F42.3.315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Increase in glutamine-nonamidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50</span></div><div class="casAuthors">Hanaki, H.; Labischinski, H.; Inaba, Y.; Kondo, N.; Murakami, H.; Hiramatsu, K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">315-320</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The peptidoglycan compns. of vancomycin-resistant Staphylococcus aureus (VRSA) strain Mu50 (MIC 8 mg/L) and hetero-VRSA strain Mu3 (MIC 3 mg/L) were compared in order to understand the mechanism of vancomycin resistance.  As compared with Mu3, the cell wall of Mu50 had increased amts. of glutamine-non-amidated muropeptides and decreased crosslinking of peptidoglycan with a greatly decreased dimer/monomer ratio of muropeptides.  In agreement with this observation, the peptidoglycan of Mu50 bound 1.4 times more vancomycin than that of Mu3.  The increase in non-amidated muropeptides and the reduced crosslinking of the cell-wall peptidoglycan may contribute to the vancomycin resistance by increasing the consumption of vancomycin by the pre-existing cell wall of Mu50 and reducing the amt. of vancomycin reaching the cytoplasmic membrane where the vital targets of the antibiotic are situated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFi3vTOPvfXrVg90H21EOLACvtfcHk0lhZJTBzwlK7LQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlGiu7g%253D&md5=03cb6dd013237d757a48755cbcb4f3bf</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F42.3.315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F42.3.315%26sid%3Dliteratum%253Aachs%26aulast%3DHanaki%26aufirst%3DH.%26aulast%3DLabischinski%26aufirst%3DH.%26aulast%3DInaba%26aufirst%3DY.%26aulast%3DKondo%26aufirst%3DN.%26aulast%3DMurakami%26aufirst%3DH.%26aulast%3DHiramatsu%26aufirst%3DK.%26atitle%3DIncrease%2520in%2520glutamine-non-amidated%2520muropeptides%2520in%2520the%2520peptidoglycan%2520of%2520vancomycin-resistant%2520Staphylococcus%2520aureus%2520strain%2520Mu50%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1998%26volume%3D42%26spage%3D315%26epage%3D320%26doi%3D10.1093%2Fjac%2F42.3.315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwahara-Arai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle-Vavra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daum, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labischinski, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, K.</span></span> <span> </span><span class="NLM_article-title">Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant <i>Staphylococcus aureus</i> clinical strains Mu3 and Mu50</span>. <i>Journal of antimicrobial chemotherapy</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">199</span>â <span class="NLM_lpage">209</span>, <span class="refDoi">Â DOI: 10.1093/jac/42.2.199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1093%2Fjac%2F42.2.199" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=199-209&author=H.+Hanakiauthor=K.+Kuwahara-Araiauthor=S.+Boyle-Vavraauthor=R.+S.+Daumauthor=H.+Labischinskiauthor=K.+Hiramatsu&title=Activated+cell-wall+synthesis+is+associated+with+vancomycin+resistance+in+methicillin-resistant+Staphylococcus+aureus+clinical+strains+Mu3+and+Mu50&doi=10.1093%2Fjac%2F42.2.199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F42.2.199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F42.2.199%26sid%3Dliteratum%253Aachs%26aulast%3DHanaki%26aufirst%3DH.%26aulast%3DKuwahara-Arai%26aufirst%3DK.%26aulast%3DBoyle-Vavra%26aufirst%3DS.%26aulast%3DDaum%26aufirst%3DR.%2BS.%26aulast%3DLabischinski%26aufirst%3DH.%26aulast%3DHiramatsu%26aufirst%3DK.%26atitle%3DActivated%2520cell-wall%2520synthesis%2520is%2520associated%2520with%2520vancomycin%2520resistance%2520in%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520clinical%2520strains%2520Mu3%2520and%2520Mu50%26jtitle%3DJournal%2520of%2520antimicrobial%2520chemotherapy%26date%3D1998%26volume%3D42%26spage%3D199%26epage%3D209%26doi%3D10.1093%2Fjac%2F42.2.199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sieradzki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haber, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasz, A.</span></span> <span> </span><span class="NLM_article-title">The development of vancomycin resistance in a patient with methicillin-resistant <i>Staphylococcus aureus</i> infection</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">517</span>â <span class="NLM_lpage">523</span>, <span class="refDoi">Â DOI: 10.1056/NEJM199902183400704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1056%2FNEJM199902183400704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10021472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADyaK1M7jsVShsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=1999&pages=517-523&author=K.+Sieradzkiauthor=R.+B.+Robertsauthor=S.+W.+Haberauthor=A.+Tomasz&title=The+development+of+vancomycin+resistance+in+a+patient+with+methicillin-resistant+Staphylococcus+aureus+infection&doi=10.1056%2FNEJM199902183400704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection</span></div><div class="casAuthors">Sieradzki K; Roberts R B; Haber S W; Tomasz A</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">517-23</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6tScgPGImEVWTCLT8lX9SfW6udTcc2eas2wlm2lUnB7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7jsVShsw%253D%253D&md5=2e4247e1686e4fee14726205487deb23</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1056%2FNEJM199902183400704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199902183400704%26sid%3Dliteratum%253Aachs%26aulast%3DSieradzki%26aufirst%3DK.%26aulast%3DRoberts%26aufirst%3DR.%2BB.%26aulast%3DHaber%26aufirst%3DS.%2BW.%26aulast%3DTomasz%26aufirst%3DA.%26atitle%3DThe%2520development%2520of%2520vancomycin%2520resistance%2520in%2520a%2520patient%2520with%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D340%26spage%3D517%26epage%3D523%26doi%3D10.1056%2FNEJM199902183400704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipe, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinho, M. G.</span></span> <span> </span><span class="NLM_article-title">Fluorescence ratio imaging microscopy shows decreased access of vancomycin to cell wall synthetic sites in vancomycin-resistant <i>Staphylococcus aureus</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3627</span>â <span class="NLM_lpage">3633</span>, <span class="refDoi">Â DOI: 10.1128/AAC.00431-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.00431-07" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=3627-3633&author=P.+M.+Pereiraauthor=S.+R.+Filipeauthor=A.+Tomaszauthor=M.+G.+Pinho&title=Fluorescence+ratio+imaging+microscopy+shows+decreased+access+of+vancomycin+to+cell+wall+synthetic+sites+in+vancomycin-resistant+Staphylococcus+aureus&doi=10.1128%2FAAC.00431-07"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1128%2FAAC.00431-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00431-07%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DP.%2BM.%26aulast%3DFilipe%26aufirst%3DS.%2BR.%26aulast%3DTomasz%26aufirst%3DA.%26aulast%3DPinho%26aufirst%3DM.%2BG.%26atitle%3DFluorescence%2520ratio%2520imaging%2520microscopy%2520shows%2520decreased%2520access%2520of%2520vancomycin%2520to%2520cell%2520wall%2520synthetic%2520sites%2520in%2520vancomycin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D3627%26epage%3D3633%26doi%3D10.1128%2FAAC.00431-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weigel, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clewell, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDougal, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannagan, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolonay, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shetty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Killgore, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenover, F. C.</span></span> <span> </span><span class="NLM_article-title">Genetic analysis of a high-level vancomycin-resistant isolate of <i>Staphylococcus aureus</i></span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">1569</span>â <span class="NLM_lpage">1571</span>, <span class="refDoi">Â DOI: 10.1126/science.1090956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1126%2Fscience.1090956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=14645850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1SmsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=1569-1571&author=L.+M.+Weigelauthor=D.+B.+Clewellauthor=S.+R.+Gillauthor=N.+C.+Clarkauthor=L.+K.+McDougalauthor=S.+E.+Flannaganauthor=J.+F.+Kolonayauthor=J.+Shettyauthor=G.+E.+Killgoreauthor=F.+C.+Tenover&title=Genetic+analysis+of+a+high-level+vancomycin-resistant+isolate+of+Staphylococcus+aureus&doi=10.1126%2Fscience.1090956"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus</span></div><div class="casAuthors">Weigel, Linda M.; Clewell, Don B.; Gill, Steven R.; Clark, Nancye C.; McDougal, Linda K.; Flannagan, Susan E.; Kolonay, James F.; Shetty, Jyoti; Killgore, George E.; Tenover, Fred C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5650</span>),
    <span class="NLM_cas:pages">1569-1571</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Vancomycin is usually reserved for treatment of serious infections, including those caused by multidrug-resistant Staphylococcus aureus.  A clin. isolate of S. aureus with high-level resistance to vancomycin (minimal inhibitory concn. = 1024 Î¼g/mL) was isolated in June 2002.  This isolate harbored a 57.9-kilobase multiresistance conjugative plasmid within which Tn1546 (vanA) was integrated.  Addnl. elements on the plasmid encoded resistance to trimethoprim (dfrA), Î²-lactams (blaZ), aminoglycosides (aacA-aphD), and disinfectants (qacC).  Genetic analyses suggest that the long-anticipated transfer of vancomycin resistance to a methicillin-resistant S. aureus occurred in vivo by interspecies transfer of Tn1546 from a co-isolate of Enterococcus faecalis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPUxOI-5L0nbVg90H21EOLACvtfcHk0lh4J8BE0klDVw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1SmsLk%253D&md5=62c5066b5d48e0249f84f8838eed8d61</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1126%2Fscience.1090956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1090956%26sid%3Dliteratum%253Aachs%26aulast%3DWeigel%26aufirst%3DL.%2BM.%26aulast%3DClewell%26aufirst%3DD.%2BB.%26aulast%3DGill%26aufirst%3DS.%2BR.%26aulast%3DClark%26aufirst%3DN.%2BC.%26aulast%3DMcDougal%26aufirst%3DL.%2BK.%26aulast%3DFlannagan%26aufirst%3DS.%2BE.%26aulast%3DKolonay%26aufirst%3DJ.%2BF.%26aulast%3DShetty%26aufirst%3DJ.%26aulast%3DKillgore%26aufirst%3DG.%2BE.%26aulast%3DTenover%26aufirst%3DF.%2BC.%26atitle%3DGenetic%2520analysis%2520of%2520a%2520high-level%2520vancomycin-resistant%2520isolate%2520of%2520Staphylococcus%2520aureus%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D1569%26epage%3D1571%26doi%3D10.1126%2Fscience.1090956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glavan, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramaniam, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitesides, G. M.</span></span> <span> </span><span class="NLM_article-title">Rapid fabrication of pressure-driven open-channel microfluidic devices in omniphobic R(F) paper</span>. <i>Lab Chip</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2922</span>â <span class="NLM_lpage">2930</span>, <span class="refDoi">Â DOI: 10.1039/c3lc50371b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1039%2Fc3lc50371b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=23719764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVeitrjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=2922-2930&author=A.+C.+Glavanauthor=R.+V.+Martinezauthor=E.+J.+Maxwellauthor=A.+B.+Subramaniamauthor=R.+M.+Nunesauthor=S.+Sohauthor=G.+M.+Whitesides&title=Rapid+fabrication+of+pressure-driven+open-channel+microfluidic+devices+in+omniphobic+R%28F%29+paper&doi=10.1039%2Fc3lc50371b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid fabrication of pressure-driven open-channel microfluidic devices in omniphobic RF paper</span></div><div class="casAuthors">Glavan, Ana C.; Martinez, Ramses V.; Maxwell, E. Jane; Subramaniam, Anand Bala; Nunes, Rui M. D.; Soh, Siowling; Whitesides, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Lab on a Chip</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2922-2930</span>CODEN:
                <span class="NLM_cas:coden">LCAHAM</span>;
        ISSN:<span class="NLM_cas:issn">1473-0189</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">This paper describes the fabrication of pressure-driven, open-channel microfluidic systems with lateral dimensions of 45-300 Î¼ carved in omniphobic paper using a craft-cutting tool.  Vapor phase silanization with a fluorinated alkyltrichlorosilane renders paper omniphobic, but preserves its high gas permeability and mech. properties.  When sealed with tape, the carved channels form conduits capable of guiding liq. transport in the low-Reynolds no. regime (i.e. laminar flow).  These devices are compatible with complex fluids such as droplets of water in oil.  The combination of omniphobic paper and a craft cutter enables the development of new types of valves and switches, such as fold valves and porous switches, which provide new methods to control fluid flow.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlS6bKuzo81LVg90H21EOLACvtfcHk0ljZMoxmLXFswg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVeitrjI&md5=ca91dd0c481c2bd947cbdd5864807fc3</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fc3lc50371b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3lc50371b%26sid%3Dliteratum%253Aachs%26aulast%3DGlavan%26aufirst%3DA.%2BC.%26aulast%3DMartinez%26aufirst%3DR.%2BV.%26aulast%3DMaxwell%26aufirst%3DE.%2BJ.%26aulast%3DSubramaniam%26aufirst%3DA.%2BB.%26aulast%3DNunes%26aufirst%3DR.%2BM.%26aulast%3DSoh%26aufirst%3DS.%26aulast%3DWhitesides%26aufirst%3DG.%2BM.%26atitle%3DRapid%2520fabrication%2520of%2520pressure-driven%2520open-channel%2520microfluidic%2520devices%2520in%2520omniphobic%2520R%2528F%2529%2520paper%26jtitle%3DLab%2520Chip%26date%3D2013%26volume%3D13%26spage%3D2922%26epage%3D2930%26doi%3D10.1039%2Fc3lc50371b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ament, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamshed, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horne, J. P.</span></span> <span> </span><span class="NLM_article-title">Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections</span>. <i>Am. Fam. Physician</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">663</span>â <span class="NLM_lpage">670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=11871684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BD387jslSjtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2002&pages=663-670&author=P.+W.+Amentauthor=N.+Jamshedauthor=J.+P.+Horne&title=Linezolid%3A+its+role+in+the+treatment+of+gram-positive%2C+drug-resistant+bacterial+infections"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections</span></div><div class="casAuthors">Ament Paul W; Jamshed Namirah; Horne John P</div><div class="citationInfo"><span class="NLM_cas:title">American family physician</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">663-70</span>
        ISSN:<span class="NLM_cas:issn">0002-838X</span>.
    </div><div class="casAbstract">While the choices available for the management of gram-positive, drug-resistant bacterial infections are becoming limited, antimicrobial resistance is becoming increasingly problematic because of the widespread overuse of antibiotics.  Linezolid is a synthetic antibiotic belonging to a new class of antimicrobials called the oxazolidinones.  Linezolid disrupts bacterial growth by inhibiting the initiation process of protein synthesis--a mechanism of action that is unique to this class of drugs.  It is well absorbed with high bioavailability that allows conversion to oral therapy as soon as the patient is clinically stable.  It has been approved for certain gram-positive infections including certain drug-resistant enterococcus, staphylococcus, and pneumococcus strains.  It is generally well tolerated, with myelosuppression being the most serious adverse effect.  As a nonselective inhibitor of monoamine oxidase, caution is recommended when used with adrenergic or serotonergic agents (e.g., tyramine, dopamine, pseudoephedrine, and selective serotonin reuptake inhibitors).  Judicious use of this medication should help physicians treat patients with multidrug-resistant infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdks502CPyLCCEBeYuoi7AfW6udTcc2eZmMLHyNzaeLrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387jslSjtw%253D%253D&md5=3ffb2a78351f5ac0d63047a10de4a8f1</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAment%26aufirst%3DP.%2BW.%26aulast%3DJamshed%26aufirst%3DN.%26aulast%3DHorne%26aufirst%3DJ.%2BP.%26atitle%3DLinezolid%253A%2520its%2520role%2520in%2520the%2520treatment%2520of%2520gram-positive%252C%2520drug-resistant%2520bacterial%2520infections%26jtitle%3DAm.%2520Fam.%2520Physician%26date%3D2002%26volume%3D65%26spage%3D663%26epage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemonovich, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">File, T. M.,  Jr.</span></span> <span> </span><span class="NLM_article-title">An evidence-based review of linezolid for the treatment of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA): place in therapy</span>. <i>Core evidence</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">131</span>â <span class="NLM_lpage">143</span>, <span class="refDoi">Â DOI: 10.2147/CE.S33430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.2147%2FCE.S33430" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=131-143&author=R.+R.+Watkinsauthor=T.+L.+Lemonovichauthor=T.+M.+File&title=An+evidence-based+review+of+linezolid+for+the+treatment+of+methicillin-resistant+Staphylococcus+aureus+%28MRSA%29%3A+place+in+therapy&doi=10.2147%2FCE.S33430"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2147%2FCE.S33430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCE.S33430%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DR.%2BR.%26aulast%3DLemonovich%26aufirst%3DT.%2BL.%26aulast%3DFile%26aufirst%3DT.%2BM.%26atitle%3DAn%2520evidence-based%2520review%2520of%2520linezolid%2520for%2520the%2520treatment%2520of%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520%2528MRSA%2529%253A%2520place%2520in%2520therapy%26jtitle%3DCore%2520evidence%26date%3D2012%26volume%3D7%26spage%3D131%26epage%3D143%26doi%3D10.2147%2FCE.S33430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Guillamet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollef, M. H.</span></span> <span> </span><span class="NLM_article-title">Treatment of gram-positive infections in critically ill patients</span>. <i>BMC Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">92</span>, <span class="refDoi">Â DOI: 10.1186/1471-2334-14-92</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1186%2F1471-2334-14-92" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=25431211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFGitb%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=92&author=C.+Vazquez-Guillametauthor=M.+H.+Kollef&title=Treatment+of+gram-positive+infections+in+critically+ill+patients&doi=10.1186%2F1471-2334-14-92"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of gram - positive infections in critically ill patients</span></div><div class="casAuthors">Vazquez-Guillamet, Cristina; Kollef, Marin H.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">92/1-92/8</span>CODEN:
                <span class="NLM_cas:coden">BIDMBJ</span>;
        ISSN:<span class="NLM_cas:issn">1471-2334</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Gram-pos. bacteria to include methicillin-resistant Staphylococcus aureus (MRSA), methicillin-susceptible Staphylococcus aureus (MSSA), and enterococci, to include vancomycin-resistant enterococci (VRE), display a remarkable array of resistance and virulence factors, which have contributed to their prominent role in infections of the critically ill.  Over the last three decades infections with these pathogens has increased as has their overall resistance to available antimicrobial agents.  This has led to the development of a no. of new antibiotics for the treatment of Gram-pos. bacteria.  At present, it is important that clinicians recognize the changing resistance patterns and epidemiol. of Gram-pos. bacteria as these factors may impact patient outcomes.  The increasing range of these pathogens, such as the emergence of community-assocd. MRSA clones, emphasizes that all specialties of physicians treating infections should have a good understanding of the infections caused by Gram-pos. bacteria in their area of practice.  When initiating empiric antibiotics, it is of vital importance that this therapy be timely and appropriate, as delays in treatment are assocd. with adverse outcomes.  Although vancomycin has traditionally been considered a first-line therapy for serious MRSA infections, multiple concerns with this agent have opened the door for alternative agents demonstrating efficacy in this role.  Similarly, the expansion of VRE as a pathogen in the ICU setting has required the development of agents targeting this important pathogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6NyfQbZmX_LVg90H21EOLACvtfcHk0ljZMoxmLXFswg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFGitb%252FL&md5=3a0bb2510686c88071b73a125553db70</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1186%2F1471-2334-14-92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2334-14-92%26sid%3Dliteratum%253Aachs%26aulast%3DVazquez-Guillamet%26aufirst%3DC.%26aulast%3DKollef%26aufirst%3DM.%2BH.%26atitle%3DTreatment%2520of%2520gram-positive%2520infections%2520in%2520critically%2520ill%2520patients%26jtitle%3DBMC%2520Infect.%2520Dis.%26date%3D2014%26volume%3D14%26spage%3D92%26doi%3D10.1186%2F1471-2334-14-92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, R. A.</span></span> <span> </span><span class="NLM_article-title">Development of daptomycin resistance in vivo in methicillin-resistant <i>Staphylococcus aureus</i></span>. <i>Journal of clinical microbiology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">5285</span>â <span class="NLM_lpage">5287</span>, <span class="refDoi">Â DOI: 10.1128/JCM.43.10.5285-5287.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FJCM.43.10.5285-5287.2005" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2005&pages=5285-5287&author=M.+K.+Haydenauthor=K.+Rezaiauthor=R.+A.+Hayesauthor=K.+Lolansauthor=J.+P.+Quinnauthor=R.+A.+Weinstein&title=Development+of+daptomycin+resistance+in+vivo+in+methicillin-resistant+Staphylococcus+aureus&doi=10.1128%2FJCM.43.10.5285-5287.2005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1128%2FJCM.43.10.5285-5287.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.43.10.5285-5287.2005%26sid%3Dliteratum%253Aachs%26aulast%3DHayden%26aufirst%3DM.%2BK.%26aulast%3DRezai%26aufirst%3DK.%26aulast%3DHayes%26aufirst%3DR.%2BA.%26aulast%3DLolans%26aufirst%3DK.%26aulast%3DQuinn%26aufirst%3DJ.%2BP.%26aulast%3DWeinstein%26aufirst%3DR.%2BA.%26atitle%3DDevelopment%2520of%2520daptomycin%2520resistance%2520in%2520vivo%2520in%2520methicillin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DJournal%2520of%2520clinical%2520microbiology%26date%3D2005%26volume%3D43%26spage%3D5285%26epage%3D5287%26doi%3D10.1128%2FJCM.43.10.5285-5287.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlesworth, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walesby, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, M.</span></span> <span> </span><span class="NLM_article-title">Linezolid resistance in clinical isolates of <i>Staphylococcus aureus</i></span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">186</span>â <span class="NLM_lpage">188</span>, <span class="refDoi">Â DOI: 10.1093/jac/dkg104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1093%2Fjac%2Fdkg104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=12493812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD38XpslOgtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2003&pages=186-188&author=P.+Wilsonauthor=J.+A.+Andrewsauthor=R.+Charlesworthauthor=R.+Walesbyauthor=M.+Singerauthor=D.+J.+Farrellauthor=M.+Robbins&title=Linezolid+resistance+in+clinical+isolates+of+Staphylococcus+aureus&doi=10.1093%2Fjac%2Fdkg104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Linezolid resistance in clinical isolates of Staphylococcus aureus</span></div><div class="casAuthors">Wilson, Peter; Andrews, J. A.; Charlesworth, R.; Walesby, R.; Singer, M.; Farrell, D. J.; Robbins, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">186-188</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A 52-yr-old man underwent thoracotomy and drainage of right-sided empyema and showed a second clin. infection due to a resistant methicillin-resistant Staphylococcus aureus (MRSA) that developed from a susceptible isolate during treatment.  Eleven isolates of MRSA from this patient were collected during his hospital stay and were tested in parallel by BSAC disk testing.  The linezolid-resistant isolate was first detected in a sample 20 days after linezolid treatment was over.  Phage typing of susceptible and resistant isolates showed them to be indistinguishable E-MRSA 15.  An isolate with an MIC for linezolid of 8 mg/L had a G2576T mutation in two of six alleles, but the mutation was in five of six alleles in an isolate with an MIC of 32 mg/L.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTjVV7YpQN7LVg90H21EOLACvtfcHk0liP4M_-hEFbqQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpslOgtL0%253D&md5=c90fd768194f976ffc8e5582eb6a8819</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkg104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkg104%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DP.%26aulast%3DAndrews%26aufirst%3DJ.%2BA.%26aulast%3DCharlesworth%26aufirst%3DR.%26aulast%3DWalesby%26aufirst%3DR.%26aulast%3DSinger%26aufirst%3DM.%26aulast%3DFarrell%26aufirst%3DD.%2BJ.%26aulast%3DRobbins%26aufirst%3DM.%26atitle%3DLinezolid%2520resistance%2520in%2520clinical%2520isolates%2520of%2520Staphylococcus%2520aureus%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2003%26volume%3D51%26spage%3D186%26epage%3D188%26doi%3D10.1093%2Fjac%2Fdkg104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhanel, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelenitsky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagace-Wiens, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinstein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gin, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoban, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlowsky, J. A.</span></span> <span> </span><span class="NLM_article-title">New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">859</span>â <span class="NLM_lpage">886</span>, <span class="refDoi">Â DOI: 10.2165/11534440-000000000-00000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.2165%2F11534440-000000000-00000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=20426497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot1aqsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=859-886&author=G.+G.+Zhanelauthor=D.+Calicauthor=F.+Schweizerauthor=S.+Zelenitskyauthor=H.+Adamauthor=P.+R.+Lagace-Wiensauthor=E.+Rubinsteinauthor=A.+S.+Ginauthor=D.+J.+Hobanauthor=J.+A.+Karlowsky&title=New+lipoglycopeptides%3A+a+comparative+review+of+dalbavancin%2C+oritavancin+and+telavancin&doi=10.2165%2F11534440-000000000-00000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">New lipoglycopeptides: A comparative review of dalbavancin, oritavancin and telavancin</span></div><div class="casAuthors">Zhanel, George G.; Calic, Divna; Schweizer, Frank; Zelenitsky, Sheryl; Adam, Heather; Lagace-Wiens, Philippe R. S.; Rubinstein, Ethan; Gin, Alfred S.; Hoban, Daryl J.; Karlowsky, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">859-886</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Adis Data Information BV</span>)
        </div><div class="casAbstract">A review.  Dalbavancin, oritavancin and telavancin are semisynthetic lipoglycopeptides that demonstrate promise for the treatment of patients with infections caused by multi-drug-resistant Gram-pos. pathogens.  Each of these agents contains a heptapeptide core, common to all glycopeptides, which enables them to inhibit transglycosylation and transpeptidation (cell wall synthesis).  Modifications to the heptapeptide core result in different in vitro activities for the three semisynthetic lipoglycopeptides.  All three lipoglycopeptides contain lipophilic side chains, which prolong their half-life, help to anchor the agents to the cell membrane and increase their activity against Gram-pos. cocci.  In addn. to inhibiting cell wall synthesis, telavancin and oritavancin are also able to disrupt bacterial membrane integrity and increase membrane permeability; oritavancin also inhibits RNA synthesis.  Enterococci exhibiting the VanA phenotype (resistance to both vancomycin and teicoplanin) are resistant to both dalbavancin and telavancin, while oritavancin retains activity.  Dalbavancin, oritavancin and telavancin exhibit activity against VanB vancomycin-resistant enterococci.  All three lipoglycopeptides demonstrate potent in vitro activity against Staphylococcus aureus and Staphylococcus epidermidis regardless of their susceptibility to meticillin, as well as Streptococcus spp.  Both dalbavancin and telavancin are active against vancomycin-intermediate S. aureus (VISA), but display poor activity vs. vancomycin-resistant S. aureus (VRSA).  Oritavancin is active against both VISA and VRSA.  Telavancin displays greater activity against Clostridium spp. than dalbavancin, oritavancin or vancomycin.  The half-life of dalbavancin ranges from 147 to 258 h, which allows for once-weekly dosing, the half-life of oritavancin of 393 h may allow for one dose per treatment course, while telavancin requires daily administration.  Dalbavancin and telavancin exhibit concn.-dependent activity and AUC/MIC (area under the concn.-time curve to min. inhibitory concn. ratio) is the pharmacodynamic parameter that best describes their activities.  Oritavancin's activity is also considered concn.-dependent in vitro, while in vivo its activity has been described by both concn. and time-dependent models; however, AUC/MIC is the pharmacodynamic parameter that best describes its activity.  Clin. trials involving patients with complicated skin and skin structure infections (cSSSIs) have demonstrated that all three agents are as efficacious as comparators.  The most common adverse effects reported with dalbavancin use included nausea, diarrhoea and constipation, while injection site reactions, fever and diarrhoea were commonly obsd. with oritavancin therapy.  Patients administered telavancin frequently reported nausea, taste disturbance and insomnia.  To date, no drug-drug interactions have been identified for dalbavancin, oritavancin or telavancin.  All three of these agents are promising alternatives for the treatment of cSSSIs in cases where more economical options such as vancomycin have been ineffective, in cases of reduced vancomycin susceptibility or resistance, or where vancomycin use has been assocd. with adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2kTvXBDIDUrVg90H21EOLACvtfcHk0liP4M_-hEFbqQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot1aqsLY%253D&md5=0409400bb17ec3b413752b85443aaf0f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.2165%2F11534440-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11534440-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DZhanel%26aufirst%3DG.%2BG.%26aulast%3DCalic%26aufirst%3DD.%26aulast%3DSchweizer%26aufirst%3DF.%26aulast%3DZelenitsky%26aufirst%3DS.%26aulast%3DAdam%26aufirst%3DH.%26aulast%3DLagace-Wiens%26aufirst%3DP.%2BR.%26aulast%3DRubinstein%26aufirst%3DE.%26aulast%3DGin%26aufirst%3DA.%2BS.%26aulast%3DHoban%26aufirst%3DD.%2BJ.%26aulast%3DKarlowsky%26aufirst%3DJ.%2BA.%26atitle%3DNew%2520lipoglycopeptides%253A%2520a%2520comparative%2520review%2520of%2520dalbavancin%252C%2520oritavancin%2520and%2520telavancin%26jtitle%3DDrugs%26date%3D2010%26volume%3D70%26spage%3D859%26epage%3D886%26doi%3D10.2165%2F11534440-000000000-00000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leadbetter, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazzini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatheree, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karr, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linsell, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nodwell, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quast, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapp, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villena, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judice, J. K.</span></span> <span> </span><span class="NLM_article-title">Hydrophobic vancomycin derivatives with improved ADME properties: discovery of telavancin (TD-6424)</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">326</span>â <span class="NLM_lpage">336</span>, <span class="refDoi">Â DOI: 10.7164/antibiotics.57.326</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.7164%2Fantibiotics.57.326" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=15303493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks12hu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2004&pages=326-336&author=M.+R.+Leadbetterauthor=S.+M.+Adamsauthor=B.+Bazziniauthor=P.+R.+Fathereeauthor=D.+E.+Karrauthor=K.+M.+Krauseauthor=B.+M.+Lamauthor=M.+S.+Linsellauthor=M.+B.+Nodwellauthor=J.+L.+Paceauthor=K.+Quastauthor=J.+P.+Shawauthor=E.+Sorianoauthor=S.+G.+Trappauthor=J.+D.+Villenaauthor=T.+X.+Wuauthor=B.+G.+Christensenauthor=J.+K.+Judice&title=Hydrophobic+vancomycin+derivatives+with+improved+ADME+properties%3A+discovery+of+telavancin+%28TD-6424%29&doi=10.7164%2Fantibiotics.57.326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrophobic vancomycin derivatives with improved ADME properties: Discovery of telavancin (TD-6424)</span></div><div class="casAuthors">Leadbetter, Michael R.; Adams, Stacy M.; Bazzini, Bettina; Fatheree, Paul R.; Karr, Dane E.; Krause, Kevin M.; Lam, Bernice M. T.; Linsell, Martin S.; Nodwell, Matthew B.; Pace, John L.; Quast, Kelly; Shaw, Jeng-Pyng; Soriano, Elizabeth; Trapp, Sean G.; Villena, Jenny D.; Wu, Terry X.; Christensen, Burton G.; Judice, J. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">326-336</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">Novel derivs. of N-decylaminoethylvancomycin (2), contg. appended hydrophilic groups were synthesized and their antibacterial activity and ADME properties were evaluated.  The compds. were prepd. by reacting amines with the C-terminus (C-) of 2 using PyBOP mediated amide formation, or with the resorcinol-like (R-) position of 2 using a Mannich aminomethylation reaction.  These analogs retained the antibacterial activity of 2 against methicillin-resistant staphylococci and vancomycin-resistant enterococci.  Compds. with a neg. charged auxiliary group also exhibited improved ADME properties relative to 2.  In particular, R-phosphonomethylaminomethyl deriv. 21 displayed good in vitro antibacterial activity, high urinary recovery and low distribution to liver and kidney tissues.  Based on these results, 21 was advanced into development as TD-6424, and is currently in human clin. trials.  The generic name telavancin has recently been approved for compd. 21.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobrfFAGGvnOLVg90H21EOLACvtfcHk0liP4M_-hEFbqQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks12hu7c%253D&md5=7a24e7cda0ffe2f03280f9c7a36fe028</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.57.326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.57.326%26sid%3Dliteratum%253Aachs%26aulast%3DLeadbetter%26aufirst%3DM.%2BR.%26aulast%3DAdams%26aufirst%3DS.%2BM.%26aulast%3DBazzini%26aufirst%3DB.%26aulast%3DFatheree%26aufirst%3DP.%2BR.%26aulast%3DKarr%26aufirst%3DD.%2BE.%26aulast%3DKrause%26aufirst%3DK.%2BM.%26aulast%3DLam%26aufirst%3DB.%2BM.%26aulast%3DLinsell%26aufirst%3DM.%2BS.%26aulast%3DNodwell%26aufirst%3DM.%2BB.%26aulast%3DPace%26aufirst%3DJ.%2BL.%26aulast%3DQuast%26aufirst%3DK.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3DTrapp%26aufirst%3DS.%2BG.%26aulast%3DVillena%26aufirst%3DJ.%2BD.%26aulast%3DWu%26aufirst%3DT.%2BX.%26aulast%3DChristensen%26aufirst%3DB.%2BG.%26aulast%3DJudice%26aufirst%3DJ.%2BK.%26atitle%3DHydrophobic%2520vancomycin%2520derivatives%2520with%2520improved%2520ADME%2520properties%253A%2520discovery%2520of%2520telavancin%2520%2528TD-6424%2529%26jtitle%3DJ.%2520Antibiot.%26date%3D2004%26volume%3D57%26spage%3D326%26epage%3D336%26doi%3D10.7164%2Fantibiotics.57.326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lunde, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartouni, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janc, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mammen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benton, B. M.</span></span> <span> </span><span class="NLM_article-title">Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3375</span>â <span class="NLM_lpage">3383</span>, <span class="refDoi">Â DOI: 10.1128/AAC.01710-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.01710-08" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=3375-3383&author=C.+S.+Lundeauthor=S.+R.+Hartouniauthor=J.+W.+Jancauthor=M.+Mammenauthor=P.+P.+Humphreyauthor=B.+M.+Benton&title=Telavancin+disrupts+the+functional+integrity+of+the+bacterial+membrane+through+targeted+interaction+with+the+cell+wall+precursor+lipid+II&doi=10.1128%2FAAC.01710-08"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1128%2FAAC.01710-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01710-08%26sid%3Dliteratum%253Aachs%26aulast%3DLunde%26aufirst%3DC.%2BS.%26aulast%3DHartouni%26aufirst%3DS.%2BR.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26aulast%3DMammen%26aufirst%3DM.%26aulast%3DHumphrey%26aufirst%3DP.%2BP.%26aulast%3DBenton%26aufirst%3DB.%2BM.%26atitle%3DTelavancin%2520disrupts%2520the%2520functional%2520integrity%2520of%2520the%2520bacterial%2520membrane%2520through%2520targeted%2520interaction%2520with%2520the%2520cell%2520wall%2520precursor%2520lipid%2520II%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D3375%26epage%3D3383%26doi%3D10.1128%2FAAC.01710-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saravolatz, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billeter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zervos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalovisio, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurukularatne, C.</span></span> <span> </span><span class="NLM_article-title">Dalbavancin: a novel once-weekly lipoglycopeptide antibiotic</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">577</span>â <span class="NLM_lpage">583</span>, <span class="refDoi">Â DOI: 10.1086/526772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1086%2F526772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=18199045" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=577-583&author=L.+D.+Saravolatzauthor=M.+Billeterauthor=M.+J.+Zervosauthor=A.+Y.+Chenauthor=J.+R.+Dalovisioauthor=C.+Kurukularatne&title=Dalbavancin%3A+a+novel+once-weekly+lipoglycopeptide+antibiotic&doi=10.1086%2F526772"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1086%2F526772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F526772%26sid%3Dliteratum%253Aachs%26aulast%3DSaravolatz%26aufirst%3DL.%2BD.%26aulast%3DBilleter%26aufirst%3DM.%26aulast%3DZervos%26aufirst%3DM.%2BJ.%26aulast%3DChen%26aufirst%3DA.%2BY.%26aulast%3DDalovisio%26aufirst%3DJ.%2BR.%26aulast%3DKurukularatne%26aufirst%3DC.%26atitle%3DDalbavancin%253A%2520a%2520novel%2520once-weekly%2520lipoglycopeptide%2520antibiotic%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2008%26volume%3D46%26spage%3D577%26epage%3D583%26doi%3D10.1086%2F526772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arhin, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draghi, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillar, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parr, T. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeck, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahm, D. F.</span></span> <span> </span><span class="NLM_article-title">Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4762</span>â <span class="NLM_lpage">4771</span>, <span class="refDoi">Â DOI: 10.1128/AAC.00952-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.00952-09" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=4762-4771&author=F.+F.+Arhinauthor=D.+C.+Draghiauthor=C.+M.+Pillarauthor=T.+R.+Parrauthor=G.+Moeckauthor=D.+F.+Sahm&title=Comparative+in+vitro+activity+profile+of+oritavancin+against+recent+gram-positive+clinical+isolates&doi=10.1128%2FAAC.00952-09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1128%2FAAC.00952-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00952-09%26sid%3Dliteratum%253Aachs%26aulast%3DArhin%26aufirst%3DF.%2BF.%26aulast%3DDraghi%26aufirst%3DD.%2BC.%26aulast%3DPillar%26aufirst%3DC.%2BM.%26aulast%3DParr%26aufirst%3DT.%2BR.%26aulast%3DMoeck%26aufirst%3DG.%26aulast%3DSahm%26aufirst%3DD.%2BF.%26atitle%3DComparative%2520in%2520vitro%2520activity%2520profile%2520of%2520oritavancin%2520against%2520recent%2520gram-positive%2520clinical%2520isolates%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D4762%26epage%3D4771%26doi%3D10.1128%2FAAC.00952-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saravolatz, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, G. E.</span></span> <span> </span><span class="NLM_article-title">Oritavancin: A long-half-life lipoglycopeptide</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">627</span>â <span class="NLM_lpage">632</span>, <span class="refDoi">Â DOI: 10.1093/cid/civ311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1093%2Fcid%2Fciv311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=25900171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFKltrvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2015&pages=627-632&author=L.+D.+Saravolatzauthor=G.+E.+Stein&title=Oritavancin%3A+A+long-half-life+lipoglycopeptide&doi=10.1093%2Fcid%2Fciv311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Oritavancin: a long-half-life lipoglycopeptide</span></div><div class="casAuthors">Saravolatz, Louis D.; Stein, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">627-632</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Oritavancin is a lipoglycopeptide antibiotic that has been shown to be effective for the treatment of acute bacterial skin and skin structure infections (ABSSSIs).  This antibiotic has multiple mechanisms of action including inhibiting peptidoglycan cell wall synthesis and disrupting bacterial cell membrane, leading to cell death.  Oritavancin is highly active against common gram-pos. pathogens including methicillin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, vancomycin-resistant S. aureus, and vancomycin-resistant enterococci.  The drug is administered as a single i.v. dose of 1200 mg over 3 h in adult patients, and because of its terminal half-life of 393 h, repeat dosing is not required in the treatment of ABSSIs.  There is a very slow elimination from tissue sites, and no dosing adjustments are required for renal or hepatic insufficiency.  Two clin. trials have demonstrated noninferiority compared with vancomycin in the treatment of ABSSSIs.  Other than liver enzyme elevation and the occurrence of osteomyelitis, oritavancin has been assocd. with adverse events similar to those of vancomycin in follow-up for up to 60 days.  Patients should be monitored for osteomyelitis and alternate therapy given in the case of confirmed or suspected osteomyelitis.  Although oritavancin is an attractive antibiotic to consider in the outpatient area, its efficacy and safety in the treatment of other sites of infection are yet to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy18lyLxNVerVg90H21EOLACvtfcHk0ljd9ZcqquqmoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFKltrvM&md5=797ba49d4b23e57b5c0f977acce9584a</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fciv311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fciv311%26sid%3Dliteratum%253Aachs%26aulast%3DSaravolatz%26aufirst%3DL.%2BD.%26aulast%3DStein%26aufirst%3DG.%2BE.%26atitle%3DOritavancin%253A%2520A%2520long-half-life%2520lipoglycopeptide%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2015%26volume%3D61%26spage%3D627%26epage%3D632%26doi%3D10.1093%2Fcid%2Fciv311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaskovich, M. A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansford, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mark, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. A.</span></span> <span> </span><span class="NLM_article-title">Developments in glycopeptide antibiotics</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">715</span>â <span class="NLM_lpage">735</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.7b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.7b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVGhtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=715-735&author=M.+A.+T.+Blaskovichauthor=K.+A.+Hansfordauthor=M.+S.+Butlerauthor=Z.+Jiaauthor=A.+E.+Markauthor=M.+A.+Cooper&title=Developments+in+glycopeptide+antibiotics&doi=10.1021%2Facsinfecdis.7b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Developments in Glycopeptide Antibiotics</span></div><div class="casAuthors">Blaskovich, Mark A. T.; Hansford, Karl A.; Butler, Mark S.; Jia, ZhiGuang; Mark, Alan E.; Cooper, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">715-735</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Glycopeptide antibiotics (GPA) are a key weapon in the fight against drug resistant bacteria, with vancomycin still a mainstream therapy against serious Gram-pos. infections more than 50 years after it was first introduced.  New, more potent semisynthetic derivs. that have entered the clinic, such as dalbavancin and oritavancin, have superior pharmacokinetic and target engagement profiles that enable successful treatment of vancomycin-resistant infections.  In the face of resistance development, with multi-drug resistant (MDR) S. pneumonia and MRSA together causing 20-fold more infections than all MDR Gram-neg. infections combined, further improvements are desirable to ensure the Gram-pos. armamentarium is adequately maintained for future generations.  A range of modified glycopeptides has been generated in the last decade via total syntheses, semisynthetic modifications of a natural product or biol. engineering.  Several of these have undergone extensive characterization with demonstrated in vivo efficacy, good PK/PD profiles and no reported pre-clin. toxicity; some may be suitable for formal preclin. development.  The natural product monobactam, cephalosporin and beta-lactam antibiotics all spawned multiple generations of com. and clin. successful semi-synthetic derivs.  Similarly, next-generation glycopeptides are now tech. well positioned to advance to the clinic, if sufficient funding and market support returns to antibiotic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLGv_FtL7T-rVg90H21EOLACvtfcHk0ligx2u19a88vQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVGhtLs%253D&md5=c384f5eb681053896c19c0d33e268b34</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.7b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.7b00258%26sid%3Dliteratum%253Aachs%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%2BT.%26aulast%3DHansford%26aufirst%3DK.%2BA.%26aulast%3DButler%26aufirst%3DM.%2BS.%26aulast%3DJia%26aufirst%3DZ.%26aulast%3DMark%26aufirst%3DA.%2BE.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26atitle%3DDevelopments%2520in%2520glycopeptide%2520antibiotics%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2018%26volume%3D4%26spage%3D715%26epage%3D735%26doi%3D10.1021%2Facsinfecdis.7b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashford, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bew, S. P.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the synthesis of new glycopeptide antibiotics</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">957</span>â <span class="NLM_lpage">978</span>, <span class="refDoi">Â DOI: 10.1039/C1CS15125H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1039%2FC1CS15125H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=21829829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC38Xns1ygsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2012&pages=957-978&author=P.+A.+Ashfordauthor=S.+P.+Bew&title=Recent+advances+in+the+synthesis+of+new+glycopeptide+antibiotics&doi=10.1039%2FC1CS15125H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the synthesis of new glycopeptide antibiotics</span></div><div class="casAuthors">Ashford, Polly-Anna; Bew, Sean P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">957-978</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The vancomycin family of glycopeptide antibiotics has been inspiring research in the field of synthetic chem. since the 1980s.  Recent studies have moved away from the focus of total synthesis into new territory: the design and evaluation of novel compds. based on the natural products which exhibit improved antibacterial activity.  Modern approaches to drug synthesis draw together investigations into the nature of the binding environment, and innovative synthetic methodologies which provide solns. to the challenging structural features and stereochem. assocd. with this intriguing class of compds.  New analogs, derivs. and dimers of the natural products, as well as recent successes in the total synthesis of the complestatins are described in this tutorial review, covering literature from the last decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGGvGnH7SF-7Vg90H21EOLACvtfcHk0ligx2u19a88vQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xns1ygsg%253D%253D&md5=cb7c903a6d6ff88c98490431a0d4d7bd</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1039%2FC1CS15125H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC1CS15125H%26sid%3Dliteratum%253Aachs%26aulast%3DAshford%26aufirst%3DP.%2BA.%26aulast%3DBew%26aufirst%3DS.%2BP.%26atitle%3DRecent%2520advances%2520in%2520the%2520synthesis%2520of%2520new%2520glycopeptide%2520antibiotics%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2012%26volume%3D41%26spage%3D957%26epage%3D978%26doi%3D10.1039%2FC1CS15125H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagarajan, R.</span></span> <i>Glycopeptide Antibiotics</i>; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>, <span class="NLM_year">1994</span>; Vol.  <span class="NLM_volume">63</span>, pp  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">448</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&pages=1-448&author=R.+Nagarajan&title=Glycopeptide+Antibiotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNagarajan%26aufirst%3DR.%26btitle%3DGlycopeptide%2520Antibiotics%26pub%3DCRC%2520Press%26date%3D1994%26volume%3D63%26spage%3D1%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McComas, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">9314</span>â <span class="NLM_lpage">9315</span>, <span class="refDoi">Â DOI: 10.1021/ja035901x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja035901x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltlCksbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=9314-9315&author=C.+C.+McComasauthor=B.+M.+Crowleyauthor=D.+L.+Boger&title=Partitioning+the+loss+in+vancomycin+binding+affinity+for+D-Ala-D-Lac+into+lost+H-bond+and+repulsive+lone+pair+contributions&doi=10.1021%2Fja035901x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Partitioning the Loss in Vancomycin Binding Affinity for D-Ala-D-Lac into Lost H-Bond and Repulsive Lone Pair Contributions</span></div><div class="casAuthors">McComas, Casey C.; Crowley, Brendan M.; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">9314-9315</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The binding affinity of AcNH(CH2)4CH(AcNH)C:ONHCH(CH3)C:OCH2CH(CH3)CO2H (I), which incorporates a methylene (CH2) in place of the key linking amide of Ac2-L-Lys-D-Ala-D-Ala, for vancomycin was compared with that of Ac2-L-Lys-D-Ala-D-Ala and Ac2-L-Lys-D-Ala-D-Lac.  The vancomycin affinity for I was approx. 10-fold less than that of Ac2-L-Lys-D-Ala-D-Ala, but 100-fold greater than that of Ac2-L-Lys-D-Ala-D-Lac.  This suggests that the reduced binding affinity of Ac2-L-Lys-D-Ala-D-Lac (4.1 kcal/mol) may be attributed to both the loss of a key H-bond (1.5 kcal/mol) and a destabilizing lone pair/lone pair electrostatic interaction introduced with the ester oxygen of Ac2-L-Lys-D-Ala-D-Lac (2.6 kcal/mol) with the latter, not the H-bond, being responsible for the largest share of the 1000-fold redn.  These observations have significant ramifications in the reengineering of the vancomycin structure to bind D-Ala-D-Lac and thus overcoming bacterial resistance to vancomycin in its binding to precursor peptidoglycan in cell wall biosynthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb8pKB_Ped6rVg90H21EOLACvtfcHk0ligx2u19a88vQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltlCksbs%253D&md5=322f71e8dfe940e24a7b7ec360a417b6</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fja035901x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja035901x%26sid%3Dliteratum%253Aachs%26aulast%3DMcComas%26aufirst%3DC.%2BC.%26aulast%3DCrowley%26aufirst%3DB.%2BM.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DPartitioning%2520the%2520loss%2520in%2520vancomycin%2520binding%2520affinity%2520for%2520D-Ala-D-Lac%2520into%2520lost%2520H-bond%2520and%2520repulsive%2520lone%2520pair%2520contributions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D9314%26epage%3D9315%26doi%3D10.1021%2Fja035901x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">Total synthesis and evaluation of [Î¨ [CH<sub>2</sub>NH] Tpg<sup>4</sup>] vancomycin aglycon: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">2885</span>â <span class="NLM_lpage">2892</span>, <span class="refDoi">Â DOI: 10.1021/ja0572912</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0572912" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=2885-2892&author=B.+M.+Crowleyauthor=D.+L.+Boger&title=Total+synthesis+and+evaluation+of+%5B%CE%A8+%5BCH2NH%5D+Tpg4%5D+vancomycin+aglycon%3A+reengineering+vancomycin+for+dual+D-Ala-D-Ala+and+D-Ala-D-Lac+binding&doi=10.1021%2Fja0572912"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fja0572912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0572912%26sid%3Dliteratum%253Aachs%26aulast%3DCrowley%26aufirst%3DB.%2BM.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DTotal%2520synthesis%2520and%2520evaluation%2520of%2520%255B%25CE%25A8%2520%255BCH2NH%255D%2520Tpg4%255D%2520vancomycin%2520aglycon%253A%2520reengineering%2520vancomycin%2520for%2520dual%2520D-Ala-D-Ala%2520and%2520D-Ala-D-Lac%2520binding%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D2885%26epage%3D2892%26doi%3D10.1021%2Fja0572912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schammel, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">Total Synthesis of [Î¨ [C (=NH) NH] Tpg<sup>4</sup>] vancomycin and its (4-Chlorobiphenyl) methyl Derivative: impact of peripheral modifications on vancomycin analogues redesigned for dual D-Ala-D-Ala and D-Ala-D-Lac binding</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">13522</span>â <span class="NLM_lpage">13525</span>, <span class="refDoi">Â DOI: 10.1021/ja507009a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja507009a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=13522-13525&author=A.+Okanoauthor=A.+Nakayamaauthor=A.+W.+Schammelauthor=D.+L.+Boger&title=Total+Synthesis+of+%5B%CE%A8+%5BC+%28%3DNH%29+NH%5D+Tpg4%5D+vancomycin+and+its+%284-Chlorobiphenyl%29+methyl+Derivative%3A+impact+of+peripheral+modifications+on+vancomycin+analogues+redesigned+for+dual+D-Ala-D-Ala+and+D-Ala-D-Lac+binding&doi=10.1021%2Fja507009a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fja507009a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja507009a%26sid%3Dliteratum%253Aachs%26aulast%3DOkano%26aufirst%3DA.%26aulast%3DNakayama%26aufirst%3DA.%26aulast%3DSchammel%26aufirst%3DA.%2BW.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DTotal%2520Synthesis%2520of%2520%255B%25CE%25A8%2520%255BC%2520%2528%253DNH%2529%2520NH%255D%2520Tpg4%255D%2520vancomycin%2520and%2520its%2520%25284-Chlorobiphenyl%2529%2520methyl%2520Derivative%253A%2520impact%2520of%2520peripheral%2520modifications%2520on%2520vancomycin%2520analogues%2520redesigned%2520for%2520dual%2520D-Ala-D-Ala%2520and%2520D-Ala-D-Lac%2520binding%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D13522%26epage%3D13525%26doi%3D10.1021%2Fja507009a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isley, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">Peripheral modifications of [Î¨ [CH<sub>2</sub>NH]Tpg<sup>4</sup>] vancomycin with added synergistic mechanisms of action provide durable and potent antibiotics</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E5052</span>â <span class="NLM_lpage">E5061</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1704125114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1073%2Fpnas.1704125114" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E5052-E5061&author=A.+Okanoauthor=N.+A.+Isleyauthor=D.+L.+Boger&title=Peripheral+modifications+of+%5B%CE%A8+%5BCH2NH%5DTpg4%5D+vancomycin+with+added+synergistic+mechanisms+of+action+provide+durable+and+potent+antibiotics&doi=10.1073%2Fpnas.1704125114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1704125114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1704125114%26sid%3Dliteratum%253Aachs%26aulast%3DOkano%26aufirst%3DA.%26aulast%3DIsley%26aufirst%3DN.%2BA.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DPeripheral%2520modifications%2520of%2520%255B%25CE%25A8%2520%255BCH2NH%255DTpg4%255D%2520vancomycin%2520with%2520added%2520synergistic%2520mechanisms%2520of%2520action%2520provide%2520durable%2520and%2520potent%2520antibiotics%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3DE5052%26epage%3DE5061%26doi%3D10.1073%2Fpnas.1704125114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nitanai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakoi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanamaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujisawa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, K.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of the complexes between vancomycin and cell-wall precursor analogs</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>385</i></span>,  <span class="NLM_fpage">1422</span>â <span class="NLM_lpage">1432</span>, <span class="refDoi">Â DOI: 10.1016/j.jmb.2008.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.jmb.2008.10.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=18976660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSmsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2009&pages=1422-1432&author=Y.+Nitanaiauthor=T.+Kikuchiauthor=K.+Kakoiauthor=S.+Hanamakiauthor=I.+Fujisawaauthor=K.+Aoki&title=Crystal+structures+of+the+complexes+between+vancomycin+and+cell-wall+precursor+analogs&doi=10.1016%2Fj.jmb.2008.10.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of the Complexes between Vancomycin and Cell-Wall Precursor Analogs</span></div><div class="casAuthors">Nitanai, Yasushi; Kikuchi, Takanori; Kakoi, Kouji; Hanamaki, Shinji; Fujisawa, Ikuhide; Aoki, Katsuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1422-1432</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The crystal structures of three vancomycin complexes with two vancomycin-sensitive cell-wall precursor analogs (diacetyl-Lys-D-Ala-D-Ala and acetyl-D-Ala-D-Ala) and a vancomycin-resistant cell-wall precursor analog (diacetyl-Lys-D-Ala-D-lactate) were detd. at at. resolns. of 1.80 Ã, 1.07 Ã, and 0.93 Ã, resp.  These structures not only reconfirm the "back-to-back" dimerization of vancomycin monomers and the ligand-binding scheme proposed by previous expts. but also show important structural features of strategies for the generation of new glycopeptide antibiotics.  These structural features involve a water-mediated antibiotic-ligand interaction and supramol. structures such as "side-by-side" arranged dimer-to-dimer structures, in addn. to ligand-mediated and "face-to-face" arranged dimer-to-dimer structures.  In the diacetyl-Lys-D-Ala-D-lactate complex, the interat. OÂ·Â·Â·O distance between the carbonyl oxygen of the fourth residue of the antibiotic backbone and the ester oxygen of the D-lactate moiety of the ligand is clearly longer than the corresponding N-HÂ·Â·Â·O hydrogen-bonding distance obsd. in the two other complexes due to electrostatic repulsion.  In addn., two neighboring hydrogen bonds are concomitantly lengthened.  These observations provide, at least in part, a mol. basis for the reduced antibacterial activity of vancomycin toward vancomycin-resistant bacteria with cell-wall precursors terminating in -D-Ala-D-lactate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFyNh5WabH1rVg90H21EOLACvtfcHk0liR2fkNVMWvtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSmsL8%253D&md5=bb8666ff0899c33055430364c559905a</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DNitanai%26aufirst%3DY.%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DKakoi%26aufirst%3DK.%26aulast%3DHanamaki%26aufirst%3DS.%26aulast%3DFujisawa%26aufirst%3DI.%26aulast%3DAoki%26aufirst%3DK.%26atitle%3DCrystal%2520structures%2520of%2520the%2520complexes%2520between%2520vancomycin%2520and%2520cell-wall%2520precursor%2520analogs%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D385%26spage%3D1422%26epage%3D1432%26doi%3D10.1016%2Fj.jmb.2008.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konai, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Tackling vancomycin-resistant bacteria with âlipophilic-vancomycin-carbohydrate conjugatesâ</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">302</span>â <span class="NLM_lpage">312</span>, <span class="refDoi">Â DOI: 10.1038/ja.2014.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fja.2014.144" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2015&pages=302-312&author=V.+Yarlagaddaauthor=M.+M.+Konaiauthor=G.+B.+Manjunathauthor=C.+Ghoshauthor=J.+Haldar&title=Tackling+vancomycin-resistant+bacteria+with+%E2%80%99lipophilic-vancomycin-carbohydrate+conjugates%E2%80%99&doi=10.1038%2Fja.2014.144"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fja.2014.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2014.144%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DKonai%26aufirst%3DM.%2BM.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DGhosh%26aufirst%3DC.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DTackling%2520vancomycin-resistant%2520bacteria%2520with%2520%25E2%2580%2599lipophilic-vancomycin-carbohydrate%2520conjugates%25E2%2580%2599%26jtitle%3DJ.%2520Antibiot.%26date%3D2015%26volume%3D68%26spage%3D302%26epage%3D312%26doi%3D10.1038%2Fja.2014.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sundram, U. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicas, T. I.</span></span> <span> </span><span class="NLM_article-title">Novel vancomycin dimers with activity against vancomycin-resistant enterococci</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">13107</span>â <span class="NLM_lpage">13108</span>, <span class="refDoi">Â DOI: 10.1021/ja9621298</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9621298" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=13107-13108&author=U.+N.+Sundramauthor=J.+H.+Griffinauthor=T.+I.+Nicas&title=Novel+vancomycin+dimers+with+activity+against+vancomycin-resistant+enterococci&doi=10.1021%2Fja9621298"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fja9621298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9621298%26sid%3Dliteratum%253Aachs%26aulast%3DSundram%26aufirst%3DU.%2BN.%26aulast%3DGriffin%26aufirst%3DJ.%2BH.%26aulast%3DNicas%26aufirst%3DT.%2BI.%26atitle%3DNovel%2520vancomycin%2520dimers%2520with%2520activity%2520against%2520vancomycin-resistant%2520enterococci%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D13107%26epage%3D13108%26doi%3D10.1021%2Fja9621298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahiri, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitesides, G. M.</span></span> <span> </span><span class="NLM_article-title">A trivalent system from vancomycin D-Ala-D-Ala with higher affinity than avidin.biotin</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">708</span>â <span class="NLM_lpage">711</span>, <span class="refDoi">Â DOI: 10.1126/science.280.5364.708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1126%2Fscience.280.5364.708" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=9563940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVOksL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1998&pages=708-711&author=J.+Raoauthor=J.+Lahiriauthor=L.+Isaacsauthor=R.+M.+Weisauthor=G.+M.+Whitesides&title=A+trivalent+system+from+vancomycin+D-Ala-D-Ala+with+higher+affinity+than+avidin.biotin&doi=10.1126%2Fscience.280.5364.708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A trivalent system from vancomycinÂ·D-Ala-D-Ala with higher affinity than avidinÂ·biotin</span></div><div class="casAuthors">Rao, Jianghong; Lahiri, Joydeep; Isaacs, Lyle; Weis, Robert M.; Whitesides, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">5364</span>),
    <span class="NLM_cas:pages">708-711</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Tris(vancomycin carboxamide) binds a trivalent ligand derived from D-Ala-D-Ala with very high affinity: dissocn. const. (Kd) â 4 Ã 10-17 Â± 1 Ã 10-17 M.  High-affinity trivalent binding and monovalent binding are fundamentally different.  For example, in trivalent (and more generally, polyvalent) binding, dissocn. occurs in stages, and its rate can be accelerated by monovalent ligand at sufficiently high concns.  In monovalent binding, dissocn. is detd. solely by the rate const. for dissocn. and cannot be accelerated by added monomer.  Calorimetric measurements for the trivalent system indicate an approx. additive gain in enthalpy relative to the corresponding monomers.  This system is one of the most stable org. receptor-ligand pairs involving small mols. that is known.  It illustrates the practicality of designing very high-affinity systems based on polyvalency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSggeK1okPHrVg90H21EOLACvtfcHk0lju_gO3c5vyFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVOksL8%253D&md5=29e1ff57508b981053669f5732d3d221</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1126%2Fscience.280.5364.708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.280.5364.708%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DJ.%26aulast%3DLahiri%26aufirst%3DJ.%26aulast%3DIsaacs%26aufirst%3DL.%26aulast%3DWeis%26aufirst%3DR.%2BM.%26aulast%3DWhitesides%26aufirst%3DG.%2BM.%26atitle%3DA%2520trivalent%2520system%2520from%2520vancomycin%2520D-Ala-D-Ala%2520with%2520higher%2520affinity%2520than%2520avidin.biotin%26jtitle%3DScience%26date%3D1998%26volume%3D280%26spage%3D708%26epage%3D711%26doi%3D10.1126%2Fscience.280.5364.708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayakawa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinumi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uemura, D.</span></span> <span> </span><span class="NLM_article-title">Multi-valent polymer of vancomycin: enhanced antibacterial activity against VRE</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_fpage">1361</span>â <span class="NLM_lpage">1362</span>, <span class="refDoi">Â DOI: 10.1039/a903529j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1039%2Fa903529j" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=1361-1362&author=H.+Arimotoauthor=K.+Nishimuraauthor=I.+Hayakawaauthor=T.+Kinumiauthor=D.+Uemura&title=Multi-valent+polymer+of+vancomycin%3A+enhanced+antibacterial+activity+against+VRE&doi=10.1039%2Fa903529j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1039%2Fa903529j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa903529j%26sid%3Dliteratum%253Aachs%26aulast%3DArimoto%26aufirst%3DH.%26aulast%3DNishimura%26aufirst%3DK.%26aulast%3DHayakawa%26aufirst%3DI.%26aulast%3DKinumi%26aufirst%3DT.%26aulast%3DUemura%26aufirst%3DD.%26atitle%3DMulti-valent%2520polymer%2520of%2520vancomycin%253A%2520enhanced%2520antibacterial%2520activity%2520against%2520VRE%26jtitle%3DChem.%2520Commun.%26date%3D1999%26spage%3D1361%26epage%3D1362%26doi%3D10.1039%2Fa903529j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicolaou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winssinger, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smethurst, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labischinski, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endermann, R.</span></span> <span> </span><span class="NLM_article-title">Target-accelerated combinatorial synthesis and discovery of highly potent antibiotics effective against vancomycin-resistant bacteria</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">3823</span>â <span class="NLM_lpage">3828</span>, <span class="refDoi">Â DOI: 10.1002/1521-3773(20001103)39:21<3823::AID-ANIE3823>3.0.CO;2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1002%2F1521-3773%2820001103%2939%3A21%3C3823%3A%3AAID-ANIE3823%3E3.0.CO%3B2-3" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=3823-3828&author=K.+Nicolaouauthor=R.+Hughesauthor=S.+Y.+Choauthor=N.+Winssingerauthor=C.+Smethurstauthor=H.+Labischinskiauthor=R.+Endermann&title=Target-accelerated+combinatorial+synthesis+and+discovery+of+highly+potent+antibiotics+effective+against+vancomycin-resistant+bacteria&doi=10.1002%2F1521-3773%2820001103%2939%3A21%3C3823%3A%3AAID-ANIE3823%3E3.0.CO%3B2-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820001103%2939%3A21%3C3823%3A%3AAID-ANIE3823%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820001103%252939%253A21%253C3823%253A%253AAID-ANIE3823%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DK.%26aulast%3DHughes%26aufirst%3DR.%26aulast%3DCho%26aufirst%3DS.%2BY.%26aulast%3DWinssinger%26aufirst%3DN.%26aulast%3DSmethurst%26aufirst%3DC.%26aulast%3DLabischinski%26aufirst%3DH.%26aulast%3DEndermann%26aufirst%3DR.%26atitle%3DTarget-accelerated%2520combinatorial%2520synthesis%2520and%2520discovery%2520of%2520highly%2520potent%2520antibiotics%2520effective%2520against%2520vancomycin-resistant%2520bacteria%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2000%26volume%3D39%26spage%3D3823%26epage%3D3828%26doi%3D10.1002%2F1521-3773%2820001103%2939%3A21%3C3823%3A%3AAID-ANIE3823%3E3.0.CO%3B2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mammen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitesides, G. M.</span></span> <span> </span><span class="NLM_article-title">Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">2754</span>â <span class="NLM_lpage">2794</span>, <span class="refDoi">Â DOI: 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1002%2F%28SICI%291521-3773%2819981102%2937%3A20%3C2754%3A%3AAID-ANIE2754%3E3.0.CO%3B2-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BC1Mjot1KmtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=2754-2794&author=M.+Mammenauthor=S.-K.+Choiauthor=G.+M.+Whitesides&title=Polyvalent+interactions+in+biological+systems%3A+implications+for+design+and+use+of+multivalent+ligands+and+inhibitors&doi=10.1002%2F%28SICI%291521-3773%2819981102%2937%3A20%3C2754%3A%3AAID-ANIE2754%3E3.0.CO%3B2-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors</span></div><div class="casAuthors">Mammen Mathai; Choi Seok-Ki; Whitesides George M</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2754-2794</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Found throughout biology, polyvalent interactions are characterized by the simultaneous binding of multiple ligands on one biological entity to multiple receptors on another (top part of the illustration) and have a number of characteristics that monovalent interactions do not (bottom).  In particular, polyvalent interactions can be collectively much stronger than corresponding monovalent interactions, and they can provide the basis for mechanisms of both agonizing and antagonizing biological interactions that are fundamentally different from those available in monovalent systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrUE9xYfhSJT0O18WR3iAofW6udTcc2eYLDSmJF_pH5bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mjot1KmtA%253D%253D&md5=361c0469fe15045296ee208336a0d4ab</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819981102%2937%3A20%3C2754%3A%3AAID-ANIE2754%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819981102%252937%253A20%253C2754%253A%253AAID-ANIE2754%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DMammen%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DS.-K.%26aulast%3DWhitesides%26aufirst%3DG.%2BM.%26atitle%3DPolyvalent%2520interactions%2520in%2520biological%2520systems%253A%2520implications%2520for%2520design%2520and%2520use%2520of%2520multivalent%2520ligands%2520and%2520inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1998%26volume%3D37%26spage%3D2754%26epage%3D2794%26doi%3D10.1002%2F%28SICI%291521-3773%2819981102%2937%3A20%3C2754%3A%3AAID-ANIE2754%3E3.0.CO%3B2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mammen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakhnovich, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitesides, G. M.</span></span> <span> </span><span class="NLM_article-title">Using a convenient, quantitative model for torsional entropy to establish qualitative trends for molecular processes that restrict conformational freedom</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">3168</span>â <span class="NLM_lpage">3175</span>, <span class="refDoi">Â DOI: 10.1021/jo970943n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo970943n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK1cXislGnurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=3168-3175&author=M.+Mammenauthor=E.+I.+Shakhnovichauthor=G.+M.+Whitesides&title=Using+a+convenient%2C+quantitative+model+for+torsional+entropy+to+establish+qualitative+trends+for+molecular+processes+that+restrict+conformational+freedom&doi=10.1021%2Fjo970943n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Using a Convenient, Quantitative Model for Torsional Entropy To Establish Qualitative Trends for Molecular Processes That Restrict Conformational Freedom</span></div><div class="casAuthors">Mammen, Mathai; Shakhnovich, Eugene I.; Whitesides, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3168-3175</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A non-quantum-mech., readily applied model is described that ests. torsional entropy (Stor, the entropy assocd. with torsional motions about a single bond) quant.  Using this model, torsional entropies are evaluated for a variety of mol. arrangements.  Qual. trends emerge from these ests. that are consistent with chem. intuition.  The entropy assocd. with torsional motion is not const.: values of Stor range from 0 to 15 J mol-1 K-1 and are sensitive to details of the bond around which the torsion occurs.  Important characteristics include the bond length, the hybridization, the symmetry, the sizes of these atoms or groups of atoms, and the extent of conjugation to adjacent bonds.  These values are relatively independent of one another in a no. of important cases, and therefore the total change in conformational entropy for a given process may be estd. by adding changes in entropy due to restricting torsions around individual bonds.  A model that permits quant. estns. of changes in conformational entropy will be useful in a wide range of chem. and biochem. applications that include the design of tight-binding polyvalent pharmaceuticals and stable multiparticle mol. assemblies, as well as in the kinetic and thermodn. anal. of almost any chem. reaction that involves the restriction of the torsions of rotors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9qaZcu6bcFrVg90H21EOLACvtfcHk0lhC8pRs5u7vNQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXislGnurs%253D&md5=0d4c24b7c421e39845d8102e0dd3728c</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjo970943n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo970943n%26sid%3Dliteratum%253Aachs%26aulast%3DMammen%26aufirst%3DM.%26aulast%3DShakhnovich%26aufirst%3DE.%2BI.%26aulast%3DWhitesides%26aufirst%3DG.%2BM.%26atitle%3DUsing%2520a%2520convenient%252C%2520quantitative%2520model%2520for%2520torsional%2520entropy%2520to%2520establish%2520qualitative%2520trends%2520for%2520molecular%2520processes%2520that%2520restrict%2520conformational%2520freedom%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D3168%26epage%3D3175%26doi%3D10.1021%2Fjo970943n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Searle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. H.</span></span> <span> </span><span class="NLM_article-title">The cost of conformational order: entropy changes in molecular associations</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">10690</span>â <span class="NLM_lpage">10697</span>, <span class="refDoi">Â DOI: 10.1021/ja00053a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00053a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVSn" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1992&pages=10690-10697&author=M.+S.+Searleauthor=D.+H.+Williams&title=The+cost+of+conformational+order%3A+entropy+changes+in+molecular+associations&doi=10.1021%2Fja00053a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The cost of conformational order:  entropy changes in molecular associations</span></div><div class="casAuthors">Searle, Mark S.; Williams, Dudley H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">10690-7</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Mols. in soln. have degrees of freedom of overall translation and rotation, as well as internal rotations about single bonds, that become highly constrained when two mols. assoc. to forma stable complex.  The thermodn. of fusion and sublimation of hydrocarbons and polar org. mols. were studied as instructive models for features of complex dissocn.  The entropy of fusion within homologous series of alkanes, alkyl carboxylic acids, and 2-Me ketones provides an est. of the entropic cost of restricting a rotor, within a hydrocarbon chain, as -1.6 to -3.6 kJ mol-1 (TÎS at 300 K) upon crystn.  Data on the fusion and sublimation of a range of org. substances (RMM 100-300 g mol-1) that are essentially free of internal rotors illustrate the compensatory relationship between enthalpy and entropy of phase transitions that bear on the cost of restraining a freely translating and rotating mol. in forming a crystal (cf. mol. recognition complex).  A comparison of calcd. gas phase translational and rotational entropies with entropies of sublimation reveals that the latter can account for only 40-70% of the gas phase entropies.  The difference, attributed mainly to the entropy of residual motions in the crystal, gives an insight into the favorable entropy of residual motions in mol. recognition complexes.  When entropies of sublimation are cor. by Trouton's rule for condensation to a liq., it is concluded that some bimol. assocns. that form complexes with little exothermicity may have relatively small adverse entropies, which may lie anywhere in the range -9 to -45 kJ mol-1 (in terms of TÎS at 300 K), opposing binding by a factor of 10-1.6 to 10-8 M-1.  These enthalpy/entropy compensations are of general relevance to binding interactions of biol. importance and are discussed with respect to the binding of agonists vs. antagonists to a common receptor site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo94T7aTW6eSLVg90H21EOLACvtfcHk0lhC8pRs5u7vNQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVSn&md5=205ee6aa9d7ac09864daad99c55fdc1c</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fja00053a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00053a002%26sid%3Dliteratum%253Aachs%26aulast%3DSearle%26aufirst%3DM.%2BS.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26atitle%3DThe%2520cost%2520of%2520conformational%2520order%253A%2520entropy%2520changes%2520in%2520molecular%2520associations%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1992%26volume%3D114%26spage%3D10690%26epage%3D10697%26doi%3D10.1021%2Fja00053a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span> <span> </span><span class="NLM_article-title">Multivalent antibiotics via metal complexes: potent divalent vancomycins against vancomycin-resistant enterococci</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4904</span>â <span class="NLM_lpage">4909</span>, <span class="refDoi">Â DOI: 10.1021/jm030417q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030417q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvFOisbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4904-4909&author=B.+Xingauthor=C.+W.+Yuauthor=P.+L.+Hoauthor=K.+H.+Chowauthor=T.+Cheungauthor=H.+Guauthor=Z.+Caiauthor=B.+Xu&title=Multivalent+antibiotics+via+metal+complexes%3A+potent+divalent+vancomycins+against+vancomycin-resistant+enterococci&doi=10.1021%2Fjm030417q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Multivalent Antibiotics via Metal Complexes: Potent Divalent Vancomycins against Vancomycin-Resistant Enterococci</span></div><div class="casAuthors">Xing, Bengang; Yu, Chun-Wing; Ho, Pak-Leung; Chow, Kin-Hung; Cheung, Terence; Gu, Hongwei; Cai, Zongwei; Xu, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4904-4909</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dimers of vancomycin (Van), linked by a rigid metal complex, [Pt(en)(H2O)2]2+, exhibit potent activities (MIC â¼0.8 Î¼g/mL, â¼720 times more potent than that of Van itself) against vancomycin-resistant enterococci (VRE).  The result suggests that combining metal complexation and receptor/ligand interaction offers a useful method to construct multivalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaLz3HgtmGe7Vg90H21EOLACvtfcHk0lhC8pRs5u7vNQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvFOisbw%253D&md5=ef2a110415f0c508f138d25f5d47fba8</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm030417q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030417q%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DC.%2BW.%26aulast%3DHo%26aufirst%3DP.%2BL.%26aulast%3DChow%26aufirst%3DK.%2BH.%26aulast%3DCheung%26aufirst%3DT.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DB.%26atitle%3DMultivalent%2520antibiotics%2520via%2520metal%2520complexes%253A%2520potent%2520divalent%2520vancomycins%2520against%2520vancomycin-resistant%2520enterococci%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4904%26epage%3D4909%26doi%3D10.1021%2Fjm030417q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Lipophilic vancomycin aglycon dimer with high activity against vancomycin-resistant bacteria</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5477</span>â <span class="NLM_lpage">5480</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2015.10.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.bmcl.2015.10.083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=26525861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslOgu7zN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=5477-5480&author=V.+Yarlagaddaauthor=P.+Sarkarauthor=G.+B.+Manjunathauthor=J.+Haldar&title=Lipophilic+vancomycin+aglycon+dimer+with+high+activity+against+vancomycin-resistant+bacteria&doi=10.1016%2Fj.bmcl.2015.10.083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic vancomycin aglycon dimer with high activity against vancomycin-resistant bacteria</span></div><div class="casAuthors">Yarlagadda, Venkateswarlu; Sarkar, Paramita; Manjunath, Goutham B.; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5477-5480</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Antibiotic-resistant superbugs such as vancomycin-resistant Enterococci (VRE) and Staphylococci have become a major global health hazard.  To address this issue, we synthesized vancomycin aglycon dimers to systematically probe the impact of a linker on biol. activity.  A dimer having a pendant lipophilic moiety in the linker showed â¼300-fold more activity than vancomycin against VRE.  The high activity of the compd. is attributed to its enhanced binding affinity to target peptides which resulted in improved peptidoglycan (cell wall) biosynthesis inhibition.  Therefore, our studies suggest that these compds., prepd. by using facile synthetic methodol., can be used to combat vancomycin-resistant bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRQM5hJqcjV7Vg90H21EOLACvtfcHk0li0wNCGdbv6nA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslOgu7zN&md5=80900ffeee2d81de7a17902091ccdee0</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.10.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.10.083%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DSarkar%26aufirst%3DP.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DLipophilic%2520vancomycin%2520aglycon%2520dimer%2520with%2520high%2520activity%2520against%2520vancomycin-resistant%2520bacteria%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D5477%26epage%3D5480%26doi%3D10.1016%2Fj.bmcl.2015.10.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moses, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpless, K. B.</span></span> <span> </span><span class="NLM_article-title">Reengineering antibiotics to combat bacterial resistance: click chemistry [1,2,3]-triazole vancomycin dimers with potent activity against MRSA and VRE</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">79</span>â <span class="NLM_lpage">83</span>, <span class="refDoi">Â DOI: 10.1002/chem.201604765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1002%2Fchem.201604765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=27747932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVGjtbvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=79-83&author=S.+M.+Silvermanauthor=J.+E.+Mosesauthor=K.+B.+Sharpless&title=Reengineering+antibiotics+to+combat+bacterial+resistance%3A+click+chemistry+%5B1%2C2%2C3%5D-triazole+vancomycin+dimers+with+potent+activity+against+MRSA+and+VRE&doi=10.1002%2Fchem.201604765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Reengineering Antibiotics to Combat Bacterial Resistance: Click Chemistry [1,2,3]-Triazole Vancomycin Dimers with Potent Activity against MRSA and VRE</span></div><div class="casAuthors">Silverman, Steven M.; Moses, John E.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-83</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Vancomycin has long been considered a drug of last resort.  Its efficiency in treating multiple drug-resistant bacterial infections, particularly methicillin-resistant Staphylococcus aureus (MRSA), has had a profound effect on the treatment of life-threatening infections.  However, the emergence of resistance to vancomycin is a cause for significant worldwide concern, prompting the urgent development of new effective treatments for antibiotic resistant bacterial infections.  Harnessing the benefits of multivalency and cooperativity against vancomycin-resistant strains, we report a Click Chem. approach towards reengineered vancomycin derivs. and the synthesis of a no. of dimers with increased potency against MRSA and vancomycin resistant Enterococci (VRE; VanB).  These semi-synthetic dimeric ligands were linked together with great efficiency using the powerful CuAAC reaction, demonstrating high levels of selectivity and purity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmQ1uG1ifJYbVg90H21EOLACvtfcHk0li0wNCGdbv6nA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVGjtbvP&md5=614570f145edfc6e6579a44706b32f7c</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2Fchem.201604765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201604765%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DS.%2BM.%26aulast%3DMoses%26aufirst%3DJ.%2BE.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DReengineering%2520antibiotics%2520to%2520combat%2520bacterial%2520resistance%253A%2520click%2520chemistry%2520%255B1%252C2%252C3%255D-triazole%2520vancomycin%2520dimers%2520with%2520potent%2520activity%2520against%2520MRSA%2520and%2520VRE%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D79%26epage%3D83%26doi%3D10.1002%2Fchem.201604765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crane, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirado-Rives, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of selected key methyl ether derivatives of vancomycin aglycon</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7229</span>â <span class="NLM_lpage">7235</span>, <span class="refDoi">Â DOI: 10.1021/jm100946e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100946e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7229-7235&author=C.+M.+Craneauthor=J.+G.+Pierceauthor=S.+S.+Leungauthor=J.+Tirado-Rivesauthor=W.+L.+Jorgensenauthor=D.+L.+Boger&title=Synthesis+and+evaluation+of+selected+key+methyl+ether+derivatives+of+vancomycin+aglycon&doi=10.1021%2Fjm100946e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm100946e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100946e%26sid%3Dliteratum%253Aachs%26aulast%3DCrane%26aufirst%3DC.%2BM.%26aulast%3DPierce%26aufirst%3DJ.%2BG.%26aulast%3DLeung%26aufirst%3DS.%2BS.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520selected%2520key%2520methyl%2520ether%2520derivatives%2520of%2520vancomycin%2520aglycon%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7229%26epage%3D7235%26doi%3D10.1021%2Fjm100946e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimoto, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel series of semisynthetic vancomycin derivatives effective against vancomycin-resistant bacteria</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2528</span>â <span class="NLM_lpage">2533</span>, <span class="refDoi">Â DOI: 10.1021/jm9017543</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9017543" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlKiur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2528-2533&author=Y.+Nakamaauthor=O.+Yoshidaauthor=M.+Yodaauthor=K.+Arakiauthor=Y.+Sawadaauthor=J.+Nakamuraauthor=S.+Xuauthor=K.+Miuraauthor=H.+Makiauthor=H.+Arimoto&title=Discovery+of+a+novel+series+of+semisynthetic+vancomycin+derivatives+effective+against+vancomycin-resistant+bacteria&doi=10.1021%2Fjm9017543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Series of Semisynthetic Vancomycin Derivatives Effective against Vancomycin-Resistant Bacteria</span></div><div class="casAuthors">Nakama, Yuki; Yoshida, Osamu; Yoda, Masanori; Araki, Keisuke; Sawada, Yuri; Nakamura, Jun; Xu, Shu; Miura, Kenji; Maki, Hideki; Arimoto, Hirokazu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2528-2533</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel semisynthetic vancomycin derivs. with antibacterial activity against vancomycin-resistant S. aureus (VRSA) were prepd.  Replacement of Cl groups of vancomycin by Suzuki-Miyaura cross-coupling reaction, which gave the title compds., is described for the first time.  Introduction of a carbon substituent at the amino acid residue 2 of vancomycin led to an enhancement of antibacterial activity against vancomycin-resistant strains, whereas the addnl. introduction at the amino acid residue 6 resulted in a redn. in activity even against vancomycin-susceptible strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8GEa3LG1jCrVg90H21EOLACvtfcHk0li0wNCGdbv6nA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlKiur8%253D&md5=16ce81f3ae391da4c36b145e15c4a452</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm9017543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9017543%26sid%3Dliteratum%253Aachs%26aulast%3DNakama%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DO.%26aulast%3DYoda%26aufirst%3DM.%26aulast%3DAraki%26aufirst%3DK.%26aulast%3DSawada%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DMiura%26aufirst%3DK.%26aulast%3DMaki%26aufirst%3DH.%26aulast%3DArimoto%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520semisynthetic%2520vancomycin%2520derivatives%2520effective%2520against%2520vancomycin-resistant%2520bacteria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2528%26epage%3D2533%26doi%3D10.1021%2Fjm9017543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoganathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. J.</span></span> <span> </span><span class="NLM_article-title">Structure diversification of vancomycin through peptide-catalyzed, site-selective lipidation: a catalysis-based approach to combat glycopeptide-resistant pathogens</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2367</span>â <span class="NLM_lpage">2377</span>, <span class="refDoi">Â DOI: 10.1021/jm501872s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501872s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisF2ht7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2367-2377&author=S.+Yoganathanauthor=S.+J.+Miller&title=Structure+diversification+of+vancomycin+through+peptide-catalyzed%2C+site-selective+lipidation%3A+a+catalysis-based+approach+to+combat+glycopeptide-resistant+pathogens&doi=10.1021%2Fjm501872s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Diversification of Vancomycin through Peptide-Catalyzed, Site-Selective Lipidation: A Catalysis-Based Approach To Combat Glycopeptide-Resistant Pathogens</span></div><div class="casAuthors">Yoganathan, Sabesan; Miller, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2367-2377</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The emergence of antibiotic-resistant infections highlights the need for novel antibiotic leads, perhaps with a broader spectrum of activity.  Herein, the authors disclose a semisynthetic, catalytic approach for structure diversification of vancomycin.  The authors have identified three unique peptide catalysts that exhibit site-selectivity for the lipidation of the aliph. hydroxyls on vancomycin, generating three new derivs.  Incorporation of lipid chains into the vancomycin scaffold provides promising improvement of its bioactivity against vancomycin-resistant enterococci (Van A and Van B phenotypes of VRE).  The MICs for the new derivs. against MRSA and VRE (Van B phenotype) range from 0.12 to 0.25 Î¼g/mL.  The authors have also performed a structure-activity relationship (SAR) study to investigate the effect of lipid chain length at the newly accessible G4-OH derivatization site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBqmVrTjYNT7Vg90H21EOLACvtfcHk0liv-8-tqaLFJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisF2ht7Y%253D&md5=9aafed77399f231be3dbd0d9d878eafb</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm501872s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501872s%26sid%3Dliteratum%253Aachs%26aulast%3DYoganathan%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DS.%2BJ.%26atitle%3DStructure%2520diversification%2520of%2520vancomycin%2520through%2520peptide-catalyzed%252C%2520site-selective%2520lipidation%253A%2520a%2520catalysis-based%2520approach%2520to%2520combat%2520glycopeptide-resistant%2520pathogens%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2367%26epage%3D2377%26doi%3D10.1021%2Fjm501872s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faridoon</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span> <span> </span><span class="NLM_article-title">Extra sugar on vancomycin: new analogues for combating multidrug-resistant <i>Staphylococcus aureus</i> and vancomycin-resistant enterococci</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">286</span>â <span class="NLM_lpage">304</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b01345</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01345" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2gsLbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=286-304&author=D.+Guanauthor=F.+Chenauthor=L.+Xiongauthor=F.+Tangauthor=+Faridoonauthor=Y.+Qiuauthor=N.+Zhangauthor=L.+Gongauthor=J.+Liauthor=L.+Lanauthor=W.+Huang&title=Extra+sugar+on+vancomycin%3A+new+analogues+for+combating+multidrug-resistant+Staphylococcus+aureus+and+vancomycin-resistant+enterococci&doi=10.1021%2Facs.jmedchem.7b01345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci</span></div><div class="casAuthors">Guan, Dongliang; Chen, Feifei; Xiong, Lun; Tang, Feng; Faridoon; Qiu, Yunguang; Zhang, Naixia; Gong, Likun; Li, Jian; Lan, Lefu; Huang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">286-304</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipophilic substitution on vancomycin is an effective strategy for the development of novel vancomycin analogs against drug-resistant bacteria by enhancing bacterial cell wall interactions.  However, hydrophobic structures usually lead to long elimination half-life and accumulative toxicity; therefore, hydrophilic fragments were also introduced to the lipo-vancomycin to regulate their pharmacokinetic/pharmacodynamic properties.  Here, we synthesized a series of new vancomycin analogs carrying various sugar moieties on the seventh-amino acid Ph ring and lipophilic substitutions on vancosamine with extensive structure-activity relationship anal.  The optimal analogs indicated 128-1024-fold higher activity against methicillin-susceptible S. aureus, vancomycin-intermediate resistant S. aureus (VISA), and vancomycin-resistant Enterococci (VRE) compared with that of vancomycin.  In vivo pharmacokinetics studies demonstrated the effective regulation of extra sugar motifs, which shortened the half-life and addressed concerns of accumulative toxicity of lipo-vancomycin.  This work presents an effective strategy for lipo-vancomycin deriv. design by introducing extra sugars, which leads to better antibiotic-like properties of enhanced efficacy, optimal pharmacokinetics, and lower toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0OFw0tAYTLbVg90H21EOLACvtfcHk0liv-8-tqaLFJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2gsLbJ&md5=230da2640080a83c0838002ace3435c0</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01345%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DXiong%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DFaridoon%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DGong%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DW.%26atitle%3DExtra%2520sugar%2520on%2520vancomycin%253A%2520new%2520analogues%2520for%2520combating%2520multidrug-resistant%2520Staphylococcus%2520aureus%2520and%2520vancomycin-resistant%2520enterococci%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D286%26epage%3D304%26doi%3D10.1021%2Facs.jmedchem.7b01345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malabarba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicas, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R. C.</span></span> <span> </span><span class="NLM_article-title">Structural modifications of glycopeptide antibiotics</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">69</span>â <span class="NLM_lpage">137</span>, <span class="refDoi">Â DOI: 10.1002/(SICI)1098-1128(199701)17:1<69::AID-MED3>3.0.CO;2-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=8979249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK2sXkslSmsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=69-137&author=A.+Malabarbaauthor=T.+I.+Nicasauthor=R.+C.+Thompson&title=Structural+modifications+of+glycopeptide+antibiotics&doi=10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Structural modifications of glycopeptide antibiotics</span></div><div class="casAuthors">Malabarba, Adriano; Nicas, Thalia I.; Thompson, Richard C.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-137</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">A review with 90 refs.  Topics include modulation of activity by alteration of sugars, modification of functional groups, and alterations of the binding pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpjavadS6X7bVg90H21EOLACvtfcHk0liv-8-tqaLFJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslSmsg%253D%253D&md5=cf3781956a1f9dbae4969b848665cf90</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199701%252917%253A1%253C69%253A%253AAID-MED3%253E3.0.CO%253B2-R%26sid%3Dliteratum%253Aachs%26aulast%3DMalabarba%26aufirst%3DA.%26aulast%3DNicas%26aufirst%3DT.%2BI.%26aulast%3DThompson%26aufirst%3DR.%2BC.%26atitle%3DStructural%2520modifications%2520of%2520glycopeptide%2520antibiotics%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1997%26volume%3D17%26spage%3D69%26epage%3D137%26doi%3D10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Membrane active vancomycin analogues: a strategy to combat bacterial resistance</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4558</span>â <span class="NLM_lpage">4568</span>, <span class="refDoi">Â DOI: 10.1021/jm500270w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500270w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntlKgtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4558-4568&author=V.+Yarlagaddaauthor=P.+Akkapeddiauthor=G.+B.+Manjunathauthor=J.+Haldar&title=Membrane+active+vancomycin+analogues%3A+a+strategy+to+combat+bacterial+resistance&doi=10.1021%2Fjm500270w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane active vancomycin analogs: a strategy to combat bacterial resistance</span></div><div class="casAuthors">Yarlagadda, Venkateswarlu; Akkapeddi, Padma; Manjunath, Goutham B.; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4558-4568</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The alarming growth of antibiotic-resistant superbugs such as vancomycin-resistant enterococci and staphylococci has become a major global health hazard.  To address this issue, the authors report the development of lipophilic cationic vancomycin analogs possessing excellent antibacterial activity against several drug-resistant strains.  Compared to vancomycin, efficacy greater than 1000-fold was demonstrated against vancomycin-resistant Enterococci (VRE).  Significantly, unlike vancomycin, these compds. were shown to be bactericidal at low concns. and did not induce bacterial resistance.  An optimized compd. in the series, compared to vancomycin, showed higher activity in methicillin-resistant Staphylococcus aureus (MRSA) infected mouse model and exhibited superior antibacterial activity in whole blood with no obsd. toxicity.  The remarkable activity of these compds. is attributed to the incorporation of a new membrane disruption mechanism into vancomycin and opens up a great opportunity for the development of novel antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6JcPQP0Jqj7Vg90H21EOLACvtfcHk0lg1rMDRw7gOWQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntlKgtrk%253D&md5=30e565c1d5f25b1e8d69b83ea5cab397</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm500270w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500270w%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DAkkapeddi%26aufirst%3DP.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DMembrane%2520active%2520vancomycin%2520analogues%253A%2520a%2520strategy%2520to%2520combat%2520bacterial%2520resistance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4558%26epage%3D4568%26doi%3D10.1021%2Fjm500270w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konai, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paramanandham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranjan, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravikumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">In vivo antibacterial activity and pharmacological properties of the membrane-active glycopeptide antibiotic YV11455</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">627</span>â <span class="NLM_lpage">634</span>, <span class="refDoi">Â DOI: 10.1016/j.ijantimicag.2015.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.ijantimicag.2015.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=25900818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1Gktbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2015&pages=627-634&author=V.+Yarlagaddaauthor=M.+M.+Konaiauthor=G.+B.+Manjunathauthor=R.+G.+Prakashauthor=B.+Maniauthor=K.+Paramanandhamauthor=S.+B.+Ranjanauthor=R.+Ravikumarauthor=S.+P.+Chakrabortyauthor=S.+Royauthor=J.+Haldar&title=In+vivo+antibacterial+activity+and+pharmacological+properties+of+the+membrane-active+glycopeptide+antibiotic+YV11455&doi=10.1016%2Fj.ijantimicag.2015.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo antibacterial activity and pharmacological properties of the membrane-active glycopeptide antibiotic YV11455</span></div><div class="casAuthors">Yarlagadda, Venkateswarlu; Konai, Mohini M.; Manjunath, Goutham B.; Prakash, Relekar G.; Mani, Bhuvana; Paramanandham, Krishnamoorthy; Ranjan, Shome B.; Ravikumar, Raju; Chakraborty, Subhankari P.; Roy, Somenath; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">627-634</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The membrane-active glycopeptide antibiotic YV11455 is a lipophilic cationic vancomycin analog that demonstrates rapid and concn.-dependent killing of clin. relevant multidrug-resistant (MDR) Gram-pos. bacteria in vitro.  YV11455 was 2-fold and 54-270-fold more effective than vancomycin against clin. isolates of vancomycin-sensitive and vancomycin-resistant bacteria, resp.  In this study, the in vivo efficacy, pharmacodynamics, pharmacokinetics and acute toxicol. of YV11455 were investigated.  In vivo activity and pharmacodynamics were detd. in the neutropenic mouse thigh infection model against meticillin-resistant Staphylococcus aureus (MRSA).  YV11455 produced dose-dependent redns. in MRSA titers in thigh muscle.  When administered i.v., the 50% ED (ED50) for YV11455 against MRSA was found to be 3.3 mg/kg body wt., and titers were reduced by up to ca. 3 log10 CFU/g from pre-treatment values at a dosage of 12 mg/kg with single treatment.  Single-dose pharmacokinetic studies demonstrated linear kinetics and a prolonged half-life, with an increase in drug exposure (area under the concn.-time curve) compared with vancomycin.  The peak plasma concn. following an i.v. dose of 12 mg/kg was 543.5 Î¼g/mL.  Acute toxicol. studies revealed that YV11455 did not cause any significant alterations in biochem. parameters or histol. pictures related to major organs such as the liver and kidney at its pharmacodynamic endpoint (ED3-log kill).  These findings collectively suggest that YV11455 could be used clin. for the treatment of infections caused by MDR Gram-pos. bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy_VOe44FWtLVg90H21EOLACvtfcHk0lg1rMDRw7gOWQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1Gktbs%253D&md5=b42643710fd83b893cd22021a2090916</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2015.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2015.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DKonai%26aufirst%3DM.%2BM.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DPrakash%26aufirst%3DR.%2BG.%26aulast%3DMani%26aufirst%3DB.%26aulast%3DParamanandham%26aufirst%3DK.%26aulast%3DRanjan%26aufirst%3DS.%2BB.%26aulast%3DRavikumar%26aufirst%3DR.%26aulast%3DChakraborty%26aufirst%3DS.%2BP.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DIn%2520vivo%2520antibacterial%2520activity%2520and%2520pharmacological%2520properties%2520of%2520the%2520membrane-active%2520glycopeptide%2520antibiotic%2520YV11455%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2015%26volume%3D45%26spage%3D627%26epage%3D634%26doi%3D10.1016%2Fj.ijantimicag.2015.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paramanandham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shome, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Membrane disruption and enhanced inhibition of cell-wall biosynthesis: a synergistic approach to tackle vancomycin-resistant bacteria</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">13644</span>â <span class="NLM_lpage">13649</span>, <span class="refDoi">Â DOI: 10.1002/anie.201507567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1002%2Fanie.201507567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=26473305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Kqs7%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=13644-13649&author=V.+Yarlagaddaauthor=S.+Samaddarauthor=K.+Paramanandhamauthor=B.+R.+Shomeauthor=J.+Haldar&title=Membrane+disruption+and+enhanced+inhibition+of+cell-wall+biosynthesis%3A+a+synergistic+approach+to+tackle+vancomycin-resistant+bacteria&doi=10.1002%2Fanie.201507567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane Disruption and Enhanced Inhibition of Cell-Wall Biosynthesis: A Synergistic Approach to Tackle Vancomycin-Resistant Bacteria</span></div><div class="casAuthors">Yarlagadda, Venkateswarlu; Samaddar, Sandip; Paramanandham, Krishnamoorthy; Shome, Bibek R.; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">13644-13649</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Resistance to glycopeptide antibiotics, the drugs of choice for life-threatening bacterial infections, is on the rise.  To counter the threat of glycopeptide-resistant bacteria, the authors report development of a new class of semi-synthetic glycopeptide antibiotics, which not only target the bacterial membrane but also display enhanced inhibition of cell-wall biosynthesis through increased binding affinity to their target peptides.  The combined effect of these two mechanisms resulted in improved in vitro activity of two to three orders of magnitude over vancomycin and no propensity to trigger drug resistance in bacteria.  In murine model of kidney infection, the optimized compd. was able to bring bacterial burden down by about 6 logs at 12 mg kg-1 with no obsd. toxicity.  The results furnished emphasize the potential of this class of compds. as future antibiotics for drug-resistant Gram-pos. infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdntAtQFj3MrVg90H21EOLACvtfcHk0ljW5gddF5f2HA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Kqs7%252FI&md5=6612d63cd53b251565cddd6727df5e9c</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fanie.201507567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201507567%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DParamanandham%26aufirst%3DK.%26aulast%3DShome%26aufirst%3DB.%2BR.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DMembrane%2520disruption%2520and%2520enhanced%2520inhibition%2520of%2520cell-wall%2520biosynthesis%253A%2520a%2520synergistic%2520approach%2520to%2520tackle%2520vancomycin-resistant%2520bacteria%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D13644%26epage%3D13649%26doi%3D10.1002%2Fanie.201507567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaskovich, M. A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansford, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muldoon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziora, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Premraj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindahl, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karoli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelingon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phetsang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daud, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deecke, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidjabat, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaologa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuegg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betley, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beevers, A. P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterson, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. A.</span></span> <span> </span><span class="NLM_article-title">Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">22</span>, <span class="refDoi">Â DOI: 10.1038/s41467-017-02123-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fs41467-017-02123-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=29295973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BC1MzmvFGktw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=22&author=M.+A.+T.+Blaskovichauthor=K.+A.+Hansfordauthor=Y.+Gongauthor=M.+S.+Butlerauthor=C.+Muldoonauthor=J.+X.+Huangauthor=S.+Ramuauthor=A.+B.+Silvaauthor=M.+Chengauthor=A.+M.+Kavanaghauthor=Z.+Zioraauthor=R.+Premrajauthor=F.+Lindahlauthor=T.+A.+Bradfordauthor=J.+C.+Leeauthor=T.+Karoliauthor=R.+Pelingonauthor=D.+J.+Edwardsauthor=M.+Amadoauthor=A.+G.+Elliottauthor=W.+Phetsangauthor=N.+H.+Daudauthor=J.+E.+Deeckeauthor=H.+E.+Sidjabatauthor=S.+Ramaologaauthor=J.+Zueggauthor=J.+R.+Betleyauthor=A.+P.+G.+Beeversauthor=R.+A.+G.+Smithauthor=J.+A.+Robertsauthor=D.+L.+Patersonauthor=M.+A.+Cooper&title=Protein-inspired+antibiotics+active+against+vancomycin-+and+daptomycin-resistant+bacteria&doi=10.1038%2Fs41467-017-02123-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria</span></div><div class="casAuthors">Blaskovich Mark A T; Hansford Karl A; Gong Yujing; Butler Mark S; Muldoon Craig; Huang Johnny X; Ramu Soumya; Silva Alberto B; Cheng Mu; Kavanagh Angela M; Ziora Zyta; Premraj Rajaratnam; Lindahl Fredrik; Bradford Tanya A; Lee June C; Karoli Tomislav; Pelingon Ruby; Edwards David J; Amado Maite; Elliott Alysha G; Phetsang Wanida; Daud Noor Huda; Deecke Johan E; Ramaologa Sefetogi; Zuegg Johannes; Cooper Matthew A; Silva Alberto B; Karoli Tomislav; Sidjabat Hanna E; Roberts Jason A; Paterson David L; Betley Jason R; Beevers Andrew P G; Smith Richard A G; Betley Jason R; Beevers Andrew P G; Smith Richard A G; Roberts Jason A</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The public health threat posed by a looming 'post-antibiotic' era necessitates new approaches to antibiotic discovery.  Drug development has typically avoided exploitation of membrane-binding properties, in contrast to nature's control of biological pathways via modulation of membrane-associated proteins and membrane lipid composition.  Here, we describe the rejuvenation of the glycopeptide antibiotic vancomycin via selective targeting of bacterial membranes.  Peptide libraries based on positively charged electrostatic effector sequences are ligated to N-terminal lipophilic membrane-insertive elements and then conjugated to vancomycin.  These modified lipoglycopeptides, the 'vancapticins', possess enhanced membrane affinity and activity against methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive bacteria, and retain activity against glycopeptide-resistant strains.  Optimised antibiotics show in vivo efficacy in multiple models of bacterial infection.  This membrane-targeting strategy has potential to 'revitalise' antibiotics that have lost effectiveness against recalcitrant bacteria, or enhance the activity of other intravenous-administered drugs that target membrane-associated receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRFg9X85G-ufWZyxfu64m4ffW6udTcc2ea9Y4b4CXGoIbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzmvFGktw%253D%253D&md5=f9ed17b63af3bc555660bf5b6141c7b8</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02123-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02123-w%26sid%3Dliteratum%253Aachs%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%2BT.%26aulast%3DHansford%26aufirst%3DK.%2BA.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DButler%26aufirst%3DM.%2BS.%26aulast%3DMuldoon%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DJ.%2BX.%26aulast%3DRamu%26aufirst%3DS.%26aulast%3DSilva%26aufirst%3DA.%2BB.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DKavanagh%26aufirst%3DA.%2BM.%26aulast%3DZiora%26aufirst%3DZ.%26aulast%3DPremraj%26aufirst%3DR.%26aulast%3DLindahl%26aufirst%3DF.%26aulast%3DBradford%26aufirst%3DT.%2BA.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DKaroli%26aufirst%3DT.%26aulast%3DPelingon%26aufirst%3DR.%26aulast%3DEdwards%26aufirst%3DD.%2BJ.%26aulast%3DAmado%26aufirst%3DM.%26aulast%3DElliott%26aufirst%3DA.%2BG.%26aulast%3DPhetsang%26aufirst%3DW.%26aulast%3DDaud%26aufirst%3DN.%2BH.%26aulast%3DDeecke%26aufirst%3DJ.%2BE.%26aulast%3DSidjabat%26aufirst%3DH.%2BE.%26aulast%3DRamaologa%26aufirst%3DS.%26aulast%3DZuegg%26aufirst%3DJ.%26aulast%3DBetley%26aufirst%3DJ.%2BR.%26aulast%3DBeevers%26aufirst%3DA.%2BP.%2BG.%26aulast%3DSmith%26aufirst%3DR.%2BA.%2BG.%26aulast%3DRoberts%26aufirst%3DJ.%2BA.%26aulast%3DPaterson%26aufirst%3DD.%2BL.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26atitle%3DProtein-inspired%2520antibiotics%2520active%2520against%2520vancomycin-%2520and%2520daptomycin-resistant%2520bacteria%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D22%26doi%3D10.1038%2Fs41467-017-02123-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">A vancomycin derivative with a pyrophosphate binding group: a strategy to combat vancomycin-resistant bacteria</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7836</span>â <span class="NLM_lpage">7840</span>, <span class="refDoi">Â DOI: 10.1002/anie.201601621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1002%2Fanie.201601621" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=7836-7840&author=V.+Yarlagaddaauthor=P.+Sarkarauthor=S.+Samaddarauthor=J.+Haldar&title=A+vancomycin+derivative+with+a+pyrophosphate+binding+group%3A+a+strategy+to+combat+vancomycin-resistant+bacteria&doi=10.1002%2Fanie.201601621"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1002%2Fanie.201601621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201601621%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DSarkar%26aufirst%3DP.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DA%2520vancomycin%2520derivative%2520with%2520a%2520pyrophosphate%2520binding%2520group%253A%2520a%2520strategy%2520to%2520combat%2520vancomycin-resistant%2520bacteria%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D7836%26epage%3D7840%26doi%3D10.1002%2Fanie.201601621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Printsevskaya, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reznikova, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korolev, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapa, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsufyeva, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preobrazhenskaya, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">641</span>â <span class="NLM_lpage">652</span>, <span class="refDoi">Â DOI: 10.4155/fmc.13.16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.4155%2Ffmc.13.16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=23617428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsFWrsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=641-652&author=S.+S.+Printsevskayaauthor=M.+I.+Reznikovaauthor=A.+M.+Korolevauthor=G.+B.+Lapaauthor=E.+N.+Olsufyevaauthor=M.+N.+Preobrazhenskayaauthor=J.+J.+Plattnerauthor=Y.+K.+Zhang&title=Synthesis+and+study+of+antibacterial+activities+of+antibacterial+glycopeptide+antibiotics+conjugated+with+benzoxaboroles&doi=10.4155%2Ffmc.13.16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles</span></div><div class="casAuthors">Printsevskaya, S. S.; Reznikova, M. I.; Korolev, A. M.; Lapa, G. B.; Olsufyeva, E. N.; Preobrazhenskaya, M. N.; Plattner, J. J.; Zhang, Y. K.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">641-652</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">The ability of boron-contg. compds. to undergo a no. of novel binding interactions with drug target functional groups has recently been described.  Here, the authors incorporated a boron-contg. scaffold, the benzoxaborole, into several glycopeptides antibiotics.  The aim of this work is to exploit the inherent reactivity of boron to gain addnl. interactions with the bacterial cell wall components to improve binding affinity and to thereby overcome resistance.  Three antibacterial glycopeptides (vancomycin, eremomycin and teicoplanin aglycon) were selected for the construction of a series of 12 new benzoxaborole-glycopeptide conjugates.  The hybrid antibiotics, in which the benzoxaborole and glycopeptide moieties were sepd. by a linker, exhibited excellent antibacterial activity against Gram-pos. bacteria, including those with intermediate susceptibility to glycopeptides.  Some analogs also demonstrated activity against vancomycin-resistant enterococci.  It was obsd. that conjugation with benzoxaborole derivs. provided the antibiotics with new and useful properties.  It was also obsd. that teicoplanin aglycon-benzoxaborole derivs. overcame the resistance of Gram-pos. bacteria to vancomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqueWz0kbAGsrVg90H21EOLACvtfcHk0liBNANZ8n3thQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsFWrsrc%253D&md5=f33f1f5bb8144a13b54385dece8de54e</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.16%26sid%3Dliteratum%253Aachs%26aulast%3DPrintsevskaya%26aufirst%3DS.%2BS.%26aulast%3DReznikova%26aufirst%3DM.%2BI.%26aulast%3DKorolev%26aufirst%3DA.%2BM.%26aulast%3DLapa%26aufirst%3DG.%2BB.%26aulast%3DOlsufyeva%26aufirst%3DE.%2BN.%26aulast%3DPreobrazhenskaya%26aufirst%3DM.%2BN.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26atitle%3DSynthesis%2520and%2520study%2520of%2520antibacterial%2520activities%2520of%2520antibacterial%2520glycopeptide%2520antibiotics%2520conjugated%2520with%2520benzoxaboroles%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D641%26epage%3D652%26doi%3D10.4155%2Ffmc.13.16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnusch, C.
J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonvin, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verel, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kruijff, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieters, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breukink, E.</span></span> <span> </span><span class="NLM_article-title">The vancomycin-nisin(1â12) hybrid restores activity against vancomycin resistant enterococci</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">12661</span>â <span class="NLM_lpage">12663</span>, <span class="refDoi">Â DOI: 10.1021/bi801597b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi801597b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlCns7fE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=12661-12663&author=C.%0AJ.+Arnuschauthor=A.+M.+Bonvinauthor=A.+M.+Verelauthor=W.+T.+Jansenauthor=R.+M.+Liskampauthor=B.+de+Kruijffauthor=R.+J.+Pietersauthor=E.+Breukink&title=The+vancomycin-nisin%281%E2%80%9312%29+hybrid+restores+activity+against+vancomycin+resistant+enterococci&doi=10.1021%2Fbi801597b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">The vancomycin-nisin(1-12) hybrid restores activity against vancomycin resistant enterococci</span></div><div class="casAuthors">Arnusch, Christopher J.; Bonvin, Alexandre M. J. J.; Verel, Anne Marie; Jansen, Wouter T. M.; Liskamp, Rob M. J.; de Kruijff, Ben; Pieters, Roland J.; Breukink, Eefjan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">12661-12663</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipid II is a crucial component in bacterial cell wall synthesis.  It is the target of a no. of important antibiotics, which include vancomycin and nisin.  Here we show that a hybrid antibiotic that consists of vancomycin and nisin fragments is significantly more active than the sep. fragments against vancomycin-resistant enterococci.  Three different hybrids were synthesized using click chem. and compared.  Optimal spacer lengths and connection points were predicted using computer modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptaZL2Flm7brVg90H21EOLACvtfcHk0lhJReTzy6cMfw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlCns7fE&md5=cfdcca0f596cbe5272f7968bfd53f9f4</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fbi801597b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi801597b%26sid%3Dliteratum%253Aachs%26aulast%3DArnusch%26aufirst%3DC.%2BJ.%26aulast%3DBonvin%26aufirst%3DA.%2BM.%26aulast%3DVerel%26aufirst%3DA.%2BM.%26aulast%3DJansen%26aufirst%3DW.%2BT.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%26aulast%3Dde%2BKruijff%26aufirst%3DB.%26aulast%3DPieters%26aufirst%3DR.%2BJ.%26aulast%3DBreukink%26aufirst%3DE.%26atitle%3DThe%2520vancomycin-nisin%25281%25E2%2580%259312%2529%2520hybrid%2520restores%2520activity%2520against%2520vancomycin%2520resistant%2520enterococci%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D12661%26epage%3D12663%26doi%3D10.1021%2Fbi801597b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggen, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatheree, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judice, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaniga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leadbetter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linsell, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquess, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nodwell, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapp, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turne, S. D.</span></span> <span> </span><span class="NLM_article-title">Exploring the positional attachment of glycopeptide/Î²-lactam heterodimers</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">603</span>â <span class="NLM_lpage">614</span>, <span class="refDoi">Â DOI: 10.1038/ja.2008.80</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fja.2008.80" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=19168974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOqtbzL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2008&pages=603-614&author=D.+D.+Longauthor=J.+B.+Aggenauthor=J.+Chinnauthor=S.+K.+Choiauthor=B.+G.+Christensenauthor=P.+R.+Fathereeauthor=D.+Greenauthor=S.+S.+Hegdeauthor=J.+K.+Judiceauthor=K.+Kanigaauthor=K.+M.+Krauseauthor=M.+Leadbetterauthor=M.+S.+Linsellauthor=D.+G.+Marquessauthor=E.+J.+Moranauthor=M.+B.+Nodwellauthor=J.+L.+Paceauthor=S.+G.+Trappauthor=S.+D.+Turne&title=Exploring+the+positional+attachment+of+glycopeptide%2F%CE%B2-lactam+heterodimers&doi=10.1038%2Fja.2008.80"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the positional attachment of glycopeptide/Î²-lactam heterodimers</span></div><div class="casAuthors">Long, Daniel D.; Aggen, James B.; Chinn, Jason; Choi, Seok-Ki; Christensen, Burton G.; Fatheree, Paul R.; Green, David; Hegde, Sharath S.; Judice, J. Kevin; Kaniga, Kone; Krause, Kevin M.; Leadbetter, Michael; Linsell, Martin S.; Marquess, Daniel G.; Moran, Edmund J.; Nodwell, Matthew B.; Pace, John L.; Trapp, Sean G.; Turner, S. Derek</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">603-614</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">Further investigations towards novel glycopeptide/Î²-lactam heterodimers are reported.  Employing a multivalent approach to drug discovery, vancomycin and cephalosporin synthons, 4, 2, 5 and 10, 18, 25 resp., were chem. linked to yield heterodimer antibiotics.  These novel compds. were designed to inhibit Gram pos. bacterial cell wall biosynthesis by simultaneously targeting the principal cellular targets of both glycopeptides and Î²-lactams.  The positional attachment of both the vancomycin and the cephalosporin central cores has been explored and the SAR is reported.  This novel class of bifunctional antibiotics 28â¼36 all displayed remarkable potency against a wide range of Gram-pos. organisms, including methicillin-resistant Staphylococcus aureus (MRSA).  A subset of compds., 29, 31 and 35 demonstrated excellent bactericidal activity against MRSA (ATCC 33591) and 31 and 35 also exhibited superb in vivo efficacy in a mouse model of MRSA infection.  As a result of this work compd. 35 was selected as a clin. candidate, TD-1792.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW2IngyblS3rVg90H21EOLACvtfcHk0lhJReTzy6cMfw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOqtbzL&md5=431074c957601703dfb64f8f86015199</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fja.2008.80&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2008.80%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DD.%2BD.%26aulast%3DAggen%26aufirst%3DJ.%2BB.%26aulast%3DChinn%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DS.%2BK.%26aulast%3DChristensen%26aufirst%3DB.%2BG.%26aulast%3DFatheree%26aufirst%3DP.%2BR.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DHegde%26aufirst%3DS.%2BS.%26aulast%3DJudice%26aufirst%3DJ.%2BK.%26aulast%3DKaniga%26aufirst%3DK.%26aulast%3DKrause%26aufirst%3DK.%2BM.%26aulast%3DLeadbetter%26aufirst%3DM.%26aulast%3DLinsell%26aufirst%3DM.%2BS.%26aulast%3DMarquess%26aufirst%3DD.%2BG.%26aulast%3DMoran%26aufirst%3DE.%2BJ.%26aulast%3DNodwell%26aufirst%3DM.%2BB.%26aulast%3DPace%26aufirst%3DJ.%2BL.%26aulast%3DTrapp%26aufirst%3DS.%2BG.%26aulast%3DTurne%26aufirst%3DS.%2BD.%26atitle%3DExploring%2520the%2520positional%2520attachment%2520of%2520glycopeptide%252F%25CE%25B2-lactam%2520heterodimers%26jtitle%3DJ.%2520Antibiot.%26date%3D2008%26volume%3D61%26spage%3D603%26epage%3D614%26doi%3D10.1038%2Fja.2008.80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span> <i>Antibiotics
Currently in Clinical Development</i>; <span class="NLM_publisher-name">Pew Charitable
Trusts</span>, May <span class="NLM_year">2017</span>; <a href="http://www.pewtrusts.org/~/media/assets/2017/05/antibiotics-currently-in-clinical-development-03-2017.pdf" class="extLink">http://www.pewtrusts.org/~/media/assets/2017/05/antibiotics-currently-in-clinical-development-03-2017.pdf</a> (accessed April 1, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Antibiotics%0ACurrently+in+Clinical+Development%3B+Pew+Charitable%0ATrusts%2C+May+2017%3B+http%3A%2F%2Fwww.pewtrusts.org%2F%7E%2Fmedia%2Fassets%2F2017%2F05%2Fantibiotics-currently-in-clinical-development-03-2017.pdf+%28accessed+April+1%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DAntibiotics%250ACurrently%2520in%2520Clinical%2520Development%26pub%3DPew%2520Charitable%250ATrusts%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paramanandham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shome, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravikumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Glycopeptide antibiotic to overcome the intrinsic resistance of gram-negative bacteria</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">132</span>â <span class="NLM_lpage">139</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.5b00114</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.5b00114" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyit7jK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=132-139&author=V.+Yarlagaddaauthor=G.+B.+Manjunathauthor=P.+Sarkarauthor=P.+Akkapeddiauthor=K.+Paramanandhamauthor=B.+R.+Shomeauthor=R.+Ravikumarauthor=J.+Haldar&title=Glycopeptide+antibiotic+to+overcome+the+intrinsic+resistance+of+gram-negative+bacteria&doi=10.1021%2Facsinfecdis.5b00114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Glycopeptide antibiotics to overcome the intrinsic resistance of Gram-negative bacteria</span></div><div class="casAuthors">Yarlagadda, Venkateswarlu; Manjunath, Goutham B.; Sarkar, Paramita; Akkapeddi, Padma; Paramanandham, Krishnamoorthy; Shome, Bibek R.; Ravikumar, Raju; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-139</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The emergence of drug resistance along with a declining pipeline of clin. useful antibiotics has made it vital to develop more effective antimicrobial therapeutics, particularly against difficult-to-treat Gram-neg. pathogens (GNPs).  Many antibacterial agents, including glycopeptide antibiotics such as vancomycin, are inherently inactive toward GNPs because of their inability to cross the outer membrane of these pathogens.  Here, the authors demonstrate that lipophilic cationic (permanent pos. charge) vancomycin analogs were able to permeabilize the outer membrane of GNPs and overcome the inherent resistance of GNPs toward glycopeptides.  Unlike vancomycin, these analogs were shown to have a high activity against a variety of multidrug-resistant clin. isolates such as Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii.  In the murine model of carbapenem-resistant A. baumannii infection, the optimized compd. showed potent activity with no obsd. toxicity.  The notable activity of these compds. is attributed to the incorporation of new membrane disruption mechanisms (cytoplasmic membrane depolarization along with outer and inner (cytoplasmic) membrane permeabilization) into vancomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogjz78A74zirVg90H21EOLACvtfcHk0lhJReTzy6cMfw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyit7jK&md5=19faed63d23e6a1431f13bfb3e2f46b5</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.5b00114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.5b00114%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DSarkar%26aufirst%3DP.%26aulast%3DAkkapeddi%26aufirst%3DP.%26aulast%3DParamanandham%26aufirst%3DK.%26aulast%3DShome%26aufirst%3DB.%2BR.%26aulast%3DRavikumar%26aufirst%3DR.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DGlycopeptide%2520antibiotic%2520to%2520overcome%2520the%2520intrinsic%2520resistance%2520of%2520gram-negative%2520bacteria%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2016%26volume%3D2%26spage%3D132%26epage%3D139%26doi%3D10.1021%2Facsinfecdis.5b00114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morones-Ramirez, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spina, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. J.</span></span> <span> </span><span class="NLM_article-title">Silver enhances antibiotic activity against gram-negative bacteria</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">190ra81</span>, <span class="refDoi">Â DOI: 10.1126/scitranslmed.3006276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1126%2Fscitranslmed.3006276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=23785037" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=190ra81&author=J.+R.+Morones-Ramirezauthor=J.+A.+Winklerauthor=C.+S.+Spinaauthor=J.+J.+Collins&title=Silver+enhances+antibiotic+activity+against+gram-negative+bacteria&doi=10.1126%2Fscitranslmed.3006276"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3006276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3006276%26sid%3Dliteratum%253Aachs%26aulast%3DMorones-Ramirez%26aufirst%3DJ.%2BR.%26aulast%3DWinkler%26aufirst%3DJ.%2BA.%26aulast%3DSpina%26aufirst%3DC.%2BS.%26aulast%3DCollins%26aufirst%3DJ.%2BJ.%26atitle%3DSilver%2520enhances%2520antibiotic%2520activity%2520against%2520gram-negative%2520bacteria%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D190ra81%26doi%3D10.1126%2Fscitranslmed.3006276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Domalaon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhanel, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, F.</span></span> <span> </span><span class="NLM_article-title">Polymyxin B3-tobramycin hybrids with <i>Pseudomonas aeruginosa</i>-selective antibacterial activity and strong potentiation of rifampicin, minocycline, and vancomycin</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">941</span>â <span class="NLM_lpage">954</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.7b00145</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.7b00145" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1KqsrjJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=941-954&author=R.+Domalaonauthor=X.+Yangauthor=Y.+Lyuauthor=G.+G.+Zhanelauthor=F.+Schweizer&title=Polymyxin+B3-tobramycin+hybrids+with+Pseudomonas+aeruginosa-selective+antibacterial+activity+and+strong+potentiation+of+rifampicin%2C+minocycline%2C+and+vancomycin&doi=10.1021%2Facsinfecdis.7b00145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Polymyxin B3-Tobramycin Hybrids with Pseudomonas aeruginosa-Selective Antibacterial Activity and Strong Potentiation of Rifampicin, Minocycline, and Vancomycin</span></div><div class="casAuthors">Domalaon, Ronald; Yang, Xuan; Lyu, Yinfeng; Zhanel, George G.; Schweizer, Frank</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">941-954</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is an urgent need to develop novel antibacterial agents able to eradicate drug-resistant Gram-neg. pathogens such as Pseudomonas aeruginosa.  Antimicrobial hybrids have emerged as a promising strategy to combat bacterial resistance, as a stand-alone drug but also as an adjuvant in combination with existing antibiotics.  Herein, we report for the first time the synthesis and biol. evaluation of polymyxin-aminoglycoside heterodimers composed of polymyxin B3 covalently linked to tobramycin via an aliph. hydrocarbon linker.  The polymyxin B3-tobramycin hybrids demonstrate potent activity against carbapenem-resistant as well as multidrug- or extensively drug-resistant (MDR/XDR) P. aeruginosa clin. isolates.  Furthermore, the most potent hybrid was synergistic with currently used antibiotics against wild-type and MDR/XDR P. aeruginosa but also against Acinetobacter baumannii as well.  The promising biol. activity described herein warrants addnl. studies into design and development of new antimicrobial hybrids able to surmount the problem of antimicrobial resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8YSmonnn0sbVg90H21EOLACvtfcHk0lhc24DHxLfaxw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1KqsrjJ&md5=2f17be1865925aa4d8a33204e13d2d95</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.7b00145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.7b00145%26sid%3Dliteratum%253Aachs%26aulast%3DDomalaon%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLyu%26aufirst%3DY.%26aulast%3DZhanel%26aufirst%3DG.%2BG.%26aulast%3DSchweizer%26aufirst%3DF.%26atitle%3DPolymyxin%2520B3-tobramycin%2520hybrids%2520with%2520Pseudomonas%2520aeruginosa-selective%2520antibacterial%2520activity%2520and%2520strong%2520potentiation%2520of%2520rifampicin%252C%2520minocycline%252C%2520and%2520vancomycin%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2017%26volume%3D3%26spage%3D941%26epage%3D954%26doi%3D10.1021%2Facsinfecdis.7b00145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zarkan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macklyne, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirgadze, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bond, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesketh, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H. J.</span></span> <span> </span><span class="NLM_article-title">Zn(II) mediates vancomycin polymerization and potentiates its antibiotic activity against resistant bacteria</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">4893</span>, <span class="refDoi">Â DOI: 10.1038/s41598-017-04868-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fs41598-017-04868-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=28687742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BC1cjlsFOntQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=4893&author=A.+Zarkanauthor=H.+R.+Macklyneauthor=D.+Y.+Chirgadzeauthor=A.+D.+Bondauthor=A.+R.+Heskethauthor=H.+J.+Hong&title=Zn%28II%29+mediates+vancomycin+polymerization+and+potentiates+its+antibiotic+activity+against+resistant+bacteria&doi=10.1038%2Fs41598-017-04868-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Zn(II) mediates vancomycin polymerization and potentiates its antibiotic activity against resistant bacteria</span></div><div class="casAuthors">Zarkan Ashraf; Macklyne Heather-Rose; Chirgadze Dimitri Y; Hesketh Andrew R; Hong Hee-Jeon; Zarkan Ashraf; Bond Andrew D; Hesketh Andrew R; Hong Hee-Jeon</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4893</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Vancomycin is known to bind to Zn(II) and can induce a zinc starvation response in bacteria.  Here we identify a novel polymerization of vancomycin dimers by structural analysis of vancomycin-Zn(II) crystals and fibre X-ray diffraction.  Bioassays indicate that this structure is associated with an increased antibiotic activity against bacterial strains possessing high level vancomycin resistance mediated by the reprogramming of peptidoglycan biosynthesis to use precursors terminating in D-Ala-D-Lac in place of D-Ala-D-Ala.  Polymerization occurs via interaction of Zn(II) with the N-terminal methylleucine group of vancomycin, and we show that the activity of other glycopeptide antibiotics with this feature can also be similarly augmented by Zn(II).  Construction and analysis of a model strain predominantly using D-Ala-D-Lac precursors for peptidoglycan biosynthesis during normal growth supports the hypothesis that Zn(II) mediated vancomycin polymerization enhances the binding affinity towards these precursors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR2aszz8ssiQYkFb3mqPUYDfW6udTcc2eZ6XjPlRFCaxbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjlsFOntQ%253D%253D&md5=fa39e86e40dcd59ce95149ba8473fc92</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-04868-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-04868-2%26sid%3Dliteratum%253Aachs%26aulast%3DZarkan%26aufirst%3DA.%26aulast%3DMacklyne%26aufirst%3DH.%2BR.%26aulast%3DChirgadze%26aufirst%3DD.%2BY.%26aulast%3DBond%26aufirst%3DA.%2BD.%26aulast%3DHesketh%26aufirst%3DA.%2BR.%26aulast%3DHong%26aufirst%3DH.%2BJ.%26atitle%3DZn%2528II%2529%2520mediates%2520vancomycin%2520polymerization%2520and%2520potentiates%2520its%2520antibiotic%2520activity%2520against%2520resistant%2520bacteria%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D4893%26doi%3D10.1038%2Fs41598-017-04868-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wareham, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornsey, M.</span></span> <span> </span><span class="NLM_article-title">In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of <i>Acinetobacter baumannii</i></span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1047</span>â <span class="NLM_lpage">1051</span>, <span class="refDoi">Â DOI: 10.1093/jac/dkr069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1093%2Fjac%2Fdkr069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=21393131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFejtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2011&pages=1047-1051&author=D.+W.+Warehamauthor=N.+C.+Gordonauthor=M.+Hornsey&title=In+vitro+activity+of+teicoplanin+combined+with+colistin+versus+multidrug-resistant+strains+of+Acinetobacter+baumannii&doi=10.1093%2Fjac%2Fdkr069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii</span></div><div class="casAuthors">Wareham, D. W.; Gordon, N. C.; Hornsey, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1047-1051</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives Antimicrobial treatment of multidrug-resistant Acinetobacter baumannii (MDRAB) remains an important therapeutic challenge.  With isolates resistant to all conventional agents now reported, clinicians are increasingly forced to turn to unorthodox combination treatments in the hope that these may be efficacious.  Although a potent interaction between vancomycin and colistin has been demonstrated, there are concerns regarding the inherent toxicity of combining these agents in clin. practice.  As teicoplanin has less nephrotoxic potential than vancomycin, we assessed whether a colistin/teicoplanin combination would have similar antimicrobial activities in vitro.  Methods The antimicrobial activity of colistin alone and in combination with teicoplanin was assessed vs. a collection of MDRAB belonging to a no. of epidemic lineages present in the UK.  Synergy studies were undertaken using microtiter plate chequerboard assays, an Etest agar diln. method and std. time-kill methodol.  Results The combination of teicoplanin and colistin was bactericidal vs. all of the strains tested.  In chequerboard assays, fractional inhibitory concn. indexes of <0.5 were obtained, consistent with significant in vitro synergy.  Using the Etest method the MIC of teicoplanin fell from >256 mg/L to â¤2 mg/L in the presence of subinhibitory concns. of colistin.  Conclusions Significant synergy was obsd. when colistin was combined with teicoplanin vs. MDRAB in vitro.  This may represent a useful therapeutic combination for the treatment of A. baumannii infections, esp. when renal toxicity is a significant concern.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooT3jFMSn4VbVg90H21EOLACvtfcHk0lhBbYLzDI8l1A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFejtbw%253D&md5=4ef529baf8737b02fe867264dcc5e166</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkr069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkr069%26sid%3Dliteratum%253Aachs%26aulast%3DWareham%26aufirst%3DD.%2BW.%26aulast%3DGordon%26aufirst%3DN.%2BC.%26aulast%3DHornsey%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520activity%2520of%2520teicoplanin%2520combined%2520with%2520colistin%2520versus%2520multidrug-resistant%2520strains%2520of%2520Acinetobacter%2520baumannii%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2011%26volume%3D66%26spage%3D1047%26epage%3D1051%26doi%3D10.1093%2Fjac%2Fdkr069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hornsey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longshaw, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wareham, D. W.</span></span> <span> </span><span class="NLM_article-title">In vitro activity of telavancin in combination with colistin versus gram-negative bacterial pathogens</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3080</span>â <span class="NLM_lpage">3085</span>, <span class="refDoi">Â DOI: 10.1128/AAC.05870-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.05870-11" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3080-3085&author=M.+Hornseyauthor=C.+Longshawauthor=L.+Pheeauthor=D.+W.+Wareham&title=In+vitro+activity+of+telavancin+in+combination+with+colistin+versus+gram-negative+bacterial+pathogens&doi=10.1128%2FAAC.05870-11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1128%2FAAC.05870-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.05870-11%26sid%3Dliteratum%253Aachs%26aulast%3DHornsey%26aufirst%3DM.%26aulast%3DLongshaw%26aufirst%3DC.%26aulast%3DPhee%26aufirst%3DL.%26aulast%3DWareham%26aufirst%3DD.%2BW.%26atitle%3DIn%2520vitro%2520activity%2520of%2520telavancin%2520in%2520combination%2520with%2520colistin%2520versus%2520gram-negative%2520bacterial%2520pathogens%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3080%26epage%3D3085%26doi%3D10.1128%2FAAC.05870-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beppler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. H.</span></span> <span> </span><span class="NLM_article-title">Synergistic interactions of vancomycin with different antibiotics against <i>Escherichia coli</i>: trimethoprim and nitrofurantoin display strong synergies with vancomycin against wild-type <i>E. coli</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">276</span>â <span class="NLM_lpage">281</span>, <span class="refDoi">Â DOI: 10.1128/AAC.03502-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.03502-14" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=276-281&author=A.+Zhouauthor=T.+M.+Kangauthor=J.+Yuanauthor=C.+Bepplerauthor=C.+Nguyenauthor=Z.+Maoauthor=M.+Q.+Nguyenauthor=P.+Yehauthor=J.+H.+Miller&title=Synergistic+interactions+of+vancomycin+with+different+antibiotics+against+Escherichia+coli%3A+trimethoprim+and+nitrofurantoin+display+strong+synergies+with+vancomycin+against+wild-type+E.+coli&doi=10.1128%2FAAC.03502-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1128%2FAAC.03502-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03502-14%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DT.%2BM.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DBeppler%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DMao%26aufirst%3DZ.%26aulast%3DNguyen%26aufirst%3DM.%2BQ.%26aulast%3DYeh%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DJ.%2BH.%26atitle%3DSynergistic%2520interactions%2520of%2520vancomycin%2520with%2520different%2520antibiotics%2520against%2520Escherichia%2520coli%253A%2520trimethoprim%2520and%2520nitrofurantoin%2520display%2520strong%2520synergies%2520with%2520vancomycin%2520against%2520wild-type%2520E.%2520coli%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D276%26epage%3D281%26doi%3D10.1128%2FAAC.03502-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paramanandham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shome, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Vancomycin analogue restores Meropenem activity against NDM-1 gram-negative pathogens</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1093</span>â <span class="NLM_lpage">1101</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.8b00011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.8b00011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVSrt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=1093-1101&author=V.+Yarlagaddaauthor=P.+Sarkarauthor=S.+Samaddarauthor=G.+B.+Manjunathauthor=S.+D.+Mitraauthor=K.+Paramanandhamauthor=B.+R.+Shomeauthor=J.+Haldar&title=Vancomycin+analogue+restores+Meropenem+activity+against+NDM-1+gram-negative+pathogens&doi=10.1021%2Facsinfecdis.8b00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Vancomycin Analogue Restores Meropenem Activity against NDM-1 Gram-Negative Pathogens</span></div><div class="casAuthors">Yarlagadda, Venkateswarlu; Sarkar, Paramita; Samaddar, Sandip; Manjunath, Goutham Belagula; Das Mitra, Susweta; Paramanandham, Krishnamoorthy; Shome, Bibek Ranjan; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1093-1101</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New Delhi Metallo-Î²-lactamase-1 (NDM-1) is the major contributor to the emergence of carbapenem-resistance in Gram-neg. pathogens (GNPs) and has caused many clin. available Î²-lactam antibiotics to become obsolete.  A clin. approved inhibitor of metallo-Î²-lactamase (MBL) that could restore the activity of carbapenems against resistant GNPs has not yet been found, making NDM-1 a serious threat to human health.  Here, we have rationally developed an inhibitor for the NDM-1 enzyme, which has the ability to penetrate the outer membrane of GNPs and inactivate the enzyme by depleting the metal ion (Zn2+) from the active site.  The inhibitor reinstated the activity of meropenem against NDM-1 producing clin. isolates of GNPs like Klebsiella pneumoniae and Escherichia coli.  Further, the inhibitor efficiently restored meropenem activity against NDM-1 producing K. pneumoniae in a murine sepsis infection model.  These findings demonstrate that a combination of the present inhibitor and meropenem has high potential to be translated clin. to combat carbapenem-resistant GNPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocDgSp9O5MR7Vg90H21EOLACvtfcHk0lhBbYLzDI8l1A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVSrt7Y%253D&md5=9bf0cab8f7701c610613ebb4cd3bffcf</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.8b00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.8b00011%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DSarkar%26aufirst%3DP.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DMitra%26aufirst%3DS.%2BD.%26aulast%3DParamanandham%26aufirst%3DK.%26aulast%3DShome%26aufirst%3DB.%2BR.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DVancomycin%2520analogue%2520restores%2520Meropenem%2520activity%2520against%2520NDM-1%2520gram-negative%2520pathogens%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2018%26volume%3D4%26spage%3D1093%26epage%3D1101%26doi%3D10.1021%2Facsinfecdis.8b00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicolosi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolosi, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pignatello, R.</span></span> <span> </span><span class="NLM_article-title">Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against gram-negative bacteria</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">553</span>â <span class="NLM_lpage">558</span>, <span class="refDoi">Â DOI: 10.1016/j.ijantimicag.2010.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.ijantimicag.2010.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=20219328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFOjtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=553-558&author=D.+Nicolosiauthor=M.+Scaliaauthor=V.+M.+Nicolosiauthor=R.+Pignatello&title=Encapsulation+in+fusogenic+liposomes+broadens+the+spectrum+of+action+of+vancomycin+against+gram-negative+bacteria&doi=10.1016%2Fj.ijantimicag.2010.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria</span></div><div class="casAuthors">Nicolosi, Daria; Scalia, Marina; Nicolosi, Vito M.; Pignatello, Rosario</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">553-558</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Many antibacterial agents, including the glycopeptides, are inactive against Gram-neg. bacteria because of their inability to cross the outer membrane of these cells.  Different chem. and technol. approaches have been described to circumvent such limitation.  In this study, the authors aimed to apply the strategy of fusogenic liposomes, up to now used to carry biol. compds. and materials inside cells, to localize a glycopeptide antibiotic, vancomycin (VAN), to the periplasmic space, thus allowing it to exert its bactericidal activity.  Small unilamellar liposome vesicles were prepd. by an extrusion procedure (SUVETs) from a phospholipid-cholesterol hemisuccinate mixt. known for its fusogenic properties with the eukaryotic cell membrane.  VAN was loaded with high efficiency into these vesicles and in microbiol. expts. in vitro was shown to be able to inhibit to a different extent the growth of wild and std. Gram-neg. bacterial strains.  Min. inhibitory concns. as low as 6 mg/L were obsd., for instance against clin. isolates of Escherichia coli and Acinetobacter baumannii.  In comparison, neither the free antibiotic nor VAN-loaded classical' (non-fusogenic) liposomes showed any activity against the same bacteria.  Scanning and TEM studies allowed confirmation that the produced SUVETs were able to adhere to and fuse with the external membrane of E. coli.  According to preliminary expts., this technol. strategy can be proposed as a potentially successful way to enlarge the spectrum of activity of VAN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVcBdxeQfoFLVg90H21EOLACvtfcHk0lhdQMUGSazbJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFOjtbY%253D&md5=7fd8349eb27b1ed280f93ac0484a58c8</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2010.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2010.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DNicolosi%26aufirst%3DD.%26aulast%3DScalia%26aufirst%3DM.%26aulast%3DNicolosi%26aufirst%3DV.%2BM.%26aulast%3DPignatello%26aufirst%3DR.%26atitle%3DEncapsulation%2520in%2520fusogenic%2520liposomes%2520broadens%2520the%2520spectrum%2520of%2520action%2520of%2520vancomycin%2520against%2520gram-negative%2520bacteria%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2010%26volume%3D35%26spage%3D553%26epage%3D558%26doi%3D10.1016%2Fj.ijantimicag.2010.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span> <span> </span><span class="NLM_article-title">Presenting vancomycin on nanoparticles to enhance antimicrobial activities</span>. <i>Nano Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1261</span>â <span class="NLM_lpage">1263</span>, <span class="refDoi">Â DOI: 10.1021/nl034396z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/nl034396z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFOitr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=1261-1263&author=H.+W.+Guauthor=P.+L.+Hoauthor=E.+Tongauthor=L.+Wangauthor=B.+Xu&title=Presenting+vancomycin+on+nanoparticles+to+enhance+antimicrobial+activities&doi=10.1021%2Fnl034396z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Presenting vancomycin on nanoparticles to enhance antimicrobial activities</span></div><div class="casAuthors">Gu, Hongwei; Ho, P. L.; Tong, Edmond; Wang, Ling; Xu, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Nano Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1261-1263</span>CODEN:
                <span class="NLM_cas:coden">NALEFD</span>;
        ISSN:<span class="NLM_cas:issn">1530-6984</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here we report the synthesis of vancomycin (Van)-capped Au nanoparticles (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="2263576274434c">[emailÂ protected]</a>) and their enhanced in vitro antibacterial activities. <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="e0a195a0b6818e">[emailÂ protected]</a> presumably acts as a rigid polyvalent inhibitor of vancomycin-resistant enterococci (VRE).  It also has unexpected activity against an E. coli strain.  Our results suggest that gold nanoparticles may serve as a useful model system to explore multi/polyvalent interactions of ligand-receptor pairs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNga9njR0l2bVg90H21EOLACvtfcHk0lhdQMUGSazbJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFOitr0%253D&md5=a03c694ad6e94661d8ac35c9fd1519ec</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Fnl034396z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnl034396z%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DH.%2BW.%26aulast%3DHo%26aufirst%3DP.%2BL.%26aulast%3DTong%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DB.%26atitle%3DPresenting%2520vancomycin%2520on%2520nanoparticles%2520to%2520enhance%2520antimicrobial%2520activities%26jtitle%3DNano%2520Lett.%26date%3D2003%26volume%3D3%26spage%3D1261%26epage%3D1263%26doi%3D10.1021%2Fnl034396z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neesham-Grenon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arhin, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beveridge, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parr, T. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeck, G.</span></span> <span> </span><span class="NLM_article-title">Oritavancin kills stationary-phase and biofilm <i>Staphylococcus aureus</i> cells in vitro</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">918</span>â <span class="NLM_lpage">925</span>, <span class="refDoi">Â DOI: 10.1128/AAC.00766-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.00766-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=19104027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivF2ltbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=918-925&author=A.+Belleyauthor=E.+Neesham-Grenonauthor=G.+McKayauthor=F.+F.+Arhinauthor=R.+Harrisauthor=T.+Beveridgeauthor=T.+R.+Parrauthor=G.+Moeck&title=Oritavancin+kills+stationary-phase+and+biofilm+Staphylococcus+aureus+cells+in+vitro&doi=10.1128%2FAAC.00766-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro</span></div><div class="casAuthors">Belley, Adam; Neesham-Grenon, Eve; McKay, Geoffrey; Arhin, Francis F.; Harris, Robert; Beveridge, Terry; Parr, Thomas R., Jr.; Moeck, Gregory</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">918-925</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Slow-growing bacteria and biofilms are notoriously tolerant to antibiotics.  Oritavancin is a lipoglycopeptide with multiple mechanisms of action that contribute to its bactericidal action against exponentially growing gram-pos. pathogens, including the inhibition of cell wall synthesis and perturbation of membrane barrier function.  We sought to det. whether oritavancin could eradicate cells known to be tolerant to many antimicrobial agents, i.e., stationary-phase and biofilm cultures of Staphylococcus aureus in vitro.  Oritavancin exhibited concn.-dependent bactericidal activity against stationary-phase inocula of methicillin-susceptible S. aureus (MSSA) ATCC 29213, methicillin-resistant S. aureus (MRSA) ATCC 33591, and vancomycin-resistant S. aureus (VRSA) VRS5 inoculated into nutrient-depleted cation-adjusted Mueller-Hinton broth.  As has been described for exponential-phase cells, oritavancin induced membrane depolarization, increased membrane permeability, and caused ultrastructural defects including a loss of nascent septal cross walls in stationary-phase MSSA.  Furthermore, oritavancin sterilized biofilms of MSSA, MRSA, and VRSA at minimal biofilm eradication concns. (MBECs) of between 0.5 and 8 Î¼g/mL.  Importantly, MBECs for oritavancin were within 1 doubling diln. of their resp. planktonic broth MICs, highlighting the potency of oritavancin against biofilms.  These results demonstrate a significant activity of oritavancin against S. aureus in phases of growth that exhibit tolerance to other antimicrobial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp37UJTKLDCv7Vg90H21EOLACvtfcHk0lhdQMUGSazbJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivF2ltbs%253D&md5=b529fb3ae2518d75fab48175415d2284</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1128%2FAAC.00766-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00766-08%26sid%3Dliteratum%253Aachs%26aulast%3DBelley%26aufirst%3DA.%26aulast%3DNeesham-Grenon%26aufirst%3DE.%26aulast%3DMcKay%26aufirst%3DG.%26aulast%3DArhin%26aufirst%3DF.%2BF.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DBeveridge%26aufirst%3DT.%26aulast%3DParr%26aufirst%3DT.%2BR.%26aulast%3DMoeck%26aufirst%3DG.%26atitle%3DOritavancin%2520kills%2520stationary-phase%2520and%2520biofilm%2520Staphylococcus%2520aureus%2520cells%2520in%2520vitro%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D918%26epage%3D925%26doi%3D10.1128%2FAAC.00766-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LaPlante, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mermel, L. A.</span></span> <span> </span><span class="NLM_article-title">In vitro activities of telavancin and vancomycin against biofilm-producing <i>Staphylococcus aureus, S. epidermidis</i>, and <i>Enterococcus faecalis</i> strains</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3166</span>â <span class="NLM_lpage">3169</span>, <span class="refDoi">Â DOI: 10.1128/AAC.01642-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.01642-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=19451302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotlajtr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=3166-3169&author=K.+L.+LaPlanteauthor=L.+A.+Mermel&title=In+vitro+activities+of+telavancin+and+vancomycin+against+biofilm-producing+Staphylococcus+aureus%2C+S.+epidermidis%2C+and+Enterococcus+faecalis+strains&doi=10.1128%2FAAC.01642-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activities of telavancin and vancomycin against biofilm-producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis strains</span></div><div class="casAuthors">LaPlante, Kerry L.; Mermel, Leonard A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3166-3169</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We investigated the activities of telavancin and vancomycin against biofilm-producing Staphylococcus and Enterococcus strains.  At clin. attainable concns., telavancin was active against bacteria embedded in biofilm (minimal biofilm eradication concn. [MBEC], 0.125 to 2 Î¼g/mL) and inhibited biofilm formation at concns. below the MIC.  Vancomycin did not demonstrate the same activity (MBEC, â¥512 Î¼g/mL) against Staphylococcus aureus and Enterococcus faecalis.  Telavancin may have a unique role in biofilm-assocd. infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmJDhsWgdvDrVg90H21EOLACvtfcHk0lgwQ33LWCyOzg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotlajtr4%253D&md5=29c296f881ab0b8b740d1a8414f69cc7</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1128%2FAAC.01642-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01642-08%26sid%3Dliteratum%253Aachs%26aulast%3DLaPlante%26aufirst%3DK.%2BL.%26aulast%3DMermel%26aufirst%3DL.%2BA.%26atitle%3DIn%2520vitro%2520activities%2520of%2520telavancin%2520and%2520vancomycin%2520against%2520biofilm-producing%2520Staphylococcus%2520aureus%252C%2520S.%2520epidermidis%252C%2520and%2520Enterococcus%2520faecalis%2520strains%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D3166%26epage%3D3169%26doi%3D10.1128%2FAAC.01642-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barcia-Macay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seral, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mingeot-Leclercq, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulkens, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Bambeke, F.</span></span> <span> </span><span class="NLM_article-title">Pharmacodynamic evaluation of the intracellular activities of antibiotics against <i>Staphylococcus aureus</i> in a model of THP-1 macrophages</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">841</span>â <span class="NLM_lpage">851</span>, <span class="refDoi">Â DOI: 10.1128/AAC.50.3.841-851.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.50.3.841-851.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=16495241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFamtrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=841-851&author=M.+Barcia-Macayauthor=C.+Seralauthor=M.+P.+Mingeot-Leclercqauthor=P.+M.+Tulkensauthor=F.+Van+Bambeke&title=Pharmacodynamic+evaluation+of+the+intracellular+activities+of+antibiotics+against+Staphylococcus+aureus+in+a+model+of+THP-1+macrophages&doi=10.1128%2FAAC.50.3.841-851.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages</span></div><div class="casAuthors">Barcia-Macay, Maritza; Seral, Cristina; Mingeot-Leclercq, Marie-Paule; Tulkens, Paul M.; Van Bambeke, Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">841-851</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The pharmacodynamic properties governing the activities of antibiotics against intracellular Staphylococcus aureus are still largely undetd.  Sixteen antibiotics of seven different pharmacol. classes (azithromycin and telithromycin [macrolides]; gentamicin [an aminoglycoside]; linezolid [an oxazolidinone]; penicillin V, nafcillin, ampicillin, and oxacillin [Î²-lactams]; teicoplanin, vancomycin, and oritavancin [glycopeptides]; rifampin [an ansamycin]; and ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin [quinolones]) have been examd. for their activities against S. aureus (ATCC 25923) in human THP-1 macrophages (intracellular) vs. that in culture medium (extracellular) by using a 0- to 24-h exposure time and a wide range of extracellular concns. (including the range of the MIC to the max. concn. in serum [Cmax; total drug] of humans).  All mols. except the macrolides caused a net redn. in bacterial counts that was time and concn./MIC ratio dependent (four mols. tested in detail [gentamicin, oxacillin, moxifloxacin, and oritavancin] showed typical sigmoidal dose-response curves at 24 h).  Maximal intracellular activities remained consistently lower than extracellular activities, irresp. of the level of drug accumulation and of the pharmacol. class.  Relative potencies (50% effective concn. or at a fixed extracellular concn./MIC ratio) were also decreased, but to different extents.  At an extracellular concn. corresponding to their Cmaxs (total drug) in humans, only oxacillin, levofloxacin, garenoxacin, moxifloxacin, and oritavancin had truly intracellular bactericidal effects (2-log decrease or more, as defined by the Clin. and Lab. Stds. Institute guidelines).  The intracellular activities of antibiotics against S. aureus (i) are critically dependent upon their extracellular concns. and the duration of cell exposure (within the 0- to 24-h time frame) to antibiotics and (ii) are always lower than those that can be obsd. extracellularly.  This model may help in rationalizing the choice of antibiotic for the treatment of S. aureus intracellular infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowGfdgdcW6aLVg90H21EOLACvtfcHk0lgwQ33LWCyOzg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFamtrs%253D&md5=ffeb868ce556e346522f2fca2f84989c</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1128%2FAAC.50.3.841-851.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.50.3.841-851.2006%26sid%3Dliteratum%253Aachs%26aulast%3DBarcia-Macay%26aufirst%3DM.%26aulast%3DSeral%26aufirst%3DC.%26aulast%3DMingeot-Leclercq%26aufirst%3DM.%2BP.%26aulast%3DTulkens%26aufirst%3DP.%2BM.%26aulast%3DVan%2BBambeke%26aufirst%3DF.%26atitle%3DPharmacodynamic%2520evaluation%2520of%2520the%2520intracellular%2520activities%2520of%2520antibiotics%2520against%2520Staphylococcus%2520aureus%2520in%2520a%2520model%2520of%2520THP-1%2520macrophages%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D841%26epage%3D851%26doi%3D10.1128%2FAAC.50.3.841-851.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barcia-Macay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouaden, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mingeot-Leclercq, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulkens, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Bambeke, F.</span></span> <span> </span><span class="NLM_article-title">Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts)</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1288</span>â <span class="NLM_lpage">1294</span>, <span class="refDoi">Â DOI: 10.1093/jac/dkn120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1093%2Fjac%2Fdkn120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=18375379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVajtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2008&pages=1288-1294&author=M.+Barcia-Macayauthor=F.+Mouadenauthor=M.+P.+Mingeot-Leclercqauthor=P.+M.+Tulkensauthor=F.+Van+Bambeke&title=Cellular+pharmacokinetics+of+telavancin%2C+a+novel+lipoglycopeptide+antibiotic%2C+and+analysis+of+lysosomal+changes+in+cultured+eukaryotic+cells+%28J774+mouse+macrophages+and+rat+embryonic+fibroblasts%29&doi=10.1093%2Fjac%2Fdkn120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts)</span></div><div class="casAuthors">Barcia-Macay, Maritza; Mouaden, Fatima; Mingeot-Leclercq, Marie-Paule; Tulkens, Paul M.; Van Bambeke, Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1288-1294</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Telavancin is a lipoglycopeptide with multiple mechanisms of action that include membrane-destabilizing effects towards bacterial cells.  It shows bactericidal activity against forms of Staphylococcus aureus (phagolysosomal infection) with different resistance phenotypes [methicillin-resistant S. aureus, vancomycin-intermediate S. aureus or vancomycin-resistant S. aureus].  We examine here the uptake, efflux and intracellular distribution of telavancin in eukaryotic cells as well as its potential to induce lysosomal changes (in comparison with vancomycin and oritavancin).  J774 macrophages and rat embryo fibroblasts were exposed for up to 24 and 72 h to telavancin (5-90 mg/L).  The following studies were performed: measurement of 14C-labeled telavancin cellular uptake and subcellular distribution (cell fractionation), detn. of pericellular membrane integrity (lactate dehydrogenase release), electron microscopy with morphometric anal. of changes in lysosome size and detn. of total phospholipid and cholesterol content.  The uptake of telavancin proceeded linearly as a function of time and concn. in both cell types (clearance rate of â¼10 mL/g of protein/h).  Efflux (macrophages) was â¼5.7-fold slower.  Telavancin subcellular distribution was superimposable on that of a lysosomal marker (N-acetyl-Î²-hexosaminidase).  It did not cause an increase in the release of lactate dehydrogenase and did not induce significant increases in total phospholipid or cholesterol content.  It caused only mild morphol. lysosomal alterations (similar to vancomycin and much less than oritavancin by morphometric anal.).  Telavancin is taken up by eukaryotic cells and localizes in lysosomes, causing mild morphol. alterations without evidence of lipid metab. alterations.  These data support our observations that telavancin is active against intracellular S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9uqlZCHoGjbVg90H21EOLACvtfcHk0lgwQ33LWCyOzg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVajtbs%253D&md5=6f8543f1be11b9428723a2ce43c3928a</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkn120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkn120%26sid%3Dliteratum%253Aachs%26aulast%3DBarcia-Macay%26aufirst%3DM.%26aulast%3DMouaden%26aufirst%3DF.%26aulast%3DMingeot-Leclercq%26aufirst%3DM.%2BP.%26aulast%3DTulkens%26aufirst%3DP.%2BM.%26aulast%3DVan%2BBambeke%26aufirst%3DF.%26atitle%3DCellular%2520pharmacokinetics%2520of%2520telavancin%252C%2520a%2520novel%2520lipoglycopeptide%2520antibiotic%252C%2520and%2520analysis%2520of%2520lysosomal%2520changes%2520in%2520cultured%2520eukaryotic%2520cells%2520%2528J774%2520mouse%2520macrophages%2520and%2520rat%2520embryonic%2520fibroblasts%2529%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2008%26volume%3D61%26spage%3D1288%26epage%3D1294%26doi%3D10.1093%2Fjac%2Fdkn120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Intracellular activity of a membrane-active glycopeptide antibiotic against meticillin-resistant <i>Staphylococcus aureus</i> infection</span>. <i>J. Glob. Antimicrob. Resist.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">71</span>â <span class="NLM_lpage">74</span>, <span class="refDoi">Â DOI: 10.1016/j.jgar.2015.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.jgar.2015.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=27436471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BC2s3isVSntw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=71-74&author=V.+Yarlagaddaauthor=S.+Samaddarauthor=J.+Haldar&title=Intracellular+activity+of+a+membrane-active+glycopeptide+antibiotic+against+meticillin-resistant+Staphylococcus+aureus+infection&doi=10.1016%2Fj.jgar.2015.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular activity of a membrane-active glycopeptide antibiotic against meticillin-resistant Staphylococcus aureus infection</span></div><div class="casAuthors">Yarlagadda Venkateswarlu; Samaddar Sandip; Haldar Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of global antimicrobial resistance</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">71-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Staphylococcus aureus is a facultative intracellular pathogen and there are limited options for the treatment of severe intracellular bacterial infections.  The membrane-active glycopeptide antibiotic Van-QC8 is a permanent positively charged lipophilic vancomycin analogue that demonstrates high activity against clinically relevant drug-resistant Gram-positive bacteria both in vitro and in vivo.  In this study, the intracellular activity of Van-QC8 was evaluated against meticillin-resistant S. aureus (MRSA) infection in RAW macrophages.  Furthermore, the mechanism of intracellular uptake of Van-QC8 was investigated.  Van-QC8 showed time- and concentration-dependent bactericidal activity against intracellular MRSA.  Van-QC8 displayed significantly higher intracellular activity compared with vancomycin and linezolid.  Cellular uptake of Van-QC8 was found to be through clathrin-dependent and -independent and caveolin-dependent and -independent endocytic pathways.  The findings of this study suggest that Van-QC8 could be translated clinically for the treatment of intracellular infections due to MRSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRdo7BVSJQulysZ1x6zOs0vfW6udTcc2eYHmBP0AQ3A-7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3isVSntw%253D%253D&md5=c007218f773e8bd0d5403e2b7d3083d9</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.jgar.2015.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jgar.2015.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DIntracellular%2520activity%2520of%2520a%2520membrane-active%2520glycopeptide%2520antibiotic%2520against%2520meticillin-resistant%2520Staphylococcus%2520aureus%2520infection%26jtitle%3DJ.%2520Glob.%2520Antimicrob.%2520Resist.%26date%3D2016%26volume%3D5%26spage%3D71%26epage%3D74%26doi%3D10.1016%2Fj.jgar.2015.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lehar, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillow, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajihara, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandlen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePalatis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raab, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazenbos, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiroshi Morisaki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darwish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loyet, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalouni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khalfin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plise, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strandh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koefoed, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wah Tan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariathasan, S.</span></span> <span> </span><span class="NLM_article-title">Novel antibody-antibiotic conjugate eliminates intracellular <i>S. aureus</i></span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>527</i></span>,  <span class="NLM_fpage">323</span>â <span class="NLM_lpage">328</span>, <span class="refDoi">Â DOI: 10.1038/nature16057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fnature16057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=26536114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslOrtLfP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=527&publication_year=2015&pages=323-328&author=S.+M.+Leharauthor=T.+Pillowauthor=M.+Xuauthor=L.+Stabenauthor=K.+K.+Kajiharaauthor=R.+Vandlenauthor=L.+DePalatisauthor=H.+Raabauthor=W.+L.+Hazenbosauthor=J.+Hiroshi+Morisakiauthor=J.+Kimauthor=S.+Parkauthor=M.+Darwishauthor=B.+C.+Leeauthor=H.+Hernandezauthor=K.+M.+Loyetauthor=P.+Lupardusauthor=R.+Fongauthor=D.+Yanauthor=C.+Chalouniauthor=E.+Luisauthor=Y.+Khalfinauthor=E.+Pliseauthor=J.+Cheongauthor=J.+P.+Lyssikatosauthor=M.+Strandhauthor=K.+Koefoedauthor=P.+S.+Andersenauthor=J.+A.+Flygareauthor=M.+Wah+Tanauthor=E.+J.+Brownauthor=S.+Mariathasan&title=Novel+antibody-antibiotic+conjugate+eliminates+intracellular+S.+aureus&doi=10.1038%2Fnature16057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Novel antibody-antibiotic conjugate eliminates intracellular S. aureus</span></div><div class="casAuthors">Lehar, Sophie M.; Pillow, Thomas; Xu, Min; Staben, Leanna; Kajihara, Kimberly K.; Vandlen, Richard; De Palatis, Laura; Raab, Helga; Hazenbos, Wouter L.; Hiroshi Morisaki, J.; Kim, Janice; Park, Summer; Darwish, Martine; Lee, Byoung-Chul; Hernandez, Hilda; Loyet, Kelly M.; Lupardus, Patrick; Fong, Rina; Yan, Donghong; Chalouni, Cecile; Luis, Elizabeth; Khalfin, Yana; Plise, Emile; Cheong, Jonathan; Lyssikatos, Joseph P.; Strandh, Magnus; Koefoed, Klaus; Andersen, Peter S.; Flygare, John A.; Tan, Man Wah; Brown, Eric J.; Mariathasan, Sanjeev</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">527</span>
        (<span class="NLM_cas:issue">7578</span>),
    <span class="NLM_cas:pages">323-328</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Staphylococcus aureus is considered to be an extracellular pathogen.  However, survival of S. aureus within host cells may provide a reservoir relatively protected from antibiotics, thus enabling long-term colonization of the host and explaining clin. failures and relapses after antibiotic therapy.  Here we confirm that intracellular reservoirs of S. aureus in mice comprise a virulent subset of bacteria that can establish infection even in the presence of vancomycin, and we introduce a novel therapeutic that effectively kills intracellular S. aureus.  This antibody-antibiotic conjugate consists of an anti-S. aureus antibody conjugated to a highly efficacious antibiotic that is activated only after it is released in the proteolytic environment of the phagolysosome.  The antibody-antibiotic conjugate is superior to vancomycin for treatment of bacteremia and provides direct evidence that intracellular S. aureus represents an important component of invasive infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9cwgfxu2hErVg90H21EOLACvtfcHk0liSKdXtOBKk_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslOrtLfP&md5=09cc42906a456aaa772530d69c36aa50</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1038%2Fnature16057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature16057%26sid%3Dliteratum%253Aachs%26aulast%3DLehar%26aufirst%3DS.%2BM.%26aulast%3DPillow%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DStaben%26aufirst%3DL.%26aulast%3DKajihara%26aufirst%3DK.%2BK.%26aulast%3DVandlen%26aufirst%3DR.%26aulast%3DDePalatis%26aufirst%3DL.%26aulast%3DRaab%26aufirst%3DH.%26aulast%3DHazenbos%26aufirst%3DW.%2BL.%26aulast%3DHiroshi%2BMorisaki%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DDarwish%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DB.%2BC.%26aulast%3DHernandez%26aufirst%3DH.%26aulast%3DLoyet%26aufirst%3DK.%2BM.%26aulast%3DLupardus%26aufirst%3DP.%26aulast%3DFong%26aufirst%3DR.%26aulast%3DYan%26aufirst%3DD.%26aulast%3DChalouni%26aufirst%3DC.%26aulast%3DLuis%26aufirst%3DE.%26aulast%3DKhalfin%26aufirst%3DY.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DCheong%26aufirst%3DJ.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DStrandh%26aufirst%3DM.%26aulast%3DKoefoed%26aufirst%3DK.%26aulast%3DAndersen%26aufirst%3DP.%2BS.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DWah%2BTan%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DE.%2BJ.%26aulast%3DMariathasan%26aufirst%3DS.%26atitle%3DNovel%2520antibody-antibiotic%2520conjugate%2520eliminates%2520intracellular%2520S.%2520aureus%26jtitle%3DNature%26date%3D2015%26volume%3D527%26spage%3D323%26epage%3D328%26doi%3D10.1038%2Fnature16057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariathasan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, M. W.</span></span> <span> </span><span class="NLM_article-title">Antibody-antibiotic conjugates: a novel therapeutic platform against bacterial infections</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">135</span>â <span class="NLM_lpage">149</span>, <span class="refDoi">Â DOI: 10.1016/j.molmed.2016.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.molmed.2016.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=28126271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvVWgtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=135-149&author=S.+Mariathasanauthor=M.+W.+Tan&title=Antibody-antibiotic+conjugates%3A+a+novel+therapeutic+platform+against+bacterial+infections&doi=10.1016%2Fj.molmed.2016.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody-Antibiotic Conjugates: A Novel Therapeutic Platform against Bacterial Infections</span></div><div class="casAuthors">Mariathasan, Sanjeev; Tan, Man-Wah</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-149</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Antibodies are potent components of the immune repertoire and have been successfully exploited to treat bacterial infections.  Recently an antibody-antibiotic conjugate (AAC) that combines key attributes of an antibody and antibiotic has been shown to be efficacious against Staphylococcus aureus infection.  An AAC has three components: an antibiotic payload to kill bacteria, an antibody to target delivery of the payload to bacteria, and a linker attaching the payload to the antibody.  With increasing understanding of the biol. and pathophysiol. of S. aureus, this article highlights how this knowledge has led to the design principles of an efficacious AAC, and discusses how the AAC platform could be translationally applied to treat other perilous infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXJPXDVg4x6LVg90H21EOLACvtfcHk0liSKdXtOBKk_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvVWgtg%253D%253D&md5=a647ef11e4a702f356a617b94c9876b0</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2016.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2016.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DMariathasan%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DM.%2BW.%26atitle%3DAntibody-antibiotic%2520conjugates%253A%2520a%2520novel%2520therapeutic%2520platform%2520against%2520bacterial%2520infections%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2017%26volume%3D23%26spage%3D135%26epage%3D149%26doi%3D10.1016%2Fj.molmed.2016.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peoples, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spoering, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engels, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conlon, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaberle, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarides, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felix, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fetterman, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millett, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitti, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zullo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, K.</span></span> <span> </span><span class="NLM_article-title">A new antibiotic kills pathogens without detectable resistance</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>517</i></span>,  <span class="NLM_fpage">455</span>â <span class="NLM_lpage">459</span>, <span class="refDoi">Â DOI: 10.1038/nature14098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fnature14098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=25561178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOju7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=517&publication_year=2015&pages=455-459&author=L.+L.+Lingauthor=T.+Schneiderauthor=A.+J.+Peoplesauthor=A.+L.+Spoeringauthor=I.+Engelsauthor=B.+P.+Conlonauthor=A.+Muellerauthor=T.+F.+Schaberleauthor=D.+E.+Hughesauthor=S.+Epsteinauthor=M.+Jonesauthor=L.+Lazaridesauthor=V.+A.+Steadmanauthor=D.+R.+Cohenauthor=C.+R.+Felixauthor=K.+A.+Fettermanauthor=W.+P.+Millettauthor=A.+G.+Nittiauthor=A.+M.+Zulloauthor=C.+Chenauthor=K.+Lewis&title=A+new+antibiotic+kills+pathogens+without+detectable+resistance&doi=10.1038%2Fnature14098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">A new antibiotic kills pathogens without detectable resistance</span></div><div class="casAuthors">Ling, Losee L.; Schneider, Tanja; Peoples, Aaron J.; Spoering, Amy L.; Engels, Ina; Conlon, Brian P.; Mueller, Anna; Schaberle, Till F.; Hughes, Dallas E.; Epstein, Slava; Jones, Michael; Lazarides, Linos; Steadman, Victoria A.; Cohen, Douglas R.; Felix, Cintia R.; Fetterman, K. Ashley; Millett, William P.; Nitti, Anthony G.; Zullo, Ashley M.; Chen, Chao; Lewis, Kim</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">517</span>
        (<span class="NLM_cas:issue">7535</span>),
    <span class="NLM_cas:pages">455-459</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Antibiotic resistance is spreading faster than the introduction of new compds. into clin. practice, causing a public health crisis.  Most antibiotics were produced by screening soil microorganisms, but this limited resource of cultivable bacteria was overmined by the 1960s.  Synthetic approaches to produce antibiotics have been unable to replace this platform.  Uncultured bacteria make up approx. 99% of all species in external environments, and are an untapped source of new antibiotics.  We developed several methods to grow uncultured organisms by cultivation in situ or by using specific growth factors.  Here we report a new antibiotic that we term teixobactin, discovered in a screen of uncultured bacteria.  Teixobactin inhibits cell wall synthesis by binding to a highly conserved motif of lipid II (precursor of peptidoglycan) and lipid III (precursor of cell wall teichoic acid).  We did not obtain any mutants of Staphylococcus aureus or Mycobacterium tuberculosis resistant to teixobactin.  The properties of this compd. suggest a path towards developing antibiotics that are likely to avoid development of resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV0hZrSZheoLVg90H21EOLACvtfcHk0lhw4MlbPjVRig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOju7w%253D&md5=27e302d7d44a549a91aa52113c3b4ad8</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1038%2Fnature14098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14098%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DL.%2BL.%26aulast%3DSchneider%26aufirst%3DT.%26aulast%3DPeoples%26aufirst%3DA.%2BJ.%26aulast%3DSpoering%26aufirst%3DA.%2BL.%26aulast%3DEngels%26aufirst%3DI.%26aulast%3DConlon%26aufirst%3DB.%2BP.%26aulast%3DMueller%26aufirst%3DA.%26aulast%3DSchaberle%26aufirst%3DT.%2BF.%26aulast%3DHughes%26aufirst%3DD.%2BE.%26aulast%3DEpstein%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DLazarides%26aufirst%3DL.%26aulast%3DSteadman%26aufirst%3DV.%2BA.%26aulast%3DCohen%26aufirst%3DD.%2BR.%26aulast%3DFelix%26aufirst%3DC.%2BR.%26aulast%3DFetterman%26aufirst%3DK.%2BA.%26aulast%3DMillett%26aufirst%3DW.%2BP.%26aulast%3DNitti%26aufirst%3DA.%2BG.%26aulast%3DZullo%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLewis%26aufirst%3DK.%26atitle%3DA%2520new%2520antibiotic%2520kills%2520pathogens%2520without%2520detectable%2520resistance%26jtitle%3DNature%26date%3D2015%26volume%3D517%26spage%3D455%26epage%3D459%26doi%3D10.1038%2Fnature14098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moraski, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanassi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podos, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pucci, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. J.</span></span> <span> </span><span class="NLM_article-title">One-step syntheses of nitrofuranyl benzimidazoles that are active against multidrug-resistant bacteria</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">667</span>â <span class="NLM_lpage">671</span>, <span class="refDoi">Â DOI: 10.1038/ja.2011.67</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fja.2011.67" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2011&pages=667-671&author=G.+C.+Moraskiauthor=J.+A.+Thanassiauthor=S.+D.+Podosauthor=M.+J.+Pucciauthor=M.+J.+Miller&title=One-step+syntheses+of+nitrofuranyl+benzimidazoles+that+are+active+against+multidrug-resistant+bacteria&doi=10.1038%2Fja.2011.67"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1038%2Fja.2011.67&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2011.67%26sid%3Dliteratum%253Aachs%26aulast%3DMoraski%26aufirst%3DG.%2BC.%26aulast%3DThanassi%26aufirst%3DJ.%2BA.%26aulast%3DPodos%26aufirst%3DS.%2BD.%26aulast%3DPucci%26aufirst%3DM.%2BJ.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26atitle%3DOne-step%2520syntheses%2520of%2520nitrofuranyl%2520benzimidazoles%2520that%2520are%2520active%2520against%2520multidrug-resistant%2520bacteria%26jtitle%3DJ.%2520Antibiot.%26date%3D2011%26volume%3D64%26spage%3D667%26epage%3D671%26doi%3D10.1038%2Fja.2011.67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fuda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heilmayer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vakulenko, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobashery, S.</span></span> <span> </span><span class="NLM_article-title">Mechanistic basis for the action of new cephalosporin antibiotics effective against methicillin- and vancomycin-resistant <i>Staphylococcus aureus</i></span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">10035</span>â <span class="NLM_lpage">10041</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M508846200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1074%2Fjbc.M508846200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=16459335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjt1KgtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=10035-10041&author=C.+Fudaauthor=D.+Hesekauthor=M.+Leeauthor=W.+Heilmayerauthor=R.+Novakauthor=S.+B.+Vakulenkoauthor=S.+Mobashery&title=Mechanistic+basis+for+the+action+of+new+cephalosporin+antibiotics+effective+against+methicillin-+and+vancomycin-resistant+Staphylococcus+aureus&doi=10.1074%2Fjbc.M508846200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic basis for the action of new cephalosporin antibiotics effective against methicillin- and vancomycin-resistant Staphylococcus aureus</span></div><div class="casAuthors">Fuda, Cosimo; Hesek, Dusan; Lee, Mijoon; Heilmayer, Werner; Novak, Rodger; Vakulenko, Sergei B.; Mobashery, Shahriar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">10035-10041</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Emergence of methicillin-resistant Staphylococcus aureus (MRSA) has created challenges in treatment of nosocomial infections.  The recent clin. emergence of vancomycin-resistant MRSA is a new disconcerting chapter in the evolution of these strains.  S. aureus normally produces four PBPs, which are susceptible to modification byÎ²-lactam antibiotics, an event that leads to bacterial death.  The gene product of mecA from MRSA is a penicillin-binding protein (PBP) designated PBP 2a.  PBP 2a is refractory to the action of all com. available Î²-lactam antibiotics.  Furthermore, PBP 2a is capable of taking over the functions of the other PBPs of S. aureus in the face of the challenge by Î²-lactam antibiotics.  Three cephalosporins (compds. 1-3) have been studied herein, which show antibacterial activities against MRSA, including the clin. important vancomycin-resistant strains.  These cephalosporins exhibit substantially smaller dissocn. consts. for the preacylation complex compared with the case of typical cephalosporins, but their pseudo-second-order rate consts. for encounter with PBP 2a (k2/Ks) are not very large (â¤200 M-1 s-1).  It is documented herein that these cephalosporins facilitate a conformational change in PBP 2a, a process that is enhanced in the presence of a synthetic surrogate for cell wall, resulting in increases in the k2/Ks parameter and in more facile enzyme inhibition.  These findings argue that the novel cephalosporins are able to co-opt interactions between PBP 2a and the cell wall in gaining access to the active site in the inhibition process, a set of events that leads to effective inhibition of PBP 2a and the attendant killing of the MRSA strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4U3-57JYP4bVg90H21EOLACvtfcHk0lhw4MlbPjVRig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjt1KgtbY%253D&md5=a833e7fddfd2d920d10f14f49a4c3422</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M508846200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M508846200%26sid%3Dliteratum%253Aachs%26aulast%3DFuda%26aufirst%3DC.%26aulast%3DHesek%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DHeilmayer%26aufirst%3DW.%26aulast%3DNovak%26aufirst%3DR.%26aulast%3DVakulenko%26aufirst%3DS.%2BB.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DMechanistic%2520basis%2520for%2520the%2520action%2520of%2520new%2520cephalosporin%2520antibiotics%2520effective%2520against%2520methicillin-%2520and%2520vancomycin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D10035%26epage%3D10041%26doi%3D10.1074%2Fjbc.M508846200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janardhanan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobashery, S.</span></span> <span> </span><span class="NLM_article-title">The oxadiazole antibacterials</span>. <i>Curr. Opin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">13</span>â <span class="NLM_lpage">17</span>, <span class="refDoi">Â DOI: 10.1016/j.mib.2016.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.mib.2016.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=27239942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC28XoslWlur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=13-17&author=J.+Janardhananauthor=M.+Changauthor=S.+Mobashery&title=The+oxadiazole+antibacterials&doi=10.1016%2Fj.mib.2016.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">The oxadiazole antibacterials</span></div><div class="casAuthors">Janardhanan, Jeshina; Chang, Mayland; Mobashery, Shahriar</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Microbiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-17</span>CODEN:
                <span class="NLM_cas:coden">COMIF7</span>;
        ISSN:<span class="NLM_cas:issn">1369-5274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The oxadiazoles are a class of antibacterials discovered by in silico docking and scoring of compds. against the X-ray structure of a penicillin-binding protein.  These antibacterials exhibit activity against Gram-pos. bacteria, including against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).  They show in vivo efficacy in murine models of peritonitis/sepsis and neutropenic thigh MRSA infection.  They are bactericidal and orally bioavailable.  The oxadiazoles show promise in treatment of MRSA infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGkNPBwBHezbVg90H21EOLACvtfcHk0ljAxmnoc6rjxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XoslWlur0%253D&md5=b0a236214aa4f89149d7197e43c8d4e7</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.mib.2016.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mib.2016.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DJanardhanan%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DThe%2520oxadiazole%2520antibacterials%26jtitle%3DCurr.%2520Opin.%2520Microbiol.%26date%3D2016%26volume%3D33%26spage%3D13%26epage%3D17%26doi%3D10.1016%2Fj.mib.2016.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phumisantiphong, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siripanichgon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reamtong, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diraphat, P.</span></span> <span> </span><span class="NLM_article-title">A novel bacteriocin from <i>Enterococcus faecalis</i> 478 exhibits a potent activity against vancomycin-resistant enterococci</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0186415</span>, <span class="refDoi">Â DOI: 10.1371/journal.pone.0186415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1371%2Fjournal.pone.0186415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=29023515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFegur3O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0186415&author=U.+Phumisantiphongauthor=K.+Siripanichgonauthor=O.+Reamtongauthor=P.+Diraphat&title=A+novel+bacteriocin+from+Enterococcus+faecalis+478+exhibits+a+potent+activity+against+vancomycin-resistant+enterococci&doi=10.1371%2Fjournal.pone.0186415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">A novel bacteriocin from Enterococcus faecalis 478 exhibits a potent activity against vancomycin-resistant enterococci</span></div><div class="casAuthors">Phumisantiphong, Uraporn; Siripanichgon, Kanokrat; Reamtong, Onrapak; Diraphat, Pornphan</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e0186415/1-e0186415/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The emergence of multidrug-resistant enterococci (MDRE) and particularly vancomycin-resistant enterococci (VRE) is considered a serious health problem worldwide, causing the need for new antimicrobials.  The aim of this study was to discover and characterize bacteriocin against clin. isolates of MDRE and VRE.  Over 10,000 bacterial isolates from water, environment and clin. samples were screened.  E. faecalis strain 478 isolated from human feces produced the highest antibacterial activity against several MDRE and VRE strains.  The optimum condition for bacteriocin prodn. was cultivation in MRS broth at 37Â°C, pH 5-6 for 16 h.  The bacteriocin-like substance produced from E. faecalis strain EF478 was stable at 60Â°C for at least 1 h and retained its antimicrobial activity after storage at -20Â°C for 1 yr, at 4Â°C for 6 mo, and at 25Â°C for 2 mo.  A nano-HPLC electrospray ionization multi-stage tandem mass spectrometry (nLC-ESI-MS/MS) anal. showed that the amino acid sequences of the bacteriocin-like substance was similar to serine protease of E. faecalis, gi|488296663 (NCBI database), which has never been reported as a bacteriocin.  This study reported a novel bacteriocin with high antibacterial activity against VRE and MDRE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH32a9tPkHp7Vg90H21EOLACvtfcHk0ljAxmnoc6rjxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFegur3O&md5=f2f69b11797985e7d3d90346270204d2</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0186415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0186415%26sid%3Dliteratum%253Aachs%26aulast%3DPhumisantiphong%26aufirst%3DU.%26aulast%3DSiripanichgon%26aufirst%3DK.%26aulast%3DReamtong%26aufirst%3DO.%26aulast%3DDiraphat%26aufirst%3DP.%26atitle%3DA%2520novel%2520bacteriocin%2520from%2520Enterococcus%2520faecalis%2520478%2520exhibits%2520a%2520potent%2520activity%2520against%2520vancomycin-resistant%2520enterococci%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0186415%26doi%3D10.1371%2Fjournal.pone.0186415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zipperer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konnerth, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berscheid, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidenmaier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slavetinsky, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marschal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalbacher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schittek, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brotz-Oesterhelt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grond, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peschel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krismer, B.</span></span> <span> </span><span class="NLM_article-title">Human commensals producing a novel antibiotic impair pathogen colonization</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>535</i></span>,  <span class="NLM_fpage">511</span>â <span class="NLM_lpage">516</span>, <span class="refDoi">Â DOI: 10.1038/nature18634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fnature18634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=27466123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Ont73P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2016&pages=511-516&author=A.+Zippererauthor=M.+C.+Konnerthauthor=C.+Lauxauthor=A.+Berscheidauthor=D.+Janekauthor=C.+Weidenmaierauthor=M.+Burianauthor=N.+A.+Schillingauthor=C.+Slavetinskyauthor=M.+Marschalauthor=M.+Willmannauthor=H.+Kalbacherauthor=B.+Schittekauthor=H.+Brotz-Oesterheltauthor=S.+Grondauthor=A.+Peschelauthor=B.+Krismer&title=Human+commensals+producing+a+novel+antibiotic+impair+pathogen+colonization&doi=10.1038%2Fnature18634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Human commensals producing a novel antibiotic impair pathogen colonization</span></div><div class="casAuthors">Zipperer, Alexander; Konnerth, Martin C.; Laux, Claudia; Berscheid, Anne; Janek, Daniela; Weidenmaier, Christopher; Burian, Marc; Schilling, Nadine A.; Slavetinsky, Christoph; Marschal, Matthias; Willmann, Matthias; Kalbacher, Hubert; Schittek, Birgit; Broetz-Oesterhelt, Heike; Grond, Stephanie; Peschel, Andreas; Krismer, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">7613</span>),
    <span class="NLM_cas:pages">511-516</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nasal Staphylococcus lugdunensis strains produce lugdunin, a novel thiazolidine-contg. cyclic peptide antibiotic that prohibits colonization by Staphylococcus aureus, and a rare example of a non-ribosomally synthesized bioactive compd. from human-assocd. bacteria.  Lugdunin is bactericidal against major pathogens, effective in animal models, and not prone to causing development of resistance in S. aureus.  Notably, human nasal colonization by S. lugdunensis was assocd. with a significantly reduced S. aureus carriage rate, suggesting that lugdunin or lugdunin-producing commensal bacteria could be valuable for preventing staphylococcal infections.  Moreover, human microbiota should be considered as a source for new antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIXuvnunypn7Vg90H21EOLACvtfcHk0ljAxmnoc6rjxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Ont73P&md5=04c4e8b4dac5aa1c56edf164e8360a3d</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2Fnature18634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18634%26sid%3Dliteratum%253Aachs%26aulast%3DZipperer%26aufirst%3DA.%26aulast%3DKonnerth%26aufirst%3DM.%2BC.%26aulast%3DLaux%26aufirst%3DC.%26aulast%3DBerscheid%26aufirst%3DA.%26aulast%3DJanek%26aufirst%3DD.%26aulast%3DWeidenmaier%26aufirst%3DC.%26aulast%3DBurian%26aufirst%3DM.%26aulast%3DSchilling%26aufirst%3DN.%2BA.%26aulast%3DSlavetinsky%26aufirst%3DC.%26aulast%3DMarschal%26aufirst%3DM.%26aulast%3DWillmann%26aufirst%3DM.%26aulast%3DKalbacher%26aufirst%3DH.%26aulast%3DSchittek%26aufirst%3DB.%26aulast%3DBrotz-Oesterhelt%26aufirst%3DH.%26aulast%3DGrond%26aufirst%3DS.%26aulast%3DPeschel%26aufirst%3DA.%26aulast%3DKrismer%26aufirst%3DB.%26atitle%3DHuman%2520commensals%2520producing%2520a%2520novel%2520antibiotic%2520impair%2520pathogen%2520colonization%26jtitle%3DNature%26date%3D2016%26volume%3D535%26spage%3D511%26epage%3D516%26doi%3D10.1038%2Fnature18634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohamed, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelkhalek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seleem, M. N.</span></span> <span> </span><span class="NLM_article-title">Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular <i>Staphylococcus aureus</i></span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">29707</span>, <span class="refDoi">Â DOI: 10.1038/srep29707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fsrep29707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=27405275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BC2s7pslOqug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=29707&author=M.+F.+Mohamedauthor=A.+Abdelkhalekauthor=M.+N.+Seleem&title=Evaluation+of+short+synthetic+antimicrobial+peptides+for+treatment+of+drug-resistant+and+intracellular+Staphylococcus+aureus&doi=10.1038%2Fsrep29707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus</span></div><div class="casAuthors">Mohamed Mohamed F; Abdelkhalek Ahmed; Seleem Mohamed N; Seleem Mohamed N</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29707</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Methicillin-resistant Staphylococcus aureus (MRSA) infections present a serious challenge because of the emergence of resistance to numerous conventional antibiotics.  Due to their unique mode of action, antimicrobial peptides are novel alternatives to traditional antibiotics for tackling the issue of bacterial multidrug resistance.  Herein, we investigated the antibacterial activity of two short novel peptides (WR12, a 12 residue peptide composed exclusively of arginine and tryptophan, and D-IK8, an eight residue Î²-sheet peptide) against multidrug resistant staphylococci.  In vitro, both peptides exhibited good antibacterial activity against MRSA, vancomycin-resistant S. aureus, linezolid-resistant S. aureus, and methicillin-resistant S. epidermidis.  WR12 and D-IK8 were able to eradicate persisters, MRSA in stationary growth phase, and showed significant clearance of intracellular MRSA in comparison to both vancomycin and linezolid.  In vivo, topical WR12 and D-IK8 significantly reduced both the bacterial load and the levels of the pro-inflammatory cytokines including tumor necrosis factor-Î± (TNF-Î±) and interleukin-6 (IL-6) in MRSA-infected skin lesions.  Moreover, both peptides disrupted established in vitro biofilms of S. aureus and S. epidermidis significantly more so than traditional antimicrobials tested.  Taken together, these results support the potential of WR12 and D-IK8 to be used as a topical antimicrobial agent for the treatment of staphylococcal skin infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAE8XpIz_IilMGsG_HTXYFfW6udTcc2eYKAQJwdLO3jbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7pslOqug%253D%253D&md5=bb332990a7df476b0f93535713307e9a</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1038%2Fsrep29707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep29707%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DM.%2BF.%26aulast%3DAbdelkhalek%26aufirst%3DA.%26aulast%3DSeleem%26aufirst%3DM.%2BN.%26atitle%3DEvaluation%2520of%2520short%2520synthetic%2520antimicrobial%2520peptides%2520for%2520treatment%2520of%2520drug-resistant%2520and%2520intracellular%2520Staphylococcus%2520aureus%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D29707%26doi%3D10.1038%2Fsrep29707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoque, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uppu, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konai, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Small molecular antibacterial peptoid mimics: the simpler the better!</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1428</span>â <span class="NLM_lpage">1436</span>, <span class="refDoi">Â DOI: 10.1021/jm401680a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401680a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsF2mtrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1428-1436&author=C.+Ghoshauthor=G.+B.+Manjunathauthor=P.+Akkapeddiauthor=V.+Yarlagaddaauthor=J.+Hoqueauthor=D.+S.+Uppuauthor=M.+M.+Konaiauthor=J.+Haldar&title=Small+molecular+antibacterial+peptoid+mimics%3A+the+simpler+the+better%21&doi=10.1021%2Fjm401680a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecular antibacterial peptoid mimics: the simpler the better!</span></div><div class="casAuthors">Ghosh, Chandradhish; Manjunath, Goutham B.; Akkapeddi, Padma; Yarlagadda, Venkateswarlu; Hoque, Jiaul; Uppu, Divakara S. S. M.; Konai, Mohini M.; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1428-1436</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The emergence of multidrug-resistant bacteria compounded by the depleting arsenal of antibiotics has accelerated efforts toward development of antibiotics with novel mechanisms of action.  The authors present a series of small mol. antibacterial peptoid mimics which exhibit high in vitro potency against a variety of Gram-pos. and Gram-neg. bacteria, including drug-resistant species such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium.  The highlight of these compds. is their superior activity against the major nosocomial pathogen Pseudomonas aeruginosa.  Nontoxic toward mammalian cells, these rapidly bactericidal compds. primarily act by permeabilization and depolarization of bacterial membrane.  Synthetically simple and selectively antibacterial, these compds. can be developed into a newer class of therapeutic agents against multidrug resistant bacterial species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD3gv-iZUu8bVg90H21EOLACvtfcHk0lhoMm1pXzUkVA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsF2mtrs%253D&md5=5d047aae6b6218f01525953fdf452979</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1021%2Fjm401680a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401680a%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DC.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DAkkapeddi%26aufirst%3DP.%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DHoque%26aufirst%3DJ.%26aulast%3DUppu%26aufirst%3DD.%2BS.%26aulast%3DKonai%26aufirst%3DM.%2BM.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DSmall%2520molecular%2520antibacterial%2520peptoid%2520mimics%253A%2520the%2520simpler%2520the%2520better%2521%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1428%26epage%3D1436%26doi%3D10.1021%2Fjm401680a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uppu, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoque, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Polymers with tunable side-chain amphiphilicity as non-hemolytic antibacterial agents</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">9389</span>â <span class="NLM_lpage">9391</span>, <span class="refDoi">Â DOI: 10.1039/c3cc43751e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1039%2Fc3cc43751e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=23868724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2it7jL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=9389-9391&author=D.+S.+Uppuauthor=P.+Akkapeddiauthor=G.+B.+Manjunathauthor=V.+Yarlagaddaauthor=J.+Hoqueauthor=J.+Haldar&title=Polymers+with+tunable+side-chain+amphiphilicity+as+non-hemolytic+antibacterial+agents&doi=10.1039%2Fc3cc43751e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Polymers with tunable side-chain amphiphilicity as non-hemolytic antibacterial agents</span></div><div class="casAuthors">Uppu, Divakara S. S. M.; Akkapeddi, Padma; Manjunath, Goutham B.; Yarlagadda, Venkateswarlu; Hoque, Jiaul; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">82</span>),
    <span class="NLM_cas:pages">9389-9391</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Quaternized polymers mimicking the antimicrobial peptides were created by tuning the side-chain amphiphilicity using a first-time approach of post-functionalization.  They displayed excellent efficacy against pathogenic bacteria even in human plasma and membrane disruptive mode of action.  The optimized polymers and degraded products were non-hemolytic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0q4c7w8PIFrVg90H21EOLACvtfcHk0lhoMm1pXzUkVA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2it7jL&md5=c735f000f6202efb8780063c52fda9bf</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1039%2Fc3cc43751e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cc43751e%26sid%3Dliteratum%253Aachs%26aulast%3DUppu%26aufirst%3DD.%2BS.%26aulast%3DAkkapeddi%26aufirst%3DP.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DHoque%26aufirst%3DJ.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DPolymers%2520with%2520tunable%2520side-chain%2520amphiphilicity%2520as%2520non-hemolytic%2520antibacterial%2520agents%26jtitle%3DChem.%2520Commun.%26date%3D2013%26volume%3D49%26spage%3D9389%26epage%3D9391%26doi%3D10.1039%2Fc3cc43751e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoque, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konai, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonuguntla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Membrane active small molecules show selective broad spectrum antibacterial activity with no detectable resistance and eradicate biofilms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5486</span>â <span class="NLM_lpage">5500</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b00443</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00443" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKit7%252FM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5486-5500&author=J.+Hoqueauthor=M.+M.+Konaiauthor=S.+Gonuguntlaauthor=G.+B.+Manjunathauthor=S.+Samaddarauthor=V.+Yarlagaddaauthor=J.+Haldar&title=Membrane+active+small+molecules+show+selective+broad+spectrum+antibacterial+activity+with+no+detectable+resistance+and+eradicate+biofilms&doi=10.1021%2Facs.jmedchem.5b00443"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-active small molecules show selective broad spectrum antibacterial activity with no detectable resistance and eradicate biofilms</span></div><div class="casAuthors">Hoque, Jiaul; Konai, Mohini M.; Gonuguntla, Spandhana; Manjunath, Goutham B.; Samaddar, Sandip; Yarlagadda, Venkateswarlu; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5486-5500</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Treating bacterial biofilms with conventional antibiotics is limited due to ineffectiveness of the drugs and higher propensity to develop bacterial resistance.  Development of new classes of antibacterial therapeutics with alternative mechanisms of action has become imperative.  Here, the authors report the design, synthesis, and biol. evaluations of novel membrane-active small mols. featuring two pos. charges, four nonpeptidic amide groups, and variable hydrophobic/hydrophilic (amphiphilic) character.  The biocides synthesized via a facile methodol. not only displayed good antibacterial activity against wild-type bacteria but also showed high activity against various drug-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium (VRE), and Î²-lactam-resistant Klebsiella pneumoniae.  Further, these biocides not only inhibited the formation of biofilms but also disrupted the established S. aureus and E. coli biofilms.  The membrane-active biocides hindered the propensity to develop bacterial resistance.  Moreover, the biocides showed negligible toxicity against mammalian cells and thus bear potential to be used as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUd-NAG1Bl6rVg90H21EOLACvtfcHk0lii8jhOyPwAmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKit7%252FM&md5=dae696b7992515ade5fcd9145594e0ee</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00443%26sid%3Dliteratum%253Aachs%26aulast%3DHoque%26aufirst%3DJ.%26aulast%3DKonai%26aufirst%3DM.%2BM.%26aulast%3DGonuguntla%26aufirst%3DS.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DMembrane%2520active%2520small%2520molecules%2520show%2520selective%2520broad%2520spectrum%2520antibacterial%2520activity%2520with%2520no%2520detectable%2520resistance%2520and%2520eradicate%2520biofilms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5486%26epage%3D5500%26doi%3D10.1021%2Facs.jmedchem.5b00443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konai, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adhikary, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of amino acid tunable lipidated norspermidine conjugates: disrupting biofilms with potent activity against bacterial persisters</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2442</span>â <span class="NLM_lpage">2453</span>, <span class="refDoi">Â DOI: 10.1021/acs.bioconjchem.5b00494</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.5b00494" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1ekurjL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=2442-2453&author=M.+M.+Konaiauthor=U.+Adhikaryauthor=S.+Samaddarauthor=C.+Ghoshauthor=J.+Haldar&title=Structure-activity+relationship+of+amino+acid+tunable+lipidated+norspermidine+conjugates%3A+disrupting+biofilms+with+potent+activity+against+bacterial+persisters&doi=10.1021%2Facs.bioconjchem.5b00494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship of Amino Acid Tunable Lipidated Norspermidine Conjugates: Disrupting Biofilms with Potent Activity against Bacterial Persisters</span></div><div class="casAuthors">Konai, Mohini M.; Adhikary, Utsarga; Samaddar, Sandip; Ghosh, Chandradhish; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2442-2453</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The emergence of bacterial resistance and biofilm assocd. infections has created a challenging situation in global health.  In this present state of affairs where conventional antibiotics are falling short of being able to provide a soln. to these problems, development of novel antibacterial compds. possessing the twin prowess of antibacterial and antibiofilm efficacy is imperative.  Herein, we report a library of amino acid tunable lipidated norspermidine conjugates that were prepd. by conjugating both amino acids and fatty acids with the amine functionalities of norspermidine through amide bond formation.  These lipidated conjugates displayed potent antibacterial activity against various planktonic Gram-pos. and Gram-neg. bacteria including drug-resistant superbugs such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and Î²-lactam-resistant Klebsiella pneumoniae.  This class of nontoxic and fast-acting antibacterial mols. (capable of killing bacteria within 15 min) did not allow bacteria to develop resistance against them after several passages.  Most importantly, an optimized compd. in the series was also capable of killing metabolically inactive persisters and stationary phase bacteria.  Addnl., this compd. was capable of disrupting the preformed biofilms of S. aureus and E. coli.  Therefore, this class of antibacterial conjugates have potential in tackling the challenging situation posed by both bacterial resistance as well as drug tolerance due to biofilm formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvjwlv1w8fLLVg90H21EOLACvtfcHk0lii8jhOyPwAmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1ekurjL&md5=3a3cb9395e60476cf47b93555afed587</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.5b00494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.5b00494%26sid%3Dliteratum%253Aachs%26aulast%3DKonai%26aufirst%3DM.%2BM.%26aulast%3DAdhikary%26aufirst%3DU.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DC.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520of%2520amino%2520acid%2520tunable%2520lipidated%2520norspermidine%2520conjugates%253A%2520disrupting%2520biofilms%2520with%2520potent%2520activity%2520against%2520bacterial%2520persisters%26jtitle%3DBioconjugate%2520Chem.%26date%3D2015%26volume%3D26%26spage%3D2442%26epage%3D2453%26doi%3D10.1021%2Facs.bioconjchem.5b00494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmagadda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span> <span> </span><span class="NLM_article-title">Novel bis-cyclic guanidines as potent membrane-active antibacterial agents with therapeutic potential</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">11948</span>â <span class="NLM_lpage">11951</span>, <span class="refDoi">Â DOI: 10.1039/C7CC07285F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1039%2FC7CC07285F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=29052670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1GmurzE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=11948-11951&author=P.+Tengauthor=A.+Nimmagaddaauthor=M.+Suauthor=Y.+Hongauthor=N.+Shenauthor=C.+Liauthor=L.+Y.+Tsaiauthor=J.+Caoauthor=Q.+Liauthor=J.+Cai&title=Novel+bis-cyclic+guanidines+as+potent+membrane-active+antibacterial+agents+with+therapeutic+potential&doi=10.1039%2FC7CC07285F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Novel bis-cyclic guanidines as potent membrane-active antibacterial agents with therapeutic potential</span></div><div class="casAuthors">Teng, Peng; Nimmagadda, Alekhya; Su, Ma; Hong, Yuzhu; Shen, Ning; Li, Chunpu; Tsai, Ling-Yu; Cao, Jessica; Li, Qi; Cai, Jianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">87</span>),
    <span class="NLM_cas:pages">11948-11951</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We designed a class of small dimeric cyclic guanidine derivs. which display potent antibacterial activity against both multidrug-resistant Gram-neg. and Gram-pos. bacteria.  They could compromise bacterial membranes without developing resistance, inhibit biofilms formed by E. coli, and exhibit excellent in vivo activity in the MRSA-infected thigh burden mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovKB8nHZUHYrVg90H21EOLACvtfcHk0lii8jhOyPwAmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1GmurzE&md5=b46b06f9e2545fbf0c94889a02e26596</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1039%2FC7CC07285F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC07285F%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DP.%26aulast%3DNimmagadda%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DTsai%26aufirst%3DL.%2BY.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DJ.%26atitle%3DNovel%2520bis-cyclic%2520guanidines%2520as%2520potent%2520membrane-active%2520antibacterial%2520agents%2520with%2520therapeutic%2520potential%26jtitle%3DChem.%2520Commun.%26date%3D2017%26volume%3D53%26spage%3D11948%26epage%3D11951%26doi%3D10.1039%2FC7CC07285F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmagadda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odom, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span> <span> </span><span class="NLM_article-title">Membrane-active hydantoin derivatives as antibiotic agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8456</span>â <span class="NLM_lpage">8465</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00847</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00847" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Sku7jK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8456-8465&author=M.+Suauthor=D.+Xiaauthor=P.+Tengauthor=A.+Nimmagaddaauthor=C.+Zhangauthor=T.+Odomauthor=A.+Caoauthor=Y.+Huauthor=J.+Cai&title=Membrane-active+hydantoin+derivatives+as+antibiotic+agents&doi=10.1021%2Facs.jmedchem.7b00847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-Active Hydantoin Derivatives as Antibiotic Agents</span></div><div class="casAuthors">Su, Ma; Xia, Donglin; Teng, Peng; Nimmagadda, Alekhya; Zhang, Chao; Odom, Timothy; Cao, Annie; Hu, Yong; Cai, Jianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8456-8465</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydantoin (imidazolidinedione) derivs. such as nitrofurantoin are small mols. that have aroused considerable interest recently due to their low rate of bacterial resistance.  However, their moderate antimicrobial activity may hamper their application combating antibiotic resistance in the long run.  Herein we report the design of bacterial membrane-active hydantoin derivs., from which we identified compds. that show much more potent antimicrobial activity against a panel of clin. relevant Gram-pos. and Gram-neg. bacterial strains than nitrofurantoin.  These compds. are able to act on bacterial membranes, analogous to natural host-defense peptides (HDPs).  Addnl., these hydantoin compds. could not only kill bacterial pathogens rapidly, but also prevent the development of methicillin-resistant Staphylococcus aureus (MRSA) bacterial resistance under the tested conditions.  More intriguingly, the lead compd. exhibited in vivo efficacy which is much superior to vancomycin by eradicating bacteria and suppressing inflammation caused by MRSA-induced pneumonia on a rat model, demonstrating their promising therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp48yfWduVgk7Vg90H21EOLACvtfcHk0lii8jhOyPwAmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Sku7jK&md5=04a2e9ba317c8f7f444db7cdd6bffce7</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00847%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DM.%26aulast%3DXia%26aufirst%3DD.%26aulast%3DTeng%26aufirst%3DP.%26aulast%3DNimmagadda%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DOdom%26aufirst%3DT.%26aulast%3DCao%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DJ.%26atitle%3DMembrane-active%2520hydantoin%2520derivatives%2520as%2520antibiotic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8456%26epage%3D8465%26doi%3D10.1021%2Facs.jmedchem.7b00847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ichikawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsuan, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, A.</span></span> <span> </span><span class="NLM_article-title">Carbacaprazamycins: chemically stable analogues of the caprazamycin nucleoside antibiotics</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">151</span>â <span class="NLM_lpage">156</span>, <span class="refDoi">Â DOI: 10.1021/id5000376</span> </span><div class="citationLinks">[<a href="/doi/10.1021/id5000376" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVahsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=151-156&author=S.+Ichikawaauthor=M.+Yamaguchiauthor=L.+S.+Hsuanauthor=Y.+Katoauthor=A.+Matsuda&title=Carbacaprazamycins%3A+chemically+stable+analogues+of+the+caprazamycin+nucleoside+antibiotics&doi=10.1021%2Fid5000376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Carbacaprazamycins: Chemically Stable Analogues of the Caprazamycin Nucleoside Antibiotics</span></div><div class="casAuthors">Ichikawa, Satoshi; Yamaguchi, Mayumi; Hsuan, Lee Shang; Kato, Yuta; Matsuda, Akira</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">151-156</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Carbacaprazamycins, which are chem. stable analogs of caprazamycins, were designed and synthesized.  These analogs (I) were active against drug-resistant bacterial pathogens such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and their activities were comparable to those of the parent caprazamycins.  The effect of treatment with carbacaprazamycin on morphol. changes in S. aureus indicated that the mode of action was completely different from those of existing peptidoglycan inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8wPaC80lQfbVg90H21EOLACvtfcHk0lh0udNd97BtBA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVahsbg%253D&md5=9caed0fec927f4f10a0e1435660eb746</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fid5000376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fid5000376%26sid%3Dliteratum%253Aachs%26aulast%3DIchikawa%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DHsuan%26aufirst%3DL.%2BS.%26aulast%3DKato%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DA.%26atitle%3DCarbacaprazamycins%253A%2520chemically%2520stable%2520analogues%2520of%2520the%2520caprazamycin%2520nucleoside%2520antibiotics%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2015%26volume%3D1%26spage%3D151%26epage%3D156%26doi%3D10.1021%2Fid5000376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitors of staphyloxanthin virulence factor in comparison with linezolid and vancomycin versus methicillin-resistant, linezolid-resistant, and vancomycin-intermediate <i>Staphylococcus aureus</i> infections in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8145</span>â <span class="NLM_lpage">8159</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00949</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00949" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKgs7vN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8145-8159&author=S.+Niauthor=H.+Weiauthor=B.+Liauthor=F.+Chenauthor=Y.+Liuauthor=W.+Chenauthor=Y.+Xuauthor=X.+Qiuauthor=X.+Liauthor=Y.+Luauthor=W.+Liuauthor=L.+Huauthor=D.+Linauthor=M.+Wangauthor=X.+Zhengauthor=F.+Maoauthor=J.+Zhuauthor=L.+Lanauthor=J.+Li&title=Novel+inhibitors+of+staphyloxanthin+virulence+factor+in+comparison+with+linezolid+and+vancomycin+versus+methicillin-resistant%2C+linezolid-resistant%2C+and+vancomycin-intermediate+Staphylococcus+aureus+infections+in+vivo&doi=10.1021%2Facs.jmedchem.7b00949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate Staphylococcus aureus Infections in Vivo</span></div><div class="casAuthors">Ni, Shuaishuai; Wei, Hanwen; Li, Baoli; Chen, Feifei; Liu, Yifu; Chen, Wenhua; Xu, Yixiang; Qiu, Xiaoxia; Li, Xiaokang; Lu, Yanli; Liu, Wenwen; Hu, Linhao; Lin, Dazheng; Wang, Manjiong; Zheng, Xinyu; Mao, Fei; Zhu, Jin; Lan, Lefu; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8145-8159</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors' previous work (Wang, et al. J. Med. Chem. 2016, 59, 4831-4848) revealed that effective benzocycloalkane-derived staphyloxanthin inhibitors against methicillin-resistant Staphylococcus aureus (S. aureus) infections were accompanied by poor water soly. and high hERG inhibition and dosages (pre-administration).  In this study, ninety-two chroman and coumaran derivs. as novel inhibitors have been addressed for overcoming deficiencies above.  Derivs. 69 ((E)-N-(coumaran-5-methyl)-N-methyl-3-(4-biphenyl)prop-2-en-1-amine hydrochloride) and 105 ((E,E)-N-(chroman-7-methyl)-N-methyl-5-(4-biphenyl)pent-2,4-dien-1-amine hydrochloride) displayed the excellent pigment inhibitory activities and low hERG inhibition, along with the improvement of soly. by salt type selection.  The broad and significantly potent antibacterial spectra of 69 and 105 were displayed firstly with normal administration in the livers and hearts in mice against pigmented S. aureus Newman, Mu50 (vancomycin-intermediate S. aureus) and NRS271 (linezolid-resistant S. aureus), compared with linezolid and vancomycin.  In summary, both 69 and 105 have the potential to be developed as good antibacterial candidates targeting virulence factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcybrWG0xXSLVg90H21EOLACvtfcHk0lh0udNd97BtBA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKgs7vN&md5=c29f6cf0efd0584034f623d62222a943</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00949%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DNovel%2520inhibitors%2520of%2520staphyloxanthin%2520virulence%2520factor%2520in%2520comparison%2520with%2520linezolid%2520and%2520vancomycin%2520versus%2520methicillin-resistant%252C%2520linezolid-resistant%252C%2520and%2520vancomycin-intermediate%2520Staphylococcus%2520aureus%2520infections%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8145%26epage%3D8159%26doi%3D10.1021%2Facs.jmedchem.7b00949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clauditz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieland, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peschel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotz, F.</span></span> <span> </span><span class="NLM_article-title">Staphyloxanthin plays a role in the fitness of <i>Staphylococcus aureus</i> and its ability to cope with oxidative stress</span>. <i>Infection and immunity</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">4950</span>â <span class="NLM_lpage">4953</span>, <span class="refDoi">Â DOI: 10.1128/IAI.00204-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FIAI.00204-06" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2006&pages=4950-4953&author=A.+Clauditzauthor=A.+Reschauthor=K.+P.+Wielandauthor=A.+Peschelauthor=F.+Gotz&title=Staphyloxanthin+plays+a+role+in+the+fitness+of+Staphylococcus+aureus+and+its+ability+to+cope+with+oxidative+stress&doi=10.1128%2FIAI.00204-06"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1128%2FIAI.00204-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00204-06%26sid%3Dliteratum%253Aachs%26aulast%3DClauditz%26aufirst%3DA.%26aulast%3DResch%26aufirst%3DA.%26aulast%3DWieland%26aufirst%3DK.%2BP.%26aulast%3DPeschel%26aufirst%3DA.%26aulast%3DGotz%26aufirst%3DF.%26atitle%3DStaphyloxanthin%2520plays%2520a%2520role%2520in%2520the%2520fitness%2520of%2520Staphylococcus%2520aureus%2520and%2520its%2520ability%2520to%2520cope%2520with%2520oxidative%2520stress%26jtitle%3DInfection%2520and%2520immunity%26date%3D2006%26volume%3D74%26spage%3D4950%26epage%3D4953%26doi%3D10.1128%2FIAI.00204-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Essex, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastian, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fierer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizet, V.</span></span> <span> </span><span class="NLM_article-title"><i>Staphylococcus aureus</i> golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>202</i></span>,  <span class="NLM_fpage">209</span>â <span class="NLM_lpage">215</span>, <span class="refDoi">Â DOI: 10.1084/jem.20050846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1084%2Fjem.20050846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=16009720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVKht74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2005&pages=209-215&author=G.+Y.+Liuauthor=A.+Essexauthor=J.+T.+Buchananauthor=V.+Dattaauthor=H.+M.+Hoffmanauthor=J.+F.+Bastianauthor=J.+Fiererauthor=V.+Nizet&title=Staphylococcus+aureus+golden+pigment+impairs+neutrophil+killing+and+promotes+virulence+through+its+antioxidant+activity&doi=10.1084%2Fjem.20050846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity</span></div><div class="casAuthors">Liu, George Y.; Essex, Anthony; Buchanan, John T.; Datta, Vivekanand; Hoffman, Hal M.; Bastian, John F.; Fierer, Joshua; Nizet, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-215</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Golden color imparted by carotenoid pigments is the eponymous feature of the human pathogen Staphylococcus aureus.  Here the authors demonstrate a role of this hallmark phenotype in virulence.  Compared with the wild-type (WT) bacterium, a S. aureus mutant with disrupted carotenoid biosynthesis is more susceptible to oxidant killing, has impaired neutrophil survival, and is less pathogenic in a mouse s.c. abscess model.  The survival advantage of WT S. aureus over the carotenoid-deficient mutant is lost upon inhibition of neutrophil oxidative burst or in human or murine NADP oxidase-deficient hosts.  Conversely, heterologous expression of the S. aureus carotenoid in the nonpigmented Streptococcus pyogenes confers enhanced oxidant and neutrophil resistance and increased animal virulence.  Blocking S. aureus carotenogenesis increases oxidant sensitivity and decreases whole-blood survival, suggesting a novel target for antibiotic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO5jK5cytS-bVg90H21EOLACvtfcHk0liVh9P7FDilUg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVKht74%253D&md5=aaf85913e260d691a71f83d963d007c9</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1084%2Fjem.20050846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20050846%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%2BY.%26aulast%3DEssex%26aufirst%3DA.%26aulast%3DBuchanan%26aufirst%3DJ.%2BT.%26aulast%3DDatta%26aufirst%3DV.%26aulast%3DHoffman%26aufirst%3DH.%2BM.%26aulast%3DBastian%26aufirst%3DJ.%2BF.%26aulast%3DFierer%26aufirst%3DJ.%26aulast%3DNizet%26aufirst%3DV.%26atitle%3DStaphylococcus%2520aureus%2520golden%2520pigment%2520impairs%2520neutrophil%2520killing%2520and%2520promotes%2520virulence%2520through%2520its%2520antioxidant%2520activity%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2005%26volume%3D202%26spage%3D209%26epage%3D215%26doi%3D10.1084%2Fjem.20050846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oldfield, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span> <span> </span><span class="NLM_article-title">Resistance-resistant antibiotics</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">664</span>â <span class="NLM_lpage">674</span>, <span class="refDoi">Â DOI: 10.1016/j.tips.2014.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.tips.2014.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=25458541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWmtrzP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=664-674&author=E.+Oldfieldauthor=X.+Feng&title=Resistance-resistant+antibiotics&doi=10.1016%2Fj.tips.2014.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance-resistant antibiotics</span></div><div class="casAuthors">Oldfield, Eric; Feng, Xinxin</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">664-674</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">New antibiotics are needed because drug resistance is increasing while the introduction of new antibiotics is decreasing.  We discuss here six possible approaches to develop 'resistance-resistant' antibiotics.  First, multitarget inhibitors in which a single compd. inhibits more than one target may be easier to develop than conventional combination therapies with two new drugs.  Second, inhibiting multiple targets in the same metabolic pathway is expected to be an effective strategy owing to synergy.  Third, discovering multiple-target inhibitors should be possible by using sequential virtual screening.  Fourth, repurposing existing drugs can lead to combinations of multitarget therapeutics.  Fifth, targets need not be proteins.  Sixth, inhibiting virulence factor formation and boosting innate immunity may also lead to decreased susceptibility to resistance.  Although it is not possible to eliminate resistance, the approaches reviewed here offer several possibilities for reducing the effects of mutations and, in some cases, suggest that sensitivity to existing antibiotics may be restored in otherwise drug-resistant organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoFcN1H0q81rVg90H21EOLACvtfcHk0liVh9P7FDilUg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWmtrzP&md5=1fd8f53ba0e90abbc83a6616db24568a</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DOldfield%26aufirst%3DE.%26aulast%3DFeng%26aufirst%3DX.%26atitle%3DResistance-resistant%2520antibiotics%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26spage%3D664%26epage%3D674%26doi%3D10.1016%2Fj.tips.2014.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van Harten, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, R. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrickx, A. P. A.</span></span> <span> </span><span class="NLM_article-title">Multidrug-resistant enterococcal infections: new compounds, novel antimicrobial therapies?</span>. <i>Trends Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">467</span>â <span class="NLM_lpage">479</span>, <span class="refDoi">Â DOI: 10.1016/j.tim.2017.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.tim.2017.01.004" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=467-479&author=R.+M.+van+Hartenauthor=R.+J.+L.+Willemsauthor=N.+I.+Martinauthor=A.+P.+A.+Hendrickx&title=Multidrug-resistant+enterococcal+infections%3A+new+compounds%2C+novel+antimicrobial+therapies%3F&doi=10.1016%2Fj.tim.2017.01.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.tim.2017.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tim.2017.01.004%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHarten%26aufirst%3DR.%2BM.%26aulast%3DWillems%26aufirst%3DR.%2BJ.%2BL.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26aulast%3DHendrickx%26aufirst%3DA.%2BP.%2BA.%26atitle%3DMultidrug-resistant%2520enterococcal%2520infections%253A%2520new%2520compounds%252C%2520novel%2520antimicrobial%2520therapies%253F%26jtitle%3DTrends%2520Microbiol.%26date%3D2017%26volume%3D25%26spage%3D467%26epage%3D479%26doi%3D10.1016%2Fj.tim.2017.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koopmans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ât Hart, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleijn, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrickx, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breukink, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. I.</span></span> <span> </span><span class="NLM_article-title">Semisynthetic lipopeptides derived from nisin display antibacterial activity and lipid II binding on par with that of the parent compound</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">9382</span>â <span class="NLM_lpage">9389</span>, <span class="refDoi">Â DOI: 10.1021/jacs.5b04501</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b04501" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVyitb%252FO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=9382-9389&author=T.+Koopmansauthor=T.+M.+Woodauthor=P.+%E2%80%98t+Hartauthor=L.+H.+Kleijnauthor=A.+P.+Hendrickxauthor=R.+J.+Willemsauthor=E.+Breukinkauthor=N.+I.+Martin&title=Semisynthetic+lipopeptides+derived+from+nisin+display+antibacterial+activity+and+lipid+II+binding+on+par+with+that+of+the+parent+compound&doi=10.1021%2Fjacs.5b04501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Semisynthetic lipopeptides derived from nisin display antibacterial activity and lipid II binding on par with that of the parent compound</span></div><div class="casAuthors">Koopmans, Timo; Wood, Thomas M.; 't Hart, Peter; Kleijn, Laurens H. J.; Hendrickx, Antoni P. A.; Willems, Rob J. L.; Breukink, Eefjan; Martin, Nathaniel I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">9382-9389</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lipid II-binding N-terminus of nisin, comprising the so-called A/B ring system, was synthetically modified to provide antibacterially active and proteolytically stable derivs.  Various lipids were coupled to the C-terminus of the nisin A/B ring system to generate semisynthetic constructs that display potent inhibition of bacterial growth, with activities approaching that of nisin itself.  Most notable was the activity obsd. against clin. relevant bacterial strains including MRSA and VRE.  Expts. with membrane models indicate that these constructs operate via a lipid II-mediated mode of action without causing pore formation.  A lipid II-dependent mechanism of action is further supported by antagonization assays wherein the addn. of lipid II was found to effectively block the antibacterial activity of the nisin-derived lipopeptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTWVAfxVxlF7Vg90H21EOLACvtfcHk0liVh9P7FDilUg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVyitb%252FO&md5=f119eebfdd958cb5ae3aae7872746682</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b04501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b04501%26sid%3Dliteratum%253Aachs%26aulast%3DKoopmans%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DT.%2BM.%26aulast%3D%25E2%2580%2598t%2BHart%26aufirst%3DP.%26aulast%3DKleijn%26aufirst%3DL.%2BH.%26aulast%3DHendrickx%26aufirst%3DA.%2BP.%26aulast%3DWillems%26aufirst%3DR.%2BJ.%26aulast%3DBreukink%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26atitle%3DSemisynthetic%2520lipopeptides%2520derived%2520from%2520nisin%2520display%2520antibacterial%2520activity%2520and%2520lipid%2520II%2520binding%2520on%2520par%2520with%2520that%2520of%2520the%2520parent%2520compound%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D9382%26epage%3D9389%26doi%3D10.1021%2Fjacs.5b04501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castiglione, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciciliato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gastaldo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candiani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Losi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parenti, F.</span></span> <span> </span><span class="NLM_article-title">Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">22</span>â <span class="NLM_lpage">31</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2007.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.chembiol.2007.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=18215770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpt12qsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=22-31&author=F.+Castiglioneauthor=A.+Lazzariniauthor=L.+Carranoauthor=E.+Cortiauthor=I.+Ciciliatoauthor=L.+Gastaldoauthor=P.+Candianiauthor=D.+Losiauthor=F.+Marinelliauthor=E.+Selvaauthor=F.+Parenti&title=Determining+the+structure+and+mode+of+action+of+microbisporicin%2C+a+potent+lantibiotic+active+against+multiresistant+pathogens&doi=10.1016%2Fj.chembiol.2007.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Determining the Structure and Mode of Action of Microbisporicin, a Potent Lantibiotic Active Against Multiresistant Pathogens</span></div><div class="casAuthors">Castiglione, Franca; Lazzarini, Ameriga; Carrano, Lucia; Corti, Emiliana; Ciciliato, Ismaela; Gastaldo, Luciano; Candiani, Paolo; Losi, Daniele; Marinelli, Flavia; Selva, Enrico; Parenti, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-31</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Antibiotics blocking bacterial cell wall assembly (Î²-lactams and glycopeptides) are facing a challenge from the progressive spread of resistant pathogens.  Lantibiotics are promising candidates to alleviate this problem.  Microbisporicin, the most potent antibacterial among known comparable lantibiotics, was discovered during a screening applied to uncommon actinomycetes.  It is produced by Microbispora sp. as two similarly active and structurally related polypeptides (A1, 2246-Da and A2, 2230-Da) of 24 amino acids linked by 5 intramol. thioether bridges.  Microbisporicin contains two posttranslational modifications that have never been reported previously in lantibiotics: 5-chloro-trypthopan and mono- (in A2) or bis-hydroxylated (in A1) proline.  Consistent with screening criteria, microbisporicin selectively blocks peptidoglycan biosynthesis, causing cytoplasmic UDP-linked precursor accumulation.  Considering its spectrum of activity and its efficacy in vivo, microbisporicin represents a promising antibiotic to treat emerging infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5uYPrVWN1XLVg90H21EOLACvtfcHk0ljCPowmNpfLFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpt12qsw%253D%253D&md5=5d7230918250e8dd298bbb5a0027d594</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2007.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2007.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DCastiglione%26aufirst%3DF.%26aulast%3DLazzarini%26aufirst%3DA.%26aulast%3DCarrano%26aufirst%3DL.%26aulast%3DCorti%26aufirst%3DE.%26aulast%3DCiciliato%26aufirst%3DI.%26aulast%3DGastaldo%26aufirst%3DL.%26aulast%3DCandiani%26aufirst%3DP.%26aulast%3DLosi%26aufirst%3DD.%26aulast%3DMarinelli%26aufirst%3DF.%26aulast%3DSelva%26aufirst%3DE.%26aulast%3DParenti%26aufirst%3DF.%26atitle%3DDetermining%2520the%2520structure%2520and%2520mode%2520of%2520action%2520of%2520microbisporicin%252C%2520a%2520potent%2520lantibiotic%2520active%2520against%2520multiresistant%2520pathogens%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D22%26epage%3D31%26doi%3D10.1016%2Fj.chembiol.2007.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sinko, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feixas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldfield, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span> <span> </span><span class="NLM_article-title">Undecaprenyl diphosphate synthase inhibitors: antibacterial drug leads</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5693</span>â <span class="NLM_lpage">5701</span>, <span class="refDoi">Â DOI: 10.1021/jm5004649</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5004649" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5693-5701&author=W.+Sinkoauthor=Y.+Wangauthor=W.+Zhuauthor=Y.+Zhangauthor=F.+Feixasauthor=C.+L.+Coxauthor=D.+A.+Mitchellauthor=E.+Oldfieldauthor=J.+A.+McCammon&title=Undecaprenyl+diphosphate+synthase+inhibitors%3A+antibacterial+drug+leads&doi=10.1021%2Fjm5004649"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm5004649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5004649%26sid%3Dliteratum%253Aachs%26aulast%3DSinko%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFeixas%26aufirst%3DF.%26aulast%3DCox%26aufirst%3DC.%2BL.%26aulast%3DMitchell%26aufirst%3DD.%2BA.%26aulast%3DOldfield%26aufirst%3DE.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26atitle%3DUndecaprenyl%2520diphosphate%2520synthase%2520inhibitors%253A%2520antibacterial%2520drug%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5693%26epage%3D5701%26doi%3D10.1021%2Fjm5004649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 30 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Paramita Sarkar, Debajyoti Basak, Riya Mukherjee, Julia E. Bandow, <span class="NLM_string-name hlFld-ContribAuthor">Jayanta Haldar</span>. </span><span class="cited-content_cbyCitation_article-title">Alkyl-Aryl-Vancomycins: Multimodal Glycopeptides with Weak Dependence on the Bacterial Metabolic State. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 10185-10202. <a href="https://doi.org/10.1021/acs.jmedchem.1c00449" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00449</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00449%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAlkyl-Aryl-Vancomycins%25253A%252BMultimodal%252BGlycopeptides%252Bwith%252BWeak%252BDependence%252Bon%252Bthe%252BBacterial%252BMetabolic%252BState%26aulast%3DSarkar%26aufirst%3DParamita%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15032021%26date%3D07072021%26volume%3D64%26issue%3D14%26spage%3D10185%26epage%3D10202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jatinder Kaur, Xufeng Cao, Nader S. Abutaleb, Ahmed Elkashif, Amanda L. Graboski, Aaron D. Krabill, Ahmed Hassan AbdelKhalek, Weiwei An, Atul Bhardwaj, Mohamed N. Seleem, <span class="NLM_string-name hlFld-ContribAuthor">Daniel P. Flaherty</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Acetazolamide-Based Scaffold as Potent Inhibitors of Vancomycin-Resistant Enterococcus. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9540-9562. <a href="https://doi.org/10.1021/acs.jmedchem.0c00734" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00734</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00734%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BAcetazolamide-Based%252BScaffold%252Bas%252BPotent%252BInhibitors%252Bof%252BVancomycin-Resistant%252BEnterococcus%26aulast%3DKaur%26aufirst%3DJatinder%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01052020%26date%3D11082020%26date%3D28072020%26volume%3D63%26issue%3D17%26spage%3D9540%26epage%3D9562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Paramita Sarkar, Sandip Samaddar, Veena Ammanathan, Venkateswarlu Yarlagadda, Chandradhish Ghosh, Manjulika Shukla, Grace Kaul, Ravi Manjithaya, Sidharth Chopra, <span class="NLM_string-name hlFld-ContribAuthor">Jayanta Haldar</span>. </span><span class="cited-content_cbyCitation_article-title">Vancomycin Derivative Inactivates Carbapenem-Resistant Acinetobacter baumannii and Induces Autophagy. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2020,</strong> <em>15 </em>
                                    (4)
                                     , 884-889. <a href="https://doi.org/10.1021/acschembio.0c00091" title="DOI URL">https://doi.org/10.1021/acschembio.0c00091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.0c00091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.0c00091%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DVancomycin%252BDerivative%252BInactivates%252BCarbapenem-Resistant%252BAcinetobacter%252Bbaumannii%252Band%252BInduces%252BAutophagy%26aulast%3DSarkar%26aufirst%3DParamita%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03022020%26date%3D20032020%26date%3D27032020%26date%3D20032020%26volume%3D15%26issue%3D4%26spage%3D884%26epage%3D889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ke Liu, <span class="NLM_string-name hlFld-ContribAuthor">Robert W. Huigens, III</span>. </span><span class="cited-content_cbyCitation_article-title">Instructive Advances in Chemical Microbiology Inspired by Natureâs Diverse Inventory of Molecules. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (4)
                                     , 541-562. <a href="https://doi.org/10.1021/acsinfecdis.9b00413" title="DOI URL">https://doi.org/10.1021/acsinfecdis.9b00413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.9b00413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.9b00413%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DInstructive%252BAdvances%252Bin%252BChemical%252BMicrobiology%252BInspired%252Bby%252BNature%2525E2%252580%252599s%252BDiverse%252BInventory%252Bof%252BMolecules%26aulast%3DLiu%26aufirst%3DKe%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D05112019%26date%3D06012020%26date%3D16122019%26volume%3D6%26issue%3D4%26spage%3D541%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhi-Chen Wu, Nicholas A. Isley, Akinori Okano, William J. Weiss, <span class="NLM_string-name hlFld-ContribAuthor">Dale L. Boger</span>. </span><span class="cited-content_cbyCitation_article-title">C1-CBP-vancomycin: Impact of a Vancomycin C-Terminus Trimethylammonium Cation on Pharmacological Properties and Insights into Its Newly Introduced Mechanism of Action. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (3)
                                     , 1365-1375. <a href="https://doi.org/10.1021/acs.joc.9b02314" title="DOI URL">https://doi.org/10.1021/acs.joc.9b02314</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b02314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b02314%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DC1-CBP-vancomycin%25253A%252BImpact%252Bof%252Ba%252BVancomycin%252BC-Terminus%252BTrimethylammonium%252BCation%252Bon%252BPharmacological%252BProperties%252Band%252BInsights%252Binto%252BIts%252BNewly%252BIntroduced%252BMechanism%252Bof%252BAction%26aulast%3DWu%26aufirst%3DZhi-Chen%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D26082019%26date%3D31102019%26volume%3D85%26issue%3D3%26spage%3D1365%26epage%3D1375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">GyÃ¶rgy AbrusÃ¡n, <span class="NLM_string-name hlFld-ContribAuthor">Joseph A. Marsh</span>. </span><span class="cited-content_cbyCitation_article-title">Ligands and Receptors with Broad Binding Capabilities Have Common Structural Characteristics: An Antibiotic Design Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9357-9374. <a href="https://doi.org/10.1021/acs.jmedchem.9b00220" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00220</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00220%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLigands%252Band%252BReceptors%252Bwith%252BBroad%252BBinding%252BCapabilities%252BHave%252BCommon%252BStructural%252BCharacteristics%25253A%252BAn%252BAntibiotic%252BDesign%252BPerspective%26aulast%3DAbrus%25C3%25A1n%26aufirst%3DGy%25C3%25B6rgy%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D01022019%26date%3D25062019%26date%3D12062019%26volume%3D62%26issue%3D21%26spage%3D9357%26epage%3D9374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sahin  Reja</span>, <span class="hlFld-ContribAuthor ">Deboshmita  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Purak  Das</span>, <span class="hlFld-ContribAuthor ">Pranesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Rajesh Kumar  Das</span>. </span><span class="cited-content_cbyCitation_article-title">3-(1,3-Dioxoisoindolin-2-yl)-N,N-dimethylpropan-1-ammonium perchlorate: Synthesis, crystal structure, docking study and in vitro anticancer activity against the human hepatomas cell line (Hep G2). </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1245 </em>, 131006. <a href="https://doi.org/10.1016/j.molstruc.2021.131006" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.131006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.131006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.131006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3D3-%2525281%25252C3-Dioxoisoindolin-2-yl%252529-N%25252CN-dimethylpropan-1-ammonium%252Bperchlorate%25253A%252BSynthesis%25252C%252Bcrystal%252Bstructure%25252C%252Bdocking%252Bstudy%252Band%252Bin%252Bvitro%252Banticancer%252Bactivity%252Bagainst%252Bthe%252Bhuman%252Bhepatomas%252Bcell%252Bline%252B%252528Hep%252BG2%252529%26aulast%3DReja%26aufirst%3DSahin%26date%3D2021%26volume%3D1245%26spage%3D131006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiwei  Shi</span>, <span class="hlFld-ContribAuthor ">Feifei  Chen</span>, <span class="hlFld-ContribAuthor ">Xiangman  Zou</span>, <span class="hlFld-ContribAuthor ">Shang  Jiao</span>, <span class="hlFld-ContribAuthor ">Siqi  Wang</span>, <span class="hlFld-ContribAuthor ">Yu  Hu</span>, <span class="hlFld-ContribAuthor ">Lefu  Lan</span>, <span class="hlFld-ContribAuthor ">Feng  Tang</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and antibacterial evaluation of vancomycin-LPS binding peptide conjugates. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>45 </em>, 128122. <a href="https://doi.org/10.1016/j.bmcl.2021.128122" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128122%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bantibacterial%252Bevaluation%252Bof%252Bvancomycin-LPS%252Bbinding%252Bpeptide%252Bconjugates%26aulast%3DShi%26aufirst%3DWeiwei%26date%3D2021%26volume%3D45%26spage%3D128122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabriella  Balasa</span>, <span class="hlFld-ContribAuthor ">Enjolie S.  Levengood</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Battistelli</span>, <span class="hlFld-ContribAuthor ">Rima B.  Franklin</span>. </span><span class="cited-content_cbyCitation_article-title">Diversity of Multidrug-Resistant Bacteria in an Urbanized River: A Case Study of the Potential Risks from Combined Sewage Overflows. </span><span class="cited-content_cbyCitation_journal-name">Water</span><span> <strong>2021,</strong> <em>13 </em>
                                    (15)
                                     , 2122. <a href="https://doi.org/10.3390/w13152122" title="DOI URL">https://doi.org/10.3390/w13152122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/w13152122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fw13152122%26sid%3Dliteratum%253Aachs%26jtitle%3DWater%26atitle%3DDiversity%252Bof%252BMultidrug-Resistant%252BBacteria%252Bin%252Ban%252BUrbanized%252BRiver%25253A%252BA%252BCase%252BStudy%252Bof%252Bthe%252BPotential%252BRisks%252Bfrom%252BCombined%252BSewage%252BOverflows%26aulast%3DBalasa%26aufirst%3DGabriella%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D15%26spage%3D2122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rafael F. A.  Gomes</span>, <span class="hlFld-ContribAuthor ">Vera M. S.  Isca</span>, <span class="hlFld-ContribAuthor ">KÃ©ssia  Andrade</span>, <span class="hlFld-ContribAuthor ">PatrÃ­cia  Rijo</span>, <span class="hlFld-ContribAuthor ">Carlos A. M.  Afonso</span>. </span><span class="cited-content_cbyCitation_article-title">Functionalized Cyclopentenones and an Oxime Ether as Antimicrobial Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>14 </em><a href="https://doi.org/10.1002/cmdc.202100369" title="DOI URL">https://doi.org/10.1002/cmdc.202100369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100369%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DFunctionalized%252BCyclopentenones%252Band%252Ban%252BOxime%252BEther%252Bas%252BAntimicrobial%252BAgents%26aulast%3DGomes%26aufirst%3DRafael%2BF.%2BA.%26date%3D2021%26date%3D2021%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Devashish  Mehta</span>, <span class="hlFld-ContribAuthor ">Varsha  Saini</span>, <span class="hlFld-ContribAuthor ">Bharti  Aggarwal</span>, <span class="hlFld-ContribAuthor ">Ali  Khan</span>, <span class="hlFld-ContribAuthor ">Avinash  Bajaj</span>. </span><span class="cited-content_cbyCitation_article-title">Unlocking the bacterial membrane as a therapeutic target for next-generation antimicrobial amphiphiles. </span><span class="cited-content_cbyCitation_journal-name">Molecular Aspects of Medicine</span><span> <strong>2021,</strong> <em>61 </em>, 100999. <a href="https://doi.org/10.1016/j.mam.2021.100999" title="DOI URL">https://doi.org/10.1016/j.mam.2021.100999</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mam.2021.100999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mam.2021.100999%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Aspects%2520of%2520Medicine%26atitle%3DUnlocking%252Bthe%252Bbacterial%252Bmembrane%252Bas%252Ba%252Btherapeutic%252Btarget%252Bfor%252Bnext-generation%252Bantimicrobial%252Bamphiphiles%26aulast%3DMehta%26aufirst%3DDevashish%26date%3D2021%26volume%3D61%26spage%3D100999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam J.  Plaunt</span>, <span class="hlFld-ContribAuthor ">Sasha J.  Rose</span>, <span class="hlFld-ContribAuthor ">Jeong Yeon  Kang</span>, <span class="hlFld-ContribAuthor ">Kuan-Ju  Chen</span>, <span class="hlFld-ContribAuthor ">Daniel  LaSala</span>, <span class="hlFld-ContribAuthor ">Ryan P.  Heckler</span>, <span class="hlFld-ContribAuthor ">Arielle  Dorfman</span>, <span class="hlFld-ContribAuthor ">Barrett T.  Smith</span>, <span class="hlFld-ContribAuthor ">Donald  Chun</span>, <span class="hlFld-ContribAuthor ">Veronica  Viramontes</span>, <span class="hlFld-ContribAuthor ">Antonio  Macaluso</span>, <span class="hlFld-ContribAuthor ">Zhili  Li</span>, <span class="hlFld-ContribAuthor ">Yuchen  Zhou</span>, <span class="hlFld-ContribAuthor ">Lilly  Mark</span>, <span class="hlFld-ContribAuthor ">Jessica  Basso</span>, <span class="hlFld-ContribAuthor ">Franziska G.  Leifer</span>, <span class="hlFld-ContribAuthor ">Michel R.  Corboz</span>, <span class="hlFld-ContribAuthor ">Richard W.  Chapman</span>, <span class="hlFld-ContribAuthor ">David  Cipolla</span>, <span class="hlFld-ContribAuthor ">Walter R.  Perkins</span>, <span class="hlFld-ContribAuthor ">Vladimir S.  Malinin</span>, <span class="hlFld-ContribAuthor ">Donna M.  Konicek</span>. </span><span class="cited-content_cbyCitation_article-title">Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2021,</strong> <em>65 </em>
                                    (7)
                                     <a href="https://doi.org/10.1128/AAC.00316-21" title="DOI URL">https://doi.org/10.1128/AAC.00316-21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00316-21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00316-21%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DDevelopment%252Band%252BPreclinical%252BEvaluation%252Bof%252BNew%252BInhaled%252BLipoglycopeptides%252Bfor%252Bthe%252BTreatment%252Bof%252BPersistent%252BPulmonary%252BMethicillin-Resistant%252BStaphylococcus%252Baureus%252BInfections%26aulast%3DPlaunt%26aufirst%3DAdam%2BJ.%26date%3D2021%26volume%3D65%26issue%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yajuan  Su</span>, <span class="hlFld-ContribAuthor ">Alec  McCarthy</span>, <span class="hlFld-ContribAuthor ">Shannon L.  Wong</span>, <span class="hlFld-ContribAuthor ">Ronald R.  Hollins</span>, <span class="hlFld-ContribAuthor ">Guangshun  Wang</span>, <span class="hlFld-ContribAuthor ">Jingwei  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Simultaneous Delivery of Multiple Antimicrobial Agents by Biphasic Scaffolds for Effective Treatment of Wound Biofilms. </span><span class="cited-content_cbyCitation_journal-name">Advanced Healthcare Materials</span><span> <strong>2021,</strong> <em>10 </em>
                                    (12)
                                     , 2100135. <a href="https://doi.org/10.1002/adhm.202100135" title="DOI URL">https://doi.org/10.1002/adhm.202100135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adhm.202100135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadhm.202100135%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Healthcare%2520Materials%26atitle%3DSimultaneous%252BDelivery%252Bof%252BMultiple%252BAntimicrobial%252BAgents%252Bby%252BBiphasic%252BScaffolds%252Bfor%252BEffective%252BTreatment%252Bof%252BWound%252BBiofilms%26aulast%3DSu%26aufirst%3DYajuan%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D12%26spage%3D2100135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. Shiroud  Ghorbani</span>, <span class="hlFld-ContribAuthor ">N.  Montazeri</span>, <span class="hlFld-ContribAuthor ">M. M.  Zeydi</span>, <span class="hlFld-ContribAuthor ">M.  Ghane</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Novel Tris-1,2,4-triazole Derivatives and Their Antibacterial Activity. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>57 </em>
                                    (4)
                                     , 605-610. <a href="https://doi.org/10.1134/S1070428021040151" title="DOI URL">https://doi.org/10.1134/S1070428021040151</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428021040151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428021040151%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BNovel%252BTris-1%25252C2%25252C4-triazole%252BDerivatives%252Band%252BTheir%252BAntibacterial%252BActivity%26aulast%3DGhorbani%26aufirst%3DS.%2BShiroud%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D4%26spage%3D605%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lewis F.  Neville</span>, <span class="hlFld-ContribAuthor ">Itamar  Shalit</span>, <span class="hlFld-ContribAuthor ">Peter A.  Warn</span>, <span class="hlFld-ContribAuthor ">Marc H.  Scheetz</span>, <span class="hlFld-ContribAuthor ">Jiuzhi  Sun</span>, <span class="hlFld-ContribAuthor ">Madeline B.  Chosy</span>, <span class="hlFld-ContribAuthor ">Paul A.  Wender</span>, <span class="hlFld-ContribAuthor ">Lynette  Cegelski</span>, <span class="hlFld-ContribAuthor ">Jacob T.  Rendell</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo
              Targeting of Escherichia coli with Vancomycin-Arginine. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2021,</strong> <em>65 </em>
                                    (4)
                                     <a href="https://doi.org/10.1128/AAC.02416-20" title="DOI URL">https://doi.org/10.1128/AAC.02416-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.02416-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.02416-20%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DIn%252BVivo%252BTargeting%252Bof%252BEscherichia%252Bcoli%252Bwith%252BVancomycin-Arginine%26aulast%3DNeville%26aufirst%3DLewis%2BF.%26date%3D2021%26volume%3D65%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nader S.  Abutaleb</span>, <span class="hlFld-ContribAuthor ">Ahmed E.M.  Elhassanny</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Flaherty</span>, <span class="hlFld-ContribAuthor ">Mohamed N.  Seleem</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci. </span><span class="cited-content_cbyCitation_journal-name">PeerJ</span><span> <strong>2021,</strong> <em>9 </em>, e11059. <a href="https://doi.org/10.7717/peerj.11059" title="DOI URL">https://doi.org/10.7717/peerj.11059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7717/peerj.11059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7717%2Fpeerj.11059%26sid%3Dliteratum%253Aachs%26jtitle%3DPeerJ%26atitle%3DIn%252Bvitro%252Band%252Bin%252Bvivo%252Bactivities%252Bof%252Bthe%252Bcarbonic%252Banhydrase%252Binhibitor%25252C%252Bdorzolamide%25252C%252Bagainst%252Bvancomycin-resistant%252Benterococci%26aulast%3DAbutaleb%26aufirst%3DNader%2BS.%26date%3D2021%26date%3D2021%26volume%3D9%26spage%3De11059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hang  Zhang</span>, <span class="hlFld-ContribAuthor ">Haiwei  Xu</span>, <span class="hlFld-ContribAuthor ">Charles R.  Ashby</span>, <span class="hlFld-ContribAuthor ">Yehuda G.  Assaraf</span>, <span class="hlFld-ContribAuthor ">ZheâSheng  Chen</span>, <span class="hlFld-ContribAuthor ">HongâMin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical molecularâbased approach to overcome multidrug resistance in cancer by targeting Pâglycoprotein (Pâgp). </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>41 </em>
                                    (1)
                                     , 525-555. <a href="https://doi.org/10.1002/med.21739" title="DOI URL">https://doi.org/10.1002/med.21739</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21739%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DChemical%252Bmolecular%2525E2%252580%252590based%252Bapproach%252Bto%252Bovercome%252Bmultidrug%252Bresistance%252Bin%252Bcancer%252Bby%252Btargeting%252BP%2525E2%252580%252590glycoprotein%252B%252528P%2525E2%252580%252590gp%252529%26aulast%3DZhang%26aufirst%3DHang%26date%3D2021%26date%3D2020%26volume%3D41%26issue%3D1%26spage%3D525%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Di  Song</span>, <span class="hlFld-ContribAuthor ">Fangchao  Bi</span>, <span class="hlFld-ContribAuthor ">Nan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yinhui  Qin</span>, <span class="hlFld-ContribAuthor ">Xingbang  Liu</span>, <span class="hlFld-ContribAuthor ">Yuetai  Teng</span>, <span class="hlFld-ContribAuthor ">Shutao  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis of novel 4,5-dihydroisoxazole-containing benzamide derivatives as highly potent FtsZ inhibitors capable of killing a variety of MDR Staphylococcus aureus. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (21)
                                     , 115729. <a href="https://doi.org/10.1016/j.bmc.2020.115729" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115729%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Bof%252Bnovel%252B4%25252C5-dihydroisoxazole-containing%252Bbenzamide%252Bderivatives%252Bas%252Bhighly%252Bpotent%252BFtsZ%252Binhibitors%252Bcapable%252Bof%252Bkilling%252Ba%252Bvariety%252Bof%252BMDR%252BStaphylococcus%252Baureus%26aulast%3DSong%26aufirst%3DDi%26date%3D2020%26volume%3D28%26issue%3D21%26spage%3D115729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng  Song</span>, <span class="hlFld-ContribAuthor ">Zhenghua  Li</span>, <span class="hlFld-ContribAuthor ">Yunqiang  Bian</span>, <span class="hlFld-ContribAuthor ">Xiankai  Huo</span>, <span class="hlFld-ContribAuthor ">Junman  Fang</span>, <span class="hlFld-ContribAuthor ">Linlin  Shao</span>, <span class="hlFld-ContribAuthor ">Meng  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Indole/isatinâcontaining hybrids as potential antibacterial agents. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2020,</strong> <em>353 </em>
                                    (10)
                                     , 2000143. <a href="https://doi.org/10.1002/ardp.202000143" title="DOI URL">https://doi.org/10.1002/ardp.202000143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.202000143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.202000143%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DIndole%25252Fisatin%2525E2%252580%252590containing%252Bhybrids%252Bas%252Bpotential%252Bantibacterial%252Bagents%26aulast%3DSong%26aufirst%3DFeng%26date%3D2020%26date%3D2020%26volume%3D353%26issue%3D10%26spage%3D2000143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Åule  Ceylan</span>, <span class="hlFld-ContribAuthor ">YÄ±ldÄ±z Uygun  Cebeci</span>, <span class="hlFld-ContribAuthor ">Neslihan  DemirbaÅ</span>, <span class="hlFld-ContribAuthor ">Ãzge ÃzÅen  Batur</span>, <span class="hlFld-ContribAuthor ">Ãzlem BingÃ¶l  ÃzakpÄ±nar</span>. </span><span class="cited-content_cbyCitation_article-title">Antimicrobial, Antioxidant and Antiproliferative Activities of Novel Quinolones. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (36)
                                     , 11340-11346. <a href="https://doi.org/10.1002/slct.202002779" title="DOI URL">https://doi.org/10.1002/slct.202002779</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202002779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202002779%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DAntimicrobial%25252C%252BAntioxidant%252Band%252BAntiproliferative%252BActivities%252Bof%252BNovel%252BQuinolones%26aulast%3DCeylan%26aufirst%3D%25C5%259Eule%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D36%26spage%3D11340%26epage%3D11346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Syeda Fatima  Nadeem</span>, <span class="hlFld-ContribAuthor ">Umar Farooq  Gohar</span>, <span class="hlFld-ContribAuthor ">Syed Fahad  Tahir</span>, <span class="hlFld-ContribAuthor ">Hamid  Mukhtar</span>, <span class="hlFld-ContribAuthor ">Soisuda  Pornpukdeewattana</span>, <span class="hlFld-ContribAuthor ">Pikunthong  Nukthamna</span>, <span class="hlFld-ContribAuthor ">Ali Muhammed  Moula Ali</span>, <span class="hlFld-ContribAuthor ">Sri Charan Bindu  Bavisetty</span>, <span class="hlFld-ContribAuthor ">Salvatore  Massa</span>. </span><span class="cited-content_cbyCitation_article-title">Antimicrobial resistance: more than 70 years of war between humans and bacteria. </span><span class="cited-content_cbyCitation_journal-name">Critical Reviews in Microbiology</span><span> <strong>2020,</strong> <em>46 </em>
                                    (5)
                                     , 578-599. <a href="https://doi.org/10.1080/1040841X.2020.1813687" title="DOI URL">https://doi.org/10.1080/1040841X.2020.1813687</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1040841X.2020.1813687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1040841X.2020.1813687%26sid%3Dliteratum%253Aachs%26jtitle%3DCritical%2520Reviews%2520in%2520Microbiology%26atitle%3DAntimicrobial%252Bresistance%25253A%252Bmore%252Bthan%252B70%252Byears%252Bof%252Bwar%252Bbetween%252Bhumans%252Band%252Bbacteria%26aulast%3DNadeem%26aufirst%3DSyeda%2BFatima%26date%3D2020%26date%3D2020%26volume%3D46%26issue%3D5%26spage%3D578%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weize  Sun</span>, <span class="hlFld-ContribAuthor ">Rena  Boerhan</span>, <span class="hlFld-ContribAuthor ">Na  Tian</span>, <span class="hlFld-ContribAuthor ">Yang  Feng</span>, <span class="hlFld-ContribAuthor ">Jian  Lu</span>, <span class="hlFld-ContribAuthor ">Xuesong  Wang</span>, <span class="hlFld-ContribAuthor ">Qianxiong  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorination in enhancing photoactivated antibacterial activity of Ru(
              ii
              ) complexes with photo-labile ligands. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (42)
                                     , 25364-25369. <a href="https://doi.org/10.1039/D0RA01806F" title="DOI URL">https://doi.org/10.1039/D0RA01806F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA01806F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA01806F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DFluorination%252Bin%252Benhancing%252Bphotoactivated%252Bantibacterial%252Bactivity%252Bof%252BRu%252528%252Bii%252B%252529%252Bcomplexes%252Bwith%252Bphoto-labile%252Bligands%26aulast%3DSun%26aufirst%3DWeize%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D42%26spage%3D25364%26epage%3D25369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atukuri  Dorababu</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacology Profile of Recently Developed MultiâFunctional Azoles; SARâBased Predictive Structural Modification. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (22)
                                     , 6730-6758. <a href="https://doi.org/10.1002/slct.202000294" title="DOI URL">https://doi.org/10.1002/slct.202000294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202000294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202000294%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DPharmacology%252BProfile%252Bof%252BRecently%252BDeveloped%252BMulti%2525E2%252580%252590Functional%252BAzoles%25253B%252BSAR%2525E2%252580%252590Based%252BPredictive%252BStructural%252BModification%26aulast%3DDorababu%26aufirst%3DAtukuri%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D22%26spage%3D6730%26epage%3D6758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sudip  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Swagatam  Barman</span>, <span class="hlFld-ContribAuthor ">Riya  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Jayanta  Haldar</span>. </span><span class="cited-content_cbyCitation_article-title">Amphiphilic Cationic Macromolecules Highly Effective Against Multi-Drug Resistant Gram-Positive Bacteria and Fungi With No Detectable Resistance. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Bioengineering and Biotechnology</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.3389/fbioe.2020.00055" title="DOI URL">https://doi.org/10.3389/fbioe.2020.00055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fbioe.2020.00055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffbioe.2020.00055%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Bioengineering%2520and%2520Biotechnology%26atitle%3DAmphiphilic%252BCationic%252BMacromolecules%252BHighly%252BEffective%252BAgainst%252BMulti-Drug%252BResistant%252BGram-Positive%252BBacteria%252Band%252BFungi%252BWith%252BNo%252BDetectable%252BResistance%26aulast%3DMukherjee%26aufirst%3DSudip%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Quentin  Laurent</span>, <span class="hlFld-ContribAuthor ">MathÃ©o  Berthet</span>, <span class="hlFld-ContribAuthor ">Yangyang  Cheng</span>, <span class="hlFld-ContribAuthor ">Naomi  Sakai</span>, <span class="hlFld-ContribAuthor ">Sofia  Barluenga</span>, <span class="hlFld-ContribAuthor ">Nicolas  Winssinger</span>, <span class="hlFld-ContribAuthor ">Stefan  Matile</span>. </span><span class="cited-content_cbyCitation_article-title">Probing for ThiolâMediated Uptake into Bacteria. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2020,</strong> <em>21 </em>
                                    (1-2)
                                     , 69-73. <a href="https://doi.org/10.1002/cbic.201900378" title="DOI URL">https://doi.org/10.1002/cbic.201900378</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201900378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201900378%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DProbing%252Bfor%252BThiol%2525E2%252580%252590Mediated%252BUptake%252Binto%252BBacteria%26aulast%3DLaurent%26aufirst%3DQuentin%26date%3D2020%26date%3D2019%26volume%3D21%26issue%3D1-2%26spage%3D69%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohini Mohan  Konai</span>, <span class="hlFld-ContribAuthor ">Swagatam  Barman</span>, <span class="hlFld-ContribAuthor ">Yash  Acharya</span>, <span class="hlFld-ContribAuthor ">Kathakali  De</span>, <span class="hlFld-ContribAuthor ">Jayanta  Haldar</span>. </span><span class="cited-content_cbyCitation_article-title">Recent development of antibacterial agents to combat drug-resistant Gram-positive bacteria. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 71-104. <a href="https://doi.org/10.1016/B978-0-12-818480-6.00004-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-818480-6.00004-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818480-6.00004-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818480-6.00004-7%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252Bdevelopment%252Bof%252Bantibacterial%252Bagents%252Bto%252Bcombat%252Bdrug-resistant%252BGram-positive%252Bbacteria%26aulast%3DKonai%26aufirst%3DMohini%2BMohan%26date%3D2020%26spage%3D71%26epage%3D104%26pub%3DElsevier%26atitle%3DDrug%252BDiscovery%252BTargeting%252BDrug-Resistant%252BBacteria%26date%3D2020%26volume%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jyoti  Yadav</span>, <span class="hlFld-ContribAuthor ">Jai  Devi</span>. </span><span class="cited-content_cbyCitation_article-title">Antimicrobial and Antioxidant Activities of Diorganotin(IV)
Complexes Synthesized from 1,2,4-Triazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Chemistry</span><span> <strong>2020,</strong> <em>32 </em>
                                    (10)
                                     , 2553-2558. <a href="https://doi.org/10.14233/ajchem.2020.22819" title="DOI URL">https://doi.org/10.14233/ajchem.2020.22819</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14233/ajchem.2020.22819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14233%2Fajchem.2020.22819%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Chemistry%26atitle%3DAntimicrobial%252Band%252BAntioxidant%252BActivities%252Bof%252BDiorganotin%252528IV%252529%252BComplexes%252BSynthesized%252Bfrom%252B1%25252C2%25252C4-Triazole%252BDerivatives%26aulast%3DYadav%26aufirst%3DJyoti%26date%3D2020%26date%3D2020%26volume%3D32%26issue%3D10%26spage%3D2553%26epage%3D2558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajib  Dey</span>, <span class="hlFld-ContribAuthor ">Kathakali  De</span>, <span class="hlFld-ContribAuthor ">Riya  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Sreyan  Ghosh</span>, <span class="hlFld-ContribAuthor ">Jayanta  Haldar</span>. </span><span class="cited-content_cbyCitation_article-title">Small antibacterial molecules highly active against drug-resistant
              Staphylococcus aureus. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (11)
                                     , 1907-1915. <a href="https://doi.org/10.1039/C9MD00329K" title="DOI URL">https://doi.org/10.1039/C9MD00329K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00329K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00329K%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSmall%252Bantibacterial%252Bmolecules%252Bhighly%252Bactive%252Bagainst%252Bdrug-resistant%252BStaphylococcus%252Baureus%26aulast%3DDey%26aufirst%3DRajib%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D11%26spage%3D1907%26epage%3D1915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Su  Wang</span>, <span class="hlFld-ContribAuthor ">Yanyan  Ba</span>, <span class="hlFld-ContribAuthor ">Zhi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,4-Triazole-quinoline/quinolone hybrids as potential anti-bacterial agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>174 </em>, 1-8. <a href="https://doi.org/10.1016/j.ejmech.2019.04.033" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.04.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.04.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.04.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1%25252C2%25252C4-Triazole-quinoline%25252Fquinolone%252Bhybrids%252Bas%252Bpotential%252Banti-bacterial%252Bagents%26aulast%3DZhang%26aufirst%3DJingyu%26date%3D2019%26volume%3D174%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng  Gao</span>, <span class="hlFld-ContribAuthor ">Tengfei  Wang</span>, <span class="hlFld-ContribAuthor ">Jiaqi  Xiao</span>, <span class="hlFld-ContribAuthor ">Gang  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Antibacterial activity study of 1,2,4-triazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>173 </em>, 274-281. <a href="https://doi.org/10.1016/j.ejmech.2019.04.043" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.04.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.04.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.04.043%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAntibacterial%252Bactivity%252Bstudy%252Bof%252B1%25252C2%25252C4-triazole%252Bderivatives%26aulast%3DGao%26aufirst%3DFeng%26date%3D2019%26volume%3D173%26spage%3D274%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Glycopeptide progenitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Mechanism of action of vancomycin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Acquired resistance to vancomycin; VSSA = vancomycin-susceptible <i>S. aureus</i>, VISA = vancomycin intermediate <i>S. aureus</i>, hVISA = heterovancomycin intermediate <i>S. aureus</i>, VRSA = vancomycin-resistant <i>S. aureus</i>, VRE = vancomycin-resistant Enterococci.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Clinically approved antibiotics for the treatment of vancomycin-resistant bacteria.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Clinically approved semisynthetic glycopeptides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Enhancement of binding affinity through core modifications.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Enhancement of binding affinity through peripheral modifications.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0009.jpeg" id="rightTab-GRAPHIC-d7e1819-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Enhancement of binding affinity through development of multivalent homomeric analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0008.jpeg jm-2018-01093n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Lipidation without investigation of membrane-interaction properties (<b>13</b>â<b>16</b>) and incorporation of membrane-disruptive properties (<b>17</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Incorporation of membrane-disruptive properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A) Structure of Dipi-van. (B) Complex formation of Dipi-van-Zn<sup>2+</sup> with geranyl pyrophosphate which was identified through mass spectrometry. (C) Identification of intracellular UDPMurNAc-pp in the presence of Dipi-van by monitoring absorbance at Î» = 260 nm. Parts B and C reproduced with permission from ref <a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a>. Copyright 2016 John Wiley and Sons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Conjugation of groups to enhance interactions with cell-wall components (<b>21</b>) and vancomycinânisin hybrid for multiple-target binding (<b>22</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/medium/jm-2018-01093n_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. (A) Combination of NDM-1 inhibitor (Dipi-van) and Î²-lactam antibiotic (Meropenem). (B) Antibacterial activity of combination of Meropenem and Dipi-van and (C) NDM-1 enzyme inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01093/20190404/images/large/jm-2018-01093n_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01093&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30480" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30480" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 128 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">OâNeill, J.</span></span> <span> </span><span class="NLM_article-title">Tackling Drug-Resistant Infections Globally: Final Report and Recommendations</span>.  <i>Review on Antimicrobial Resistance</i>; <span class="NLM_publisher-name">Wellcome Trust</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+O%E2%80%99Neill&title=Tackling+Drug-Resistant+Infections+Globally%3A+Final+Report+and+Recommendations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%26atitle%3DTackling%2520Drug-Resistant%2520Infections%2520Globally%253A%2520Final%2520Report%2520and%2520Recommendations%26jtitle%3DReview%2520on%2520Antimicrobial%2520Resistance%26pub%3DWellcome%2520Trust%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span> <i>High Levels of Antibiotic Resistance Found Worldwide, New Data Shows</i>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, January 28, <span class="NLM_year">2018</span>; <a href="http://www.who.int/mediacentre/news/releases/2018/antibiotic-resistance-found/en/" class="extLink">http://www.who.int/mediacentre/news/releases/2018/antibiotic-resistance-found/en/</a> (accessed March 20, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+High+Levels+of+Antibiotic+Resistance+Found+Worldwide%2C+New+Data+Shows%3B+World+Health+Organization%3A+Geneva%2C+January+28%2C+2018%3B+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Fnews%2Freleases%2F2018%2Fantibiotic-resistance-found%2Fen%2F+%28accessed+March+20%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DHigh%2520Levels%2520of%2520Antibiotic%2520Resistance%2520Found%2520Worldwide%252C%2520New%2520Data%2520Shows%26pub%3DWorld%2520Health%2520Organization%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tommasi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkup, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manchester, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. A.</span></span> <span> </span><span class="NLM_article-title">ESKAPEing the labyrinth of antibacterial discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">529</span>â <span class="NLM_lpage">542</span>, <span class="refDoi">Â DOI: 10.1038/nrd4572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fnrd4572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=26139286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyks77M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=529-542&author=R.+Tommasiauthor=D.+G.+Brownauthor=G.+K.+Walkupauthor=J.+I.+Manchesterauthor=A.+A.+Miller&title=ESKAPEing+the+labyrinth+of+antibacterial+discovery&doi=10.1038%2Fnrd4572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">ESKAPEing the labyrinth of antibacterial discovery</span></div><div class="casAuthors">Tommasi, Ruben; Brown, Dean G.; Walkup, Grant K.; Manchester, John I.; Miller, Alita A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">529-542</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antimicrobial drug resistance is a growing threat to global public health.  Multidrug resistance among the 'ESKAPE' organisms - encompassing Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. - is of particular concern because they are responsible for many serious infections in hospitals.  Although some promising agents are in the pipeline, there is an urgent need for new antibiotic scaffolds.  However, antibacterial researchers have struggled to identify new small mols. with meaningful cellular activity, esp. those effective against multidrug-resistant Gram-neg. pathogens.  This difficulty ultimately stems from an incomplete understanding of efflux systems and compd. permeation through bacterial membranes.  This Opinion article describes findings from target-based and phenotypic screening efforts carried out at AstraZeneca over the past decade, discusses some of the subsequent chem. challenges and concludes with a description of new approaches comprising a combination of computational modeling and advanced biol. tools which may pave the way towards the discovery of new antibacterial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolJg6HXnn7BLVg90H21EOLACvtfcHk0lhafY4IIIgxvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyks77M&md5=0d3159250e27926ab280c305ea5fb9ef</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd4572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4572%26sid%3Dliteratum%253Aachs%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DWalkup%26aufirst%3DG.%2BK.%26aulast%3DManchester%26aufirst%3DJ.%2BI.%26aulast%3DMiller%26aufirst%3DA.%2BA.%26atitle%3DESKAPEing%2520the%2520labyrinth%2520of%2520antibacterial%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D529%26epage%3D542%26doi%3D10.1038%2Fnrd4572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levin, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozen, D. E.</span></span> <span> </span><span class="NLM_article-title">Non-inherited antibiotic resistance</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">556</span>â <span class="NLM_lpage">562</span>, <span class="refDoi">Â DOI: 10.1038/nrmicro1445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fnrmicro1445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=16778840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvVGlurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=556-562&author=B.+R.+Levinauthor=D.+E.+Rozen&title=Non-inherited+antibiotic+resistance&doi=10.1038%2Fnrmicro1445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Non-inherited antibiotic resistance</span></div><div class="casAuthors">Levin, Bruce R.; Rozen, Daniel E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">556-562</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In addn. to their impressive, well-publicized and well-researched propensity to evolve and acquire genetically detd. mechanisms for resistance to antibiotics, bacteria that are inherently susceptible to these drugs can also be phenotypically refractory to their action.  This phenomenon of non-inherited resistance to antibiotics was known since the beginning of the antibiotic era but, relative to inherited resistance, it was given little attention.  Here, the authors review the in vitro and in vivo evidence for the different forms of non-inherited resistance and the mechanisms responsible.  With the aid of a simple math. model and computer simulations, the authors show how non-inherited resistance could extend the duration of antibiotic treatment, cause treatment failure and promote the generation and ascent of inherited resistance in treated patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO0moi9krOQbVg90H21EOLACvtfcHk0lhafY4IIIgxvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvVGlurw%253D&md5=22a627ccfd1443eca63dde7c8e0f3b2a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1445%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DB.%2BR.%26aulast%3DRozen%26aufirst%3DD.%2BE.%26atitle%3DNon-inherited%2520antibiotic%2520resistance%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2006%26volume%3D4%26spage%3D556%26epage%3D562%26doi%3D10.1038%2Fnrmicro1445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span> <i>Global Priority List of Antibiotic-Resistant Bacteria
To Guide Research,
Discovery, and Development of New Antibiotics</i>;  <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2018</span>; <a href="https://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/" class="extLink">https://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/</a> (accessed April 3, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Global+Priority+List+of+Antibiotic-Resistant+Bacteria%0ATo+Guide+Research%2C%0ADiscovery%2C+and+Development+of+New+Antibiotics%3B+World+Health+Organization%3A+Geneva%2C+2018%3B+https%3A%2F%2Fwww.who.int%2Fmedicines%2Fpublications%2Fglobal-priority-list-antibiotic-resistant-bacteria%2Fen%2F+%28accessed+April+3%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%2520Priority%2520List%2520of%2520Antibiotic-Resistant%2520Bacteria%250ATo%2520Guide%2520Research%252C%250ADiscovery%252C%2520and%2520Development%2520of%2520New%2520Antibiotics%26pub%3DWorld%2520Health%2520Organization%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicolaou, K.
C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boddy, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brase, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winssinger, N.</span></span> <span> </span><span class="NLM_article-title">Chemistry, biology, and medicine of the glycopeptide antibiotics</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2096</span>â <span class="NLM_lpage">2152</span>, <span class="refDoi">Â DOI: 10.1002/(SICI)1521-3773(19990802)38:15<2096::AID-ANIE2096>3.0.CO;2-F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1002%2F%28SICI%291521-3773%2819990802%2938%3A15%3C2096%3A%3AAID-ANIE2096%3E3.0.CO%3B2-F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10425471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BC2sbgslCrsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=2096-2152&author=K.%0AC.+Nicolaouauthor=C.+N.+Boddyauthor=S.+Braseauthor=N.+Winssinger&title=Chemistry%2C+biology%2C+and+medicine+of+the+glycopeptide+antibiotics&doi=10.1002%2F%28SICI%291521-3773%2819990802%2938%3A15%3C2096%3A%3AAID-ANIE2096%3E3.0.CO%3B2-F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry, Biology, and Medicine of the Glycopeptide Antibiotics</span></div><div class="casAuthors">Nicolaou; Boddy; Brase; Winssinger</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2096-2152</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The war against infectious bacteria is not over! Although vancomycin and glycopeptide antibiotics have provided a strong last line of defence against many drug-resistant bacteria, their overuse has given rise to more dangerous strains of bacteria.  An understanding of the chemistry and biology of these highly complex glycopeptides are destined to play a crucial role in the discovery of new antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHXUM29xIhol1C8OJBvdfbfW6udTcc2eYrEfMJYDKKG7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbgslCrsA%253D%253D&md5=522c0e94fef28bd6457bc310e1be341a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819990802%2938%3A15%3C2096%3A%3AAID-ANIE2096%3E3.0.CO%3B2-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819990802%252938%253A15%253C2096%253A%253AAID-ANIE2096%253E3.0.CO%253B2-F%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DK.%2BC.%26aulast%3DBoddy%26aufirst%3DC.%2BN.%26aulast%3DBrase%26aufirst%3DS.%26aulast%3DWinssinger%26aufirst%3DN.%26atitle%3DChemistry%252C%2520biology%252C%2520and%2520medicine%2520of%2520the%2520glycopeptide%2520antibiotics%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D2096%26epage%3D2152%26doi%3D10.1002%2F%28SICI%291521-3773%2819990802%2938%3A15%3C2096%3A%3AAID-ANIE2096%3E3.0.CO%3B2-F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kahne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimkuhler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, C.</span></span> <span> </span><span class="NLM_article-title">Glycopeptide and lipoglycopeptide antibiotics</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">425</span>â <span class="NLM_lpage">448</span>, <span class="refDoi">Â DOI: 10.1021/cr030103a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr030103a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVaksw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=425-448&author=D.+Kahneauthor=C.+Leimkuhlerauthor=W.+Luauthor=C.+Walsh&title=Glycopeptide+and+lipoglycopeptide+antibiotics&doi=10.1021%2Fcr030103a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Glycopeptide and Lipoglycopeptide Antibiotics</span></div><div class="casAuthors">Kahne, Dan; Leimkuhler, Catherine; Lu, Wei; Walsh, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">425-448</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on glycopeptide and lipoglycopeptide antibiotics.  Structural features, chem. synthesis, mechanism of action, resistance mechanisms and new directions for treating drug resistance are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBnRcMTFq_cbVg90H21EOLACvtfcHk0lit_zfaJTJ2EA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVaksw%253D%253D&md5=ef3f1a5f07faeacd22c0444d42637fd1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fcr030103a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr030103a%26sid%3Dliteratum%253Aachs%26aulast%3DKahne%26aufirst%3DD.%26aulast%3DLeimkuhler%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DWalsh%26aufirst%3DC.%26atitle%3DGlycopeptide%2520and%2520lipoglycopeptide%2520antibiotics%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D425%26epage%3D448%26doi%3D10.1021%2Fcr030103a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansford, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaskovich, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. A.</span></span> <span> </span><span class="NLM_article-title">Glycopeptide antibiotics: back to the future</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">631</span>â <span class="NLM_lpage">644</span>, <span class="refDoi">Â DOI: 10.1038/ja.2014.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fja.2014.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=25118105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ehsrvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2014&pages=631-644&author=M.+S.+Butlerauthor=K.+A.+Hansfordauthor=M.+A.+Blaskovichauthor=R.+Halaiauthor=M.+A.+Cooper&title=Glycopeptide+antibiotics%3A+back+to+the+future&doi=10.1038%2Fja.2014.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Glycopeptide antibiotics: Back to the future</span></div><div class="casAuthors">Butler, Mark S.; Hansford, Karl A.; Blaskovich, Mark A. T.; Halai, Reena; Cooper, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">631-644</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Glycopeptide antibiotics have been a key weapon in the fight against bacterial infections for over half a century, with the progenitors, vancomycin (1) and teicoplanin (2), still used extensively.  The increased occurrence of resistance and the effectiveness of these 'last resort' treatments for Gram-pos. infections has led to the discovery and clin. development of second generation, semisynthetic lipoglycopeptide derivs. such as telavancin (3), dalbavancin (4) and oritavancin (5), which all possess broader spectra of activity and improved pharmacokinetic properties.  Two of these new antibiotics, telavancin (3) and dalbavancin (4), were approved in the past 5 years and the third, oritavancin (5), is awaiting regulatory approval.  In this review, the discovery, development and assocd. resistance of vancomycin (1) and teicoplanin (2), and semi-synthetic glycopeptides, telavancin (3), dalbavancin (4) and oritavancin (5), are detailed.  The clin. implications of glycopeptide resistance, esp. vancomycin (1), as well as the future prospects for current glycopeptide drugs and the development of new glycopeptides are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBXjY3YHnypbVg90H21EOLACvtfcHk0lit_zfaJTJ2EA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ehsrvK&md5=04a3089be94990f1f3891cd6958ae79a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fja.2014.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2014.111%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DM.%2BS.%26aulast%3DHansford%26aufirst%3DK.%2BA.%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%26aulast%3DHalai%26aufirst%3DR.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26atitle%3DGlycopeptide%2520antibiotics%253A%2520back%2520to%2520the%2520future%26jtitle%3DJ.%2520Antibiot.%26date%3D2014%26volume%3D67%26spage%3D631%26epage%3D644%26doi%3D10.1038%2Fja.2014.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">516</span>â <span class="NLM_lpage">533</span>, <span class="refDoi">Â DOI: 10.1039/C6MD00585C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1039%2FC6MD00585C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=30108769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Wmt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=516-533&author=P.+Sarkarauthor=V.+Yarlagaddaauthor=C.+Ghoshauthor=J.+Haldar&title=A+review+on+cell+wall+synthesis+inhibitors+with+an+emphasis+on+glycopeptide+antibiotics&doi=10.1039%2FC6MD00585C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics</span></div><div class="casAuthors">Sarkar, Paramita; Yarlagadda, Venkateswarlu; Ghosh, Chandradhish; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">516-533</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cell wall biosynthesis inhibitors (CBIs) have historically been one of the most effective classes of antibiotics.  They are the most extensively used class of antibiotics and their importance is exemplified by the Î²-lactams and glycopeptide antibiotics.  However, this class of antibiotics has not received impunity from resistance development.  In the wake of this predicament, this review presents the progress of CBIs, esp. glycopeptide derivs. as antibiotics to confront antibacterial resistance.  The various strategies used for the development of CBIs, their clin. status and possible directions in which this field can evolve have also been discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroG-nR7J34fLVg90H21EOLACvtfcHk0ljbQ-NvxH0mqw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Wmt7w%253D&md5=3ae2916276ca7fc960f137788705c555</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1039%2FC6MD00585C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00585C%26sid%3Dliteratum%253Aachs%26aulast%3DSarkar%26aufirst%3DP.%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DC.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DA%2520review%2520on%2520cell%2520wall%2520synthesis%2520inhibitors%2520with%2520an%2520emphasis%2520on%2520glycopeptide%2520antibiotics%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26spage%3D516%26epage%3D533%26doi%3D10.1039%2FC6MD00585C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McComas, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">9314</span>â <span class="NLM_lpage">9315</span>, <span class="refDoi">Â DOI: 10.1021/ja035901x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja035901x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltlCksbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=9314-9315&author=C.+C.+McComasauthor=B.+M.+Crowleyauthor=D.+L.+Boger&title=Partitioning+the+loss+in+vancomycin+binding+affinity+for+D-Ala-D-Lac+into+lost+H-bond+and+repulsive+lone+pair+contributions&doi=10.1021%2Fja035901x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Partitioning the Loss in Vancomycin Binding Affinity for D-Ala-D-Lac into Lost H-Bond and Repulsive Lone Pair Contributions</span></div><div class="casAuthors">McComas, Casey C.; Crowley, Brendan M.; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">9314-9315</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The binding affinity of AcNH(CH2)4CH(AcNH)C:ONHCH(CH3)C:OCH2CH(CH3)CO2H (I), which incorporates a methylene (CH2) in place of the key linking amide of Ac2-L-Lys-D-Ala-D-Ala, for vancomycin was compared with that of Ac2-L-Lys-D-Ala-D-Ala and Ac2-L-Lys-D-Ala-D-Lac.  The vancomycin affinity for I was approx. 10-fold less than that of Ac2-L-Lys-D-Ala-D-Ala, but 100-fold greater than that of Ac2-L-Lys-D-Ala-D-Lac.  This suggests that the reduced binding affinity of Ac2-L-Lys-D-Ala-D-Lac (4.1 kcal/mol) may be attributed to both the loss of a key H-bond (1.5 kcal/mol) and a destabilizing lone pair/lone pair electrostatic interaction introduced with the ester oxygen of Ac2-L-Lys-D-Ala-D-Lac (2.6 kcal/mol) with the latter, not the H-bond, being responsible for the largest share of the 1000-fold redn.  These observations have significant ramifications in the reengineering of the vancomycin structure to bind D-Ala-D-Lac and thus overcoming bacterial resistance to vancomycin in its binding to precursor peptidoglycan in cell wall biosynthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb8pKB_Ped6rVg90H21EOLACvtfcHk0ljbQ-NvxH0mqw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltlCksbs%253D&md5=322f71e8dfe940e24a7b7ec360a417b6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fja035901x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja035901x%26sid%3Dliteratum%253Aachs%26aulast%3DMcComas%26aufirst%3DC.%2BC.%26aulast%3DCrowley%26aufirst%3DB.%2BM.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DPartitioning%2520the%2520loss%2520in%2520vancomycin%2520binding%2520affinity%2520for%2520D-Ala-D-Lac%2520into%2520lost%2520H-bond%2520and%2520repulsive%2520lone%2520pair%2520contributions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D9314%26epage%3D9315%26doi%3D10.1021%2Fja035901x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uttley, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidoo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, R. C.</span></span> <span> </span><span class="NLM_article-title">Vancomycin-resistant enterococci</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>331</i></span>,  <span class="NLM_fpage">57</span>â <span class="NLM_lpage">58</span>, <span class="refDoi">Â DOI: 10.1016/S0140-6736(88)91037-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2FS0140-6736%2888%2991037-9" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1988&pages=57-58&author=A.+H.+Uttleyauthor=C.+H.+Collinsauthor=J.+Naidooauthor=R.+C.+George&title=Vancomycin-resistant+enterococci&doi=10.1016%2FS0140-6736%2888%2991037-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2888%2991037-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252888%252991037-9%26sid%3Dliteratum%253Aachs%26aulast%3DUttley%26aufirst%3DA.%2BH.%26aulast%3DCollins%26aufirst%3DC.%2BH.%26aulast%3DNaidoo%26aufirst%3DJ.%26aulast%3DGeorge%26aufirst%3DR.%2BC.%26atitle%3DVancomycin-resistant%2520enterococci%26jtitle%3DLancet%26date%3D1988%26volume%3D331%26spage%3D57%26epage%3D58%26doi%3D10.1016%2FS0140-6736%2888%2991037-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Acar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casewell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, H.</span></span> <span> </span><span class="NLM_article-title">Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making</span>. <i>Clin. Microbiol. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">477</span>â <span class="NLM_lpage">482</span>, <span class="refDoi">Â DOI: 10.1046/j.1469-0691.2000.00128.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1046%2Fj.1469-0691.2000.00128.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=11168181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVGjtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=477-482&author=J.+Acarauthor=M.+Casewellauthor=J.+Freemanauthor=C.+Friisauthor=H.+Goossens&title=Avoparcin+and+virginiamycin+as+animal+growth+promoters%3A+a+plea+for+science+in+decision-making&doi=10.1046%2Fj.1469-0691.2000.00128.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making</span></div><div class="casAuthors">Acar, J.; Casewell, M.; Freeman, J.; Friis, C.; Goossens, H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology and Infection</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">477-482</span>CODEN:
                <span class="NLM_cas:coden">CMINFM</span>;
        ISSN:<span class="NLM_cas:issn">1198-743X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review with 51 refs.  There is a need to clarify the issue of gene transfer and bacterial population dynamics.  Specifically, several issues have to be answered: the extent to which growth promoters select for resistant organisms in animals; the prevalence of resistant enterococci in human populations; their ability to transfer resistance to other organisms; and the question on whether animal enterococci colonize humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCevqacSjIGbVg90H21EOLACvtfcHk0ljbQ-NvxH0mqw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVGjtb8%253D&md5=be20c45be4c01874c3454c1727fb8149</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1046%2Fj.1469-0691.2000.00128.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1469-0691.2000.00128.x%26sid%3Dliteratum%253Aachs%26aulast%3DAcar%26aufirst%3DJ.%26aulast%3DCasewell%26aufirst%3DM.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DFriis%26aufirst%3DC.%26aulast%3DGoossens%26aufirst%3DH.%26atitle%3DAvoparcin%2520and%2520virginiamycin%2520as%2520animal%2520growth%2520promoters%253A%2520a%2520plea%2520for%2520science%2520in%2520decision-making%26jtitle%3DClin.%2520Microbiol.%2520Infect.%26date%3D2000%26volume%3D6%26spage%3D477%26epage%3D482%26doi%3D10.1046%2Fj.1469-0691.2000.00128.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabuta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oguri, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenover, F. C.</span></span> <span> </span><span class="NLM_article-title">Methicillin-resistant <i>Staphylococcus aureus</i> clinical strain with reduced vancomycin susceptibility</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">135</span>â <span class="NLM_lpage">136</span>, <span class="refDoi">Â DOI: 10.1093/jac/40.1.135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1093%2Fjac%2F40.1.135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=9249217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK2sXltVCit7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=135-136&author=K.+Hiramatsuauthor=H.+Hanakiauthor=T.+Inoauthor=K.+Yabutaauthor=T.+Oguriauthor=F.+C.+Tenover&title=Methicillin-resistant+Staphylococcus+aureus+clinical+strain+with+reduced+vancomycin+susceptibility&doi=10.1093%2Fjac%2F40.1.135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility</span></div><div class="casAuthors">Hiramatsu, K.; Hanaki, H.; Ino, T.; Yabuta, K.; Oguri, T.; Tenover, F. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">135-136</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A clin. strain of methicillin-resistant S. aureus strain (Mu50) with reduced susceptibility to vancomycin (MIC = 8 mg/L) is described.  The strain did not carry vanA or van B genes, and the exact mechanism of reduced vancomycin susceptibility remains to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXrFXWdBg6c7Vg90H21EOLACvtfcHk0lhyJixNQuHnMQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXltVCit7w%253D&md5=d86e21c3e97d29df20cc1e2bd11c1dd2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F40.1.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F40.1.135%26sid%3Dliteratum%253Aachs%26aulast%3DHiramatsu%26aufirst%3DK.%26aulast%3DHanaki%26aufirst%3DH.%26aulast%3DIno%26aufirst%3DT.%26aulast%3DYabuta%26aufirst%3DK.%26aulast%3DOguri%26aufirst%3DT.%26aulast%3DTenover%26aufirst%3DF.%2BC.%26atitle%3DMethicillin-resistant%2520Staphylococcus%2520aureus%2520clinical%2520strain%2520with%2520reduced%2520vancomycin%2520susceptibility%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1997%26volume%3D40%26spage%3D135%26epage%3D136%26doi%3D10.1093%2Fjac%2F40.1.135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sievert, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hageman, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulton, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenover, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downes, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudrik, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pupp, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridkin, S. K.</span></span> <span> </span><span class="NLM_article-title">Infection with vancomycin-resistant <i>Staphylococcus aureus</i> containing the vanA resistance gene</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">1342</span>â <span class="NLM_lpage">1347</span>, <span class="refDoi">Â DOI: 10.1056/NEJMoa025025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1056%2FNEJMoa025025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=12672861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BD3s7lvVShsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=1342-1347&author=S.+Changauthor=D.+M.+Sievertauthor=J.+C.+Hagemanauthor=M.+L.+Boultonauthor=F.+C.+Tenoverauthor=F.+P.+Downesauthor=S.+Shahauthor=J.+T.+Rudrikauthor=G.+R.+Puppauthor=W.+J.+Brownauthor=D.+Cardoauthor=S.+K.+Fridkin&title=Infection+with+vancomycin-resistant+Staphylococcus+aureus+containing+the+vanA+resistance+gene&doi=10.1056%2FNEJMoa025025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene</span></div><div class="casAuthors">Chang Soju; Sievert Dawn M; Hageman Jeffrey C; Boulton Matthew L; Tenover Fred C; Downes Frances Pouch; Shah Sandip; Rudrik James T; Pupp Guy R; Brown William J; Cardo Denise; Fridkin Scott K</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1342-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcvhBy2uNOo0Gy1nwu7K2mfW6udTcc2eYkK_8o3e2Ce7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7lvVShsw%253D%253D&md5=2a58e80ddfe077d13d47d9ba059986c2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa025025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa025025%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DS.%26aulast%3DSievert%26aufirst%3DD.%2BM.%26aulast%3DHageman%26aufirst%3DJ.%2BC.%26aulast%3DBoulton%26aufirst%3DM.%2BL.%26aulast%3DTenover%26aufirst%3DF.%2BC.%26aulast%3DDownes%26aufirst%3DF.%2BP.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DRudrik%26aufirst%3DJ.%2BT.%26aulast%3DPupp%26aufirst%3DG.%2BR.%26aulast%3DBrown%26aufirst%3DW.%2BJ.%26aulast%3DCardo%26aufirst%3DD.%26aulast%3DFridkin%26aufirst%3DS.%2BK.%26atitle%3DInfection%2520with%2520vancomycin-resistant%2520Staphylococcus%2520aureus%2520containing%2520the%2520vanA%2520resistance%2520gene%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26spage%3D1342%26epage%3D1347%26doi%3D10.1056%2FNEJMoa025025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tenover, F. C.</span>; <span class="NLM_string-name">Biddle, J. W.</span>; <span class="NLM_string-name">Lancaster, M. V.</span></span> <span> </span><span class="NLM_article-title">Increasing Resistance to Vancomycin and Other Glycopeptides in <i>Staphylococcus aureus</i></span>.  <i>Emerging Infectious Diseases</i>; <span class="NLM_publisher-name">Centers for Disease Control and Prevention</span>: <span class="NLM_publisher-loc">Atlanta</span>, <span class="NLM_year">2012</span>; Vol.  <span class="NLM_volume">7</span> <a href="https://wwwnc.cdc.gov/eid/article/7/2/07-0327_article" class="extLink">https://wwwnc.cdc.gov/eid/article/7/2/07-0327_article</a> (accessed March 25, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=F.+C.+Tenover&author=J.+W.+Biddle&author=M.+V.+Lancaster&title=Increasing+Resistance+to+Vancomycin+and+Other+Glycopeptides+in+Staphylococcus+aureus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DTenover%26aufirst%3DF.%2BC.%26atitle%3DIncreasing%2520Resistance%2520to%2520Vancomycin%2520and%2520Other%2520Glycopeptides%2520in%2520Staphylococcus%2520aureus%26jtitle%3DEmerging%2520Infectious%2520Diseases%26pub%3DCenters%2520for%2520Disease%2520Control%2520and%2520Prevention%26date%3D2012%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bugg, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutka-Malen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courvalin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, C. T.</span></span> <span> </span><span class="NLM_article-title">Molecular basis for vancomycin resistance in <i>Enterococcus faecium</i> BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">10408</span>â <span class="NLM_lpage">10415</span>, <span class="refDoi">Â DOI: 10.1021/bi00107a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00107a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK3MXmtVeisbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1991&pages=10408-10415&author=T.+D.+Buggauthor=G.+D.+Wrightauthor=S.+Dutka-Malenauthor=M.+Arthurauthor=P.+Courvalinauthor=C.+T.+Walsh&title=Molecular+basis+for+vancomycin+resistance+in+Enterococcus+faecium+BM4147%3A+biosynthesis+of+a+depsipeptide+peptidoglycan+precursor+by+vancomycin+resistance+proteins+VanH+and+VanA&doi=10.1021%2Fbi00107a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis for vancomycin resistance in Enterococcus faecium BM4147:  biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA</span></div><div class="casAuthors">Bugg, Timothy D. H.; Wright, Gerard D.; Dutka-Malen, Sylvie; Arthur, Michel; Courvalin, Patrice; Walsh, Christopher T.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">10408-15</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">Vancomycin resistance in E. faecium BM4147 is mediated by vancomycin resistance proteins VanA and VanH.  VanA is a D-alanine:D-alanine ligase of altered substrate specificity, while the sequence of VanH is related to those of Î±-keto acid dehydrogenases.  VanH was purified to homogeneity, characterized as a D-specific Î±-keto acid dehydrogenase, and compared with D-lactate dehydrogenases from Leuconostoc mesenteroides and Lactobacillus leichmanii.  VanA was found to catalyze ester bond formation between D-alanine and the D-hydroxy acid products of VanH, the best substrate being D-2-hydroxybutyrate (Km = 0.60 mM).  The VanA product D-alanyl-D-2-hydroxybutyrate could then be incorporated into the UDPMurNac-pentapeptide peptidoglycan precursor by D-Ala-D-Ala adding enzyme from Escherichia coli or by crude ext. from E. faecium BM4147.  The vancomycin-binding const. of a synthetic modified peptidoglycan analog, N-acetyl-D-alanyl-D-2-hydroxybutyrate, (Kd > 73 mM) was >1000-fold higher than the binding const. for N-acetyl-D-alanyl-D-alanine (Kd = 54 Î¼M), partly due to the disruption of a H-bond in the vancomycin-target complex, thus providing a mol. rationale for high-level vancomycin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2uZ4SabTxLLVg90H21EOLACvtfcHk0lgI_m5orn_yYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmtVeisbw%253D&md5=39d58fd11f656b5f048551cd93604b16</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fbi00107a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00107a007%26sid%3Dliteratum%253Aachs%26aulast%3DBugg%26aufirst%3DT.%2BD.%26aulast%3DWright%26aufirst%3DG.%2BD.%26aulast%3DDutka-Malen%26aufirst%3DS.%26aulast%3DArthur%26aufirst%3DM.%26aulast%3DCourvalin%26aufirst%3DP.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26atitle%3DMolecular%2520basis%2520for%2520vancomycin%2520resistance%2520in%2520Enterococcus%2520faecium%2520BM4147%253A%2520biosynthesis%2520of%2520a%2520depsipeptide%2520peptidoglycan%2520precursor%2520by%2520vancomycin%2520resistance%2520proteins%2520VanH%2520and%2520VanA%26jtitle%3DBiochemistry%26date%3D1991%26volume%3D30%26spage%3D10408%26epage%3D10415%26doi%3D10.1021%2Fbi00107a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courvalin, P.</span></span> <span> </span><span class="NLM_article-title">Regulation of vanB-type vancomycin resistance gene expression by the vanS(B)-vanR (B) two-component regulatory system in <i>Enterococcus faecalis</i> V583</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">1302</span>â <span class="NLM_lpage">1309</span>, <span class="refDoi">Â DOI: 10.1128/jb.178.5.1302-1309.1996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2Fjb.178.5.1302-1309.1996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=8631706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK28XhsVSquro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=1996&pages=1302-1309&author=S.+Eversauthor=P.+Courvalin&title=Regulation+of+vanB-type+vancomycin+resistance+gene+expression+by+the+vanS%28B%29-vanR+%28B%29+two-component+regulatory+system+in+Enterococcus+faecalis+V583&doi=10.1128%2Fjb.178.5.1302-1309.1996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of VanB-type vancomycin resistance gene expression by the VanSB-VanRB two-component regulatory system in Enterococcus faecalis V583</span></div><div class="casAuthors">Evers, Stefan; Courvalin, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1302-9</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Acquired VanA- and VanB-type glycopeptide resistance in enterococci is due to synthesis of modified peptidoglycan precursors terminating in D-lactate.  As opposed to VanA-type strains which are resistant to both vancomycin and teicoplanin, VanB-type strains remain teicoplanin susceptible.  The authors have detd. the sequence of a 7,160-bp DNA fragment assocd. with VanB-type resistance in Enterococcus faecalis V583 that contains seven open reading frames.  The distal part encoded the VanHB, VanB, and VanXB proteins that are highly similar to the putative VanH, VanA, and VanX proteins responsible for VanA-type resistance.  Upstream from the structural genes for these proteins were the vanYB gene encoding a D,D-carboxypeptidase and an open reading frame vanW with an unknown function.  The proximal part of the gene cluster coded for the apparent VanSB-VanRB two-component regulatory system.  VanRB was related to response regulators of the OmpR subclass, and VanSB was related to membrane-assocd. histidine protein kinases.  Anal. of transcriptional fusions with a reporter gene and promoter mapping indicated that the VanRB-VanSB two-component regulatory system activates a promoter located immediately downstream from the vanSB gene.  Vancomycin, but not teicoplanin, was an inducer, which explains teicoplanin susceptibility of VanB-type enterococci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGvpda3GfjR7Vg90H21EOLACvtfcHk0lgI_m5orn_yYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhsVSquro%253D&md5=4765ba8d37c4c0eaa468542b6064dd80</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1128%2Fjb.178.5.1302-1309.1996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fjb.178.5.1302-1309.1996%26sid%3Dliteratum%253Aachs%26aulast%3DEvers%26aufirst%3DS.%26aulast%3DCourvalin%26aufirst%3DP.%26atitle%3DRegulation%2520of%2520vanB-type%2520vancomycin%2520resistance%2520gene%2520expression%2520by%2520the%2520vanS%2528B%2529-vanR%2520%2528B%2529%2520two-component%2520regulatory%2520system%2520in%2520Enterococcus%2520faecalis%2520V583%26jtitle%3DJ.%2520Bacteriol.%26date%3D1996%26volume%3D178%26spage%3D1302%26epage%3D1309%26doi%3D10.1128%2Fjb.178.5.1302-1309.1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintiliani, R.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Regulation of vanA- and vanB-type glycopeptide resistance in enterococci</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">375</span>â <span class="NLM_lpage">381</span>, <span class="refDoi">Â DOI: 10.1128/AAC.45.2.375-381.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.45.2.375-381.2001" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=375-381&author=M.+Arthurauthor=R.+Quintiliani&title=Regulation+of+vanA-+and+vanB-type+glycopeptide+resistance+in+enterococci&doi=10.1128%2FAAC.45.2.375-381.2001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1128%2FAAC.45.2.375-381.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.45.2.375-381.2001%26sid%3Dliteratum%253Aachs%26aulast%3DArthur%26aufirst%3DM.%26aulast%3DQuintiliani%26aufirst%3DR.%26atitle%3DRegulation%2520of%2520vanA-%2520and%2520vanB-type%2520glycopeptide%2520resistance%2520in%2520enterococci%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2001%26volume%3D45%26spage%3D375%26epage%3D381%26doi%3D10.1128%2FAAC.45.2.375-381.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courvalin, P.</span></span> <span> </span><span class="NLM_article-title">The vanS-vanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in <i>Enterococcus faecium</i> BM4147</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">2582</span>â <span class="NLM_lpage">2591</span>, <span class="refDoi">Â DOI: 10.1128/jb.174.8.2582-2591.1992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2Fjb.174.8.2582-2591.1992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1556077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK38XkvVCntrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=1992&pages=2582-2591&author=M.+Arthurauthor=C.+Molinasauthor=P.+Courvalin&title=The+vanS-vanR+two-component+regulatory+system+controls+synthesis+of+depsipeptide+peptidoglycan+precursors+in+Enterococcus+faecium+BM4147&doi=10.1128%2Fjb.174.8.2582-2591.1992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147</span></div><div class="casAuthors">Arthur, Michel; Molinas, Catherine; Courvalin, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2582-91</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    </div><div class="casAbstract">Plasmid pIP816 of E. faecium BM4147 confers inducible resistance to vancomycin and encodes the VanH dehydrogenase and the VanA ligase for synthesis of depsipeptide-contg. peptidoglycan precursors which bind the antibiotic with reduced affinity.  A cluster of 5 genes of pIP816 sufficient for peptidoglycan synthesis in the presence of vancomycin was characterized.  The distal part of the van cluster encodes VanH, VanA, and a third enzyme, VanX, all of which are necessary for resistance.  Synthesis of these enzymes was regulated at the transcriptional level by the VanS-VAnR two-component regulatory system encoded by the proximal part of the cluster.  VanR was a transcriptional activator related to response regulators of the OmpR subclass.  VanS stimulated VanR-dependent transcription and was related to membrane-assocd. histidine protein kinases which control the level of phosphorylation of response regulators.  Anal. of transcriptional fusions with a reporter gene and RNA mapping indicated that the VanR-VanS two-component regulatory system activates a promoter used for cotranscription of the vanH, vanA, and vanX resistance gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgG74tz2QKILVg90H21EOLACvtfcHk0lgI_m5orn_yYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XkvVCntrw%253D&md5=2997551edb8792123273f06e9d17f5a8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2Fjb.174.8.2582-2591.1992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fjb.174.8.2582-2591.1992%26sid%3Dliteratum%253Aachs%26aulast%3DArthur%26aufirst%3DM.%26aulast%3DMolinas%26aufirst%3DC.%26aulast%3DCourvalin%26aufirst%3DP.%26atitle%3DThe%2520vanS-vanR%2520two-component%2520regulatory%2520system%2520controls%2520synthesis%2520of%2520depsipeptide%2520peptidoglycan%2520precursors%2520in%2520Enterococcus%2520faecium%2520BM4147%26jtitle%3DJ.%2520Bacteriol.%26date%3D1992%26volume%3D174%26spage%3D2582%26epage%3D2591%26doi%3D10.1128%2Fjb.174.8.2582-2591.1992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depardieu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courvalin, P.</span></span> <span> </span><span class="NLM_article-title">Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">33</span>â <span class="NLM_lpage">44</span>, <span class="refDoi">Â DOI: 10.1046/j.1365-2958.1996.00617.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1046%2Fj.1365-2958.1996.00617.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=8843432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK28Xks1Gjtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1996&pages=33-44&author=M.+Arthurauthor=F.+Depardieuauthor=P.+Reynoldsauthor=P.+Courvalin&title=Quantitative+analysis+of+the+metabolism+of+soluble+cytoplasmic+peptidoglycan+precursors+of+glycopeptide-resistant+enterococci&doi=10.1046%2Fj.1365-2958.1996.00617.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci</span></div><div class="casAuthors">Arthur, Michel; Depardieu, Florence; Reynolds, Peter; Courvalin, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-44</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">Transposon Tn1546 from Enterococcus faecium BM4147 mediates high-level resistance to the glycopeptide antibiotics vancomycin and teicoplanin.  Tn1546 encodes a dehydrogenase (VanH) and a ligase (VanA) that synthesize D-alanyl-D-lactate (D-Ala-D-Lac), a D,D-dipeptidase (VanX) that hydrolyses D-Ala-D-Ala, and a 2-component regulatory system (VanR-VanS) that controls transcription of the vanHAX operon.  Strains of Enterococcus faecalis harboring various copy nos. of the vanRSHAX cluster were tested to det. if there was a correlation between the levels of resistance to glycopeptides, the levels of expression of the corresponding resistance genes, and the relative proportions of the different cytoplasmic peptidoglycan precursors.  Increased transcription of the vanHAX operon was assocd. with increased incorporation of D-Ala-D-Lac into peptidoglycan precursors to the detriment of D-Ala-D-Ala, and with a gradual increase in the vancomycin-resistance levels.  More complete elimination of D-Ala-D-Ala-contg. precursors was required for teicoplanin resistance.  The VanY and VanZ proteins also encoded by Tn1546 were not effectors of the regulation of the vanHAX operon but contributed to vancomycin and teicoplanin resistance, resp.  Differences at the regulatory level accounted for phenotypic diversity in acquired glycopeptide resistance by prodn. of D-lac-ending precursors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9EnJW9ZatDrVg90H21EOLACvtfcHk0lgn2nh_Gy4BTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xks1Gjtbs%253D&md5=199cb5bf66e27511f5e19cb9ce7eae32</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.1996.00617.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.1996.00617.x%26sid%3Dliteratum%253Aachs%26aulast%3DArthur%26aufirst%3DM.%26aulast%3DDepardieu%26aufirst%3DF.%26aulast%3DReynolds%26aufirst%3DP.%26aulast%3DCourvalin%26aufirst%3DP.%26atitle%3DQuantitative%2520analysis%2520of%2520the%2520metabolism%2520of%2520soluble%2520cytoplasmic%2520peptidoglycan%2520precursors%2520of%2520glycopeptide-resistant%2520enterococci%26jtitle%3DMol.%2520Microbiol.%26date%3D1996%26volume%3D21%26spage%3D33%26epage%3D44%26doi%3D10.1046%2Fj.1365-2958.1996.00617.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depardieu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabanie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courvalin, P.</span></span> <span> </span><span class="NLM_article-title">Requirement of the vanY and vanX D,D-peptidases for glycopeptide resistance in enterococci</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">819</span>â <span class="NLM_lpage">830</span>, <span class="refDoi">Â DOI: 10.1046/j.1365-2958.1998.01114.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1046%2Fj.1365-2958.1998.01114.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10094630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK1cXotVejs7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1998&pages=819-830&author=M.+Arthurauthor=F.+Depardieuauthor=L.+Cabanieauthor=P.+Reynoldsauthor=P.+Courvalin&title=Requirement+of+the+vanY+and+vanX+D%2CD-peptidases+for+glycopeptide+resistance+in+enterococci&doi=10.1046%2Fj.1365-2958.1998.01114.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of the VanY and VanX D,D-peptidases for glycopeptide resistance in enterococci</span></div><div class="casAuthors">Arthur, Michel; Depardieu, Florence; Cabanie, Lucien; Reynolds, Peter; Courvalin, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">819-830</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Transposon Tn1546 confers resistance to glycopeptide antibiotics in enterococci and encodes two D,D-peptidases (VanX and VanY) in addn. to the enzymes for the synthesis of D-alanyl-D-lactate (D-Ala-D-Lac).  VanY was produced in the baculovirus expression system and purified as a proteolytic fragment that lacked the putative N-terminal membrane anchor of the protein.  The enzyme was a Zn2+-dependent D,D-carboxypeptidase that cleaved the C-terminal residue of peptidoglycan precursors ending in R-D-Ala-D-Ala or R-D-Ala-D-Lac but not the dipeptide D-Ala-D-Ala.  The specificity consts. kcat/Km were 17- to 67-fold higher for substrates ending in the R-D-Ala-D-Ala target of glycopeptides.  In Enterococcus faecalis, VanY was present in membrane and cytoplasmic fractions, produced UDP-MurNAc-tetrapeptide from cytoplasmic peptidoglycan precursors and was required for high-level glycopeptide resistance in a medium supplemented with D-Ala.  The enzyme could not replace the VanX D,D-dipeptidase for the expression of glycopeptide resistance but a G237D substitution in the host D-Ala:D-Ala ligase restored resistance in a vanX null mutant.  Deletion of the membrane anchor of VanY led to an active D,D-carboxypeptidase exclusively located in the cytoplasmic fraction that did not contribute to glycopeptide resistance in a D-Ala-contg. medium.  Thus, VanX and VanY had non-overlapping functions involving the hydrolysis of D-Ala-D-Ala and the removal of D-Ala from membrane-bound lipid intermediates, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7KmmqClbHqrVg90H21EOLACvtfcHk0lgn2nh_Gy4BTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVejs7w%253D&md5=9480d7d9cff343e85bfeee8b69525e3f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.1998.01114.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.1998.01114.x%26sid%3Dliteratum%253Aachs%26aulast%3DArthur%26aufirst%3DM.%26aulast%3DDepardieu%26aufirst%3DF.%26aulast%3DCabanie%26aufirst%3DL.%26aulast%3DReynolds%26aufirst%3DP.%26aulast%3DCourvalin%26aufirst%3DP.%26atitle%3DRequirement%2520of%2520the%2520vanY%2520and%2520vanX%2520D%252CD-peptidases%2520for%2520glycopeptide%2520resistance%2520in%2520enterococci%26jtitle%3DMol.%2520Microbiol.%26date%3D1998%26volume%3D30%26spage%3D819%26epage%3D830%26doi%3D10.1046%2Fj.1365-2958.1998.01114.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depardieu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courvalin, P.</span></span> <span> </span><span class="NLM_article-title">The vanZ gene of Tn1546 from <i>Enterococcus faecium</i> BM4147 confers resistance to teicoplanin</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">87</span>â <span class="NLM_lpage">92</span>, <span class="refDoi">Â DOI: 10.1016/0378-1119(94)00851-I</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2F0378-1119%2894%2900851-I" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=7867956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK2MXjvFyhsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=1995&pages=87-92&author=M.+Arthurauthor=F.+Depardieuauthor=C.+Molinasauthor=P.+Reynoldsauthor=P.+Courvalin&title=The+vanZ+gene+of+Tn1546+from+Enterococcus+faecium+BM4147+confers+resistance+to+teicoplanin&doi=10.1016%2F0378-1119%2894%2900851-I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin</span></div><div class="casAuthors">Arthur, Michel; Depardieu, Florence; Molinas, Catherine; Reynolds, Peter; Courvalin, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-92</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A 5-gene cluster from Tn1546 confers resistance to the glycopeptide antibiotics vancomycin (Vm) and teicoplanin (Te) by synthesis of pentadepsipeptide peptidoglycan precursors terminating in D-lactate, which replaces D-alanine in the same position of precursors utilized by susceptible enterococci.  Cloning and nucleotide sequencing indicated that Tn1546 contains an addnl. gene, designated vanZ, which confers low-level Te resistance, in the absence of the genes required for pentadepsipeptide synthesis.  Anal. of cytoplasmic peptidoglycan precursors, accumulated in the presence of ramoplanin, showed that VanZ-mediated Te resistance does not involve incorporation of a substituent of D-alanine into the precursors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7UxYWUpxqCLVg90H21EOLACvtfcHk0lgn2nh_Gy4BTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvFyhsr8%253D&md5=0d514e7d19547199011a5d061325255f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2F0378-1119%2894%2900851-I&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-1119%252894%252900851-I%26sid%3Dliteratum%253Aachs%26aulast%3DArthur%26aufirst%3DM.%26aulast%3DDepardieu%26aufirst%3DF.%26aulast%3DMolinas%26aufirst%3DC.%26aulast%3DReynolds%26aufirst%3DP.%26aulast%3DCourvalin%26aufirst%3DP.%26atitle%3DThe%2520vanZ%2520gene%2520of%2520Tn1546%2520from%2520Enterococcus%2520faecium%2520BM4147%2520confers%2520resistance%2520to%2520teicoplanin%26jtitle%3DGene%26date%3D1995%26volume%3D154%26spage%3D87%26epage%3D92%26doi%3D10.1016%2F0378-1119%2894%2900851-I" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arias, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courvalin, P.</span></span> <span> </span><span class="NLM_article-title">Gene vanXYC encodes D,D -dipeptidase (vanX) and D,D-carboxypeptidase (vanY) activities in vancomycin-resistant <i>Enterococcus gallinarum</i> BM4174</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">341</span>â <span class="NLM_lpage">349</span>, <span class="refDoi">Â DOI: 10.1046/j.1365-2958.1999.01604.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1046%2Fj.1365-2958.1999.01604.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10564477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK1MXntVSkt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1999&pages=341-349&author=P.+E.+Reynoldsauthor=C.+A.+Ariasauthor=P.+Courvalin&title=Gene+vanXYC+encodes+D%2CD+-dipeptidase+%28vanX%29+and+D%2CD-carboxypeptidase+%28vanY%29+activities+in+vancomycin-resistant+Enterococcus+gallinarum+BM4174&doi=10.1046%2Fj.1365-2958.1999.01604.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Gene vanXYC encodes D,D-dipeptidase (VanX) and D,D-carboxypeptidase (VanY) activities in vancomycin-resistant Enterococcus gallinarum BM4174</span></div><div class="casAuthors">Reynolds, Peter E.; Arias, Cesar A.; Courvalin, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">341-349</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">VanX and VanY have strict D,D-dipeptidase and D,D-carboxypeptidase activity, resp., that eliminates prodn. of peptidoglycan precursors ending in D-alanyl-D-alanine (D-Ala-D-Ala) in glycopeptide-resistant enterococci in which the C-terminal D-Ala residue has been replaced by D-lactate.  Enterococcus gallinarum BM4174 synthesizes peptidoglycan precursors ending in D-Ala-D-serine (D-Ala-D-Ser) essential for VanC-type vancomycin resistance.  Insertional inactivation of the vanC-1 gene encoding the ligase that catalyzes synthesis of D-Ala-D-Ser has a polar effect on both D,D-dipeptidase and D,D-carboxypeptidase activities.  The open reading frame downstream from vanC-1 encoded a sol. protein designated VanXYC (Mr22318), which had both of these activities.  It had 39% identity and 74% similarity to VanY in an overlap of 158 amino acids, and contained consensus sequences for binding zinc, stabilizing the binding of substrate and catalyzing hydrolysis that are present in both VanX- and VanY-type enzymes.  It had very low dipeptidase activity against D-Ala-D-Ser, unlike VanX, and no activity against UDP-MurNAc-pentapeptide[D-Ser], unlike VanY.  The introduction of plasmid pAT708(vanC-1,XYC) or pAT717(vanXYC) into vancomycin-susceptible Enterococcus faecalis JH2-2 conferred low-level vancomycin resistance only when D-Ser was present in the growth medium.  The peptidoglycan precursor profiles of E. faecalis JH2-2 and JH2-2(pAT708) and JH2-2(pAT717) indicated that the function of VanXYC was hydrolysis of D-Ala-D-Ala and removal of D-Ala from UDP-MurNAc-pentapeptide[D-Ala].  VanC-1 and VanXYC were essential, but not sufficient, for vancomycin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWCVngviwAn7Vg90H21EOLACvtfcHk0lj3y0GH67_XFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntVSkt74%253D&md5=e3ba1aba599cbaf0f59644a5ca65b0af</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.1999.01604.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.1999.01604.x%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DP.%2BE.%26aulast%3DArias%26aufirst%3DC.%2BA.%26aulast%3DCourvalin%26aufirst%3DP.%26atitle%3DGene%2520vanXYC%2520encodes%2520D%252CD%2520-dipeptidase%2520%2528vanX%2529%2520and%2520D%252CD-carboxypeptidase%2520%2528vanY%2529%2520activities%2520in%2520vancomycin-resistant%2520Enterococcus%2520gallinarum%2520BM4174%26jtitle%3DMol.%2520Microbiol.%26date%3D1999%26volume%3D34%26spage%3D341%26epage%3D349%26doi%3D10.1046%2Fj.1365-2958.1999.01604.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Podmore, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, P. E.</span></span> <span> </span><span class="NLM_article-title">Purification and characterization of vanXY(C), a D,D-dipeptidase/D,D-carboxypeptidase in vancomycin-resistant <i>Enterococcus gallinarum</i> BM4174</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>269</i></span>,  <span class="NLM_fpage">2740</span>â <span class="NLM_lpage">2746</span>, <span class="refDoi">Â DOI: 10.1046/j.1432-1033.2002.02946.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1046%2Fj.1432-1033.2002.02946.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=12047383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD38XkslWku7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=2002&pages=2740-2746&author=A.+H.+Podmoreauthor=P.+E.+Reynolds&title=Purification+and+characterization+of+vanXY%28C%29%2C+a+D%2CD-dipeptidase%2FD%2CD-carboxypeptidase+in+vancomycin-resistant+Enterococcus+gallinarum+BM4174&doi=10.1046%2Fj.1432-1033.2002.02946.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and characterization of VanXYC, a D,D-dipeptidase/D,D-carboxypeptidase in vancomycin-resistant Enterococcus gallinarum BM4174</span></div><div class="casAuthors">Podmore, Adrian H. B.; Reynolds, Peter E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2740-2746</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">VanXYC, a bifunctional enzyme from VanC-phenotype Enterococcus gallinarum BM4174 that catalyzes D,D-peptidase and D,D-carboxypeptidase activities, was purified as the native protein, as a maltose-binding protein fusion and with an N-terminal tag contg. six histidine residues.  The kinetic parameters of His6-VanXYC were measured for a variety of precursors of peptidoglycan synthesis involved in resistance: for D-Ala-D-Ala, the Km was 3.6 mM and kcat, 2.5 s-1; for UDP-MurNAc-L-Ala-D-Glu-L-Lys-D-Ala-D-Ala (UDP-MurNAc-pentapeptide[Ala]), Km was 18.8 mM and kcat 6.2 s-1; for D-Ala-D-Ser, Km was 15.5 mM and kcat 0.35 s-1.  His6-VanXYC was inactive against the peptidoglycan precursor UDP-MurNAc-L-Ala-D-Glu-L-Lys-D-Ala-D-Ser (UDP-MurNAc-pentapeptide[Ser]).  The rate of hydrolysis of the terminal D-Ala of UDP-MurNAc-pentapeptide[Ala] was inhibited 30% by 2 mM D-Ala-D-Ser or UDP-MurNAc-pentapeptide[Ser].  Therefore preferential hydrolysis of substrates terminating in D-Ala would occur during peptidoglycan synthesis in E. gallinarum BM4174, leaving precursors ending in D-Ser with a lower affinity for glycopeptides to be incorporated into peptidoglycan.  Mutation of an aspartate residue (Asp59) of His-tagged VanXYC corresponding to Asp68 in VanX to Ser or Ala, resulted in a 50% increase and 73% decrease, resp., of the specificity const. (kcat/Km) for D-Ala-D-Ala.  This situation is in contrast to VanX in which mutation of Asp68âAla produced a greater than 200 000-fold decrease in the substrate specificity const.  This suggests that Asp59, unlike Asp68 in VanX, does not have a pivotal role in catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_2UwQnL0qY7Vg90H21EOLACvtfcHk0lj3y0GH67_XFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkslWku7s%253D&md5=af2908e10604c0809612c7dc5b4c33a6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1033.2002.02946.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1033.2002.02946.x%26sid%3Dliteratum%253Aachs%26aulast%3DPodmore%26aufirst%3DA.%2BH.%26aulast%3DReynolds%26aufirst%3DP.%2BE.%26atitle%3DPurification%2520and%2520characterization%2520of%2520vanXY%2528C%2529%252C%2520a%2520D%252CD-dipeptidase%252FD%252CD-carboxypeptidase%2520in%2520vancomycin-resistant%2520Enterococcus%2520gallinarum%2520BM4174%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2002%26volume%3D269%26spage%3D2740%26epage%3D2746%26doi%3D10.1046%2Fj.1432-1033.2002.02946.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hafer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornblum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowy, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlemann, A. C.</span></span> <span> </span><span class="NLM_article-title">Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate <i>Staphylococcus aureus</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5845</span>â <span class="NLM_lpage">5851</span>, <span class="refDoi">Â DOI: 10.1128/AAC.01139-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.01139-12" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=5845-5851&author=C.+Haferauthor=Y.+Linauthor=J.+Kornblumauthor=F.+D.+Lowyauthor=A.+C.+Uhlemann&title=Contribution+of+selected+gene+mutations+to+resistance+in+clinical+isolates+of+vancomycin-intermediate+Staphylococcus+aureus&doi=10.1128%2FAAC.01139-12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FAAC.01139-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01139-12%26sid%3Dliteratum%253Aachs%26aulast%3DHafer%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DKornblum%26aufirst%3DJ.%26aulast%3DLowy%26aufirst%3DF.%2BD.%26aulast%3DUhlemann%26aufirst%3DA.%2BC.%26atitle%3DContribution%2520of%2520selected%2520gene%2520mutations%2520to%2520resistance%2520in%2520clinical%2520isolates%2520of%2520vancomycin-intermediate%2520Staphylococcus%2520aureus%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D5845%26epage%3D5851%26doi%3D10.1128%2FAAC.01139-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howden, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEvoy, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chua, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coombs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett-Wood, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robins-Browne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seemann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinear, T. P.</span></span> <span> </span><span class="NLM_article-title">Evolution of multidrug resistance during <i>Staphylococcus aureus</i> infection involves mutation of the essential two component regulator WalKR</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e1002359</span>, <span class="refDoi">Â DOI: 10.1371/journal.ppat.1002359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1371%2Fjournal.ppat.1002359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=22102812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFKqtLnI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=e1002359&author=B.+P.+Howdenauthor=C.+R.+McEvoyauthor=D.+L.+Allenauthor=K.+Chuaauthor=W.+Gaoauthor=P.+F.+Harrisonauthor=J.+Bellauthor=G.+Coombsauthor=V.+Bennett-Woodauthor=J.+L.+Porterauthor=R.+Robins-Browneauthor=J.+K.+Daviesauthor=T.+Seemannauthor=T.+P.+Stinear&title=Evolution+of+multidrug+resistance+during+Staphylococcus+aureus+infection+involves+mutation+of+the+essential+two+component+regulator+WalKR&doi=10.1371%2Fjournal.ppat.1002359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR</span></div><div class="casAuthors">Howden, Benjamin P.; McEvoy, Christopher R. E.; Allen, David L.; Chua, Kyra; Gao, Wei; Harrison, Paul F.; Bell, Jan; Coombs, Geoffrey; Bennett-Wood, Vicki; Porter, Jessica L.; Robins-Browne, Roy; Davies, John K.; Seemann, Torsten; Stinear, Timothy P.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e1002359</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Antimicrobial resistance in Staphylococcus aureus is a major public health threat, compounded by emergence of strains with resistance to vancomycin and daptomycin, both last line antimicrobials.  Here, the authors have performed high throughput DNA sequencing and comparative genomics for five clin. pairs of vancomycin-susceptible (VSSA) and vancomycin-intermediate ST239 S. aureus (VISA); each pair isolated before and after vancomycin treatment failure.  These comparisons revealed a frequent pattern of mutation among the VISA strains within the essential walKR two-component regulatory locus involved in control of cell wall metab.  The authors then conducted bi-directional allelic exchange expts. in the clin. VSSA and VISA strains and showed that single nucleotide substitutions within either walK or walR lead to co-resistance to vancomycin and daptomycin, and caused the typical cell wall thickening obsd. in resistant clin. isolates.  Ion Torrent genome sequencing confirmed no addnl. regulatory mutations had been introduced into either the walR or walK VISA mutants during the allelic exchange process.  However, two potential compensatory mutations were detected within putative transport genes for the walK mutant.  The minimal genetic changes in either walK or walR also attenuated virulence, reduced biofilm formation, and led to consistent transcriptional changes that suggest an important role for this regulator in control of central metab.  This study highlights the dramatic impacts of single mutations that arise during persistent S. aureus infections and demonstrates the role played by walKR to increase drug resistance, control metab. and alter the virulence potential of this pathogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTaLlZ4JNmRrVg90H21EOLACvtfcHk0ljcRRdBFryMyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFKqtLnI&md5=7f90aed9bfbd12b36aebfa52b1fd99c0</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002359%26sid%3Dliteratum%253Aachs%26aulast%3DHowden%26aufirst%3DB.%2BP.%26aulast%3DMcEvoy%26aufirst%3DC.%2BR.%26aulast%3DAllen%26aufirst%3DD.%2BL.%26aulast%3DChua%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DHarrison%26aufirst%3DP.%2BF.%26aulast%3DBell%26aufirst%3DJ.%26aulast%3DCoombs%26aufirst%3DG.%26aulast%3DBennett-Wood%26aufirst%3DV.%26aulast%3DPorter%26aufirst%3DJ.%2BL.%26aulast%3DRobins-Browne%26aufirst%3DR.%26aulast%3DDavies%26aufirst%3DJ.%2BK.%26aulast%3DSeemann%26aufirst%3DT.%26aulast%3DStinear%26aufirst%3DT.%2BP.%26atitle%3DEvolution%2520of%2520multidrug%2520resistance%2520during%2520Staphylococcus%2520aureus%2520infection%2520involves%2520mutation%2520of%2520the%2520essential%2520two%2520component%2520regulator%2520WalKR%26jtitle%3DPLoS%2520Pathog.%26date%3D2011%26volume%3D7%26spage%3De1002359%26doi%3D10.1371%2Fjournal.ppat.1002359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howden, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinear, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J. K.</span></span> <span> </span><span class="NLM_article-title">Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical <i>Staphylococcus aureus</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3755</span>â <span class="NLM_lpage">3762</span>, <span class="refDoi">Â DOI: 10.1128/AAC.01613-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.01613-07" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3755-3762&author=B.+P.+Howdenauthor=T.+P.+Stinearauthor=D.+L.+Allenauthor=P.+D.+Johnsonauthor=P.+B.+Wardauthor=J.+K.+Davies&title=Genomic+analysis+reveals+a+point+mutation+in+the+two-component+sensor+gene+graS+that+leads+to+intermediate+vancomycin+resistance+in+clinical+Staphylococcus+aureus&doi=10.1128%2FAAC.01613-07"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1128%2FAAC.01613-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01613-07%26sid%3Dliteratum%253Aachs%26aulast%3DHowden%26aufirst%3DB.%2BP.%26aulast%3DStinear%26aufirst%3DT.%2BP.%26aulast%3DAllen%26aufirst%3DD.%2BL.%26aulast%3DJohnson%26aufirst%3DP.%2BD.%26aulast%3DWard%26aufirst%3DP.%2BB.%26aulast%3DDavies%26aufirst%3DJ.%2BK.%26atitle%3DGenomic%2520analysis%2520reveals%2520a%2520point%2520mutation%2520in%2520the%2520two-component%2520sensor%2520gene%2520graS%2520that%2520leads%2520to%2520intermediate%2520vancomycin%2520resistance%2520in%2520clinical%2520Staphylococcus%2520aureus%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3755%26epage%3D3762%26doi%3D10.1128%2FAAC.01613-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, K.</span></span> <span> </span><span class="NLM_article-title">Two-component system vraSR positively modulates the regulation of cell-wall biosynthesis pathway in <i>Staphylococcus aureus</i></span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">807</span>â <span class="NLM_lpage">821</span>, <span class="refDoi">Â DOI: 10.1046/j.1365-2958.2003.03599.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1046%2Fj.1365-2958.2003.03599.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=12864861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtFektb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2003&pages=807-821&author=M.+Kurodaauthor=H.+Kurodaauthor=T.+Oshimaauthor=F.+Takeuchiauthor=H.+Moriauthor=K.+Hiramatsu&title=Two-component+system+vraSR+positively+modulates+the+regulation+of+cell-wall+biosynthesis+pathway+in+Staphylococcus+aureus&doi=10.1046%2Fj.1365-2958.2003.03599.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus</span></div><div class="casAuthors">Kuroda, Makoto; Kuroda, Hiroko; Oshima, Taku; Takeuchi, Fumihiko; Mori, Hirotada; Hiramatsu, Keiichi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">807-821</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">DNA microarray covering the whole genome of Staphylococcus aureus strain N315 was prepd. to investigate transcription profiles.  The microarray analyses revealed that vancomycin induces transcription of 139 genes.  Forty-six genes among them failed to be induced in the vraSR null mutant KVR.  Part of the genes regulated by VraSR system is assocd. with cell-wall biosynthesis, such as PBP2, SgtB and MurZ.  Other cell-wall synthesis inhibitors also induced VraSR, suggesting that the sensor kinase VraS responds to the damage of cell-wall structure or inhibition of cell-wall biosynthesis.  Addnl., the vraSR null mutants derived from hetero- and homo-methicillin-resistant S. aureus showed significant decrease of resistance against teicoplanin, Î²-lactam, bacitracin and fosfomycin but not of D-cycloserine and levofloxacin.  The observation strongly indicates that VraSR constitutes a pos. regulator of cell-wall peptidoglycan synthesis, and that is deeply involved in the expression of Î²-lactam and glycopeptide resistance in S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqENYlaTCkTobVg90H21EOLACvtfcHk0ljcRRdBFryMyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtFektb8%253D&md5=5313d2f39f127f0153fadde6335e9108</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2003.03599.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2003.03599.x%26sid%3Dliteratum%253Aachs%26aulast%3DKuroda%26aufirst%3DM.%26aulast%3DKuroda%26aufirst%3DH.%26aulast%3DOshima%26aufirst%3DT.%26aulast%3DTakeuchi%26aufirst%3DF.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DHiramatsu%26aufirst%3DK.%26atitle%3DTwo-component%2520system%2520vraSR%2520positively%2520modulates%2520the%2520regulation%2520of%2520cell-wall%2520biosynthesis%2520pathway%2520in%2520Staphylococcus%2520aureus%26jtitle%3DMol.%2520Microbiol.%26date%3D2003%26volume%3D49%26spage%3D807%26epage%3D821%26doi%3D10.1046%2Fj.1365-2958.2003.03599.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, K.</span></span> <span> </span><span class="NLM_article-title">Impact of rpoB mutations on reduced vancomycin susceptibility in <i>Staphylococcus aureus</i></span>. <i>J. Clin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">2680</span>â <span class="NLM_lpage">2684</span>, <span class="refDoi">Â DOI: 10.1128/JCM.02144-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FJCM.02144-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=21525224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BC3Mnks1Kgtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2011&pages=2680-2684&author=Y.+Watanabeauthor=L.+Cuiauthor=Y.+Katayamaauthor=K.+Kozueauthor=K.+Hiramatsu&title=Impact+of+rpoB+mutations+on+reduced+vancomycin+susceptibility+in+Staphylococcus+aureus&doi=10.1128%2FJCM.02144-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus</span></div><div class="casAuthors">Watanabe Yukiko; Cui Longzhu; Katayama Yuki; Kozue Kishii; Hiramatsu Keiichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical microbiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2680-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Of 38 vancomycin-intermediate Staphylococcus aureus (VISA) clinical strains, 27 (71%) possessed a mutation(s) in rpoB encoding the Î²-subunit of RNA polymerase.  Furthermore, 95.6% of the rifampin-resistant mutants obtained from 9 methicillin-resistant S. aureus (MRSA) clinical isolates showed decreased vancomycin susceptibilities.  These data indicate the involvement of an rpoB mutation in VISA phenotype expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTG4IaFRoMovpSWdIdmEou5fW6udTcc2eZR3SBdWe0mm7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mnks1Kgtw%253D%253D&md5=bb1c2d8798ccb11e661d8623735daae6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1128%2FJCM.02144-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.02144-10%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DCui%26aufirst%3DL.%26aulast%3DKatayama%26aufirst%3DY.%26aulast%3DKozue%26aufirst%3DK.%26aulast%3DHiramatsu%26aufirst%3DK.%26atitle%3DImpact%2520of%2520rpoB%2520mutations%2520on%2520reduced%2520vancomycin%2520susceptibility%2520in%2520Staphylococcus%2520aureus%26jtitle%3DJ.%2520Clin.%2520Microbiol.%26date%3D2011%26volume%3D49%26spage%3D2680%26epage%3D2684%26doi%3D10.1128%2FJCM.02144-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiotsuka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, B. T.</span></span> <span> </span><span class="NLM_article-title">Presence of both heterogeneous vancomycin-intermediate resistance and Î²-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant <i>Staphylococcus aureus</i> bloodstream infection</span>. <i>Scand. J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">203</span>â <span class="NLM_lpage">212</span>, <span class="refDoi">Â DOI: 10.3109/00365548.2012.723221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.3109%2F00365548.2012.723221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=23113753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivFaqtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=203-212&author=T.+Takataauthor=M.+Miyazakiauthor=M.+Futoauthor=S.+Haraauthor=S.+Shiotsukaauthor=H.+Kamimuraauthor=H.+Yoshimuraauthor=A.+Matsunagaauthor=T.+Nishidaauthor=H.+Ishikuraauthor=T.+Ishikawaauthor=K.+Tamuraauthor=B.+T.+Tsuji&title=Presence+of+both+heterogeneous+vancomycin-intermediate+resistance+and+%CE%B2-lactam+antibiotic-induced+vancomycin+resistance+phenotypes+is+associated+with+the+outcome+in+methicillin-resistant+Staphylococcus+aureus+bloodstream+infection&doi=10.3109%2F00365548.2012.723221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Presence of both heterogeneous vancomycin-intermediate resistance and Î²-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection</span></div><div class="casAuthors">Takata, Tohru; Miyazaki, Motoyasu; Futo, Maki; Hara, Shuji; Shiotsuka, Shouichi; Kamimura, Hidetoshi; Yoshimura, Hisae; Matsunaga, Akira; Nishida, Takeshi; Ishikura, Hiroyasu; Ishikawa, Takahiko; Tamura, Kazuo; Tsuji, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-212</span>CODEN:
                <span class="NLM_cas:coden">SJIDB7</span>;
        ISSN:<span class="NLM_cas:issn">0036-5548</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Background: Although the individual expression of heterogeneous vancomycin-intermediate resistance (hVISA) and Î²-lactam antibiotic-induced vancomycin resistance (BIVR) phenotypes has been assocd. with treatment failure and recurrence in methicillin-resistant Staphylococcus aureus (MRSA) infections, the effect of the co-expression of these phenotypic profiles on clin. outcome has not been fully elucidated.  The aim of this study was to det. the impact of the combination of hVISA and BIVR phenotypes on the clin. outcome in MRSA bacteremia.  Methods: One hundred and sixty-two MRSA blood isolates from a 21-y period, 1987-2007, were randomly selected.  Screening for hVISA was done by the macromethod Etest and confirmed by population anal. profiles.  BIVR was identified using Mu3 agar contg. 4 Î¼g/mL of vancomycin.  Results: Thirty (18.5%) and 39 (24.1%) of the 162 MRSA blood isolates were pos. for the hVISA and BIVR phenotypes, resp.  Eighteen (11.1%) isolates possessed both hVISA and BIVR phenotypes (hVISA(+)/BIVR(+)).  In a subset of patients who received initial treatment with glycopeptides, only the patients whose isolates were hVISA(+)/BIVR(+) displayed a significantly higher mortality rate in comparison to those with non-hVISA(+)/BIVR(+) (80.0% vs 31.3%, p = 0.004).  The presence of both hVISA and BIVR phenotypes was a predictor of mortality using a logistic regression anal. (p = 0.025).  Conclusions: The combined phenotype of hVISA and BIVR was assocd. with a higher probability of mortality in patients with MRSA bacteremia.  Further prospective studies are warranted to delineate the clin. significance of the combined phenotype of hVISA and BIVR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNJtMhus8l8LVg90H21EOLACvtfcHk0ljgf6JiHEdvUw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivFaqtb0%253D&md5=5bd39f50e516fc9b63b2c47d88f2b15c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3109%2F00365548.2012.723221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00365548.2012.723221%26sid%3Dliteratum%253Aachs%26aulast%3DTakata%26aufirst%3DT.%26aulast%3DMiyazaki%26aufirst%3DM.%26aulast%3DFuto%26aufirst%3DM.%26aulast%3DHara%26aufirst%3DS.%26aulast%3DShiotsuka%26aufirst%3DS.%26aulast%3DKamimura%26aufirst%3DH.%26aulast%3DYoshimura%26aufirst%3DH.%26aulast%3DMatsunaga%26aufirst%3DA.%26aulast%3DNishida%26aufirst%3DT.%26aulast%3DIshikura%26aufirst%3DH.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DTamura%26aufirst%3DK.%26aulast%3DTsuji%26aufirst%3DB.%2BT.%26atitle%3DPresence%2520of%2520both%2520heterogeneous%2520vancomycin-intermediate%2520resistance%2520and%2520%25CE%25B2-lactam%2520antibiotic-induced%2520vancomycin%2520resistance%2520phenotypes%2520is%2520associated%2520with%2520the%2520outcome%2520in%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520bloodstream%2520infection%26jtitle%3DScand.%2520J.%2520Infect.%2520Dis.%26date%3D2013%26volume%3D45%26spage%3D203%26epage%3D212%26doi%3D10.3109%2F00365548.2012.723221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda-Dantsuji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunakawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakae, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanaki, H.</span></span> <span> </span><span class="NLM_article-title">Low level ss-lactamase production in methicillin-resistant <i>Staphylococcus aureus</i> strains with ss-lactam antibiotics-induced vancomycin resistance</span>. <i>BMC Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">69</span>, <span class="refDoi">Â DOI: 10.1186/1471-2180-12-69</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1186%2F1471-2180-12-69" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=22568976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslWjtrrF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=69&author=Y.+Hiraoauthor=Y.+Ikeda-Dantsujiauthor=H.+Matsuiauthor=M.+Yoshidaauthor=S.+Horiauthor=K.+Sunakawaauthor=T.+Nakaeauthor=H.+Hanaki&title=Low+level+ss-lactamase+production+in+methicillin-resistant+Staphylococcus+aureus+strains+with+ss-lactam+antibiotics-induced+vancomycin+resistance&doi=10.1186%2F1471-2180-12-69"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Low level Î²-lactamase production in methicillin-resistant Staphylococcus aureus strains with Î²-lactam antibiotics-induced vancomycin resistance</span></div><div class="casAuthors">Hirao, Yuriko; Ikeda-Dantsuji, Yurika; Matsui, Hidehito; Yoshida, Masaki; Hori, Seiji; Sunakawa, Keisuke; Nakae, Taiji; Hanaki, Hideaki</div><div class="citationInfo"><span class="NLM_cas:title">BMC Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">69</span>CODEN:
                <span class="NLM_cas:coden">BMMIBC</span>;
        ISSN:<span class="NLM_cas:issn">1471-2180</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: A class of methicillin-resistant Staphylococcus aureus (MRSA) shows resistance to vancomycin only in the presence of Î²-lactam antibiotics (BIVR).  This type of vancomycin resistance is mainly attributable to the rapid depletion of free vancomycin in the presence of Î²-lactam antibiotics.  This means that Î²-lactam antibiotics remain active or intact in BIVR culture, although most MRSA cells are assumed to produce Î²-lactamase.  We hypothesised that the BIVR cells either did not harbor the Î²-lactamase gene, blaZ or the gene was quiescent.  We tested this hypothesis by detg. Î²-lactamase activity and conducting PCR amplification of blaZ.  Results: Five randomly selected lab. stock BIVR strains showed an undetectable level of Î²-lactamase activity and were blaZ-neg.  Five non-BIVR stock strains showed an av. Î²-lactamase activity of 2.59 Â± 0.35 U.  To test freshly isolated MRSA, 353 clin. isolates were collected from 11 regionally distant hospitals.  Among 25 BIVR strains, only 16% and 8% were blaZ pos. and Î²-lactamase-pos., resp.  In contrast, 95% and 61% of 328 non-BIVR strains had the blaZ gene and produced active Î²-lactamase, resp.  To know the mechanism of low Î²-lactamase activity in the BIVR cells, they were transformed with the plasmid carrying the blaZ gene.  The transformants still showed a low level of Î²-lactamase activity that was several orders of magnitude lower than that of blaZ-pos. non-BIVR cells.  Presence of the Î²-lactamase gene in the transformants was tested by PCR amplification of blaZ using 11 pairs of primers covering the entire blaZ sequence.  Yield of the PCR products was consistently low compared with that using blaZ-pos. non-BIVR cells.  Nucleotide sequencing of blaZ in one of the BIVR transformants revealed 10 amino acid substitutions.  Thus, it is likely that the Î²-lactamase gene was modified in the BIVR cells to downregulate active Î²-lactamase prodn.  Conclusions: We concluded that BIVR cells gain vancomycin resistance by the elimination or inactivation of Î²-lactamase prodn., thereby preserving Î²-lactam antibiotics in milieu, stimulating peptidoglycan metab. and depleting free vancomycin to a level below the min. inhibitory concn. of vancomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIQ5BvqHVvEbVg90H21EOLACvtfcHk0ljgf6JiHEdvUw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslWjtrrF&md5=8be0228d6bc75191151d038ef4232aaf</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1186%2F1471-2180-12-69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2180-12-69%26sid%3Dliteratum%253Aachs%26aulast%3DHirao%26aufirst%3DY.%26aulast%3DIkeda-Dantsuji%26aufirst%3DY.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DHori%26aufirst%3DS.%26aulast%3DSunakawa%26aufirst%3DK.%26aulast%3DNakae%26aufirst%3DT.%26aulast%3DHanaki%26aufirst%3DH.%26atitle%3DLow%2520level%2520ss-lactamase%2520production%2520in%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520strains%2520with%2520ss-lactam%2520antibiotics-induced%2520vancomycin%2520resistance%26jtitle%3DBMC%2520Microbiol.%26date%3D2012%26volume%3D12%26spage%3D69%26doi%3D10.1186%2F1471-2180-12-69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howden, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinear, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayson, M. L.</span></span> <span> </span><span class="NLM_article-title">Reduced vancomycin susceptibility in <i>Staphylococcus aureus</i>, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">99</span>â <span class="NLM_lpage">139</span>, <span class="refDoi">Â DOI: 10.1128/CMR.00042-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FCMR.00042-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=20065327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3cXks1Sktb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=99-139&author=B.+P.+Howdenauthor=J.+K.+Daviesauthor=P.+D.+Johnsonauthor=T.+P.+Stinearauthor=M.+L.+Grayson&title=Reduced+vancomycin+susceptibility+in+Staphylococcus+aureus%2C+including+vancomycin-intermediate+and+heterogeneous+vancomycin-intermediate+strains%3A+resistance+mechanisms%2C+laboratory+detection%2C+and+clinical+implications&doi=10.1128%2FCMR.00042-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications</span></div><div class="casAuthors">Howden, Benjamin P.; Davies, John K.; Johnson, Paul D. R.; Stinear, Timothy P.; Grayson, M. Lindsay</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-139</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  The emergence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) over the past decade has provided a challenge to diagnostic microbiologists to detect these strains, clinicians treating patients with infections due to these strains, and researchers attempting to understand the resistance mechanisms.  Recent data show that these strains have been detected globally and in many cases are assocd. with glycopeptide treatment failure; however, more rigorous clin. studies are required to clearly define the contribution of hVISA to glycopeptide treatment outcomes.  It is now becoming clear that sequential point mutations in key global regulatory genes contribute to the hVISA and VISA phenotypes, which are assocd. predominately with cell wall thickening and restricted vancomycin access to its site of activity in the division septum; however, the phenotypic features of these strains can vary because the mutations leading to resistance can vary.  Interestingly, changes in the staphylococcal surface and expression of agr are likely to impact host-pathogen interactions in hVISA and VISA infections.  Given the subtleties of vancomycin susceptibility testing against S. aureus, it is imperative that diagnostic labs. use well-standardized methods and have a framework for detecting reduced vancomycin susceptibility in S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvAM9tPUh2GrVg90H21EOLACvtfcHk0lhojNs4662l1A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXks1Sktb8%253D&md5=d3c652cd4d82d78356e97e8f118524b0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1128%2FCMR.00042-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00042-09%26sid%3Dliteratum%253Aachs%26aulast%3DHowden%26aufirst%3DB.%2BP.%26aulast%3DDavies%26aufirst%3DJ.%2BK.%26aulast%3DJohnson%26aufirst%3DP.%2BD.%26aulast%3DStinear%26aufirst%3DT.%2BP.%26aulast%3DGrayson%26aufirst%3DM.%2BL.%26atitle%3DReduced%2520vancomycin%2520susceptibility%2520in%2520Staphylococcus%2520aureus%252C%2520including%2520vancomycin-intermediate%2520and%2520heterogeneous%2520vancomycin-intermediate%2520strains%253A%2520resistance%2520mechanisms%252C%2520laboratory%2520detection%252C%2520and%2520clinical%2520implications%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2010%26volume%3D23%26spage%3D99%26epage%3D139%26doi%3D10.1128%2FCMR.00042-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, K.</span></span> <span> </span><span class="NLM_article-title">Vancomycin-resistant <i>Staphylococcus aureus</i>: a new model of antibiotic resistance</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">147</span>â <span class="NLM_lpage">155</span>, <span class="refDoi">Â DOI: 10.1016/S1473-3099(01)00091-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2FS1473-3099%2801%2900091-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=11871491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVOnsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=147-155&author=K.+Hiramatsu&title=Vancomycin-resistant+Staphylococcus+aureus%3A+a+new+model+of+antibiotic+resistance&doi=10.1016%2FS1473-3099%2801%2900091-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance</span></div><div class="casAuthors">Hiramatsu, Keiichi</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">147-155</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Lancet Publishing Group</span>)
        </div><div class="casAbstract">A review.  A review.  Vancomycin was the most reliable therapeutic agent against infections caused by methicillin-resistant Staphylococcus aureus (MRSA).  However, in 1996 the first MRSA to acquire resistance to vancomycin, was isolated from a Japanese patient.  The patient had contracted a post-operative wound infection that was refractory to long-term vancomycin therapy.  Subsequent isolation of several vancomycin resistant S aureus (VRSA) strains from USA, France, Korea, South Africa, and Brazil has confirmed that emergence of vancomycin resistance in S aureus is a global issue.  A certain group of S aureus, designated hetero-VRSA, frequently generate VRSA upon exposure to vancomycin, and are assocd. with infections that are potentially refractory to vancomycin therapy.  Presence of hetero-VRSA may be an important indicator of the insidious decline of the clin. effectiveness of vancomycin in the hospitals.  Vancomycin resistance is acquired by mutation and thickening of cell wall due to accumulation of excess amts. of peptidoglycan.  This seems to be a common resistance mechanism for all VRSA strains isolated in the world so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowuaBZyorHErVg90H21EOLACvtfcHk0lhojNs4662l1A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVOnsbs%253D&md5=34781954f8fcb4be6b8d2624ef1a6ecd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2801%2900091-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252801%252900091-3%26sid%3Dliteratum%253Aachs%26aulast%3DHiramatsu%26aufirst%3DK.%26atitle%3DVancomycin-resistant%2520Staphylococcus%2520aureus%253A%2520a%2520new%2520model%2520of%2520antibiotic%2520resistance%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2001%26volume%3D1%26spage%3D147%26epage%3D155%26doi%3D10.1016%2FS1473-3099%2801%2900091-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howden, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peleg, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinear, T. P.</span></span> <span> </span><span class="NLM_article-title">The evolution of vancomycin intermediate <i>Staphylococcus aureus</i> (VISA) and heterogenous-VISA. <i>Infection, genetics and evolution</i></span>. <i>Infect., Genet. Evol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">575</span>â <span class="NLM_lpage">582</span>, <span class="refDoi">Â DOI: 10.1016/j.meegid.2013.03.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.meegid.2013.03.047" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=575-582&author=B.+P.+Howdenauthor=A.+Y.+Pelegauthor=T.+P.+Stinear&title=The+evolution+of+vancomycin+intermediate+Staphylococcus+aureus+%28VISA%29+and+heterogenous-VISA.+Infection%2C+genetics+and+evolution&doi=10.1016%2Fj.meegid.2013.03.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.meegid.2013.03.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.meegid.2013.03.047%26sid%3Dliteratum%253Aachs%26aulast%3DHowden%26aufirst%3DB.%2BP.%26aulast%3DPeleg%26aufirst%3DA.%2BY.%26aulast%3DStinear%26aufirst%3DT.%2BP.%26atitle%3DThe%2520evolution%2520of%2520vancomycin%2520intermediate%2520Staphylococcus%2520aureus%2520%2528VISA%2529%2520and%2520heterogenous-VISA.%2520Infection%252C%2520genetics%2520and%2520evolution%26jtitle%3DInfect.%252C%2520Genet.%2520Evol.%26date%3D2014%26volume%3D21%26spage%3D575%26epage%3D582%26doi%3D10.1016%2Fj.meegid.2013.03.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pfeltz, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, B. J.</span></span> <span> </span><span class="NLM_article-title">The escalating challenge of vancomycin resistance in <i>Staphylococcus aureus</i></span>. <i>Curr. Drug Targets: Infect. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">273</span>â <span class="NLM_lpage">294</span>, <span class="refDoi">Â DOI: 10.2174/1568005043340470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.2174%2F1568005043340470" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=15578969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVWgsrvF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=273-294&author=R.+F.+Pfeltzauthor=B.+J.+Wilkinson&title=The+escalating+challenge+of+vancomycin+resistance+in+Staphylococcus+aureus&doi=10.2174%2F1568005043340470"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The escalating challenge of vancomycin resistance in Staphylococcus aureus</span></div><div class="casAuthors">Pfeltz, R. F.; Wilkinson, B. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: Infectious Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">273-294</span>CODEN:
                <span class="NLM_cas:coden">CDTIAS</span>;
        ISSN:<span class="NLM_cas:issn">1568-0053</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The glycopeptide antibiotic vancomycin is considered indispensable for the treatment of multidrug-resistant Staphylococcus aureus infections, and so the acquisition by these organisms of transmissible glycopeptide resistance elements from enterococci had been anticipated with apprehension.  It was, therefore, a considerable surprise when vancomycin-intermediate S. aureus (VISA) clin. isolates were reported in 1997, with a novel, borderline-resistance phenotype acquired without genetic exchange.  Clin. vancomycin-resistant S. aureus (VRSA) were not reported until 2002, expressing high level, transmissible resistance by virtue of vanA resistance determinants within enterococcal transposable elements residing on staphylococcal plasmids.  This review provides an update on the frustratingly variable characteristics of the VISA phenotype, focus on the progress made in understanding the mol. basis of the VISA resistance mechanism from the viewpoint of genetic regulation and cell wall stress response, and summarize the information currently available on VRSA.  Finally, alternatives to vancomycin that are already available or nearing approval will be briefly reviewed, with attention to their limitations and potential for resistance development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZDY7SFW9WZ7Vg90H21EOLACvtfcHk0li3HyfJm64s1g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVWgsrvF&md5=7983b6886bb7a69ed948846a4c6af723</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F1568005043340470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568005043340470%26sid%3Dliteratum%253Aachs%26aulast%3DPfeltz%26aufirst%3DR.%2BF.%26aulast%3DWilkinson%26aufirst%3DB.%2BJ.%26atitle%3DThe%2520escalating%2520challenge%2520of%2520vancomycin%2520resistance%2520in%2520Staphylococcus%2520aureus%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520Infect.%2520Disord.%26date%3D2004%26volume%3D4%26spage%3D273%26epage%3D294%26doi%3D10.2174%2F1568005043340470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, R. A.</span></span> <span> </span><span class="NLM_article-title">The prevalence and mechanisms of vancomycin resistance in <i>Staphylococcus aureus</i></span>. <i>Annu. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">657</span>â <span class="NLM_lpage">675</span>, <span class="refDoi">Â DOI: 10.1146/annurev.micro.56.012302.160806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1146%2Fannurev.micro.56.012302.160806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=12142482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD38Xos1Gisb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2002&pages=657-675&author=T.+R.+Walshauthor=R.+A.+Howe&title=The+prevalence+and+mechanisms+of+vancomycin+resistance+in+Staphylococcus+aureus&doi=10.1146%2Fannurev.micro.56.012302.160806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus</span></div><div class="casAuthors">Walsh, Timothy R.; Howe, Robin A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">657-675</span>CODEN:
                <span class="NLM_cas:coden">ARMIAZ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4227</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The emergence of Staphylococcus aureus resistant to vancomycin has caused considerable concern.  Such strains are currently rare, although they have been isolated from many areas of the world.  Considerable controversy surrounds strains of S. aureus displaying heterogeneous resistance to vancomycin regarding their definition and methods for detection.  This has led to considerable variance in ests. of prevalence (0-1.3%-20% in Japan) and has hindered efforts to define the clin. relevance of these strains.  The mechanism of resistance involves a complex reorganization of cell wall metab., leading to a grossly thickened cell wall with reduced peptidoglycan crosslinking.  There may be many different ways in which strains achieve this endpoint.  Current knowledge and theories are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3OfdZXD3KHbVg90H21EOLACvtfcHk0li3HyfJm64s1g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xos1Gisb8%253D&md5=e04b7af25fc37d30801d10a0bdc90ad3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1146%2Fannurev.micro.56.012302.160806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.micro.56.012302.160806%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DT.%2BR.%26aulast%3DHowe%26aufirst%3DR.%2BA.%26atitle%3DThe%2520prevalence%2520and%2520mechanisms%2520of%2520vancomycin%2520resistance%2520in%2520Staphylococcus%2520aureus%26jtitle%3DAnnu.%2520Rev.%2520Microbiol.%26date%3D2002%26volume%3D56%26spage%3D657%26epage%3D675%26doi%3D10.1146%2Fannurev.micro.56.012302.160806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gardete, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mwangi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasz, A.</span></span> <span> </span><span class="NLM_article-title">Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant <i>Staphylococcus aureus</i> (MRSA) strain of clonal type USA300</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e1002505</span>, <span class="refDoi">Â DOI: 10.1371/journal.ppat.1002505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1371%2Fjournal.ppat.1002505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=22319446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFeqsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=e1002505&author=S.+Gardeteauthor=C.+Kimauthor=B.+M.+Hartmannauthor=M.+Mwangiauthor=C.+M.+Rouxauthor=P.+M.+Dunmanauthor=H.+F.+Chambersauthor=A.+Tomasz&title=Genetic+pathway+in+acquisition+and+loss+of+vancomycin+resistance+in+a+methicillin+resistant+Staphylococcus+aureus+%28MRSA%29+strain+of+clonal+type+USA300&doi=10.1371%2Fjournal.ppat.1002505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin-resistant Staphylococcus aureus (MRSA) strain of clonal type USA300</span></div><div class="casAuthors">Gardete, Susana; Kim, Choonkeun; Hartmann, Boris M.; Mwangi, Michael; Roux, Christelle M.; Dunman, Paul M.; Chambers, Henry F.; Tomasz, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e1002505</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">An isolate of the methicillin-resistant Staphylococcus aureus (MRSA) clone USA300 with reduced susceptibility to vancomycin (SG-R) (i.e., vancomycin-intermediate S. aureus, VISA) and its susceptible "parental" strain (SG-S) were recovered from a patient at the end and at the beginning of an unsuccessful vancomycin therapy.  The VISA phenotype was unstable in vitro generating a susceptible revertant strain (SG-rev).  The availability of these 3 isogenic strains allowed us to explore genetic correlates of antibiotic resistance as it emerged in vivo.  Compared to the susceptible isolate, both the VISA and revertant strains carried the same point mutations in yycH, vraG, yvqF and lspA genes and a substantial deletion within an intergenic region.  The revertant strain carried a single addnl. frameshift mutation in vraS which is part of two component regulatory system VraSR.  VISA isolate SG-R showed complex alterations in phenotype: decreased susceptibility to other antibiotics, slow autolysis, abnormal cell division and increased thickness of cell wall.  There was also altered expression of 239 genes including down-regulation of major virulence determinants.  All phenotypic properties and gene expression profile returned to parental levels in the revertant strain.  Introduction of wild-type yvqF on a multicopy plasmid into the VISA strain caused loss of resistance along with loss of all the assocd. phenotypic changes.  Introduction of the wild-type vraSR into the revertant strain caused recovery of VISA type resistance.  The yvqF/vraSR operon seems to function as an on/off switch: mutation in yvqF in strain SG-R turns on the vraSR system, which leads to increase in vancomycin resistance and down-regulation of virulence determinants.  Mutation in vraS in the revertant strain turns off this regulatory system accompanied by loss of resistance and normal expression of virulence genes.  Down-regulation of virulence genes may provide VISA strains with a "stealth" strategy to evade detection by the host immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXhBzsdiMdfLVg90H21EOLACvtfcHk0li3HyfJm64s1g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFeqsL8%253D&md5=01b164174dd56ff1cd9407cfc0c0b493</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002505%26sid%3Dliteratum%253Aachs%26aulast%3DGardete%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DHartmann%26aufirst%3DB.%2BM.%26aulast%3DMwangi%26aufirst%3DM.%26aulast%3DRoux%26aufirst%3DC.%2BM.%26aulast%3DDunman%26aufirst%3DP.%2BM.%26aulast%3DChambers%26aufirst%3DH.%2BF.%26aulast%3DTomasz%26aufirst%3DA.%26atitle%3DGenetic%2520pathway%2520in%2520acquisition%2520and%2520loss%2520of%2520vancomycin%2520resistance%2520in%2520a%2520methicillin%2520resistant%2520Staphylococcus%2520aureus%2520%2528MRSA%2529%2520strain%2520of%2520clonal%2520type%2520USA300%26jtitle%3DPLoS%2520Pathog.%26date%3D2012%26volume%3D8%26spage%3De1002505%26doi%3D10.1371%2Fjournal.ppat.1002505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sieradzki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasz, A.</span></span> <span> </span><span class="NLM_article-title">Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of <i>Staphylococcus aureus</i></span>. <i>Journal of bacteriology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">7103</span>â <span class="NLM_lpage">7110</span>, <span class="refDoi">Â DOI: 10.1128/JB.185.24.7103-7110.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FJB.185.24.7103-7110.2003" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2003&pages=7103-7110&author=K.+Sieradzkiauthor=A.+Tomasz&title=Alterations+of+cell+wall+structure+and+metabolism+accompany+reduced+susceptibility+to+vancomycin+in+an+isogenic+series+of+clinical+isolates+of+Staphylococcus+aureus&doi=10.1128%2FJB.185.24.7103-7110.2003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1128%2FJB.185.24.7103-7110.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.185.24.7103-7110.2003%26sid%3Dliteratum%253Aachs%26aulast%3DSieradzki%26aufirst%3DK.%26aulast%3DTomasz%26aufirst%3DA.%26atitle%3DAlterations%2520of%2520cell%2520wall%2520structure%2520and%2520metabolism%2520accompany%2520reduced%2520susceptibility%2520to%2520vancomycin%2520in%2520an%2520isogenic%2520series%2520of%2520clinical%2520isolates%2520of%2520Staphylococcus%2520aureus%26jtitle%3DJournal%2520of%2520bacteriology%26date%3D2003%26volume%3D185%26spage%3D7103%26epage%3D7110%26doi%3D10.1128%2FJB.185.24.7103-7110.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neoh, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Looi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamal, R.</span></span> <span> </span><span class="NLM_article-title">Activated ADI pathway: the initiator of intermediate vancomycin resistance in <i>Staphylococcus aureus</i></span>. <i>Can. J. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">260</span>â <span class="NLM_lpage">264</span>, <span class="refDoi">Â DOI: 10.1139/cjm-2016-0439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1139%2Fcjm-2016-0439" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2017&pages=260-264&author=X.+E.+Tanauthor=H.+M.+Neohauthor=M.+L.+Looiauthor=S.+F.+Chinauthor=L.+Cuiauthor=K.+Hiramatsuauthor=S.+Hussinauthor=R.+Jamal&title=Activated+ADI+pathway%3A+the+initiator+of+intermediate+vancomycin+resistance+in+Staphylococcus+aureus&doi=10.1139%2Fcjm-2016-0439"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1139%2Fcjm-2016-0439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fcjm-2016-0439%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DX.%2BE.%26aulast%3DNeoh%26aufirst%3DH.%2BM.%26aulast%3DLooi%26aufirst%3DM.%2BL.%26aulast%3DChin%26aufirst%3DS.%2BF.%26aulast%3DCui%26aufirst%3DL.%26aulast%3DHiramatsu%26aufirst%3DK.%26aulast%3DHussin%26aufirst%3DS.%26aulast%3DJamal%26aufirst%3DR.%26atitle%3DActivated%2520ADI%2520pathway%253A%2520the%2520initiator%2520of%2520intermediate%2520vancomycin%2520resistance%2520in%2520Staphylococcus%2520aureus%26jtitle%3DCan.%2520J.%2520Microbiol.%26date%3D2017%26volume%3D63%26spage%3D260%26epage%3D264%26doi%3D10.1139%2Fcjm-2016-0439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labischinski, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inaba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, K.</span></span> <span> </span><span class="NLM_article-title">Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant <i>Staphylococcus aureus</i> strain Mu50</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">315</span>â <span class="NLM_lpage">320</span>, <span class="refDoi">Â DOI: 10.1093/jac/42.3.315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1093%2Fjac%2F42.3.315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=9786471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlGiu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=315-320&author=H.+Hanakiauthor=H.+Labischinskiauthor=Y.+Inabaauthor=N.+Kondoauthor=H.+Murakamiauthor=K.+Hiramatsu&title=Increase+in+glutamine-non-amidated+muropeptides+in+the+peptidoglycan+of+vancomycin-resistant+Staphylococcus+aureus+strain+Mu50&doi=10.1093%2Fjac%2F42.3.315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Increase in glutamine-nonamidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50</span></div><div class="casAuthors">Hanaki, H.; Labischinski, H.; Inaba, Y.; Kondo, N.; Murakami, H.; Hiramatsu, K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">315-320</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The peptidoglycan compns. of vancomycin-resistant Staphylococcus aureus (VRSA) strain Mu50 (MIC 8 mg/L) and hetero-VRSA strain Mu3 (MIC 3 mg/L) were compared in order to understand the mechanism of vancomycin resistance.  As compared with Mu3, the cell wall of Mu50 had increased amts. of glutamine-non-amidated muropeptides and decreased crosslinking of peptidoglycan with a greatly decreased dimer/monomer ratio of muropeptides.  In agreement with this observation, the peptidoglycan of Mu50 bound 1.4 times more vancomycin than that of Mu3.  The increase in non-amidated muropeptides and the reduced crosslinking of the cell-wall peptidoglycan may contribute to the vancomycin resistance by increasing the consumption of vancomycin by the pre-existing cell wall of Mu50 and reducing the amt. of vancomycin reaching the cytoplasmic membrane where the vital targets of the antibiotic are situated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFi3vTOPvfXrVg90H21EOLACvtfcHk0lg6SdbJqCjNeg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlGiu7g%253D&md5=03cb6dd013237d757a48755cbcb4f3bf</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F42.3.315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F42.3.315%26sid%3Dliteratum%253Aachs%26aulast%3DHanaki%26aufirst%3DH.%26aulast%3DLabischinski%26aufirst%3DH.%26aulast%3DInaba%26aufirst%3DY.%26aulast%3DKondo%26aufirst%3DN.%26aulast%3DMurakami%26aufirst%3DH.%26aulast%3DHiramatsu%26aufirst%3DK.%26atitle%3DIncrease%2520in%2520glutamine-non-amidated%2520muropeptides%2520in%2520the%2520peptidoglycan%2520of%2520vancomycin-resistant%2520Staphylococcus%2520aureus%2520strain%2520Mu50%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1998%26volume%3D42%26spage%3D315%26epage%3D320%26doi%3D10.1093%2Fjac%2F42.3.315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwahara-Arai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle-Vavra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daum, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labischinski, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, K.</span></span> <span> </span><span class="NLM_article-title">Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant <i>Staphylococcus aureus</i> clinical strains Mu3 and Mu50</span>. <i>Journal of antimicrobial chemotherapy</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">199</span>â <span class="NLM_lpage">209</span>, <span class="refDoi">Â DOI: 10.1093/jac/42.2.199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1093%2Fjac%2F42.2.199" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=199-209&author=H.+Hanakiauthor=K.+Kuwahara-Araiauthor=S.+Boyle-Vavraauthor=R.+S.+Daumauthor=H.+Labischinskiauthor=K.+Hiramatsu&title=Activated+cell-wall+synthesis+is+associated+with+vancomycin+resistance+in+methicillin-resistant+Staphylococcus+aureus+clinical+strains+Mu3+and+Mu50&doi=10.1093%2Fjac%2F42.2.199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F42.2.199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F42.2.199%26sid%3Dliteratum%253Aachs%26aulast%3DHanaki%26aufirst%3DH.%26aulast%3DKuwahara-Arai%26aufirst%3DK.%26aulast%3DBoyle-Vavra%26aufirst%3DS.%26aulast%3DDaum%26aufirst%3DR.%2BS.%26aulast%3DLabischinski%26aufirst%3DH.%26aulast%3DHiramatsu%26aufirst%3DK.%26atitle%3DActivated%2520cell-wall%2520synthesis%2520is%2520associated%2520with%2520vancomycin%2520resistance%2520in%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520clinical%2520strains%2520Mu3%2520and%2520Mu50%26jtitle%3DJournal%2520of%2520antimicrobial%2520chemotherapy%26date%3D1998%26volume%3D42%26spage%3D199%26epage%3D209%26doi%3D10.1093%2Fjac%2F42.2.199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sieradzki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haber, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasz, A.</span></span> <span> </span><span class="NLM_article-title">The development of vancomycin resistance in a patient with methicillin-resistant <i>Staphylococcus aureus</i> infection</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">517</span>â <span class="NLM_lpage">523</span>, <span class="refDoi">Â DOI: 10.1056/NEJM199902183400704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1056%2FNEJM199902183400704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10021472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADyaK1M7jsVShsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=1999&pages=517-523&author=K.+Sieradzkiauthor=R.+B.+Robertsauthor=S.+W.+Haberauthor=A.+Tomasz&title=The+development+of+vancomycin+resistance+in+a+patient+with+methicillin-resistant+Staphylococcus+aureus+infection&doi=10.1056%2FNEJM199902183400704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection</span></div><div class="casAuthors">Sieradzki K; Roberts R B; Haber S W; Tomasz A</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">517-23</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6tScgPGImEVWTCLT8lX9SfW6udTcc2eaSvbo49ZMjwLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7jsVShsw%253D%253D&md5=2e4247e1686e4fee14726205487deb23</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1056%2FNEJM199902183400704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199902183400704%26sid%3Dliteratum%253Aachs%26aulast%3DSieradzki%26aufirst%3DK.%26aulast%3DRoberts%26aufirst%3DR.%2BB.%26aulast%3DHaber%26aufirst%3DS.%2BW.%26aulast%3DTomasz%26aufirst%3DA.%26atitle%3DThe%2520development%2520of%2520vancomycin%2520resistance%2520in%2520a%2520patient%2520with%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D340%26spage%3D517%26epage%3D523%26doi%3D10.1056%2FNEJM199902183400704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipe, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinho, M. G.</span></span> <span> </span><span class="NLM_article-title">Fluorescence ratio imaging microscopy shows decreased access of vancomycin to cell wall synthetic sites in vancomycin-resistant <i>Staphylococcus aureus</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3627</span>â <span class="NLM_lpage">3633</span>, <span class="refDoi">Â DOI: 10.1128/AAC.00431-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.00431-07" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=3627-3633&author=P.+M.+Pereiraauthor=S.+R.+Filipeauthor=A.+Tomaszauthor=M.+G.+Pinho&title=Fluorescence+ratio+imaging+microscopy+shows+decreased+access+of+vancomycin+to+cell+wall+synthetic+sites+in+vancomycin-resistant+Staphylococcus+aureus&doi=10.1128%2FAAC.00431-07"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1128%2FAAC.00431-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00431-07%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DP.%2BM.%26aulast%3DFilipe%26aufirst%3DS.%2BR.%26aulast%3DTomasz%26aufirst%3DA.%26aulast%3DPinho%26aufirst%3DM.%2BG.%26atitle%3DFluorescence%2520ratio%2520imaging%2520microscopy%2520shows%2520decreased%2520access%2520of%2520vancomycin%2520to%2520cell%2520wall%2520synthetic%2520sites%2520in%2520vancomycin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D3627%26epage%3D3633%26doi%3D10.1128%2FAAC.00431-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weigel, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clewell, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDougal, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannagan, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolonay, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shetty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Killgore, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenover, F. C.</span></span> <span> </span><span class="NLM_article-title">Genetic analysis of a high-level vancomycin-resistant isolate of <i>Staphylococcus aureus</i></span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">1569</span>â <span class="NLM_lpage">1571</span>, <span class="refDoi">Â DOI: 10.1126/science.1090956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1126%2Fscience.1090956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=14645850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1SmsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=1569-1571&author=L.+M.+Weigelauthor=D.+B.+Clewellauthor=S.+R.+Gillauthor=N.+C.+Clarkauthor=L.+K.+McDougalauthor=S.+E.+Flannaganauthor=J.+F.+Kolonayauthor=J.+Shettyauthor=G.+E.+Killgoreauthor=F.+C.+Tenover&title=Genetic+analysis+of+a+high-level+vancomycin-resistant+isolate+of+Staphylococcus+aureus&doi=10.1126%2Fscience.1090956"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus</span></div><div class="casAuthors">Weigel, Linda M.; Clewell, Don B.; Gill, Steven R.; Clark, Nancye C.; McDougal, Linda K.; Flannagan, Susan E.; Kolonay, James F.; Shetty, Jyoti; Killgore, George E.; Tenover, Fred C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5650</span>),
    <span class="NLM_cas:pages">1569-1571</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Vancomycin is usually reserved for treatment of serious infections, including those caused by multidrug-resistant Staphylococcus aureus.  A clin. isolate of S. aureus with high-level resistance to vancomycin (minimal inhibitory concn. = 1024 Î¼g/mL) was isolated in June 2002.  This isolate harbored a 57.9-kilobase multiresistance conjugative plasmid within which Tn1546 (vanA) was integrated.  Addnl. elements on the plasmid encoded resistance to trimethoprim (dfrA), Î²-lactams (blaZ), aminoglycosides (aacA-aphD), and disinfectants (qacC).  Genetic analyses suggest that the long-anticipated transfer of vancomycin resistance to a methicillin-resistant S. aureus occurred in vivo by interspecies transfer of Tn1546 from a co-isolate of Enterococcus faecalis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPUxOI-5L0nbVg90H21EOLACvtfcHk0lg3YBzn2inIzg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1SmsLk%253D&md5=62c5066b5d48e0249f84f8838eed8d61</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1126%2Fscience.1090956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1090956%26sid%3Dliteratum%253Aachs%26aulast%3DWeigel%26aufirst%3DL.%2BM.%26aulast%3DClewell%26aufirst%3DD.%2BB.%26aulast%3DGill%26aufirst%3DS.%2BR.%26aulast%3DClark%26aufirst%3DN.%2BC.%26aulast%3DMcDougal%26aufirst%3DL.%2BK.%26aulast%3DFlannagan%26aufirst%3DS.%2BE.%26aulast%3DKolonay%26aufirst%3DJ.%2BF.%26aulast%3DShetty%26aufirst%3DJ.%26aulast%3DKillgore%26aufirst%3DG.%2BE.%26aulast%3DTenover%26aufirst%3DF.%2BC.%26atitle%3DGenetic%2520analysis%2520of%2520a%2520high-level%2520vancomycin-resistant%2520isolate%2520of%2520Staphylococcus%2520aureus%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D1569%26epage%3D1571%26doi%3D10.1126%2Fscience.1090956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glavan, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramaniam, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitesides, G. M.</span></span> <span> </span><span class="NLM_article-title">Rapid fabrication of pressure-driven open-channel microfluidic devices in omniphobic R(F) paper</span>. <i>Lab Chip</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2922</span>â <span class="NLM_lpage">2930</span>, <span class="refDoi">Â DOI: 10.1039/c3lc50371b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1039%2Fc3lc50371b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=23719764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVeitrjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=2922-2930&author=A.+C.+Glavanauthor=R.+V.+Martinezauthor=E.+J.+Maxwellauthor=A.+B.+Subramaniamauthor=R.+M.+Nunesauthor=S.+Sohauthor=G.+M.+Whitesides&title=Rapid+fabrication+of+pressure-driven+open-channel+microfluidic+devices+in+omniphobic+R%28F%29+paper&doi=10.1039%2Fc3lc50371b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid fabrication of pressure-driven open-channel microfluidic devices in omniphobic RF paper</span></div><div class="casAuthors">Glavan, Ana C.; Martinez, Ramses V.; Maxwell, E. Jane; Subramaniam, Anand Bala; Nunes, Rui M. D.; Soh, Siowling; Whitesides, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Lab on a Chip</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2922-2930</span>CODEN:
                <span class="NLM_cas:coden">LCAHAM</span>;
        ISSN:<span class="NLM_cas:issn">1473-0189</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">This paper describes the fabrication of pressure-driven, open-channel microfluidic systems with lateral dimensions of 45-300 Î¼ carved in omniphobic paper using a craft-cutting tool.  Vapor phase silanization with a fluorinated alkyltrichlorosilane renders paper omniphobic, but preserves its high gas permeability and mech. properties.  When sealed with tape, the carved channels form conduits capable of guiding liq. transport in the low-Reynolds no. regime (i.e. laminar flow).  These devices are compatible with complex fluids such as droplets of water in oil.  The combination of omniphobic paper and a craft cutter enables the development of new types of valves and switches, such as fold valves and porous switches, which provide new methods to control fluid flow.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlS6bKuzo81LVg90H21EOLACvtfcHk0lg3YBzn2inIzg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVeitrjI&md5=ca91dd0c481c2bd947cbdd5864807fc3</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fc3lc50371b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3lc50371b%26sid%3Dliteratum%253Aachs%26aulast%3DGlavan%26aufirst%3DA.%2BC.%26aulast%3DMartinez%26aufirst%3DR.%2BV.%26aulast%3DMaxwell%26aufirst%3DE.%2BJ.%26aulast%3DSubramaniam%26aufirst%3DA.%2BB.%26aulast%3DNunes%26aufirst%3DR.%2BM.%26aulast%3DSoh%26aufirst%3DS.%26aulast%3DWhitesides%26aufirst%3DG.%2BM.%26atitle%3DRapid%2520fabrication%2520of%2520pressure-driven%2520open-channel%2520microfluidic%2520devices%2520in%2520omniphobic%2520R%2528F%2529%2520paper%26jtitle%3DLab%2520Chip%26date%3D2013%26volume%3D13%26spage%3D2922%26epage%3D2930%26doi%3D10.1039%2Fc3lc50371b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ament, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamshed, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horne, J. P.</span></span> <span> </span><span class="NLM_article-title">Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections</span>. <i>Am. Fam. Physician</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">663</span>â <span class="NLM_lpage">670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=11871684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BD387jslSjtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2002&pages=663-670&author=P.+W.+Amentauthor=N.+Jamshedauthor=J.+P.+Horne&title=Linezolid%3A+its+role+in+the+treatment+of+gram-positive%2C+drug-resistant+bacterial+infections"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections</span></div><div class="casAuthors">Ament Paul W; Jamshed Namirah; Horne John P</div><div class="citationInfo"><span class="NLM_cas:title">American family physician</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">663-70</span>
        ISSN:<span class="NLM_cas:issn">0002-838X</span>.
    </div><div class="casAbstract">While the choices available for the management of gram-positive, drug-resistant bacterial infections are becoming limited, antimicrobial resistance is becoming increasingly problematic because of the widespread overuse of antibiotics.  Linezolid is a synthetic antibiotic belonging to a new class of antimicrobials called the oxazolidinones.  Linezolid disrupts bacterial growth by inhibiting the initiation process of protein synthesis--a mechanism of action that is unique to this class of drugs.  It is well absorbed with high bioavailability that allows conversion to oral therapy as soon as the patient is clinically stable.  It has been approved for certain gram-positive infections including certain drug-resistant enterococcus, staphylococcus, and pneumococcus strains.  It is generally well tolerated, with myelosuppression being the most serious adverse effect.  As a nonselective inhibitor of monoamine oxidase, caution is recommended when used with adrenergic or serotonergic agents (e.g., tyramine, dopamine, pseudoephedrine, and selective serotonin reuptake inhibitors).  Judicious use of this medication should help physicians treat patients with multidrug-resistant infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdks502CPyLCCEBeYuoi7AfW6udTcc2ebsPvjm1c3k-rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387jslSjtw%253D%253D&md5=3ffb2a78351f5ac0d63047a10de4a8f1</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAment%26aufirst%3DP.%2BW.%26aulast%3DJamshed%26aufirst%3DN.%26aulast%3DHorne%26aufirst%3DJ.%2BP.%26atitle%3DLinezolid%253A%2520its%2520role%2520in%2520the%2520treatment%2520of%2520gram-positive%252C%2520drug-resistant%2520bacterial%2520infections%26jtitle%3DAm.%2520Fam.%2520Physician%26date%3D2002%26volume%3D65%26spage%3D663%26epage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemonovich, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">File, T. M.,  Jr.</span></span> <span> </span><span class="NLM_article-title">An evidence-based review of linezolid for the treatment of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA): place in therapy</span>. <i>Core evidence</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">131</span>â <span class="NLM_lpage">143</span>, <span class="refDoi">Â DOI: 10.2147/CE.S33430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.2147%2FCE.S33430" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=131-143&author=R.+R.+Watkinsauthor=T.+L.+Lemonovichauthor=T.+M.+File&title=An+evidence-based+review+of+linezolid+for+the+treatment+of+methicillin-resistant+Staphylococcus+aureus+%28MRSA%29%3A+place+in+therapy&doi=10.2147%2FCE.S33430"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2147%2FCE.S33430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCE.S33430%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DR.%2BR.%26aulast%3DLemonovich%26aufirst%3DT.%2BL.%26aulast%3DFile%26aufirst%3DT.%2BM.%26atitle%3DAn%2520evidence-based%2520review%2520of%2520linezolid%2520for%2520the%2520treatment%2520of%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520%2528MRSA%2529%253A%2520place%2520in%2520therapy%26jtitle%3DCore%2520evidence%26date%3D2012%26volume%3D7%26spage%3D131%26epage%3D143%26doi%3D10.2147%2FCE.S33430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Guillamet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollef, M. H.</span></span> <span> </span><span class="NLM_article-title">Treatment of gram-positive infections in critically ill patients</span>. <i>BMC Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">92</span>, <span class="refDoi">Â DOI: 10.1186/1471-2334-14-92</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1186%2F1471-2334-14-92" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=25431211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFGitb%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=92&author=C.+Vazquez-Guillametauthor=M.+H.+Kollef&title=Treatment+of+gram-positive+infections+in+critically+ill+patients&doi=10.1186%2F1471-2334-14-92"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of gram - positive infections in critically ill patients</span></div><div class="casAuthors">Vazquez-Guillamet, Cristina; Kollef, Marin H.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">92/1-92/8</span>CODEN:
                <span class="NLM_cas:coden">BIDMBJ</span>;
        ISSN:<span class="NLM_cas:issn">1471-2334</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Gram-pos. bacteria to include methicillin-resistant Staphylococcus aureus (MRSA), methicillin-susceptible Staphylococcus aureus (MSSA), and enterococci, to include vancomycin-resistant enterococci (VRE), display a remarkable array of resistance and virulence factors, which have contributed to their prominent role in infections of the critically ill.  Over the last three decades infections with these pathogens has increased as has their overall resistance to available antimicrobial agents.  This has led to the development of a no. of new antibiotics for the treatment of Gram-pos. bacteria.  At present, it is important that clinicians recognize the changing resistance patterns and epidemiol. of Gram-pos. bacteria as these factors may impact patient outcomes.  The increasing range of these pathogens, such as the emergence of community-assocd. MRSA clones, emphasizes that all specialties of physicians treating infections should have a good understanding of the infections caused by Gram-pos. bacteria in their area of practice.  When initiating empiric antibiotics, it is of vital importance that this therapy be timely and appropriate, as delays in treatment are assocd. with adverse outcomes.  Although vancomycin has traditionally been considered a first-line therapy for serious MRSA infections, multiple concerns with this agent have opened the door for alternative agents demonstrating efficacy in this role.  Similarly, the expansion of VRE as a pathogen in the ICU setting has required the development of agents targeting this important pathogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6NyfQbZmX_LVg90H21EOLACvtfcHk0li6d9INPN_IHg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFGitb%252FL&md5=3a0bb2510686c88071b73a125553db70</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1186%2F1471-2334-14-92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2334-14-92%26sid%3Dliteratum%253Aachs%26aulast%3DVazquez-Guillamet%26aufirst%3DC.%26aulast%3DKollef%26aufirst%3DM.%2BH.%26atitle%3DTreatment%2520of%2520gram-positive%2520infections%2520in%2520critically%2520ill%2520patients%26jtitle%3DBMC%2520Infect.%2520Dis.%26date%3D2014%26volume%3D14%26spage%3D92%26doi%3D10.1186%2F1471-2334-14-92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, R. A.</span></span> <span> </span><span class="NLM_article-title">Development of daptomycin resistance in vivo in methicillin-resistant <i>Staphylococcus aureus</i></span>. <i>Journal of clinical microbiology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">5285</span>â <span class="NLM_lpage">5287</span>, <span class="refDoi">Â DOI: 10.1128/JCM.43.10.5285-5287.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FJCM.43.10.5285-5287.2005" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2005&pages=5285-5287&author=M.+K.+Haydenauthor=K.+Rezaiauthor=R.+A.+Hayesauthor=K.+Lolansauthor=J.+P.+Quinnauthor=R.+A.+Weinstein&title=Development+of+daptomycin+resistance+in+vivo+in+methicillin-resistant+Staphylococcus+aureus&doi=10.1128%2FJCM.43.10.5285-5287.2005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1128%2FJCM.43.10.5285-5287.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.43.10.5285-5287.2005%26sid%3Dliteratum%253Aachs%26aulast%3DHayden%26aufirst%3DM.%2BK.%26aulast%3DRezai%26aufirst%3DK.%26aulast%3DHayes%26aufirst%3DR.%2BA.%26aulast%3DLolans%26aufirst%3DK.%26aulast%3DQuinn%26aufirst%3DJ.%2BP.%26aulast%3DWeinstein%26aufirst%3DR.%2BA.%26atitle%3DDevelopment%2520of%2520daptomycin%2520resistance%2520in%2520vivo%2520in%2520methicillin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DJournal%2520of%2520clinical%2520microbiology%26date%3D2005%26volume%3D43%26spage%3D5285%26epage%3D5287%26doi%3D10.1128%2FJCM.43.10.5285-5287.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlesworth, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walesby, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, M.</span></span> <span> </span><span class="NLM_article-title">Linezolid resistance in clinical isolates of <i>Staphylococcus aureus</i></span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">186</span>â <span class="NLM_lpage">188</span>, <span class="refDoi">Â DOI: 10.1093/jac/dkg104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1093%2Fjac%2Fdkg104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=12493812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD38XpslOgtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2003&pages=186-188&author=P.+Wilsonauthor=J.+A.+Andrewsauthor=R.+Charlesworthauthor=R.+Walesbyauthor=M.+Singerauthor=D.+J.+Farrellauthor=M.+Robbins&title=Linezolid+resistance+in+clinical+isolates+of+Staphylococcus+aureus&doi=10.1093%2Fjac%2Fdkg104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Linezolid resistance in clinical isolates of Staphylococcus aureus</span></div><div class="casAuthors">Wilson, Peter; Andrews, J. A.; Charlesworth, R.; Walesby, R.; Singer, M.; Farrell, D. J.; Robbins, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">186-188</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A 52-yr-old man underwent thoracotomy and drainage of right-sided empyema and showed a second clin. infection due to a resistant methicillin-resistant Staphylococcus aureus (MRSA) that developed from a susceptible isolate during treatment.  Eleven isolates of MRSA from this patient were collected during his hospital stay and were tested in parallel by BSAC disk testing.  The linezolid-resistant isolate was first detected in a sample 20 days after linezolid treatment was over.  Phage typing of susceptible and resistant isolates showed them to be indistinguishable E-MRSA 15.  An isolate with an MIC for linezolid of 8 mg/L had a G2576T mutation in two of six alleles, but the mutation was in five of six alleles in an isolate with an MIC of 32 mg/L.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTjVV7YpQN7LVg90H21EOLACvtfcHk0li6d9INPN_IHg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpslOgtL0%253D&md5=c90fd768194f976ffc8e5582eb6a8819</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkg104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkg104%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DP.%26aulast%3DAndrews%26aufirst%3DJ.%2BA.%26aulast%3DCharlesworth%26aufirst%3DR.%26aulast%3DWalesby%26aufirst%3DR.%26aulast%3DSinger%26aufirst%3DM.%26aulast%3DFarrell%26aufirst%3DD.%2BJ.%26aulast%3DRobbins%26aufirst%3DM.%26atitle%3DLinezolid%2520resistance%2520in%2520clinical%2520isolates%2520of%2520Staphylococcus%2520aureus%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2003%26volume%3D51%26spage%3D186%26epage%3D188%26doi%3D10.1093%2Fjac%2Fdkg104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhanel, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelenitsky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagace-Wiens, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinstein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gin, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoban, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlowsky, J. A.</span></span> <span> </span><span class="NLM_article-title">New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">859</span>â <span class="NLM_lpage">886</span>, <span class="refDoi">Â DOI: 10.2165/11534440-000000000-00000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.2165%2F11534440-000000000-00000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=20426497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot1aqsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=859-886&author=G.+G.+Zhanelauthor=D.+Calicauthor=F.+Schweizerauthor=S.+Zelenitskyauthor=H.+Adamauthor=P.+R.+Lagace-Wiensauthor=E.+Rubinsteinauthor=A.+S.+Ginauthor=D.+J.+Hobanauthor=J.+A.+Karlowsky&title=New+lipoglycopeptides%3A+a+comparative+review+of+dalbavancin%2C+oritavancin+and+telavancin&doi=10.2165%2F11534440-000000000-00000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">New lipoglycopeptides: A comparative review of dalbavancin, oritavancin and telavancin</span></div><div class="casAuthors">Zhanel, George G.; Calic, Divna; Schweizer, Frank; Zelenitsky, Sheryl; Adam, Heather; Lagace-Wiens, Philippe R. S.; Rubinstein, Ethan; Gin, Alfred S.; Hoban, Daryl J.; Karlowsky, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">859-886</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Adis Data Information BV</span>)
        </div><div class="casAbstract">A review.  Dalbavancin, oritavancin and telavancin are semisynthetic lipoglycopeptides that demonstrate promise for the treatment of patients with infections caused by multi-drug-resistant Gram-pos. pathogens.  Each of these agents contains a heptapeptide core, common to all glycopeptides, which enables them to inhibit transglycosylation and transpeptidation (cell wall synthesis).  Modifications to the heptapeptide core result in different in vitro activities for the three semisynthetic lipoglycopeptides.  All three lipoglycopeptides contain lipophilic side chains, which prolong their half-life, help to anchor the agents to the cell membrane and increase their activity against Gram-pos. cocci.  In addn. to inhibiting cell wall synthesis, telavancin and oritavancin are also able to disrupt bacterial membrane integrity and increase membrane permeability; oritavancin also inhibits RNA synthesis.  Enterococci exhibiting the VanA phenotype (resistance to both vancomycin and teicoplanin) are resistant to both dalbavancin and telavancin, while oritavancin retains activity.  Dalbavancin, oritavancin and telavancin exhibit activity against VanB vancomycin-resistant enterococci.  All three lipoglycopeptides demonstrate potent in vitro activity against Staphylococcus aureus and Staphylococcus epidermidis regardless of their susceptibility to meticillin, as well as Streptococcus spp.  Both dalbavancin and telavancin are active against vancomycin-intermediate S. aureus (VISA), but display poor activity vs. vancomycin-resistant S. aureus (VRSA).  Oritavancin is active against both VISA and VRSA.  Telavancin displays greater activity against Clostridium spp. than dalbavancin, oritavancin or vancomycin.  The half-life of dalbavancin ranges from 147 to 258 h, which allows for once-weekly dosing, the half-life of oritavancin of 393 h may allow for one dose per treatment course, while telavancin requires daily administration.  Dalbavancin and telavancin exhibit concn.-dependent activity and AUC/MIC (area under the concn.-time curve to min. inhibitory concn. ratio) is the pharmacodynamic parameter that best describes their activities.  Oritavancin's activity is also considered concn.-dependent in vitro, while in vivo its activity has been described by both concn. and time-dependent models; however, AUC/MIC is the pharmacodynamic parameter that best describes its activity.  Clin. trials involving patients with complicated skin and skin structure infections (cSSSIs) have demonstrated that all three agents are as efficacious as comparators.  The most common adverse effects reported with dalbavancin use included nausea, diarrhoea and constipation, while injection site reactions, fever and diarrhoea were commonly obsd. with oritavancin therapy.  Patients administered telavancin frequently reported nausea, taste disturbance and insomnia.  To date, no drug-drug interactions have been identified for dalbavancin, oritavancin or telavancin.  All three of these agents are promising alternatives for the treatment of cSSSIs in cases where more economical options such as vancomycin have been ineffective, in cases of reduced vancomycin susceptibility or resistance, or where vancomycin use has been assocd. with adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2kTvXBDIDUrVg90H21EOLACvtfcHk0lixiY2BYD0CrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot1aqsLY%253D&md5=0409400bb17ec3b413752b85443aaf0f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.2165%2F11534440-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11534440-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DZhanel%26aufirst%3DG.%2BG.%26aulast%3DCalic%26aufirst%3DD.%26aulast%3DSchweizer%26aufirst%3DF.%26aulast%3DZelenitsky%26aufirst%3DS.%26aulast%3DAdam%26aufirst%3DH.%26aulast%3DLagace-Wiens%26aufirst%3DP.%2BR.%26aulast%3DRubinstein%26aufirst%3DE.%26aulast%3DGin%26aufirst%3DA.%2BS.%26aulast%3DHoban%26aufirst%3DD.%2BJ.%26aulast%3DKarlowsky%26aufirst%3DJ.%2BA.%26atitle%3DNew%2520lipoglycopeptides%253A%2520a%2520comparative%2520review%2520of%2520dalbavancin%252C%2520oritavancin%2520and%2520telavancin%26jtitle%3DDrugs%26date%3D2010%26volume%3D70%26spage%3D859%26epage%3D886%26doi%3D10.2165%2F11534440-000000000-00000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leadbetter, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazzini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatheree, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karr, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linsell, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nodwell, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quast, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapp, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villena, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judice, J. K.</span></span> <span> </span><span class="NLM_article-title">Hydrophobic vancomycin derivatives with improved ADME properties: discovery of telavancin (TD-6424)</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">326</span>â <span class="NLM_lpage">336</span>, <span class="refDoi">Â DOI: 10.7164/antibiotics.57.326</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.7164%2Fantibiotics.57.326" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=15303493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks12hu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2004&pages=326-336&author=M.+R.+Leadbetterauthor=S.+M.+Adamsauthor=B.+Bazziniauthor=P.+R.+Fathereeauthor=D.+E.+Karrauthor=K.+M.+Krauseauthor=B.+M.+Lamauthor=M.+S.+Linsellauthor=M.+B.+Nodwellauthor=J.+L.+Paceauthor=K.+Quastauthor=J.+P.+Shawauthor=E.+Sorianoauthor=S.+G.+Trappauthor=J.+D.+Villenaauthor=T.+X.+Wuauthor=B.+G.+Christensenauthor=J.+K.+Judice&title=Hydrophobic+vancomycin+derivatives+with+improved+ADME+properties%3A+discovery+of+telavancin+%28TD-6424%29&doi=10.7164%2Fantibiotics.57.326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrophobic vancomycin derivatives with improved ADME properties: Discovery of telavancin (TD-6424)</span></div><div class="casAuthors">Leadbetter, Michael R.; Adams, Stacy M.; Bazzini, Bettina; Fatheree, Paul R.; Karr, Dane E.; Krause, Kevin M.; Lam, Bernice M. T.; Linsell, Martin S.; Nodwell, Matthew B.; Pace, John L.; Quast, Kelly; Shaw, Jeng-Pyng; Soriano, Elizabeth; Trapp, Sean G.; Villena, Jenny D.; Wu, Terry X.; Christensen, Burton G.; Judice, J. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">326-336</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">Novel derivs. of N-decylaminoethylvancomycin (2), contg. appended hydrophilic groups were synthesized and their antibacterial activity and ADME properties were evaluated.  The compds. were prepd. by reacting amines with the C-terminus (C-) of 2 using PyBOP mediated amide formation, or with the resorcinol-like (R-) position of 2 using a Mannich aminomethylation reaction.  These analogs retained the antibacterial activity of 2 against methicillin-resistant staphylococci and vancomycin-resistant enterococci.  Compds. with a neg. charged auxiliary group also exhibited improved ADME properties relative to 2.  In particular, R-phosphonomethylaminomethyl deriv. 21 displayed good in vitro antibacterial activity, high urinary recovery and low distribution to liver and kidney tissues.  Based on these results, 21 was advanced into development as TD-6424, and is currently in human clin. trials.  The generic name telavancin has recently been approved for compd. 21.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobrfFAGGvnOLVg90H21EOLACvtfcHk0lixiY2BYD0CrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks12hu7c%253D&md5=7a24e7cda0ffe2f03280f9c7a36fe028</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.57.326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.57.326%26sid%3Dliteratum%253Aachs%26aulast%3DLeadbetter%26aufirst%3DM.%2BR.%26aulast%3DAdams%26aufirst%3DS.%2BM.%26aulast%3DBazzini%26aufirst%3DB.%26aulast%3DFatheree%26aufirst%3DP.%2BR.%26aulast%3DKarr%26aufirst%3DD.%2BE.%26aulast%3DKrause%26aufirst%3DK.%2BM.%26aulast%3DLam%26aufirst%3DB.%2BM.%26aulast%3DLinsell%26aufirst%3DM.%2BS.%26aulast%3DNodwell%26aufirst%3DM.%2BB.%26aulast%3DPace%26aufirst%3DJ.%2BL.%26aulast%3DQuast%26aufirst%3DK.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3DTrapp%26aufirst%3DS.%2BG.%26aulast%3DVillena%26aufirst%3DJ.%2BD.%26aulast%3DWu%26aufirst%3DT.%2BX.%26aulast%3DChristensen%26aufirst%3DB.%2BG.%26aulast%3DJudice%26aufirst%3DJ.%2BK.%26atitle%3DHydrophobic%2520vancomycin%2520derivatives%2520with%2520improved%2520ADME%2520properties%253A%2520discovery%2520of%2520telavancin%2520%2528TD-6424%2529%26jtitle%3DJ.%2520Antibiot.%26date%3D2004%26volume%3D57%26spage%3D326%26epage%3D336%26doi%3D10.7164%2Fantibiotics.57.326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lunde, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartouni, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janc, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mammen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benton, B. M.</span></span> <span> </span><span class="NLM_article-title">Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3375</span>â <span class="NLM_lpage">3383</span>, <span class="refDoi">Â DOI: 10.1128/AAC.01710-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.01710-08" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=3375-3383&author=C.+S.+Lundeauthor=S.+R.+Hartouniauthor=J.+W.+Jancauthor=M.+Mammenauthor=P.+P.+Humphreyauthor=B.+M.+Benton&title=Telavancin+disrupts+the+functional+integrity+of+the+bacterial+membrane+through+targeted+interaction+with+the+cell+wall+precursor+lipid+II&doi=10.1128%2FAAC.01710-08"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1128%2FAAC.01710-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01710-08%26sid%3Dliteratum%253Aachs%26aulast%3DLunde%26aufirst%3DC.%2BS.%26aulast%3DHartouni%26aufirst%3DS.%2BR.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26aulast%3DMammen%26aufirst%3DM.%26aulast%3DHumphrey%26aufirst%3DP.%2BP.%26aulast%3DBenton%26aufirst%3DB.%2BM.%26atitle%3DTelavancin%2520disrupts%2520the%2520functional%2520integrity%2520of%2520the%2520bacterial%2520membrane%2520through%2520targeted%2520interaction%2520with%2520the%2520cell%2520wall%2520precursor%2520lipid%2520II%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D3375%26epage%3D3383%26doi%3D10.1128%2FAAC.01710-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saravolatz, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billeter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zervos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalovisio, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurukularatne, C.</span></span> <span> </span><span class="NLM_article-title">Dalbavancin: a novel once-weekly lipoglycopeptide antibiotic</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">577</span>â <span class="NLM_lpage">583</span>, <span class="refDoi">Â DOI: 10.1086/526772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1086%2F526772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=18199045" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=577-583&author=L.+D.+Saravolatzauthor=M.+Billeterauthor=M.+J.+Zervosauthor=A.+Y.+Chenauthor=J.+R.+Dalovisioauthor=C.+Kurukularatne&title=Dalbavancin%3A+a+novel+once-weekly+lipoglycopeptide+antibiotic&doi=10.1086%2F526772"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1086%2F526772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F526772%26sid%3Dliteratum%253Aachs%26aulast%3DSaravolatz%26aufirst%3DL.%2BD.%26aulast%3DBilleter%26aufirst%3DM.%26aulast%3DZervos%26aufirst%3DM.%2BJ.%26aulast%3DChen%26aufirst%3DA.%2BY.%26aulast%3DDalovisio%26aufirst%3DJ.%2BR.%26aulast%3DKurukularatne%26aufirst%3DC.%26atitle%3DDalbavancin%253A%2520a%2520novel%2520once-weekly%2520lipoglycopeptide%2520antibiotic%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2008%26volume%3D46%26spage%3D577%26epage%3D583%26doi%3D10.1086%2F526772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arhin, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draghi, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillar, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parr, T. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeck, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahm, D. F.</span></span> <span> </span><span class="NLM_article-title">Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4762</span>â <span class="NLM_lpage">4771</span>, <span class="refDoi">Â DOI: 10.1128/AAC.00952-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.00952-09" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=4762-4771&author=F.+F.+Arhinauthor=D.+C.+Draghiauthor=C.+M.+Pillarauthor=T.+R.+Parrauthor=G.+Moeckauthor=D.+F.+Sahm&title=Comparative+in+vitro+activity+profile+of+oritavancin+against+recent+gram-positive+clinical+isolates&doi=10.1128%2FAAC.00952-09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1128%2FAAC.00952-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00952-09%26sid%3Dliteratum%253Aachs%26aulast%3DArhin%26aufirst%3DF.%2BF.%26aulast%3DDraghi%26aufirst%3DD.%2BC.%26aulast%3DPillar%26aufirst%3DC.%2BM.%26aulast%3DParr%26aufirst%3DT.%2BR.%26aulast%3DMoeck%26aufirst%3DG.%26aulast%3DSahm%26aufirst%3DD.%2BF.%26atitle%3DComparative%2520in%2520vitro%2520activity%2520profile%2520of%2520oritavancin%2520against%2520recent%2520gram-positive%2520clinical%2520isolates%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D4762%26epage%3D4771%26doi%3D10.1128%2FAAC.00952-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saravolatz, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, G. E.</span></span> <span> </span><span class="NLM_article-title">Oritavancin: A long-half-life lipoglycopeptide</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">627</span>â <span class="NLM_lpage">632</span>, <span class="refDoi">Â DOI: 10.1093/cid/civ311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1093%2Fcid%2Fciv311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=25900171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFKltrvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2015&pages=627-632&author=L.+D.+Saravolatzauthor=G.+E.+Stein&title=Oritavancin%3A+A+long-half-life+lipoglycopeptide&doi=10.1093%2Fcid%2Fciv311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Oritavancin: a long-half-life lipoglycopeptide</span></div><div class="casAuthors">Saravolatz, Louis D.; Stein, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">627-632</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Oritavancin is a lipoglycopeptide antibiotic that has been shown to be effective for the treatment of acute bacterial skin and skin structure infections (ABSSSIs).  This antibiotic has multiple mechanisms of action including inhibiting peptidoglycan cell wall synthesis and disrupting bacterial cell membrane, leading to cell death.  Oritavancin is highly active against common gram-pos. pathogens including methicillin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, vancomycin-resistant S. aureus, and vancomycin-resistant enterococci.  The drug is administered as a single i.v. dose of 1200 mg over 3 h in adult patients, and because of its terminal half-life of 393 h, repeat dosing is not required in the treatment of ABSSIs.  There is a very slow elimination from tissue sites, and no dosing adjustments are required for renal or hepatic insufficiency.  Two clin. trials have demonstrated noninferiority compared with vancomycin in the treatment of ABSSSIs.  Other than liver enzyme elevation and the occurrence of osteomyelitis, oritavancin has been assocd. with adverse events similar to those of vancomycin in follow-up for up to 60 days.  Patients should be monitored for osteomyelitis and alternate therapy given in the case of confirmed or suspected osteomyelitis.  Although oritavancin is an attractive antibiotic to consider in the outpatient area, its efficacy and safety in the treatment of other sites of infection are yet to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy18lyLxNVerVg90H21EOLACvtfcHk0liRbD5MHu3Q-g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFKltrvM&md5=797ba49d4b23e57b5c0f977acce9584a</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fciv311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fciv311%26sid%3Dliteratum%253Aachs%26aulast%3DSaravolatz%26aufirst%3DL.%2BD.%26aulast%3DStein%26aufirst%3DG.%2BE.%26atitle%3DOritavancin%253A%2520A%2520long-half-life%2520lipoglycopeptide%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2015%26volume%3D61%26spage%3D627%26epage%3D632%26doi%3D10.1093%2Fcid%2Fciv311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaskovich, M. A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansford, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mark, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. A.</span></span> <span> </span><span class="NLM_article-title">Developments in glycopeptide antibiotics</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">715</span>â <span class="NLM_lpage">735</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.7b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.7b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVGhtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=715-735&author=M.+A.+T.+Blaskovichauthor=K.+A.+Hansfordauthor=M.+S.+Butlerauthor=Z.+Jiaauthor=A.+E.+Markauthor=M.+A.+Cooper&title=Developments+in+glycopeptide+antibiotics&doi=10.1021%2Facsinfecdis.7b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Developments in Glycopeptide Antibiotics</span></div><div class="casAuthors">Blaskovich, Mark A. T.; Hansford, Karl A.; Butler, Mark S.; Jia, ZhiGuang; Mark, Alan E.; Cooper, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">715-735</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Glycopeptide antibiotics (GPA) are a key weapon in the fight against drug resistant bacteria, with vancomycin still a mainstream therapy against serious Gram-pos. infections more than 50 years after it was first introduced.  New, more potent semisynthetic derivs. that have entered the clinic, such as dalbavancin and oritavancin, have superior pharmacokinetic and target engagement profiles that enable successful treatment of vancomycin-resistant infections.  In the face of resistance development, with multi-drug resistant (MDR) S. pneumonia and MRSA together causing 20-fold more infections than all MDR Gram-neg. infections combined, further improvements are desirable to ensure the Gram-pos. armamentarium is adequately maintained for future generations.  A range of modified glycopeptides has been generated in the last decade via total syntheses, semisynthetic modifications of a natural product or biol. engineering.  Several of these have undergone extensive characterization with demonstrated in vivo efficacy, good PK/PD profiles and no reported pre-clin. toxicity; some may be suitable for formal preclin. development.  The natural product monobactam, cephalosporin and beta-lactam antibiotics all spawned multiple generations of com. and clin. successful semi-synthetic derivs.  Similarly, next-generation glycopeptides are now tech. well positioned to advance to the clinic, if sufficient funding and market support returns to antibiotic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLGv_FtL7T-rVg90H21EOLACvtfcHk0lgK_FMZLp4Tgw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVGhtLs%253D&md5=c384f5eb681053896c19c0d33e268b34</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.7b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.7b00258%26sid%3Dliteratum%253Aachs%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%2BT.%26aulast%3DHansford%26aufirst%3DK.%2BA.%26aulast%3DButler%26aufirst%3DM.%2BS.%26aulast%3DJia%26aufirst%3DZ.%26aulast%3DMark%26aufirst%3DA.%2BE.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26atitle%3DDevelopments%2520in%2520glycopeptide%2520antibiotics%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2018%26volume%3D4%26spage%3D715%26epage%3D735%26doi%3D10.1021%2Facsinfecdis.7b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashford, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bew, S. P.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the synthesis of new glycopeptide antibiotics</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">957</span>â <span class="NLM_lpage">978</span>, <span class="refDoi">Â DOI: 10.1039/C1CS15125H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1039%2FC1CS15125H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=21829829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC38Xns1ygsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2012&pages=957-978&author=P.+A.+Ashfordauthor=S.+P.+Bew&title=Recent+advances+in+the+synthesis+of+new+glycopeptide+antibiotics&doi=10.1039%2FC1CS15125H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the synthesis of new glycopeptide antibiotics</span></div><div class="casAuthors">Ashford, Polly-Anna; Bew, Sean P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">957-978</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The vancomycin family of glycopeptide antibiotics has been inspiring research in the field of synthetic chem. since the 1980s.  Recent studies have moved away from the focus of total synthesis into new territory: the design and evaluation of novel compds. based on the natural products which exhibit improved antibacterial activity.  Modern approaches to drug synthesis draw together investigations into the nature of the binding environment, and innovative synthetic methodologies which provide solns. to the challenging structural features and stereochem. assocd. with this intriguing class of compds.  New analogs, derivs. and dimers of the natural products, as well as recent successes in the total synthesis of the complestatins are described in this tutorial review, covering literature from the last decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGGvGnH7SF-7Vg90H21EOLACvtfcHk0lgK_FMZLp4Tgw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xns1ygsg%253D%253D&md5=cb7c903a6d6ff88c98490431a0d4d7bd</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1039%2FC1CS15125H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC1CS15125H%26sid%3Dliteratum%253Aachs%26aulast%3DAshford%26aufirst%3DP.%2BA.%26aulast%3DBew%26aufirst%3DS.%2BP.%26atitle%3DRecent%2520advances%2520in%2520the%2520synthesis%2520of%2520new%2520glycopeptide%2520antibiotics%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2012%26volume%3D41%26spage%3D957%26epage%3D978%26doi%3D10.1039%2FC1CS15125H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagarajan, R.</span></span> <i>Glycopeptide Antibiotics</i>; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>, <span class="NLM_year">1994</span>; Vol.  <span class="NLM_volume">63</span>, pp  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">448</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&pages=1-448&author=R.+Nagarajan&title=Glycopeptide+Antibiotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNagarajan%26aufirst%3DR.%26btitle%3DGlycopeptide%2520Antibiotics%26pub%3DCRC%2520Press%26date%3D1994%26volume%3D63%26spage%3D1%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McComas, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">9314</span>â <span class="NLM_lpage">9315</span>, <span class="refDoi">Â DOI: 10.1021/ja035901x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja035901x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltlCksbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=9314-9315&author=C.+C.+McComasauthor=B.+M.+Crowleyauthor=D.+L.+Boger&title=Partitioning+the+loss+in+vancomycin+binding+affinity+for+D-Ala-D-Lac+into+lost+H-bond+and+repulsive+lone+pair+contributions&doi=10.1021%2Fja035901x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Partitioning the Loss in Vancomycin Binding Affinity for D-Ala-D-Lac into Lost H-Bond and Repulsive Lone Pair Contributions</span></div><div class="casAuthors">McComas, Casey C.; Crowley, Brendan M.; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">9314-9315</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The binding affinity of AcNH(CH2)4CH(AcNH)C:ONHCH(CH3)C:OCH2CH(CH3)CO2H (I), which incorporates a methylene (CH2) in place of the key linking amide of Ac2-L-Lys-D-Ala-D-Ala, for vancomycin was compared with that of Ac2-L-Lys-D-Ala-D-Ala and Ac2-L-Lys-D-Ala-D-Lac.  The vancomycin affinity for I was approx. 10-fold less than that of Ac2-L-Lys-D-Ala-D-Ala, but 100-fold greater than that of Ac2-L-Lys-D-Ala-D-Lac.  This suggests that the reduced binding affinity of Ac2-L-Lys-D-Ala-D-Lac (4.1 kcal/mol) may be attributed to both the loss of a key H-bond (1.5 kcal/mol) and a destabilizing lone pair/lone pair electrostatic interaction introduced with the ester oxygen of Ac2-L-Lys-D-Ala-D-Lac (2.6 kcal/mol) with the latter, not the H-bond, being responsible for the largest share of the 1000-fold redn.  These observations have significant ramifications in the reengineering of the vancomycin structure to bind D-Ala-D-Lac and thus overcoming bacterial resistance to vancomycin in its binding to precursor peptidoglycan in cell wall biosynthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb8pKB_Ped6rVg90H21EOLACvtfcHk0lgK_FMZLp4Tgw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltlCksbs%253D&md5=322f71e8dfe940e24a7b7ec360a417b6</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fja035901x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja035901x%26sid%3Dliteratum%253Aachs%26aulast%3DMcComas%26aufirst%3DC.%2BC.%26aulast%3DCrowley%26aufirst%3DB.%2BM.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DPartitioning%2520the%2520loss%2520in%2520vancomycin%2520binding%2520affinity%2520for%2520D-Ala-D-Lac%2520into%2520lost%2520H-bond%2520and%2520repulsive%2520lone%2520pair%2520contributions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D9314%26epage%3D9315%26doi%3D10.1021%2Fja035901x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">Total synthesis and evaluation of [Î¨ [CH<sub>2</sub>NH] Tpg<sup>4</sup>] vancomycin aglycon: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">2885</span>â <span class="NLM_lpage">2892</span>, <span class="refDoi">Â DOI: 10.1021/ja0572912</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0572912" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=2885-2892&author=B.+M.+Crowleyauthor=D.+L.+Boger&title=Total+synthesis+and+evaluation+of+%5B%CE%A8+%5BCH2NH%5D+Tpg4%5D+vancomycin+aglycon%3A+reengineering+vancomycin+for+dual+D-Ala-D-Ala+and+D-Ala-D-Lac+binding&doi=10.1021%2Fja0572912"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fja0572912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0572912%26sid%3Dliteratum%253Aachs%26aulast%3DCrowley%26aufirst%3DB.%2BM.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DTotal%2520synthesis%2520and%2520evaluation%2520of%2520%255B%25CE%25A8%2520%255BCH2NH%255D%2520Tpg4%255D%2520vancomycin%2520aglycon%253A%2520reengineering%2520vancomycin%2520for%2520dual%2520D-Ala-D-Ala%2520and%2520D-Ala-D-Lac%2520binding%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D2885%26epage%3D2892%26doi%3D10.1021%2Fja0572912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schammel, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">Total Synthesis of [Î¨ [C (=NH) NH] Tpg<sup>4</sup>] vancomycin and its (4-Chlorobiphenyl) methyl Derivative: impact of peripheral modifications on vancomycin analogues redesigned for dual D-Ala-D-Ala and D-Ala-D-Lac binding</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">13522</span>â <span class="NLM_lpage">13525</span>, <span class="refDoi">Â DOI: 10.1021/ja507009a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja507009a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=13522-13525&author=A.+Okanoauthor=A.+Nakayamaauthor=A.+W.+Schammelauthor=D.+L.+Boger&title=Total+Synthesis+of+%5B%CE%A8+%5BC+%28%3DNH%29+NH%5D+Tpg4%5D+vancomycin+and+its+%284-Chlorobiphenyl%29+methyl+Derivative%3A+impact+of+peripheral+modifications+on+vancomycin+analogues+redesigned+for+dual+D-Ala-D-Ala+and+D-Ala-D-Lac+binding&doi=10.1021%2Fja507009a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fja507009a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja507009a%26sid%3Dliteratum%253Aachs%26aulast%3DOkano%26aufirst%3DA.%26aulast%3DNakayama%26aufirst%3DA.%26aulast%3DSchammel%26aufirst%3DA.%2BW.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DTotal%2520Synthesis%2520of%2520%255B%25CE%25A8%2520%255BC%2520%2528%253DNH%2529%2520NH%255D%2520Tpg4%255D%2520vancomycin%2520and%2520its%2520%25284-Chlorobiphenyl%2529%2520methyl%2520Derivative%253A%2520impact%2520of%2520peripheral%2520modifications%2520on%2520vancomycin%2520analogues%2520redesigned%2520for%2520dual%2520D-Ala-D-Ala%2520and%2520D-Ala-D-Lac%2520binding%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D13522%26epage%3D13525%26doi%3D10.1021%2Fja507009a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isley, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">Peripheral modifications of [Î¨ [CH<sub>2</sub>NH]Tpg<sup>4</sup>] vancomycin with added synergistic mechanisms of action provide durable and potent antibiotics</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E5052</span>â <span class="NLM_lpage">E5061</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1704125114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1073%2Fpnas.1704125114" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E5052-E5061&author=A.+Okanoauthor=N.+A.+Isleyauthor=D.+L.+Boger&title=Peripheral+modifications+of+%5B%CE%A8+%5BCH2NH%5DTpg4%5D+vancomycin+with+added+synergistic+mechanisms+of+action+provide+durable+and+potent+antibiotics&doi=10.1073%2Fpnas.1704125114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1704125114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1704125114%26sid%3Dliteratum%253Aachs%26aulast%3DOkano%26aufirst%3DA.%26aulast%3DIsley%26aufirst%3DN.%2BA.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DPeripheral%2520modifications%2520of%2520%255B%25CE%25A8%2520%255BCH2NH%255DTpg4%255D%2520vancomycin%2520with%2520added%2520synergistic%2520mechanisms%2520of%2520action%2520provide%2520durable%2520and%2520potent%2520antibiotics%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3DE5052%26epage%3DE5061%26doi%3D10.1073%2Fpnas.1704125114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nitanai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakoi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanamaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujisawa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, K.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of the complexes between vancomycin and cell-wall precursor analogs</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>385</i></span>,  <span class="NLM_fpage">1422</span>â <span class="NLM_lpage">1432</span>, <span class="refDoi">Â DOI: 10.1016/j.jmb.2008.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.jmb.2008.10.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=18976660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSmsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2009&pages=1422-1432&author=Y.+Nitanaiauthor=T.+Kikuchiauthor=K.+Kakoiauthor=S.+Hanamakiauthor=I.+Fujisawaauthor=K.+Aoki&title=Crystal+structures+of+the+complexes+between+vancomycin+and+cell-wall+precursor+analogs&doi=10.1016%2Fj.jmb.2008.10.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of the Complexes between Vancomycin and Cell-Wall Precursor Analogs</span></div><div class="casAuthors">Nitanai, Yasushi; Kikuchi, Takanori; Kakoi, Kouji; Hanamaki, Shinji; Fujisawa, Ikuhide; Aoki, Katsuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1422-1432</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The crystal structures of three vancomycin complexes with two vancomycin-sensitive cell-wall precursor analogs (diacetyl-Lys-D-Ala-D-Ala and acetyl-D-Ala-D-Ala) and a vancomycin-resistant cell-wall precursor analog (diacetyl-Lys-D-Ala-D-lactate) were detd. at at. resolns. of 1.80 Ã, 1.07 Ã, and 0.93 Ã, resp.  These structures not only reconfirm the "back-to-back" dimerization of vancomycin monomers and the ligand-binding scheme proposed by previous expts. but also show important structural features of strategies for the generation of new glycopeptide antibiotics.  These structural features involve a water-mediated antibiotic-ligand interaction and supramol. structures such as "side-by-side" arranged dimer-to-dimer structures, in addn. to ligand-mediated and "face-to-face" arranged dimer-to-dimer structures.  In the diacetyl-Lys-D-Ala-D-lactate complex, the interat. OÂ·Â·Â·O distance between the carbonyl oxygen of the fourth residue of the antibiotic backbone and the ester oxygen of the D-lactate moiety of the ligand is clearly longer than the corresponding N-HÂ·Â·Â·O hydrogen-bonding distance obsd. in the two other complexes due to electrostatic repulsion.  In addn., two neighboring hydrogen bonds are concomitantly lengthened.  These observations provide, at least in part, a mol. basis for the reduced antibacterial activity of vancomycin toward vancomycin-resistant bacteria with cell-wall precursors terminating in -D-Ala-D-lactate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFyNh5WabH1rVg90H21EOLACvtfcHk0lhOOLyqq8AJcA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSmsL8%253D&md5=bb8666ff0899c33055430364c559905a</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DNitanai%26aufirst%3DY.%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DKakoi%26aufirst%3DK.%26aulast%3DHanamaki%26aufirst%3DS.%26aulast%3DFujisawa%26aufirst%3DI.%26aulast%3DAoki%26aufirst%3DK.%26atitle%3DCrystal%2520structures%2520of%2520the%2520complexes%2520between%2520vancomycin%2520and%2520cell-wall%2520precursor%2520analogs%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D385%26spage%3D1422%26epage%3D1432%26doi%3D10.1016%2Fj.jmb.2008.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konai, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Tackling vancomycin-resistant bacteria with âlipophilic-vancomycin-carbohydrate conjugatesâ</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">302</span>â <span class="NLM_lpage">312</span>, <span class="refDoi">Â DOI: 10.1038/ja.2014.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fja.2014.144" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2015&pages=302-312&author=V.+Yarlagaddaauthor=M.+M.+Konaiauthor=G.+B.+Manjunathauthor=C.+Ghoshauthor=J.+Haldar&title=Tackling+vancomycin-resistant+bacteria+with+%E2%80%99lipophilic-vancomycin-carbohydrate+conjugates%E2%80%99&doi=10.1038%2Fja.2014.144"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fja.2014.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2014.144%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DKonai%26aufirst%3DM.%2BM.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DGhosh%26aufirst%3DC.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DTackling%2520vancomycin-resistant%2520bacteria%2520with%2520%25E2%2580%2599lipophilic-vancomycin-carbohydrate%2520conjugates%25E2%2580%2599%26jtitle%3DJ.%2520Antibiot.%26date%3D2015%26volume%3D68%26spage%3D302%26epage%3D312%26doi%3D10.1038%2Fja.2014.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sundram, U. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicas, T. I.</span></span> <span> </span><span class="NLM_article-title">Novel vancomycin dimers with activity against vancomycin-resistant enterococci</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">13107</span>â <span class="NLM_lpage">13108</span>, <span class="refDoi">Â DOI: 10.1021/ja9621298</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9621298" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=13107-13108&author=U.+N.+Sundramauthor=J.+H.+Griffinauthor=T.+I.+Nicas&title=Novel+vancomycin+dimers+with+activity+against+vancomycin-resistant+enterococci&doi=10.1021%2Fja9621298"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fja9621298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9621298%26sid%3Dliteratum%253Aachs%26aulast%3DSundram%26aufirst%3DU.%2BN.%26aulast%3DGriffin%26aufirst%3DJ.%2BH.%26aulast%3DNicas%26aufirst%3DT.%2BI.%26atitle%3DNovel%2520vancomycin%2520dimers%2520with%2520activity%2520against%2520vancomycin-resistant%2520enterococci%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D13107%26epage%3D13108%26doi%3D10.1021%2Fja9621298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahiri, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitesides, G. M.</span></span> <span> </span><span class="NLM_article-title">A trivalent system from vancomycin D-Ala-D-Ala with higher affinity than avidin.biotin</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">708</span>â <span class="NLM_lpage">711</span>, <span class="refDoi">Â DOI: 10.1126/science.280.5364.708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1126%2Fscience.280.5364.708" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=9563940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVOksL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1998&pages=708-711&author=J.+Raoauthor=J.+Lahiriauthor=L.+Isaacsauthor=R.+M.+Weisauthor=G.+M.+Whitesides&title=A+trivalent+system+from+vancomycin+D-Ala-D-Ala+with+higher+affinity+than+avidin.biotin&doi=10.1126%2Fscience.280.5364.708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A trivalent system from vancomycinÂ·D-Ala-D-Ala with higher affinity than avidinÂ·biotin</span></div><div class="casAuthors">Rao, Jianghong; Lahiri, Joydeep; Isaacs, Lyle; Weis, Robert M.; Whitesides, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">5364</span>),
    <span class="NLM_cas:pages">708-711</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Tris(vancomycin carboxamide) binds a trivalent ligand derived from D-Ala-D-Ala with very high affinity: dissocn. const. (Kd) â 4 Ã 10-17 Â± 1 Ã 10-17 M.  High-affinity trivalent binding and monovalent binding are fundamentally different.  For example, in trivalent (and more generally, polyvalent) binding, dissocn. occurs in stages, and its rate can be accelerated by monovalent ligand at sufficiently high concns.  In monovalent binding, dissocn. is detd. solely by the rate const. for dissocn. and cannot be accelerated by added monomer.  Calorimetric measurements for the trivalent system indicate an approx. additive gain in enthalpy relative to the corresponding monomers.  This system is one of the most stable org. receptor-ligand pairs involving small mols. that is known.  It illustrates the practicality of designing very high-affinity systems based on polyvalency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSggeK1okPHrVg90H21EOLACvtfcHk0lgz561eWvEc4Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVOksL8%253D&md5=29e1ff57508b981053669f5732d3d221</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1126%2Fscience.280.5364.708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.280.5364.708%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DJ.%26aulast%3DLahiri%26aufirst%3DJ.%26aulast%3DIsaacs%26aufirst%3DL.%26aulast%3DWeis%26aufirst%3DR.%2BM.%26aulast%3DWhitesides%26aufirst%3DG.%2BM.%26atitle%3DA%2520trivalent%2520system%2520from%2520vancomycin%2520D-Ala-D-Ala%2520with%2520higher%2520affinity%2520than%2520avidin.biotin%26jtitle%3DScience%26date%3D1998%26volume%3D280%26spage%3D708%26epage%3D711%26doi%3D10.1126%2Fscience.280.5364.708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayakawa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinumi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uemura, D.</span></span> <span> </span><span class="NLM_article-title">Multi-valent polymer of vancomycin: enhanced antibacterial activity against VRE</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_fpage">1361</span>â <span class="NLM_lpage">1362</span>, <span class="refDoi">Â DOI: 10.1039/a903529j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1039%2Fa903529j" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=1361-1362&author=H.+Arimotoauthor=K.+Nishimuraauthor=I.+Hayakawaauthor=T.+Kinumiauthor=D.+Uemura&title=Multi-valent+polymer+of+vancomycin%3A+enhanced+antibacterial+activity+against+VRE&doi=10.1039%2Fa903529j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1039%2Fa903529j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa903529j%26sid%3Dliteratum%253Aachs%26aulast%3DArimoto%26aufirst%3DH.%26aulast%3DNishimura%26aufirst%3DK.%26aulast%3DHayakawa%26aufirst%3DI.%26aulast%3DKinumi%26aufirst%3DT.%26aulast%3DUemura%26aufirst%3DD.%26atitle%3DMulti-valent%2520polymer%2520of%2520vancomycin%253A%2520enhanced%2520antibacterial%2520activity%2520against%2520VRE%26jtitle%3DChem.%2520Commun.%26date%3D1999%26spage%3D1361%26epage%3D1362%26doi%3D10.1039%2Fa903529j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicolaou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winssinger, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smethurst, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labischinski, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endermann, R.</span></span> <span> </span><span class="NLM_article-title">Target-accelerated combinatorial synthesis and discovery of highly potent antibiotics effective against vancomycin-resistant bacteria</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">3823</span>â <span class="NLM_lpage">3828</span>, <span class="refDoi">Â DOI: 10.1002/1521-3773(20001103)39:21<3823::AID-ANIE3823>3.0.CO;2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1002%2F1521-3773%2820001103%2939%3A21%3C3823%3A%3AAID-ANIE3823%3E3.0.CO%3B2-3" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=3823-3828&author=K.+Nicolaouauthor=R.+Hughesauthor=S.+Y.+Choauthor=N.+Winssingerauthor=C.+Smethurstauthor=H.+Labischinskiauthor=R.+Endermann&title=Target-accelerated+combinatorial+synthesis+and+discovery+of+highly+potent+antibiotics+effective+against+vancomycin-resistant+bacteria&doi=10.1002%2F1521-3773%2820001103%2939%3A21%3C3823%3A%3AAID-ANIE3823%3E3.0.CO%3B2-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820001103%2939%3A21%3C3823%3A%3AAID-ANIE3823%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820001103%252939%253A21%253C3823%253A%253AAID-ANIE3823%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DK.%26aulast%3DHughes%26aufirst%3DR.%26aulast%3DCho%26aufirst%3DS.%2BY.%26aulast%3DWinssinger%26aufirst%3DN.%26aulast%3DSmethurst%26aufirst%3DC.%26aulast%3DLabischinski%26aufirst%3DH.%26aulast%3DEndermann%26aufirst%3DR.%26atitle%3DTarget-accelerated%2520combinatorial%2520synthesis%2520and%2520discovery%2520of%2520highly%2520potent%2520antibiotics%2520effective%2520against%2520vancomycin-resistant%2520bacteria%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2000%26volume%3D39%26spage%3D3823%26epage%3D3828%26doi%3D10.1002%2F1521-3773%2820001103%2939%3A21%3C3823%3A%3AAID-ANIE3823%3E3.0.CO%3B2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mammen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitesides, G. M.</span></span> <span> </span><span class="NLM_article-title">Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">2754</span>â <span class="NLM_lpage">2794</span>, <span class="refDoi">Â DOI: 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1002%2F%28SICI%291521-3773%2819981102%2937%3A20%3C2754%3A%3AAID-ANIE2754%3E3.0.CO%3B2-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BC1Mjot1KmtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=2754-2794&author=M.+Mammenauthor=S.-K.+Choiauthor=G.+M.+Whitesides&title=Polyvalent+interactions+in+biological+systems%3A+implications+for+design+and+use+of+multivalent+ligands+and+inhibitors&doi=10.1002%2F%28SICI%291521-3773%2819981102%2937%3A20%3C2754%3A%3AAID-ANIE2754%3E3.0.CO%3B2-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors</span></div><div class="casAuthors">Mammen Mathai; Choi Seok-Ki; Whitesides George M</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2754-2794</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Found throughout biology, polyvalent interactions are characterized by the simultaneous binding of multiple ligands on one biological entity to multiple receptors on another (top part of the illustration) and have a number of characteristics that monovalent interactions do not (bottom).  In particular, polyvalent interactions can be collectively much stronger than corresponding monovalent interactions, and they can provide the basis for mechanisms of both agonizing and antagonizing biological interactions that are fundamentally different from those available in monovalent systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrUE9xYfhSJT0O18WR3iAofW6udTcc2eajwXl18Rzx1Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mjot1KmtA%253D%253D&md5=361c0469fe15045296ee208336a0d4ab</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819981102%2937%3A20%3C2754%3A%3AAID-ANIE2754%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819981102%252937%253A20%253C2754%253A%253AAID-ANIE2754%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DMammen%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DS.-K.%26aulast%3DWhitesides%26aufirst%3DG.%2BM.%26atitle%3DPolyvalent%2520interactions%2520in%2520biological%2520systems%253A%2520implications%2520for%2520design%2520and%2520use%2520of%2520multivalent%2520ligands%2520and%2520inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1998%26volume%3D37%26spage%3D2754%26epage%3D2794%26doi%3D10.1002%2F%28SICI%291521-3773%2819981102%2937%3A20%3C2754%3A%3AAID-ANIE2754%3E3.0.CO%3B2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mammen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakhnovich, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitesides, G. M.</span></span> <span> </span><span class="NLM_article-title">Using a convenient, quantitative model for torsional entropy to establish qualitative trends for molecular processes that restrict conformational freedom</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">3168</span>â <span class="NLM_lpage">3175</span>, <span class="refDoi">Â DOI: 10.1021/jo970943n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo970943n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK1cXislGnurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=3168-3175&author=M.+Mammenauthor=E.+I.+Shakhnovichauthor=G.+M.+Whitesides&title=Using+a+convenient%2C+quantitative+model+for+torsional+entropy+to+establish+qualitative+trends+for+molecular+processes+that+restrict+conformational+freedom&doi=10.1021%2Fjo970943n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Using a Convenient, Quantitative Model for Torsional Entropy To Establish Qualitative Trends for Molecular Processes That Restrict Conformational Freedom</span></div><div class="casAuthors">Mammen, Mathai; Shakhnovich, Eugene I.; Whitesides, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3168-3175</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A non-quantum-mech., readily applied model is described that ests. torsional entropy (Stor, the entropy assocd. with torsional motions about a single bond) quant.  Using this model, torsional entropies are evaluated for a variety of mol. arrangements.  Qual. trends emerge from these ests. that are consistent with chem. intuition.  The entropy assocd. with torsional motion is not const.: values of Stor range from 0 to 15 J mol-1 K-1 and are sensitive to details of the bond around which the torsion occurs.  Important characteristics include the bond length, the hybridization, the symmetry, the sizes of these atoms or groups of atoms, and the extent of conjugation to adjacent bonds.  These values are relatively independent of one another in a no. of important cases, and therefore the total change in conformational entropy for a given process may be estd. by adding changes in entropy due to restricting torsions around individual bonds.  A model that permits quant. estns. of changes in conformational entropy will be useful in a wide range of chem. and biochem. applications that include the design of tight-binding polyvalent pharmaceuticals and stable multiparticle mol. assemblies, as well as in the kinetic and thermodn. anal. of almost any chem. reaction that involves the restriction of the torsions of rotors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9qaZcu6bcFrVg90H21EOLACvtfcHk0lg1dOG2dmBAPw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXislGnurs%253D&md5=0d4c24b7c421e39845d8102e0dd3728c</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjo970943n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo970943n%26sid%3Dliteratum%253Aachs%26aulast%3DMammen%26aufirst%3DM.%26aulast%3DShakhnovich%26aufirst%3DE.%2BI.%26aulast%3DWhitesides%26aufirst%3DG.%2BM.%26atitle%3DUsing%2520a%2520convenient%252C%2520quantitative%2520model%2520for%2520torsional%2520entropy%2520to%2520establish%2520qualitative%2520trends%2520for%2520molecular%2520processes%2520that%2520restrict%2520conformational%2520freedom%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D3168%26epage%3D3175%26doi%3D10.1021%2Fjo970943n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Searle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. H.</span></span> <span> </span><span class="NLM_article-title">The cost of conformational order: entropy changes in molecular associations</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">10690</span>â <span class="NLM_lpage">10697</span>, <span class="refDoi">Â DOI: 10.1021/ja00053a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00053a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVSn" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1992&pages=10690-10697&author=M.+S.+Searleauthor=D.+H.+Williams&title=The+cost+of+conformational+order%3A+entropy+changes+in+molecular+associations&doi=10.1021%2Fja00053a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The cost of conformational order:  entropy changes in molecular associations</span></div><div class="casAuthors">Searle, Mark S.; Williams, Dudley H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">10690-7</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Mols. in soln. have degrees of freedom of overall translation and rotation, as well as internal rotations about single bonds, that become highly constrained when two mols. assoc. to forma stable complex.  The thermodn. of fusion and sublimation of hydrocarbons and polar org. mols. were studied as instructive models for features of complex dissocn.  The entropy of fusion within homologous series of alkanes, alkyl carboxylic acids, and 2-Me ketones provides an est. of the entropic cost of restricting a rotor, within a hydrocarbon chain, as -1.6 to -3.6 kJ mol-1 (TÎS at 300 K) upon crystn.  Data on the fusion and sublimation of a range of org. substances (RMM 100-300 g mol-1) that are essentially free of internal rotors illustrate the compensatory relationship between enthalpy and entropy of phase transitions that bear on the cost of restraining a freely translating and rotating mol. in forming a crystal (cf. mol. recognition complex).  A comparison of calcd. gas phase translational and rotational entropies with entropies of sublimation reveals that the latter can account for only 40-70% of the gas phase entropies.  The difference, attributed mainly to the entropy of residual motions in the crystal, gives an insight into the favorable entropy of residual motions in mol. recognition complexes.  When entropies of sublimation are cor. by Trouton's rule for condensation to a liq., it is concluded that some bimol. assocns. that form complexes with little exothermicity may have relatively small adverse entropies, which may lie anywhere in the range -9 to -45 kJ mol-1 (in terms of TÎS at 300 K), opposing binding by a factor of 10-1.6 to 10-8 M-1.  These enthalpy/entropy compensations are of general relevance to binding interactions of biol. importance and are discussed with respect to the binding of agonists vs. antagonists to a common receptor site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo94T7aTW6eSLVg90H21EOLACvtfcHk0lg1dOG2dmBAPw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVSn&md5=205ee6aa9d7ac09864daad99c55fdc1c</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fja00053a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00053a002%26sid%3Dliteratum%253Aachs%26aulast%3DSearle%26aufirst%3DM.%2BS.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26atitle%3DThe%2520cost%2520of%2520conformational%2520order%253A%2520entropy%2520changes%2520in%2520molecular%2520associations%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1992%26volume%3D114%26spage%3D10690%26epage%3D10697%26doi%3D10.1021%2Fja00053a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span> <span> </span><span class="NLM_article-title">Multivalent antibiotics via metal complexes: potent divalent vancomycins against vancomycin-resistant enterococci</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4904</span>â <span class="NLM_lpage">4909</span>, <span class="refDoi">Â DOI: 10.1021/jm030417q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030417q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvFOisbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4904-4909&author=B.+Xingauthor=C.+W.+Yuauthor=P.+L.+Hoauthor=K.+H.+Chowauthor=T.+Cheungauthor=H.+Guauthor=Z.+Caiauthor=B.+Xu&title=Multivalent+antibiotics+via+metal+complexes%3A+potent+divalent+vancomycins+against+vancomycin-resistant+enterococci&doi=10.1021%2Fjm030417q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Multivalent Antibiotics via Metal Complexes: Potent Divalent Vancomycins against Vancomycin-Resistant Enterococci</span></div><div class="casAuthors">Xing, Bengang; Yu, Chun-Wing; Ho, Pak-Leung; Chow, Kin-Hung; Cheung, Terence; Gu, Hongwei; Cai, Zongwei; Xu, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4904-4909</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dimers of vancomycin (Van), linked by a rigid metal complex, [Pt(en)(H2O)2]2+, exhibit potent activities (MIC â¼0.8 Î¼g/mL, â¼720 times more potent than that of Van itself) against vancomycin-resistant enterococci (VRE).  The result suggests that combining metal complexation and receptor/ligand interaction offers a useful method to construct multivalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaLz3HgtmGe7Vg90H21EOLACvtfcHk0lg1dOG2dmBAPw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvFOisbw%253D&md5=ef2a110415f0c508f138d25f5d47fba8</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm030417q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030417q%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DC.%2BW.%26aulast%3DHo%26aufirst%3DP.%2BL.%26aulast%3DChow%26aufirst%3DK.%2BH.%26aulast%3DCheung%26aufirst%3DT.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DB.%26atitle%3DMultivalent%2520antibiotics%2520via%2520metal%2520complexes%253A%2520potent%2520divalent%2520vancomycins%2520against%2520vancomycin-resistant%2520enterococci%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4904%26epage%3D4909%26doi%3D10.1021%2Fjm030417q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Lipophilic vancomycin aglycon dimer with high activity against vancomycin-resistant bacteria</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5477</span>â <span class="NLM_lpage">5480</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2015.10.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.bmcl.2015.10.083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=26525861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslOgu7zN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=5477-5480&author=V.+Yarlagaddaauthor=P.+Sarkarauthor=G.+B.+Manjunathauthor=J.+Haldar&title=Lipophilic+vancomycin+aglycon+dimer+with+high+activity+against+vancomycin-resistant+bacteria&doi=10.1016%2Fj.bmcl.2015.10.083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic vancomycin aglycon dimer with high activity against vancomycin-resistant bacteria</span></div><div class="casAuthors">Yarlagadda, Venkateswarlu; Sarkar, Paramita; Manjunath, Goutham B.; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5477-5480</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Antibiotic-resistant superbugs such as vancomycin-resistant Enterococci (VRE) and Staphylococci have become a major global health hazard.  To address this issue, we synthesized vancomycin aglycon dimers to systematically probe the impact of a linker on biol. activity.  A dimer having a pendant lipophilic moiety in the linker showed â¼300-fold more activity than vancomycin against VRE.  The high activity of the compd. is attributed to its enhanced binding affinity to target peptides which resulted in improved peptidoglycan (cell wall) biosynthesis inhibition.  Therefore, our studies suggest that these compds., prepd. by using facile synthetic methodol., can be used to combat vancomycin-resistant bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRQM5hJqcjV7Vg90H21EOLACvtfcHk0lgfSxSypYS-QA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslOgu7zN&md5=80900ffeee2d81de7a17902091ccdee0</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.10.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.10.083%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DSarkar%26aufirst%3DP.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DLipophilic%2520vancomycin%2520aglycon%2520dimer%2520with%2520high%2520activity%2520against%2520vancomycin-resistant%2520bacteria%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D5477%26epage%3D5480%26doi%3D10.1016%2Fj.bmcl.2015.10.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moses, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpless, K. B.</span></span> <span> </span><span class="NLM_article-title">Reengineering antibiotics to combat bacterial resistance: click chemistry [1,2,3]-triazole vancomycin dimers with potent activity against MRSA and VRE</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">79</span>â <span class="NLM_lpage">83</span>, <span class="refDoi">Â DOI: 10.1002/chem.201604765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1002%2Fchem.201604765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=27747932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVGjtbvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=79-83&author=S.+M.+Silvermanauthor=J.+E.+Mosesauthor=K.+B.+Sharpless&title=Reengineering+antibiotics+to+combat+bacterial+resistance%3A+click+chemistry+%5B1%2C2%2C3%5D-triazole+vancomycin+dimers+with+potent+activity+against+MRSA+and+VRE&doi=10.1002%2Fchem.201604765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Reengineering Antibiotics to Combat Bacterial Resistance: Click Chemistry [1,2,3]-Triazole Vancomycin Dimers with Potent Activity against MRSA and VRE</span></div><div class="casAuthors">Silverman, Steven M.; Moses, John E.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-83</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Vancomycin has long been considered a drug of last resort.  Its efficiency in treating multiple drug-resistant bacterial infections, particularly methicillin-resistant Staphylococcus aureus (MRSA), has had a profound effect on the treatment of life-threatening infections.  However, the emergence of resistance to vancomycin is a cause for significant worldwide concern, prompting the urgent development of new effective treatments for antibiotic resistant bacterial infections.  Harnessing the benefits of multivalency and cooperativity against vancomycin-resistant strains, we report a Click Chem. approach towards reengineered vancomycin derivs. and the synthesis of a no. of dimers with increased potency against MRSA and vancomycin resistant Enterococci (VRE; VanB).  These semi-synthetic dimeric ligands were linked together with great efficiency using the powerful CuAAC reaction, demonstrating high levels of selectivity and purity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmQ1uG1ifJYbVg90H21EOLACvtfcHk0lgfSxSypYS-QA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVGjtbvP&md5=614570f145edfc6e6579a44706b32f7c</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2Fchem.201604765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201604765%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DS.%2BM.%26aulast%3DMoses%26aufirst%3DJ.%2BE.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DReengineering%2520antibiotics%2520to%2520combat%2520bacterial%2520resistance%253A%2520click%2520chemistry%2520%255B1%252C2%252C3%255D-triazole%2520vancomycin%2520dimers%2520with%2520potent%2520activity%2520against%2520MRSA%2520and%2520VRE%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D79%26epage%3D83%26doi%3D10.1002%2Fchem.201604765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crane, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirado-Rives, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of selected key methyl ether derivatives of vancomycin aglycon</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7229</span>â <span class="NLM_lpage">7235</span>, <span class="refDoi">Â DOI: 10.1021/jm100946e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100946e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7229-7235&author=C.+M.+Craneauthor=J.+G.+Pierceauthor=S.+S.+Leungauthor=J.+Tirado-Rivesauthor=W.+L.+Jorgensenauthor=D.+L.+Boger&title=Synthesis+and+evaluation+of+selected+key+methyl+ether+derivatives+of+vancomycin+aglycon&doi=10.1021%2Fjm100946e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm100946e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100946e%26sid%3Dliteratum%253Aachs%26aulast%3DCrane%26aufirst%3DC.%2BM.%26aulast%3DPierce%26aufirst%3DJ.%2BG.%26aulast%3DLeung%26aufirst%3DS.%2BS.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520selected%2520key%2520methyl%2520ether%2520derivatives%2520of%2520vancomycin%2520aglycon%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7229%26epage%3D7235%26doi%3D10.1021%2Fjm100946e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimoto, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel series of semisynthetic vancomycin derivatives effective against vancomycin-resistant bacteria</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2528</span>â <span class="NLM_lpage">2533</span>, <span class="refDoi">Â DOI: 10.1021/jm9017543</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9017543" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlKiur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2528-2533&author=Y.+Nakamaauthor=O.+Yoshidaauthor=M.+Yodaauthor=K.+Arakiauthor=Y.+Sawadaauthor=J.+Nakamuraauthor=S.+Xuauthor=K.+Miuraauthor=H.+Makiauthor=H.+Arimoto&title=Discovery+of+a+novel+series+of+semisynthetic+vancomycin+derivatives+effective+against+vancomycin-resistant+bacteria&doi=10.1021%2Fjm9017543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Series of Semisynthetic Vancomycin Derivatives Effective against Vancomycin-Resistant Bacteria</span></div><div class="casAuthors">Nakama, Yuki; Yoshida, Osamu; Yoda, Masanori; Araki, Keisuke; Sawada, Yuri; Nakamura, Jun; Xu, Shu; Miura, Kenji; Maki, Hideki; Arimoto, Hirokazu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2528-2533</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel semisynthetic vancomycin derivs. with antibacterial activity against vancomycin-resistant S. aureus (VRSA) were prepd.  Replacement of Cl groups of vancomycin by Suzuki-Miyaura cross-coupling reaction, which gave the title compds., is described for the first time.  Introduction of a carbon substituent at the amino acid residue 2 of vancomycin led to an enhancement of antibacterial activity against vancomycin-resistant strains, whereas the addnl. introduction at the amino acid residue 6 resulted in a redn. in activity even against vancomycin-susceptible strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8GEa3LG1jCrVg90H21EOLACvtfcHk0lhJ8cMEsbsa3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlKiur8%253D&md5=16ce81f3ae391da4c36b145e15c4a452</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm9017543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9017543%26sid%3Dliteratum%253Aachs%26aulast%3DNakama%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DO.%26aulast%3DYoda%26aufirst%3DM.%26aulast%3DAraki%26aufirst%3DK.%26aulast%3DSawada%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DMiura%26aufirst%3DK.%26aulast%3DMaki%26aufirst%3DH.%26aulast%3DArimoto%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520semisynthetic%2520vancomycin%2520derivatives%2520effective%2520against%2520vancomycin-resistant%2520bacteria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2528%26epage%3D2533%26doi%3D10.1021%2Fjm9017543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoganathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. J.</span></span> <span> </span><span class="NLM_article-title">Structure diversification of vancomycin through peptide-catalyzed, site-selective lipidation: a catalysis-based approach to combat glycopeptide-resistant pathogens</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2367</span>â <span class="NLM_lpage">2377</span>, <span class="refDoi">Â DOI: 10.1021/jm501872s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501872s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisF2ht7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2367-2377&author=S.+Yoganathanauthor=S.+J.+Miller&title=Structure+diversification+of+vancomycin+through+peptide-catalyzed%2C+site-selective+lipidation%3A+a+catalysis-based+approach+to+combat+glycopeptide-resistant+pathogens&doi=10.1021%2Fjm501872s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Diversification of Vancomycin through Peptide-Catalyzed, Site-Selective Lipidation: A Catalysis-Based Approach To Combat Glycopeptide-Resistant Pathogens</span></div><div class="casAuthors">Yoganathan, Sabesan; Miller, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2367-2377</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The emergence of antibiotic-resistant infections highlights the need for novel antibiotic leads, perhaps with a broader spectrum of activity.  Herein, the authors disclose a semisynthetic, catalytic approach for structure diversification of vancomycin.  The authors have identified three unique peptide catalysts that exhibit site-selectivity for the lipidation of the aliph. hydroxyls on vancomycin, generating three new derivs.  Incorporation of lipid chains into the vancomycin scaffold provides promising improvement of its bioactivity against vancomycin-resistant enterococci (Van A and Van B phenotypes of VRE).  The MICs for the new derivs. against MRSA and VRE (Van B phenotype) range from 0.12 to 0.25 Î¼g/mL.  The authors have also performed a structure-activity relationship (SAR) study to investigate the effect of lipid chain length at the newly accessible G4-OH derivatization site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBqmVrTjYNT7Vg90H21EOLACvtfcHk0lhJ8cMEsbsa3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisF2ht7Y%253D&md5=9aafed77399f231be3dbd0d9d878eafb</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm501872s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501872s%26sid%3Dliteratum%253Aachs%26aulast%3DYoganathan%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DS.%2BJ.%26atitle%3DStructure%2520diversification%2520of%2520vancomycin%2520through%2520peptide-catalyzed%252C%2520site-selective%2520lipidation%253A%2520a%2520catalysis-based%2520approach%2520to%2520combat%2520glycopeptide-resistant%2520pathogens%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2367%26epage%3D2377%26doi%3D10.1021%2Fjm501872s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faridoon</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span> <span> </span><span class="NLM_article-title">Extra sugar on vancomycin: new analogues for combating multidrug-resistant <i>Staphylococcus aureus</i> and vancomycin-resistant enterococci</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">286</span>â <span class="NLM_lpage">304</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b01345</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01345" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2gsLbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=286-304&author=D.+Guanauthor=F.+Chenauthor=L.+Xiongauthor=F.+Tangauthor=+Faridoonauthor=Y.+Qiuauthor=N.+Zhangauthor=L.+Gongauthor=J.+Liauthor=L.+Lanauthor=W.+Huang&title=Extra+sugar+on+vancomycin%3A+new+analogues+for+combating+multidrug-resistant+Staphylococcus+aureus+and+vancomycin-resistant+enterococci&doi=10.1021%2Facs.jmedchem.7b01345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci</span></div><div class="casAuthors">Guan, Dongliang; Chen, Feifei; Xiong, Lun; Tang, Feng; Faridoon; Qiu, Yunguang; Zhang, Naixia; Gong, Likun; Li, Jian; Lan, Lefu; Huang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">286-304</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipophilic substitution on vancomycin is an effective strategy for the development of novel vancomycin analogs against drug-resistant bacteria by enhancing bacterial cell wall interactions.  However, hydrophobic structures usually lead to long elimination half-life and accumulative toxicity; therefore, hydrophilic fragments were also introduced to the lipo-vancomycin to regulate their pharmacokinetic/pharmacodynamic properties.  Here, we synthesized a series of new vancomycin analogs carrying various sugar moieties on the seventh-amino acid Ph ring and lipophilic substitutions on vancosamine with extensive structure-activity relationship anal.  The optimal analogs indicated 128-1024-fold higher activity against methicillin-susceptible S. aureus, vancomycin-intermediate resistant S. aureus (VISA), and vancomycin-resistant Enterococci (VRE) compared with that of vancomycin.  In vivo pharmacokinetics studies demonstrated the effective regulation of extra sugar motifs, which shortened the half-life and addressed concerns of accumulative toxicity of lipo-vancomycin.  This work presents an effective strategy for lipo-vancomycin deriv. design by introducing extra sugars, which leads to better antibiotic-like properties of enhanced efficacy, optimal pharmacokinetics, and lower toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0OFw0tAYTLbVg90H21EOLACvtfcHk0lhJ8cMEsbsa3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2gsLbJ&md5=230da2640080a83c0838002ace3435c0</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01345%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DXiong%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DFaridoon%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DGong%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DW.%26atitle%3DExtra%2520sugar%2520on%2520vancomycin%253A%2520new%2520analogues%2520for%2520combating%2520multidrug-resistant%2520Staphylococcus%2520aureus%2520and%2520vancomycin-resistant%2520enterococci%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D286%26epage%3D304%26doi%3D10.1021%2Facs.jmedchem.7b01345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malabarba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicas, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R. C.</span></span> <span> </span><span class="NLM_article-title">Structural modifications of glycopeptide antibiotics</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">69</span>â <span class="NLM_lpage">137</span>, <span class="refDoi">Â DOI: 10.1002/(SICI)1098-1128(199701)17:1<69::AID-MED3>3.0.CO;2-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=8979249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADyaK2sXkslSmsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=69-137&author=A.+Malabarbaauthor=T.+I.+Nicasauthor=R.+C.+Thompson&title=Structural+modifications+of+glycopeptide+antibiotics&doi=10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Structural modifications of glycopeptide antibiotics</span></div><div class="casAuthors">Malabarba, Adriano; Nicas, Thalia I.; Thompson, Richard C.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-137</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">A review with 90 refs.  Topics include modulation of activity by alteration of sugars, modification of functional groups, and alterations of the binding pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpjavadS6X7bVg90H21EOLACvtfcHk0lhJ8cMEsbsa3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslSmsg%253D%253D&md5=cf3781956a1f9dbae4969b848665cf90</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199701%252917%253A1%253C69%253A%253AAID-MED3%253E3.0.CO%253B2-R%26sid%3Dliteratum%253Aachs%26aulast%3DMalabarba%26aufirst%3DA.%26aulast%3DNicas%26aufirst%3DT.%2BI.%26aulast%3DThompson%26aufirst%3DR.%2BC.%26atitle%3DStructural%2520modifications%2520of%2520glycopeptide%2520antibiotics%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1997%26volume%3D17%26spage%3D69%26epage%3D137%26doi%3D10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C69%3A%3AAID-MED3%3E3.0.CO%3B2-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Membrane active vancomycin analogues: a strategy to combat bacterial resistance</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4558</span>â <span class="NLM_lpage">4568</span>, <span class="refDoi">Â DOI: 10.1021/jm500270w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500270w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntlKgtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4558-4568&author=V.+Yarlagaddaauthor=P.+Akkapeddiauthor=G.+B.+Manjunathauthor=J.+Haldar&title=Membrane+active+vancomycin+analogues%3A+a+strategy+to+combat+bacterial+resistance&doi=10.1021%2Fjm500270w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane active vancomycin analogs: a strategy to combat bacterial resistance</span></div><div class="casAuthors">Yarlagadda, Venkateswarlu; Akkapeddi, Padma; Manjunath, Goutham B.; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4558-4568</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The alarming growth of antibiotic-resistant superbugs such as vancomycin-resistant enterococci and staphylococci has become a major global health hazard.  To address this issue, the authors report the development of lipophilic cationic vancomycin analogs possessing excellent antibacterial activity against several drug-resistant strains.  Compared to vancomycin, efficacy greater than 1000-fold was demonstrated against vancomycin-resistant Enterococci (VRE).  Significantly, unlike vancomycin, these compds. were shown to be bactericidal at low concns. and did not induce bacterial resistance.  An optimized compd. in the series, compared to vancomycin, showed higher activity in methicillin-resistant Staphylococcus aureus (MRSA) infected mouse model and exhibited superior antibacterial activity in whole blood with no obsd. toxicity.  The remarkable activity of these compds. is attributed to the incorporation of a new membrane disruption mechanism into vancomycin and opens up a great opportunity for the development of novel antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6JcPQP0Jqj7Vg90H21EOLACvtfcHk0ljIdWzfL-Q-_w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntlKgtrk%253D&md5=30e565c1d5f25b1e8d69b83ea5cab397</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm500270w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500270w%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DAkkapeddi%26aufirst%3DP.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DMembrane%2520active%2520vancomycin%2520analogues%253A%2520a%2520strategy%2520to%2520combat%2520bacterial%2520resistance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4558%26epage%3D4568%26doi%3D10.1021%2Fjm500270w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konai, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paramanandham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranjan, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravikumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">In vivo antibacterial activity and pharmacological properties of the membrane-active glycopeptide antibiotic YV11455</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">627</span>â <span class="NLM_lpage">634</span>, <span class="refDoi">Â DOI: 10.1016/j.ijantimicag.2015.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.ijantimicag.2015.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=25900818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1Gktbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2015&pages=627-634&author=V.+Yarlagaddaauthor=M.+M.+Konaiauthor=G.+B.+Manjunathauthor=R.+G.+Prakashauthor=B.+Maniauthor=K.+Paramanandhamauthor=S.+B.+Ranjanauthor=R.+Ravikumarauthor=S.+P.+Chakrabortyauthor=S.+Royauthor=J.+Haldar&title=In+vivo+antibacterial+activity+and+pharmacological+properties+of+the+membrane-active+glycopeptide+antibiotic+YV11455&doi=10.1016%2Fj.ijantimicag.2015.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo antibacterial activity and pharmacological properties of the membrane-active glycopeptide antibiotic YV11455</span></div><div class="casAuthors">Yarlagadda, Venkateswarlu; Konai, Mohini M.; Manjunath, Goutham B.; Prakash, Relekar G.; Mani, Bhuvana; Paramanandham, Krishnamoorthy; Ranjan, Shome B.; Ravikumar, Raju; Chakraborty, Subhankari P.; Roy, Somenath; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">627-634</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The membrane-active glycopeptide antibiotic YV11455 is a lipophilic cationic vancomycin analog that demonstrates rapid and concn.-dependent killing of clin. relevant multidrug-resistant (MDR) Gram-pos. bacteria in vitro.  YV11455 was 2-fold and 54-270-fold more effective than vancomycin against clin. isolates of vancomycin-sensitive and vancomycin-resistant bacteria, resp.  In this study, the in vivo efficacy, pharmacodynamics, pharmacokinetics and acute toxicol. of YV11455 were investigated.  In vivo activity and pharmacodynamics were detd. in the neutropenic mouse thigh infection model against meticillin-resistant Staphylococcus aureus (MRSA).  YV11455 produced dose-dependent redns. in MRSA titers in thigh muscle.  When administered i.v., the 50% ED (ED50) for YV11455 against MRSA was found to be 3.3 mg/kg body wt., and titers were reduced by up to ca. 3 log10 CFU/g from pre-treatment values at a dosage of 12 mg/kg with single treatment.  Single-dose pharmacokinetic studies demonstrated linear kinetics and a prolonged half-life, with an increase in drug exposure (area under the concn.-time curve) compared with vancomycin.  The peak plasma concn. following an i.v. dose of 12 mg/kg was 543.5 Î¼g/mL.  Acute toxicol. studies revealed that YV11455 did not cause any significant alterations in biochem. parameters or histol. pictures related to major organs such as the liver and kidney at its pharmacodynamic endpoint (ED3-log kill).  These findings collectively suggest that YV11455 could be used clin. for the treatment of infections caused by MDR Gram-pos. bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy_VOe44FWtLVg90H21EOLACvtfcHk0ljIdWzfL-Q-_w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1Gktbs%253D&md5=b42643710fd83b893cd22021a2090916</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2015.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2015.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DKonai%26aufirst%3DM.%2BM.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DPrakash%26aufirst%3DR.%2BG.%26aulast%3DMani%26aufirst%3DB.%26aulast%3DParamanandham%26aufirst%3DK.%26aulast%3DRanjan%26aufirst%3DS.%2BB.%26aulast%3DRavikumar%26aufirst%3DR.%26aulast%3DChakraborty%26aufirst%3DS.%2BP.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DIn%2520vivo%2520antibacterial%2520activity%2520and%2520pharmacological%2520properties%2520of%2520the%2520membrane-active%2520glycopeptide%2520antibiotic%2520YV11455%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2015%26volume%3D45%26spage%3D627%26epage%3D634%26doi%3D10.1016%2Fj.ijantimicag.2015.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paramanandham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shome, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Membrane disruption and enhanced inhibition of cell-wall biosynthesis: a synergistic approach to tackle vancomycin-resistant bacteria</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">13644</span>â <span class="NLM_lpage">13649</span>, <span class="refDoi">Â DOI: 10.1002/anie.201507567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1002%2Fanie.201507567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=26473305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Kqs7%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=13644-13649&author=V.+Yarlagaddaauthor=S.+Samaddarauthor=K.+Paramanandhamauthor=B.+R.+Shomeauthor=J.+Haldar&title=Membrane+disruption+and+enhanced+inhibition+of+cell-wall+biosynthesis%3A+a+synergistic+approach+to+tackle+vancomycin-resistant+bacteria&doi=10.1002%2Fanie.201507567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane Disruption and Enhanced Inhibition of Cell-Wall Biosynthesis: A Synergistic Approach to Tackle Vancomycin-Resistant Bacteria</span></div><div class="casAuthors">Yarlagadda, Venkateswarlu; Samaddar, Sandip; Paramanandham, Krishnamoorthy; Shome, Bibek R.; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">13644-13649</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Resistance to glycopeptide antibiotics, the drugs of choice for life-threatening bacterial infections, is on the rise.  To counter the threat of glycopeptide-resistant bacteria, the authors report development of a new class of semi-synthetic glycopeptide antibiotics, which not only target the bacterial membrane but also display enhanced inhibition of cell-wall biosynthesis through increased binding affinity to their target peptides.  The combined effect of these two mechanisms resulted in improved in vitro activity of two to three orders of magnitude over vancomycin and no propensity to trigger drug resistance in bacteria.  In murine model of kidney infection, the optimized compd. was able to bring bacterial burden down by about 6 logs at 12 mg kg-1 with no obsd. toxicity.  The results furnished emphasize the potential of this class of compds. as future antibiotics for drug-resistant Gram-pos. infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdntAtQFj3MrVg90H21EOLACvtfcHk0ljIdWzfL-Q-_w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Kqs7%252FI&md5=6612d63cd53b251565cddd6727df5e9c</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fanie.201507567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201507567%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DParamanandham%26aufirst%3DK.%26aulast%3DShome%26aufirst%3DB.%2BR.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DMembrane%2520disruption%2520and%2520enhanced%2520inhibition%2520of%2520cell-wall%2520biosynthesis%253A%2520a%2520synergistic%2520approach%2520to%2520tackle%2520vancomycin-resistant%2520bacteria%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D13644%26epage%3D13649%26doi%3D10.1002%2Fanie.201507567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaskovich, M. A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansford, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muldoon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziora, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Premraj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindahl, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karoli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelingon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phetsang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daud, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deecke, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidjabat, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaologa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuegg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betley, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beevers, A. P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterson, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. A.</span></span> <span> </span><span class="NLM_article-title">Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">22</span>, <span class="refDoi">Â DOI: 10.1038/s41467-017-02123-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fs41467-017-02123-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=29295973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BC1MzmvFGktw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=22&author=M.+A.+T.+Blaskovichauthor=K.+A.+Hansfordauthor=Y.+Gongauthor=M.+S.+Butlerauthor=C.+Muldoonauthor=J.+X.+Huangauthor=S.+Ramuauthor=A.+B.+Silvaauthor=M.+Chengauthor=A.+M.+Kavanaghauthor=Z.+Zioraauthor=R.+Premrajauthor=F.+Lindahlauthor=T.+A.+Bradfordauthor=J.+C.+Leeauthor=T.+Karoliauthor=R.+Pelingonauthor=D.+J.+Edwardsauthor=M.+Amadoauthor=A.+G.+Elliottauthor=W.+Phetsangauthor=N.+H.+Daudauthor=J.+E.+Deeckeauthor=H.+E.+Sidjabatauthor=S.+Ramaologaauthor=J.+Zueggauthor=J.+R.+Betleyauthor=A.+P.+G.+Beeversauthor=R.+A.+G.+Smithauthor=J.+A.+Robertsauthor=D.+L.+Patersonauthor=M.+A.+Cooper&title=Protein-inspired+antibiotics+active+against+vancomycin-+and+daptomycin-resistant+bacteria&doi=10.1038%2Fs41467-017-02123-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria</span></div><div class="casAuthors">Blaskovich Mark A T; Hansford Karl A; Gong Yujing; Butler Mark S; Muldoon Craig; Huang Johnny X; Ramu Soumya; Silva Alberto B; Cheng Mu; Kavanagh Angela M; Ziora Zyta; Premraj Rajaratnam; Lindahl Fredrik; Bradford Tanya A; Lee June C; Karoli Tomislav; Pelingon Ruby; Edwards David J; Amado Maite; Elliott Alysha G; Phetsang Wanida; Daud Noor Huda; Deecke Johan E; Ramaologa Sefetogi; Zuegg Johannes; Cooper Matthew A; Silva Alberto B; Karoli Tomislav; Sidjabat Hanna E; Roberts Jason A; Paterson David L; Betley Jason R; Beevers Andrew P G; Smith Richard A G; Betley Jason R; Beevers Andrew P G; Smith Richard A G; Roberts Jason A</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The public health threat posed by a looming 'post-antibiotic' era necessitates new approaches to antibiotic discovery.  Drug development has typically avoided exploitation of membrane-binding properties, in contrast to nature's control of biological pathways via modulation of membrane-associated proteins and membrane lipid composition.  Here, we describe the rejuvenation of the glycopeptide antibiotic vancomycin via selective targeting of bacterial membranes.  Peptide libraries based on positively charged electrostatic effector sequences are ligated to N-terminal lipophilic membrane-insertive elements and then conjugated to vancomycin.  These modified lipoglycopeptides, the 'vancapticins', possess enhanced membrane affinity and activity against methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive bacteria, and retain activity against glycopeptide-resistant strains.  Optimised antibiotics show in vivo efficacy in multiple models of bacterial infection.  This membrane-targeting strategy has potential to 'revitalise' antibiotics that have lost effectiveness against recalcitrant bacteria, or enhance the activity of other intravenous-administered drugs that target membrane-associated receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRFg9X85G-ufWZyxfu64m4ffW6udTcc2eY1s0AuRpycP7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzmvFGktw%253D%253D&md5=f9ed17b63af3bc555660bf5b6141c7b8</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02123-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02123-w%26sid%3Dliteratum%253Aachs%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%2BT.%26aulast%3DHansford%26aufirst%3DK.%2BA.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DButler%26aufirst%3DM.%2BS.%26aulast%3DMuldoon%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DJ.%2BX.%26aulast%3DRamu%26aufirst%3DS.%26aulast%3DSilva%26aufirst%3DA.%2BB.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DKavanagh%26aufirst%3DA.%2BM.%26aulast%3DZiora%26aufirst%3DZ.%26aulast%3DPremraj%26aufirst%3DR.%26aulast%3DLindahl%26aufirst%3DF.%26aulast%3DBradford%26aufirst%3DT.%2BA.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DKaroli%26aufirst%3DT.%26aulast%3DPelingon%26aufirst%3DR.%26aulast%3DEdwards%26aufirst%3DD.%2BJ.%26aulast%3DAmado%26aufirst%3DM.%26aulast%3DElliott%26aufirst%3DA.%2BG.%26aulast%3DPhetsang%26aufirst%3DW.%26aulast%3DDaud%26aufirst%3DN.%2BH.%26aulast%3DDeecke%26aufirst%3DJ.%2BE.%26aulast%3DSidjabat%26aufirst%3DH.%2BE.%26aulast%3DRamaologa%26aufirst%3DS.%26aulast%3DZuegg%26aufirst%3DJ.%26aulast%3DBetley%26aufirst%3DJ.%2BR.%26aulast%3DBeevers%26aufirst%3DA.%2BP.%2BG.%26aulast%3DSmith%26aufirst%3DR.%2BA.%2BG.%26aulast%3DRoberts%26aufirst%3DJ.%2BA.%26aulast%3DPaterson%26aufirst%3DD.%2BL.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26atitle%3DProtein-inspired%2520antibiotics%2520active%2520against%2520vancomycin-%2520and%2520daptomycin-resistant%2520bacteria%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D22%26doi%3D10.1038%2Fs41467-017-02123-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">A vancomycin derivative with a pyrophosphate binding group: a strategy to combat vancomycin-resistant bacteria</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7836</span>â <span class="NLM_lpage">7840</span>, <span class="refDoi">Â DOI: 10.1002/anie.201601621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1002%2Fanie.201601621" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=7836-7840&author=V.+Yarlagaddaauthor=P.+Sarkarauthor=S.+Samaddarauthor=J.+Haldar&title=A+vancomycin+derivative+with+a+pyrophosphate+binding+group%3A+a+strategy+to+combat+vancomycin-resistant+bacteria&doi=10.1002%2Fanie.201601621"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1002%2Fanie.201601621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201601621%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DSarkar%26aufirst%3DP.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DA%2520vancomycin%2520derivative%2520with%2520a%2520pyrophosphate%2520binding%2520group%253A%2520a%2520strategy%2520to%2520combat%2520vancomycin-resistant%2520bacteria%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D7836%26epage%3D7840%26doi%3D10.1002%2Fanie.201601621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Printsevskaya, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reznikova, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korolev, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapa, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsufyeva, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preobrazhenskaya, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">641</span>â <span class="NLM_lpage">652</span>, <span class="refDoi">Â DOI: 10.4155/fmc.13.16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.4155%2Ffmc.13.16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=23617428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsFWrsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=641-652&author=S.+S.+Printsevskayaauthor=M.+I.+Reznikovaauthor=A.+M.+Korolevauthor=G.+B.+Lapaauthor=E.+N.+Olsufyevaauthor=M.+N.+Preobrazhenskayaauthor=J.+J.+Plattnerauthor=Y.+K.+Zhang&title=Synthesis+and+study+of+antibacterial+activities+of+antibacterial+glycopeptide+antibiotics+conjugated+with+benzoxaboroles&doi=10.4155%2Ffmc.13.16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles</span></div><div class="casAuthors">Printsevskaya, S. S.; Reznikova, M. I.; Korolev, A. M.; Lapa, G. B.; Olsufyeva, E. N.; Preobrazhenskaya, M. N.; Plattner, J. J.; Zhang, Y. K.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">641-652</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">The ability of boron-contg. compds. to undergo a no. of novel binding interactions with drug target functional groups has recently been described.  Here, the authors incorporated a boron-contg. scaffold, the benzoxaborole, into several glycopeptides antibiotics.  The aim of this work is to exploit the inherent reactivity of boron to gain addnl. interactions with the bacterial cell wall components to improve binding affinity and to thereby overcome resistance.  Three antibacterial glycopeptides (vancomycin, eremomycin and teicoplanin aglycon) were selected for the construction of a series of 12 new benzoxaborole-glycopeptide conjugates.  The hybrid antibiotics, in which the benzoxaborole and glycopeptide moieties were sepd. by a linker, exhibited excellent antibacterial activity against Gram-pos. bacteria, including those with intermediate susceptibility to glycopeptides.  Some analogs also demonstrated activity against vancomycin-resistant enterococci.  It was obsd. that conjugation with benzoxaborole derivs. provided the antibiotics with new and useful properties.  It was also obsd. that teicoplanin aglycon-benzoxaborole derivs. overcame the resistance of Gram-pos. bacteria to vancomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqueWz0kbAGsrVg90H21EOLACvtfcHk0liZW-B1jRuz3A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsFWrsrc%253D&md5=f33f1f5bb8144a13b54385dece8de54e</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.16%26sid%3Dliteratum%253Aachs%26aulast%3DPrintsevskaya%26aufirst%3DS.%2BS.%26aulast%3DReznikova%26aufirst%3DM.%2BI.%26aulast%3DKorolev%26aufirst%3DA.%2BM.%26aulast%3DLapa%26aufirst%3DG.%2BB.%26aulast%3DOlsufyeva%26aufirst%3DE.%2BN.%26aulast%3DPreobrazhenskaya%26aufirst%3DM.%2BN.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26atitle%3DSynthesis%2520and%2520study%2520of%2520antibacterial%2520activities%2520of%2520antibacterial%2520glycopeptide%2520antibiotics%2520conjugated%2520with%2520benzoxaboroles%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D641%26epage%3D652%26doi%3D10.4155%2Ffmc.13.16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnusch, C.
J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonvin, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verel, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kruijff, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieters, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breukink, E.</span></span> <span> </span><span class="NLM_article-title">The vancomycin-nisin(1â12) hybrid restores activity against vancomycin resistant enterococci</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">12661</span>â <span class="NLM_lpage">12663</span>, <span class="refDoi">Â DOI: 10.1021/bi801597b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi801597b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlCns7fE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=12661-12663&author=C.%0AJ.+Arnuschauthor=A.+M.+Bonvinauthor=A.+M.+Verelauthor=W.+T.+Jansenauthor=R.+M.+Liskampauthor=B.+de+Kruijffauthor=R.+J.+Pietersauthor=E.+Breukink&title=The+vancomycin-nisin%281%E2%80%9312%29+hybrid+restores+activity+against+vancomycin+resistant+enterococci&doi=10.1021%2Fbi801597b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">The vancomycin-nisin(1-12) hybrid restores activity against vancomycin resistant enterococci</span></div><div class="casAuthors">Arnusch, Christopher J.; Bonvin, Alexandre M. J. J.; Verel, Anne Marie; Jansen, Wouter T. M.; Liskamp, Rob M. J.; de Kruijff, Ben; Pieters, Roland J.; Breukink, Eefjan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">12661-12663</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipid II is a crucial component in bacterial cell wall synthesis.  It is the target of a no. of important antibiotics, which include vancomycin and nisin.  Here we show that a hybrid antibiotic that consists of vancomycin and nisin fragments is significantly more active than the sep. fragments against vancomycin-resistant enterococci.  Three different hybrids were synthesized using click chem. and compared.  Optimal spacer lengths and connection points were predicted using computer modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptaZL2Flm7brVg90H21EOLACvtfcHk0lijq09JHcedqw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlCns7fE&md5=cfdcca0f596cbe5272f7968bfd53f9f4</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fbi801597b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi801597b%26sid%3Dliteratum%253Aachs%26aulast%3DArnusch%26aufirst%3DC.%2BJ.%26aulast%3DBonvin%26aufirst%3DA.%2BM.%26aulast%3DVerel%26aufirst%3DA.%2BM.%26aulast%3DJansen%26aufirst%3DW.%2BT.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%26aulast%3Dde%2BKruijff%26aufirst%3DB.%26aulast%3DPieters%26aufirst%3DR.%2BJ.%26aulast%3DBreukink%26aufirst%3DE.%26atitle%3DThe%2520vancomycin-nisin%25281%25E2%2580%259312%2529%2520hybrid%2520restores%2520activity%2520against%2520vancomycin%2520resistant%2520enterococci%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D12661%26epage%3D12663%26doi%3D10.1021%2Fbi801597b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggen, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatheree, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judice, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaniga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leadbetter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linsell, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquess, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nodwell, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapp, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turne, S. D.</span></span> <span> </span><span class="NLM_article-title">Exploring the positional attachment of glycopeptide/Î²-lactam heterodimers</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">603</span>â <span class="NLM_lpage">614</span>, <span class="refDoi">Â DOI: 10.1038/ja.2008.80</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fja.2008.80" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=19168974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOqtbzL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2008&pages=603-614&author=D.+D.+Longauthor=J.+B.+Aggenauthor=J.+Chinnauthor=S.+K.+Choiauthor=B.+G.+Christensenauthor=P.+R.+Fathereeauthor=D.+Greenauthor=S.+S.+Hegdeauthor=J.+K.+Judiceauthor=K.+Kanigaauthor=K.+M.+Krauseauthor=M.+Leadbetterauthor=M.+S.+Linsellauthor=D.+G.+Marquessauthor=E.+J.+Moranauthor=M.+B.+Nodwellauthor=J.+L.+Paceauthor=S.+G.+Trappauthor=S.+D.+Turne&title=Exploring+the+positional+attachment+of+glycopeptide%2F%CE%B2-lactam+heterodimers&doi=10.1038%2Fja.2008.80"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the positional attachment of glycopeptide/Î²-lactam heterodimers</span></div><div class="casAuthors">Long, Daniel D.; Aggen, James B.; Chinn, Jason; Choi, Seok-Ki; Christensen, Burton G.; Fatheree, Paul R.; Green, David; Hegde, Sharath S.; Judice, J. Kevin; Kaniga, Kone; Krause, Kevin M.; Leadbetter, Michael; Linsell, Martin S.; Marquess, Daniel G.; Moran, Edmund J.; Nodwell, Matthew B.; Pace, John L.; Trapp, Sean G.; Turner, S. Derek</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">603-614</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">Further investigations towards novel glycopeptide/Î²-lactam heterodimers are reported.  Employing a multivalent approach to drug discovery, vancomycin and cephalosporin synthons, 4, 2, 5 and 10, 18, 25 resp., were chem. linked to yield heterodimer antibiotics.  These novel compds. were designed to inhibit Gram pos. bacterial cell wall biosynthesis by simultaneously targeting the principal cellular targets of both glycopeptides and Î²-lactams.  The positional attachment of both the vancomycin and the cephalosporin central cores has been explored and the SAR is reported.  This novel class of bifunctional antibiotics 28â¼36 all displayed remarkable potency against a wide range of Gram-pos. organisms, including methicillin-resistant Staphylococcus aureus (MRSA).  A subset of compds., 29, 31 and 35 demonstrated excellent bactericidal activity against MRSA (ATCC 33591) and 31 and 35 also exhibited superb in vivo efficacy in a mouse model of MRSA infection.  As a result of this work compd. 35 was selected as a clin. candidate, TD-1792.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW2IngyblS3rVg90H21EOLACvtfcHk0lijq09JHcedqw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOqtbzL&md5=431074c957601703dfb64f8f86015199</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fja.2008.80&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2008.80%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DD.%2BD.%26aulast%3DAggen%26aufirst%3DJ.%2BB.%26aulast%3DChinn%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DS.%2BK.%26aulast%3DChristensen%26aufirst%3DB.%2BG.%26aulast%3DFatheree%26aufirst%3DP.%2BR.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DHegde%26aufirst%3DS.%2BS.%26aulast%3DJudice%26aufirst%3DJ.%2BK.%26aulast%3DKaniga%26aufirst%3DK.%26aulast%3DKrause%26aufirst%3DK.%2BM.%26aulast%3DLeadbetter%26aufirst%3DM.%26aulast%3DLinsell%26aufirst%3DM.%2BS.%26aulast%3DMarquess%26aufirst%3DD.%2BG.%26aulast%3DMoran%26aufirst%3DE.%2BJ.%26aulast%3DNodwell%26aufirst%3DM.%2BB.%26aulast%3DPace%26aufirst%3DJ.%2BL.%26aulast%3DTrapp%26aufirst%3DS.%2BG.%26aulast%3DTurne%26aufirst%3DS.%2BD.%26atitle%3DExploring%2520the%2520positional%2520attachment%2520of%2520glycopeptide%252F%25CE%25B2-lactam%2520heterodimers%26jtitle%3DJ.%2520Antibiot.%26date%3D2008%26volume%3D61%26spage%3D603%26epage%3D614%26doi%3D10.1038%2Fja.2008.80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span> <i>Antibiotics
Currently in Clinical Development</i>; <span class="NLM_publisher-name">Pew Charitable
Trusts</span>, May <span class="NLM_year">2017</span>; <a href="http://www.pewtrusts.org/~/media/assets/2017/05/antibiotics-currently-in-clinical-development-03-2017.pdf" class="extLink">http://www.pewtrusts.org/~/media/assets/2017/05/antibiotics-currently-in-clinical-development-03-2017.pdf</a> (accessed April 1, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Antibiotics%0ACurrently+in+Clinical+Development%3B+Pew+Charitable%0ATrusts%2C+May+2017%3B+http%3A%2F%2Fwww.pewtrusts.org%2F%7E%2Fmedia%2Fassets%2F2017%2F05%2Fantibiotics-currently-in-clinical-development-03-2017.pdf+%28accessed+April+1%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DAntibiotics%250ACurrently%2520in%2520Clinical%2520Development%26pub%3DPew%2520Charitable%250ATrusts%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paramanandham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shome, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravikumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Glycopeptide antibiotic to overcome the intrinsic resistance of gram-negative bacteria</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">132</span>â <span class="NLM_lpage">139</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.5b00114</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.5b00114" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyit7jK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=132-139&author=V.+Yarlagaddaauthor=G.+B.+Manjunathauthor=P.+Sarkarauthor=P.+Akkapeddiauthor=K.+Paramanandhamauthor=B.+R.+Shomeauthor=R.+Ravikumarauthor=J.+Haldar&title=Glycopeptide+antibiotic+to+overcome+the+intrinsic+resistance+of+gram-negative+bacteria&doi=10.1021%2Facsinfecdis.5b00114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Glycopeptide antibiotics to overcome the intrinsic resistance of Gram-negative bacteria</span></div><div class="casAuthors">Yarlagadda, Venkateswarlu; Manjunath, Goutham B.; Sarkar, Paramita; Akkapeddi, Padma; Paramanandham, Krishnamoorthy; Shome, Bibek R.; Ravikumar, Raju; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-139</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The emergence of drug resistance along with a declining pipeline of clin. useful antibiotics has made it vital to develop more effective antimicrobial therapeutics, particularly against difficult-to-treat Gram-neg. pathogens (GNPs).  Many antibacterial agents, including glycopeptide antibiotics such as vancomycin, are inherently inactive toward GNPs because of their inability to cross the outer membrane of these pathogens.  Here, the authors demonstrate that lipophilic cationic (permanent pos. charge) vancomycin analogs were able to permeabilize the outer membrane of GNPs and overcome the inherent resistance of GNPs toward glycopeptides.  Unlike vancomycin, these analogs were shown to have a high activity against a variety of multidrug-resistant clin. isolates such as Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii.  In the murine model of carbapenem-resistant A. baumannii infection, the optimized compd. showed potent activity with no obsd. toxicity.  The notable activity of these compds. is attributed to the incorporation of new membrane disruption mechanisms (cytoplasmic membrane depolarization along with outer and inner (cytoplasmic) membrane permeabilization) into vancomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogjz78A74zirVg90H21EOLACvtfcHk0li7IRumcXjnxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyit7jK&md5=19faed63d23e6a1431f13bfb3e2f46b5</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.5b00114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.5b00114%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DSarkar%26aufirst%3DP.%26aulast%3DAkkapeddi%26aufirst%3DP.%26aulast%3DParamanandham%26aufirst%3DK.%26aulast%3DShome%26aufirst%3DB.%2BR.%26aulast%3DRavikumar%26aufirst%3DR.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DGlycopeptide%2520antibiotic%2520to%2520overcome%2520the%2520intrinsic%2520resistance%2520of%2520gram-negative%2520bacteria%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2016%26volume%3D2%26spage%3D132%26epage%3D139%26doi%3D10.1021%2Facsinfecdis.5b00114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morones-Ramirez, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spina, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. J.</span></span> <span> </span><span class="NLM_article-title">Silver enhances antibiotic activity against gram-negative bacteria</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">190ra81</span>, <span class="refDoi">Â DOI: 10.1126/scitranslmed.3006276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1126%2Fscitranslmed.3006276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=23785037" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=190ra81&author=J.+R.+Morones-Ramirezauthor=J.+A.+Winklerauthor=C.+S.+Spinaauthor=J.+J.+Collins&title=Silver+enhances+antibiotic+activity+against+gram-negative+bacteria&doi=10.1126%2Fscitranslmed.3006276"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3006276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3006276%26sid%3Dliteratum%253Aachs%26aulast%3DMorones-Ramirez%26aufirst%3DJ.%2BR.%26aulast%3DWinkler%26aufirst%3DJ.%2BA.%26aulast%3DSpina%26aufirst%3DC.%2BS.%26aulast%3DCollins%26aufirst%3DJ.%2BJ.%26atitle%3DSilver%2520enhances%2520antibiotic%2520activity%2520against%2520gram-negative%2520bacteria%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D190ra81%26doi%3D10.1126%2Fscitranslmed.3006276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Domalaon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhanel, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, F.</span></span> <span> </span><span class="NLM_article-title">Polymyxin B3-tobramycin hybrids with <i>Pseudomonas aeruginosa</i>-selective antibacterial activity and strong potentiation of rifampicin, minocycline, and vancomycin</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">941</span>â <span class="NLM_lpage">954</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.7b00145</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.7b00145" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1KqsrjJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=941-954&author=R.+Domalaonauthor=X.+Yangauthor=Y.+Lyuauthor=G.+G.+Zhanelauthor=F.+Schweizer&title=Polymyxin+B3-tobramycin+hybrids+with+Pseudomonas+aeruginosa-selective+antibacterial+activity+and+strong+potentiation+of+rifampicin%2C+minocycline%2C+and+vancomycin&doi=10.1021%2Facsinfecdis.7b00145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Polymyxin B3-Tobramycin Hybrids with Pseudomonas aeruginosa-Selective Antibacterial Activity and Strong Potentiation of Rifampicin, Minocycline, and Vancomycin</span></div><div class="casAuthors">Domalaon, Ronald; Yang, Xuan; Lyu, Yinfeng; Zhanel, George G.; Schweizer, Frank</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">941-954</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is an urgent need to develop novel antibacterial agents able to eradicate drug-resistant Gram-neg. pathogens such as Pseudomonas aeruginosa.  Antimicrobial hybrids have emerged as a promising strategy to combat bacterial resistance, as a stand-alone drug but also as an adjuvant in combination with existing antibiotics.  Herein, we report for the first time the synthesis and biol. evaluation of polymyxin-aminoglycoside heterodimers composed of polymyxin B3 covalently linked to tobramycin via an aliph. hydrocarbon linker.  The polymyxin B3-tobramycin hybrids demonstrate potent activity against carbapenem-resistant as well as multidrug- or extensively drug-resistant (MDR/XDR) P. aeruginosa clin. isolates.  Furthermore, the most potent hybrid was synergistic with currently used antibiotics against wild-type and MDR/XDR P. aeruginosa but also against Acinetobacter baumannii as well.  The promising biol. activity described herein warrants addnl. studies into design and development of new antimicrobial hybrids able to surmount the problem of antimicrobial resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8YSmonnn0sbVg90H21EOLACvtfcHk0li7IRumcXjnxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1KqsrjJ&md5=2f17be1865925aa4d8a33204e13d2d95</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.7b00145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.7b00145%26sid%3Dliteratum%253Aachs%26aulast%3DDomalaon%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLyu%26aufirst%3DY.%26aulast%3DZhanel%26aufirst%3DG.%2BG.%26aulast%3DSchweizer%26aufirst%3DF.%26atitle%3DPolymyxin%2520B3-tobramycin%2520hybrids%2520with%2520Pseudomonas%2520aeruginosa-selective%2520antibacterial%2520activity%2520and%2520strong%2520potentiation%2520of%2520rifampicin%252C%2520minocycline%252C%2520and%2520vancomycin%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2017%26volume%3D3%26spage%3D941%26epage%3D954%26doi%3D10.1021%2Facsinfecdis.7b00145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zarkan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macklyne, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirgadze, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bond, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesketh, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H. J.</span></span> <span> </span><span class="NLM_article-title">Zn(II) mediates vancomycin polymerization and potentiates its antibiotic activity against resistant bacteria</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">4893</span>, <span class="refDoi">Â DOI: 10.1038/s41598-017-04868-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fs41598-017-04868-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=28687742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BC1cjlsFOntQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=4893&author=A.+Zarkanauthor=H.+R.+Macklyneauthor=D.+Y.+Chirgadzeauthor=A.+D.+Bondauthor=A.+R.+Heskethauthor=H.+J.+Hong&title=Zn%28II%29+mediates+vancomycin+polymerization+and+potentiates+its+antibiotic+activity+against+resistant+bacteria&doi=10.1038%2Fs41598-017-04868-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Zn(II) mediates vancomycin polymerization and potentiates its antibiotic activity against resistant bacteria</span></div><div class="casAuthors">Zarkan Ashraf; Macklyne Heather-Rose; Chirgadze Dimitri Y; Hesketh Andrew R; Hong Hee-Jeon; Zarkan Ashraf; Bond Andrew D; Hesketh Andrew R; Hong Hee-Jeon</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4893</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Vancomycin is known to bind to Zn(II) and can induce a zinc starvation response in bacteria.  Here we identify a novel polymerization of vancomycin dimers by structural analysis of vancomycin-Zn(II) crystals and fibre X-ray diffraction.  Bioassays indicate that this structure is associated with an increased antibiotic activity against bacterial strains possessing high level vancomycin resistance mediated by the reprogramming of peptidoglycan biosynthesis to use precursors terminating in D-Ala-D-Lac in place of D-Ala-D-Ala.  Polymerization occurs via interaction of Zn(II) with the N-terminal methylleucine group of vancomycin, and we show that the activity of other glycopeptide antibiotics with this feature can also be similarly augmented by Zn(II).  Construction and analysis of a model strain predominantly using D-Ala-D-Lac precursors for peptidoglycan biosynthesis during normal growth supports the hypothesis that Zn(II) mediated vancomycin polymerization enhances the binding affinity towards these precursors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR2aszz8ssiQYkFb3mqPUYDfW6udTcc2ebMWdoReXKHV7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjlsFOntQ%253D%253D&md5=fa39e86e40dcd59ce95149ba8473fc92</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-04868-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-04868-2%26sid%3Dliteratum%253Aachs%26aulast%3DZarkan%26aufirst%3DA.%26aulast%3DMacklyne%26aufirst%3DH.%2BR.%26aulast%3DChirgadze%26aufirst%3DD.%2BY.%26aulast%3DBond%26aufirst%3DA.%2BD.%26aulast%3DHesketh%26aufirst%3DA.%2BR.%26aulast%3DHong%26aufirst%3DH.%2BJ.%26atitle%3DZn%2528II%2529%2520mediates%2520vancomycin%2520polymerization%2520and%2520potentiates%2520its%2520antibiotic%2520activity%2520against%2520resistant%2520bacteria%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D4893%26doi%3D10.1038%2Fs41598-017-04868-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wareham, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornsey, M.</span></span> <span> </span><span class="NLM_article-title">In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of <i>Acinetobacter baumannii</i></span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1047</span>â <span class="NLM_lpage">1051</span>, <span class="refDoi">Â DOI: 10.1093/jac/dkr069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1093%2Fjac%2Fdkr069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=21393131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFejtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2011&pages=1047-1051&author=D.+W.+Warehamauthor=N.+C.+Gordonauthor=M.+Hornsey&title=In+vitro+activity+of+teicoplanin+combined+with+colistin+versus+multidrug-resistant+strains+of+Acinetobacter+baumannii&doi=10.1093%2Fjac%2Fdkr069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii</span></div><div class="casAuthors">Wareham, D. W.; Gordon, N. C.; Hornsey, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1047-1051</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives Antimicrobial treatment of multidrug-resistant Acinetobacter baumannii (MDRAB) remains an important therapeutic challenge.  With isolates resistant to all conventional agents now reported, clinicians are increasingly forced to turn to unorthodox combination treatments in the hope that these may be efficacious.  Although a potent interaction between vancomycin and colistin has been demonstrated, there are concerns regarding the inherent toxicity of combining these agents in clin. practice.  As teicoplanin has less nephrotoxic potential than vancomycin, we assessed whether a colistin/teicoplanin combination would have similar antimicrobial activities in vitro.  Methods The antimicrobial activity of colistin alone and in combination with teicoplanin was assessed vs. a collection of MDRAB belonging to a no. of epidemic lineages present in the UK.  Synergy studies were undertaken using microtiter plate chequerboard assays, an Etest agar diln. method and std. time-kill methodol.  Results The combination of teicoplanin and colistin was bactericidal vs. all of the strains tested.  In chequerboard assays, fractional inhibitory concn. indexes of <0.5 were obtained, consistent with significant in vitro synergy.  Using the Etest method the MIC of teicoplanin fell from >256 mg/L to â¤2 mg/L in the presence of subinhibitory concns. of colistin.  Conclusions Significant synergy was obsd. when colistin was combined with teicoplanin vs. MDRAB in vitro.  This may represent a useful therapeutic combination for the treatment of A. baumannii infections, esp. when renal toxicity is a significant concern.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooT3jFMSn4VbVg90H21EOLACvtfcHk0ljGpO-J0jRU5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFejtbw%253D&md5=4ef529baf8737b02fe867264dcc5e166</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkr069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkr069%26sid%3Dliteratum%253Aachs%26aulast%3DWareham%26aufirst%3DD.%2BW.%26aulast%3DGordon%26aufirst%3DN.%2BC.%26aulast%3DHornsey%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520activity%2520of%2520teicoplanin%2520combined%2520with%2520colistin%2520versus%2520multidrug-resistant%2520strains%2520of%2520Acinetobacter%2520baumannii%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2011%26volume%3D66%26spage%3D1047%26epage%3D1051%26doi%3D10.1093%2Fjac%2Fdkr069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hornsey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longshaw, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wareham, D. W.</span></span> <span> </span><span class="NLM_article-title">In vitro activity of telavancin in combination with colistin versus gram-negative bacterial pathogens</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3080</span>â <span class="NLM_lpage">3085</span>, <span class="refDoi">Â DOI: 10.1128/AAC.05870-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.05870-11" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3080-3085&author=M.+Hornseyauthor=C.+Longshawauthor=L.+Pheeauthor=D.+W.+Wareham&title=In+vitro+activity+of+telavancin+in+combination+with+colistin+versus+gram-negative+bacterial+pathogens&doi=10.1128%2FAAC.05870-11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1128%2FAAC.05870-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.05870-11%26sid%3Dliteratum%253Aachs%26aulast%3DHornsey%26aufirst%3DM.%26aulast%3DLongshaw%26aufirst%3DC.%26aulast%3DPhee%26aufirst%3DL.%26aulast%3DWareham%26aufirst%3DD.%2BW.%26atitle%3DIn%2520vitro%2520activity%2520of%2520telavancin%2520in%2520combination%2520with%2520colistin%2520versus%2520gram-negative%2520bacterial%2520pathogens%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3080%26epage%3D3085%26doi%3D10.1128%2FAAC.05870-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beppler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. H.</span></span> <span> </span><span class="NLM_article-title">Synergistic interactions of vancomycin with different antibiotics against <i>Escherichia coli</i>: trimethoprim and nitrofurantoin display strong synergies with vancomycin against wild-type <i>E. coli</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">276</span>â <span class="NLM_lpage">281</span>, <span class="refDoi">Â DOI: 10.1128/AAC.03502-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.03502-14" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=276-281&author=A.+Zhouauthor=T.+M.+Kangauthor=J.+Yuanauthor=C.+Bepplerauthor=C.+Nguyenauthor=Z.+Maoauthor=M.+Q.+Nguyenauthor=P.+Yehauthor=J.+H.+Miller&title=Synergistic+interactions+of+vancomycin+with+different+antibiotics+against+Escherichia+coli%3A+trimethoprim+and+nitrofurantoin+display+strong+synergies+with+vancomycin+against+wild-type+E.+coli&doi=10.1128%2FAAC.03502-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1128%2FAAC.03502-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03502-14%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DT.%2BM.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DBeppler%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DMao%26aufirst%3DZ.%26aulast%3DNguyen%26aufirst%3DM.%2BQ.%26aulast%3DYeh%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DJ.%2BH.%26atitle%3DSynergistic%2520interactions%2520of%2520vancomycin%2520with%2520different%2520antibiotics%2520against%2520Escherichia%2520coli%253A%2520trimethoprim%2520and%2520nitrofurantoin%2520display%2520strong%2520synergies%2520with%2520vancomycin%2520against%2520wild-type%2520E.%2520coli%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D276%26epage%3D281%26doi%3D10.1128%2FAAC.03502-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paramanandham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shome, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Vancomycin analogue restores Meropenem activity against NDM-1 gram-negative pathogens</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1093</span>â <span class="NLM_lpage">1101</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.8b00011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.8b00011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVSrt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=1093-1101&author=V.+Yarlagaddaauthor=P.+Sarkarauthor=S.+Samaddarauthor=G.+B.+Manjunathauthor=S.+D.+Mitraauthor=K.+Paramanandhamauthor=B.+R.+Shomeauthor=J.+Haldar&title=Vancomycin+analogue+restores+Meropenem+activity+against+NDM-1+gram-negative+pathogens&doi=10.1021%2Facsinfecdis.8b00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Vancomycin Analogue Restores Meropenem Activity against NDM-1 Gram-Negative Pathogens</span></div><div class="casAuthors">Yarlagadda, Venkateswarlu; Sarkar, Paramita; Samaddar, Sandip; Manjunath, Goutham Belagula; Das Mitra, Susweta; Paramanandham, Krishnamoorthy; Shome, Bibek Ranjan; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1093-1101</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New Delhi Metallo-Î²-lactamase-1 (NDM-1) is the major contributor to the emergence of carbapenem-resistance in Gram-neg. pathogens (GNPs) and has caused many clin. available Î²-lactam antibiotics to become obsolete.  A clin. approved inhibitor of metallo-Î²-lactamase (MBL) that could restore the activity of carbapenems against resistant GNPs has not yet been found, making NDM-1 a serious threat to human health.  Here, we have rationally developed an inhibitor for the NDM-1 enzyme, which has the ability to penetrate the outer membrane of GNPs and inactivate the enzyme by depleting the metal ion (Zn2+) from the active site.  The inhibitor reinstated the activity of meropenem against NDM-1 producing clin. isolates of GNPs like Klebsiella pneumoniae and Escherichia coli.  Further, the inhibitor efficiently restored meropenem activity against NDM-1 producing K. pneumoniae in a murine sepsis infection model.  These findings demonstrate that a combination of the present inhibitor and meropenem has high potential to be translated clin. to combat carbapenem-resistant GNPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocDgSp9O5MR7Vg90H21EOLACvtfcHk0ljGpO-J0jRU5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVSrt7Y%253D&md5=9bf0cab8f7701c610613ebb4cd3bffcf</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.8b00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.8b00011%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DSarkar%26aufirst%3DP.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DMitra%26aufirst%3DS.%2BD.%26aulast%3DParamanandham%26aufirst%3DK.%26aulast%3DShome%26aufirst%3DB.%2BR.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DVancomycin%2520analogue%2520restores%2520Meropenem%2520activity%2520against%2520NDM-1%2520gram-negative%2520pathogens%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2018%26volume%3D4%26spage%3D1093%26epage%3D1101%26doi%3D10.1021%2Facsinfecdis.8b00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicolosi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolosi, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pignatello, R.</span></span> <span> </span><span class="NLM_article-title">Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against gram-negative bacteria</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">553</span>â <span class="NLM_lpage">558</span>, <span class="refDoi">Â DOI: 10.1016/j.ijantimicag.2010.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.ijantimicag.2010.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=20219328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFOjtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=553-558&author=D.+Nicolosiauthor=M.+Scaliaauthor=V.+M.+Nicolosiauthor=R.+Pignatello&title=Encapsulation+in+fusogenic+liposomes+broadens+the+spectrum+of+action+of+vancomycin+against+gram-negative+bacteria&doi=10.1016%2Fj.ijantimicag.2010.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria</span></div><div class="casAuthors">Nicolosi, Daria; Scalia, Marina; Nicolosi, Vito M.; Pignatello, Rosario</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">553-558</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Many antibacterial agents, including the glycopeptides, are inactive against Gram-neg. bacteria because of their inability to cross the outer membrane of these cells.  Different chem. and technol. approaches have been described to circumvent such limitation.  In this study, the authors aimed to apply the strategy of fusogenic liposomes, up to now used to carry biol. compds. and materials inside cells, to localize a glycopeptide antibiotic, vancomycin (VAN), to the periplasmic space, thus allowing it to exert its bactericidal activity.  Small unilamellar liposome vesicles were prepd. by an extrusion procedure (SUVETs) from a phospholipid-cholesterol hemisuccinate mixt. known for its fusogenic properties with the eukaryotic cell membrane.  VAN was loaded with high efficiency into these vesicles and in microbiol. expts. in vitro was shown to be able to inhibit to a different extent the growth of wild and std. Gram-neg. bacterial strains.  Min. inhibitory concns. as low as 6 mg/L were obsd., for instance against clin. isolates of Escherichia coli and Acinetobacter baumannii.  In comparison, neither the free antibiotic nor VAN-loaded classical' (non-fusogenic) liposomes showed any activity against the same bacteria.  Scanning and TEM studies allowed confirmation that the produced SUVETs were able to adhere to and fuse with the external membrane of E. coli.  According to preliminary expts., this technol. strategy can be proposed as a potentially successful way to enlarge the spectrum of activity of VAN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVcBdxeQfoFLVg90H21EOLACvtfcHk0limN5Xty0y9Ew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFOjtbY%253D&md5=7fd8349eb27b1ed280f93ac0484a58c8</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2010.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2010.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DNicolosi%26aufirst%3DD.%26aulast%3DScalia%26aufirst%3DM.%26aulast%3DNicolosi%26aufirst%3DV.%2BM.%26aulast%3DPignatello%26aufirst%3DR.%26atitle%3DEncapsulation%2520in%2520fusogenic%2520liposomes%2520broadens%2520the%2520spectrum%2520of%2520action%2520of%2520vancomycin%2520against%2520gram-negative%2520bacteria%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2010%26volume%3D35%26spage%3D553%26epage%3D558%26doi%3D10.1016%2Fj.ijantimicag.2010.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span> <span> </span><span class="NLM_article-title">Presenting vancomycin on nanoparticles to enhance antimicrobial activities</span>. <i>Nano Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1261</span>â <span class="NLM_lpage">1263</span>, <span class="refDoi">Â DOI: 10.1021/nl034396z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/nl034396z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFOitr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=1261-1263&author=H.+W.+Guauthor=P.+L.+Hoauthor=E.+Tongauthor=L.+Wangauthor=B.+Xu&title=Presenting+vancomycin+on+nanoparticles+to+enhance+antimicrobial+activities&doi=10.1021%2Fnl034396z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Presenting vancomycin on nanoparticles to enhance antimicrobial activities</span></div><div class="casAuthors">Gu, Hongwei; Ho, P. L.; Tong, Edmond; Wang, Ling; Xu, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Nano Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1261-1263</span>CODEN:
                <span class="NLM_cas:coden">NALEFD</span>;
        ISSN:<span class="NLM_cas:issn">1530-6984</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here we report the synthesis of vancomycin (Van)-capped Au nanoparticles (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="0f4e7a4f596e61">[emailÂ protected]</a>) and their enhanced in vitro antibacterial activities. <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="6322162335020d">[emailÂ protected]</a> presumably acts as a rigid polyvalent inhibitor of vancomycin-resistant enterococci (VRE).  It also has unexpected activity against an E. coli strain.  Our results suggest that gold nanoparticles may serve as a useful model system to explore multi/polyvalent interactions of ligand-receptor pairs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNga9njR0l2bVg90H21EOLACvtfcHk0limN5Xty0y9Ew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFOitr0%253D&md5=a03c694ad6e94661d8ac35c9fd1519ec</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Fnl034396z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnl034396z%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DH.%2BW.%26aulast%3DHo%26aufirst%3DP.%2BL.%26aulast%3DTong%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DB.%26atitle%3DPresenting%2520vancomycin%2520on%2520nanoparticles%2520to%2520enhance%2520antimicrobial%2520activities%26jtitle%3DNano%2520Lett.%26date%3D2003%26volume%3D3%26spage%3D1261%26epage%3D1263%26doi%3D10.1021%2Fnl034396z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neesham-Grenon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arhin, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beveridge, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parr, T. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeck, G.</span></span> <span> </span><span class="NLM_article-title">Oritavancin kills stationary-phase and biofilm <i>Staphylococcus aureus</i> cells in vitro</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">918</span>â <span class="NLM_lpage">925</span>, <span class="refDoi">Â DOI: 10.1128/AAC.00766-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.00766-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=19104027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivF2ltbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=918-925&author=A.+Belleyauthor=E.+Neesham-Grenonauthor=G.+McKayauthor=F.+F.+Arhinauthor=R.+Harrisauthor=T.+Beveridgeauthor=T.+R.+Parrauthor=G.+Moeck&title=Oritavancin+kills+stationary-phase+and+biofilm+Staphylococcus+aureus+cells+in+vitro&doi=10.1128%2FAAC.00766-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro</span></div><div class="casAuthors">Belley, Adam; Neesham-Grenon, Eve; McKay, Geoffrey; Arhin, Francis F.; Harris, Robert; Beveridge, Terry; Parr, Thomas R., Jr.; Moeck, Gregory</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">918-925</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Slow-growing bacteria and biofilms are notoriously tolerant to antibiotics.  Oritavancin is a lipoglycopeptide with multiple mechanisms of action that contribute to its bactericidal action against exponentially growing gram-pos. pathogens, including the inhibition of cell wall synthesis and perturbation of membrane barrier function.  We sought to det. whether oritavancin could eradicate cells known to be tolerant to many antimicrobial agents, i.e., stationary-phase and biofilm cultures of Staphylococcus aureus in vitro.  Oritavancin exhibited concn.-dependent bactericidal activity against stationary-phase inocula of methicillin-susceptible S. aureus (MSSA) ATCC 29213, methicillin-resistant S. aureus (MRSA) ATCC 33591, and vancomycin-resistant S. aureus (VRSA) VRS5 inoculated into nutrient-depleted cation-adjusted Mueller-Hinton broth.  As has been described for exponential-phase cells, oritavancin induced membrane depolarization, increased membrane permeability, and caused ultrastructural defects including a loss of nascent septal cross walls in stationary-phase MSSA.  Furthermore, oritavancin sterilized biofilms of MSSA, MRSA, and VRSA at minimal biofilm eradication concns. (MBECs) of between 0.5 and 8 Î¼g/mL.  Importantly, MBECs for oritavancin were within 1 doubling diln. of their resp. planktonic broth MICs, highlighting the potency of oritavancin against biofilms.  These results demonstrate a significant activity of oritavancin against S. aureus in phases of growth that exhibit tolerance to other antimicrobial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp37UJTKLDCv7Vg90H21EOLACvtfcHk0limN5Xty0y9Ew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivF2ltbs%253D&md5=b529fb3ae2518d75fab48175415d2284</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1128%2FAAC.00766-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00766-08%26sid%3Dliteratum%253Aachs%26aulast%3DBelley%26aufirst%3DA.%26aulast%3DNeesham-Grenon%26aufirst%3DE.%26aulast%3DMcKay%26aufirst%3DG.%26aulast%3DArhin%26aufirst%3DF.%2BF.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DBeveridge%26aufirst%3DT.%26aulast%3DParr%26aufirst%3DT.%2BR.%26aulast%3DMoeck%26aufirst%3DG.%26atitle%3DOritavancin%2520kills%2520stationary-phase%2520and%2520biofilm%2520Staphylococcus%2520aureus%2520cells%2520in%2520vitro%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D918%26epage%3D925%26doi%3D10.1128%2FAAC.00766-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LaPlante, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mermel, L. A.</span></span> <span> </span><span class="NLM_article-title">In vitro activities of telavancin and vancomycin against biofilm-producing <i>Staphylococcus aureus, S. epidermidis</i>, and <i>Enterococcus faecalis</i> strains</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3166</span>â <span class="NLM_lpage">3169</span>, <span class="refDoi">Â DOI: 10.1128/AAC.01642-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.01642-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=19451302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotlajtr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=3166-3169&author=K.+L.+LaPlanteauthor=L.+A.+Mermel&title=In+vitro+activities+of+telavancin+and+vancomycin+against+biofilm-producing+Staphylococcus+aureus%2C+S.+epidermidis%2C+and+Enterococcus+faecalis+strains&doi=10.1128%2FAAC.01642-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activities of telavancin and vancomycin against biofilm-producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis strains</span></div><div class="casAuthors">LaPlante, Kerry L.; Mermel, Leonard A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3166-3169</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We investigated the activities of telavancin and vancomycin against biofilm-producing Staphylococcus and Enterococcus strains.  At clin. attainable concns., telavancin was active against bacteria embedded in biofilm (minimal biofilm eradication concn. [MBEC], 0.125 to 2 Î¼g/mL) and inhibited biofilm formation at concns. below the MIC.  Vancomycin did not demonstrate the same activity (MBEC, â¥512 Î¼g/mL) against Staphylococcus aureus and Enterococcus faecalis.  Telavancin may have a unique role in biofilm-assocd. infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmJDhsWgdvDrVg90H21EOLACvtfcHk0lj0nMz75yeI0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotlajtr4%253D&md5=29c296f881ab0b8b740d1a8414f69cc7</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1128%2FAAC.01642-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01642-08%26sid%3Dliteratum%253Aachs%26aulast%3DLaPlante%26aufirst%3DK.%2BL.%26aulast%3DMermel%26aufirst%3DL.%2BA.%26atitle%3DIn%2520vitro%2520activities%2520of%2520telavancin%2520and%2520vancomycin%2520against%2520biofilm-producing%2520Staphylococcus%2520aureus%252C%2520S.%2520epidermidis%252C%2520and%2520Enterococcus%2520faecalis%2520strains%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D3166%26epage%3D3169%26doi%3D10.1128%2FAAC.01642-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barcia-Macay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seral, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mingeot-Leclercq, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulkens, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Bambeke, F.</span></span> <span> </span><span class="NLM_article-title">Pharmacodynamic evaluation of the intracellular activities of antibiotics against <i>Staphylococcus aureus</i> in a model of THP-1 macrophages</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">841</span>â <span class="NLM_lpage">851</span>, <span class="refDoi">Â DOI: 10.1128/AAC.50.3.841-851.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FAAC.50.3.841-851.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=16495241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFamtrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=841-851&author=M.+Barcia-Macayauthor=C.+Seralauthor=M.+P.+Mingeot-Leclercqauthor=P.+M.+Tulkensauthor=F.+Van+Bambeke&title=Pharmacodynamic+evaluation+of+the+intracellular+activities+of+antibiotics+against+Staphylococcus+aureus+in+a+model+of+THP-1+macrophages&doi=10.1128%2FAAC.50.3.841-851.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages</span></div><div class="casAuthors">Barcia-Macay, Maritza; Seral, Cristina; Mingeot-Leclercq, Marie-Paule; Tulkens, Paul M.; Van Bambeke, Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">841-851</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The pharmacodynamic properties governing the activities of antibiotics against intracellular Staphylococcus aureus are still largely undetd.  Sixteen antibiotics of seven different pharmacol. classes (azithromycin and telithromycin [macrolides]; gentamicin [an aminoglycoside]; linezolid [an oxazolidinone]; penicillin V, nafcillin, ampicillin, and oxacillin [Î²-lactams]; teicoplanin, vancomycin, and oritavancin [glycopeptides]; rifampin [an ansamycin]; and ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin [quinolones]) have been examd. for their activities against S. aureus (ATCC 25923) in human THP-1 macrophages (intracellular) vs. that in culture medium (extracellular) by using a 0- to 24-h exposure time and a wide range of extracellular concns. (including the range of the MIC to the max. concn. in serum [Cmax; total drug] of humans).  All mols. except the macrolides caused a net redn. in bacterial counts that was time and concn./MIC ratio dependent (four mols. tested in detail [gentamicin, oxacillin, moxifloxacin, and oritavancin] showed typical sigmoidal dose-response curves at 24 h).  Maximal intracellular activities remained consistently lower than extracellular activities, irresp. of the level of drug accumulation and of the pharmacol. class.  Relative potencies (50% effective concn. or at a fixed extracellular concn./MIC ratio) were also decreased, but to different extents.  At an extracellular concn. corresponding to their Cmaxs (total drug) in humans, only oxacillin, levofloxacin, garenoxacin, moxifloxacin, and oritavancin had truly intracellular bactericidal effects (2-log decrease or more, as defined by the Clin. and Lab. Stds. Institute guidelines).  The intracellular activities of antibiotics against S. aureus (i) are critically dependent upon their extracellular concns. and the duration of cell exposure (within the 0- to 24-h time frame) to antibiotics and (ii) are always lower than those that can be obsd. extracellularly.  This model may help in rationalizing the choice of antibiotic for the treatment of S. aureus intracellular infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowGfdgdcW6aLVg90H21EOLACvtfcHk0lj0nMz75yeI0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFamtrs%253D&md5=ffeb868ce556e346522f2fca2f84989c</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1128%2FAAC.50.3.841-851.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.50.3.841-851.2006%26sid%3Dliteratum%253Aachs%26aulast%3DBarcia-Macay%26aufirst%3DM.%26aulast%3DSeral%26aufirst%3DC.%26aulast%3DMingeot-Leclercq%26aufirst%3DM.%2BP.%26aulast%3DTulkens%26aufirst%3DP.%2BM.%26aulast%3DVan%2BBambeke%26aufirst%3DF.%26atitle%3DPharmacodynamic%2520evaluation%2520of%2520the%2520intracellular%2520activities%2520of%2520antibiotics%2520against%2520Staphylococcus%2520aureus%2520in%2520a%2520model%2520of%2520THP-1%2520macrophages%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D841%26epage%3D851%26doi%3D10.1128%2FAAC.50.3.841-851.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barcia-Macay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouaden, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mingeot-Leclercq, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulkens, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Bambeke, F.</span></span> <span> </span><span class="NLM_article-title">Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts)</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1288</span>â <span class="NLM_lpage">1294</span>, <span class="refDoi">Â DOI: 10.1093/jac/dkn120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1093%2Fjac%2Fdkn120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=18375379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVajtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2008&pages=1288-1294&author=M.+Barcia-Macayauthor=F.+Mouadenauthor=M.+P.+Mingeot-Leclercqauthor=P.+M.+Tulkensauthor=F.+Van+Bambeke&title=Cellular+pharmacokinetics+of+telavancin%2C+a+novel+lipoglycopeptide+antibiotic%2C+and+analysis+of+lysosomal+changes+in+cultured+eukaryotic+cells+%28J774+mouse+macrophages+and+rat+embryonic+fibroblasts%29&doi=10.1093%2Fjac%2Fdkn120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts)</span></div><div class="casAuthors">Barcia-Macay, Maritza; Mouaden, Fatima; Mingeot-Leclercq, Marie-Paule; Tulkens, Paul M.; Van Bambeke, Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1288-1294</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Telavancin is a lipoglycopeptide with multiple mechanisms of action that include membrane-destabilizing effects towards bacterial cells.  It shows bactericidal activity against forms of Staphylococcus aureus (phagolysosomal infection) with different resistance phenotypes [methicillin-resistant S. aureus, vancomycin-intermediate S. aureus or vancomycin-resistant S. aureus].  We examine here the uptake, efflux and intracellular distribution of telavancin in eukaryotic cells as well as its potential to induce lysosomal changes (in comparison with vancomycin and oritavancin).  J774 macrophages and rat embryo fibroblasts were exposed for up to 24 and 72 h to telavancin (5-90 mg/L).  The following studies were performed: measurement of 14C-labeled telavancin cellular uptake and subcellular distribution (cell fractionation), detn. of pericellular membrane integrity (lactate dehydrogenase release), electron microscopy with morphometric anal. of changes in lysosome size and detn. of total phospholipid and cholesterol content.  The uptake of telavancin proceeded linearly as a function of time and concn. in both cell types (clearance rate of â¼10 mL/g of protein/h).  Efflux (macrophages) was â¼5.7-fold slower.  Telavancin subcellular distribution was superimposable on that of a lysosomal marker (N-acetyl-Î²-hexosaminidase).  It did not cause an increase in the release of lactate dehydrogenase and did not induce significant increases in total phospholipid or cholesterol content.  It caused only mild morphol. lysosomal alterations (similar to vancomycin and much less than oritavancin by morphometric anal.).  Telavancin is taken up by eukaryotic cells and localizes in lysosomes, causing mild morphol. alterations without evidence of lipid metab. alterations.  These data support our observations that telavancin is active against intracellular S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9uqlZCHoGjbVg90H21EOLACvtfcHk0lj0nMz75yeI0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVajtbs%253D&md5=6f8543f1be11b9428723a2ce43c3928a</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkn120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkn120%26sid%3Dliteratum%253Aachs%26aulast%3DBarcia-Macay%26aufirst%3DM.%26aulast%3DMouaden%26aufirst%3DF.%26aulast%3DMingeot-Leclercq%26aufirst%3DM.%2BP.%26aulast%3DTulkens%26aufirst%3DP.%2BM.%26aulast%3DVan%2BBambeke%26aufirst%3DF.%26atitle%3DCellular%2520pharmacokinetics%2520of%2520telavancin%252C%2520a%2520novel%2520lipoglycopeptide%2520antibiotic%252C%2520and%2520analysis%2520of%2520lysosomal%2520changes%2520in%2520cultured%2520eukaryotic%2520cells%2520%2528J774%2520mouse%2520macrophages%2520and%2520rat%2520embryonic%2520fibroblasts%2529%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2008%26volume%3D61%26spage%3D1288%26epage%3D1294%26doi%3D10.1093%2Fjac%2Fdkn120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Intracellular activity of a membrane-active glycopeptide antibiotic against meticillin-resistant <i>Staphylococcus aureus</i> infection</span>. <i>J. Glob. Antimicrob. Resist.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">71</span>â <span class="NLM_lpage">74</span>, <span class="refDoi">Â DOI: 10.1016/j.jgar.2015.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.jgar.2015.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=27436471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BC2s3isVSntw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=71-74&author=V.+Yarlagaddaauthor=S.+Samaddarauthor=J.+Haldar&title=Intracellular+activity+of+a+membrane-active+glycopeptide+antibiotic+against+meticillin-resistant+Staphylococcus+aureus+infection&doi=10.1016%2Fj.jgar.2015.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular activity of a membrane-active glycopeptide antibiotic against meticillin-resistant Staphylococcus aureus infection</span></div><div class="casAuthors">Yarlagadda Venkateswarlu; Samaddar Sandip; Haldar Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of global antimicrobial resistance</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">71-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Staphylococcus aureus is a facultative intracellular pathogen and there are limited options for the treatment of severe intracellular bacterial infections.  The membrane-active glycopeptide antibiotic Van-QC8 is a permanent positively charged lipophilic vancomycin analogue that demonstrates high activity against clinically relevant drug-resistant Gram-positive bacteria both in vitro and in vivo.  In this study, the intracellular activity of Van-QC8 was evaluated against meticillin-resistant S. aureus (MRSA) infection in RAW macrophages.  Furthermore, the mechanism of intracellular uptake of Van-QC8 was investigated.  Van-QC8 showed time- and concentration-dependent bactericidal activity against intracellular MRSA.  Van-QC8 displayed significantly higher intracellular activity compared with vancomycin and linezolid.  Cellular uptake of Van-QC8 was found to be through clathrin-dependent and -independent and caveolin-dependent and -independent endocytic pathways.  The findings of this study suggest that Van-QC8 could be translated clinically for the treatment of intracellular infections due to MRSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRdo7BVSJQulysZ1x6zOs0vfW6udTcc2eYHsGghxX0Urbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3isVSntw%253D%253D&md5=c007218f773e8bd0d5403e2b7d3083d9</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.jgar.2015.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jgar.2015.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DIntracellular%2520activity%2520of%2520a%2520membrane-active%2520glycopeptide%2520antibiotic%2520against%2520meticillin-resistant%2520Staphylococcus%2520aureus%2520infection%26jtitle%3DJ.%2520Glob.%2520Antimicrob.%2520Resist.%26date%3D2016%26volume%3D5%26spage%3D71%26epage%3D74%26doi%3D10.1016%2Fj.jgar.2015.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lehar, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillow, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajihara, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandlen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePalatis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raab, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazenbos, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiroshi Morisaki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darwish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loyet, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalouni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khalfin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plise, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strandh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koefoed, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wah Tan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariathasan, S.</span></span> <span> </span><span class="NLM_article-title">Novel antibody-antibiotic conjugate eliminates intracellular <i>S. aureus</i></span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>527</i></span>,  <span class="NLM_fpage">323</span>â <span class="NLM_lpage">328</span>, <span class="refDoi">Â DOI: 10.1038/nature16057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fnature16057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=26536114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslOrtLfP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=527&publication_year=2015&pages=323-328&author=S.+M.+Leharauthor=T.+Pillowauthor=M.+Xuauthor=L.+Stabenauthor=K.+K.+Kajiharaauthor=R.+Vandlenauthor=L.+DePalatisauthor=H.+Raabauthor=W.+L.+Hazenbosauthor=J.+Hiroshi+Morisakiauthor=J.+Kimauthor=S.+Parkauthor=M.+Darwishauthor=B.+C.+Leeauthor=H.+Hernandezauthor=K.+M.+Loyetauthor=P.+Lupardusauthor=R.+Fongauthor=D.+Yanauthor=C.+Chalouniauthor=E.+Luisauthor=Y.+Khalfinauthor=E.+Pliseauthor=J.+Cheongauthor=J.+P.+Lyssikatosauthor=M.+Strandhauthor=K.+Koefoedauthor=P.+S.+Andersenauthor=J.+A.+Flygareauthor=M.+Wah+Tanauthor=E.+J.+Brownauthor=S.+Mariathasan&title=Novel+antibody-antibiotic+conjugate+eliminates+intracellular+S.+aureus&doi=10.1038%2Fnature16057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Novel antibody-antibiotic conjugate eliminates intracellular S. aureus</span></div><div class="casAuthors">Lehar, Sophie M.; Pillow, Thomas; Xu, Min; Staben, Leanna; Kajihara, Kimberly K.; Vandlen, Richard; De Palatis, Laura; Raab, Helga; Hazenbos, Wouter L.; Hiroshi Morisaki, J.; Kim, Janice; Park, Summer; Darwish, Martine; Lee, Byoung-Chul; Hernandez, Hilda; Loyet, Kelly M.; Lupardus, Patrick; Fong, Rina; Yan, Donghong; Chalouni, Cecile; Luis, Elizabeth; Khalfin, Yana; Plise, Emile; Cheong, Jonathan; Lyssikatos, Joseph P.; Strandh, Magnus; Koefoed, Klaus; Andersen, Peter S.; Flygare, John A.; Tan, Man Wah; Brown, Eric J.; Mariathasan, Sanjeev</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">527</span>
        (<span class="NLM_cas:issue">7578</span>),
    <span class="NLM_cas:pages">323-328</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Staphylococcus aureus is considered to be an extracellular pathogen.  However, survival of S. aureus within host cells may provide a reservoir relatively protected from antibiotics, thus enabling long-term colonization of the host and explaining clin. failures and relapses after antibiotic therapy.  Here we confirm that intracellular reservoirs of S. aureus in mice comprise a virulent subset of bacteria that can establish infection even in the presence of vancomycin, and we introduce a novel therapeutic that effectively kills intracellular S. aureus.  This antibody-antibiotic conjugate consists of an anti-S. aureus antibody conjugated to a highly efficacious antibiotic that is activated only after it is released in the proteolytic environment of the phagolysosome.  The antibody-antibiotic conjugate is superior to vancomycin for treatment of bacteremia and provides direct evidence that intracellular S. aureus represents an important component of invasive infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9cwgfxu2hErVg90H21EOLACvtfcHk0linlibAf4WRTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslOrtLfP&md5=09cc42906a456aaa772530d69c36aa50</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1038%2Fnature16057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature16057%26sid%3Dliteratum%253Aachs%26aulast%3DLehar%26aufirst%3DS.%2BM.%26aulast%3DPillow%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DStaben%26aufirst%3DL.%26aulast%3DKajihara%26aufirst%3DK.%2BK.%26aulast%3DVandlen%26aufirst%3DR.%26aulast%3DDePalatis%26aufirst%3DL.%26aulast%3DRaab%26aufirst%3DH.%26aulast%3DHazenbos%26aufirst%3DW.%2BL.%26aulast%3DHiroshi%2BMorisaki%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DDarwish%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DB.%2BC.%26aulast%3DHernandez%26aufirst%3DH.%26aulast%3DLoyet%26aufirst%3DK.%2BM.%26aulast%3DLupardus%26aufirst%3DP.%26aulast%3DFong%26aufirst%3DR.%26aulast%3DYan%26aufirst%3DD.%26aulast%3DChalouni%26aufirst%3DC.%26aulast%3DLuis%26aufirst%3DE.%26aulast%3DKhalfin%26aufirst%3DY.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DCheong%26aufirst%3DJ.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DStrandh%26aufirst%3DM.%26aulast%3DKoefoed%26aufirst%3DK.%26aulast%3DAndersen%26aufirst%3DP.%2BS.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DWah%2BTan%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DE.%2BJ.%26aulast%3DMariathasan%26aufirst%3DS.%26atitle%3DNovel%2520antibody-antibiotic%2520conjugate%2520eliminates%2520intracellular%2520S.%2520aureus%26jtitle%3DNature%26date%3D2015%26volume%3D527%26spage%3D323%26epage%3D328%26doi%3D10.1038%2Fnature16057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariathasan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, M. W.</span></span> <span> </span><span class="NLM_article-title">Antibody-antibiotic conjugates: a novel therapeutic platform against bacterial infections</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">135</span>â <span class="NLM_lpage">149</span>, <span class="refDoi">Â DOI: 10.1016/j.molmed.2016.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.molmed.2016.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=28126271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvVWgtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=135-149&author=S.+Mariathasanauthor=M.+W.+Tan&title=Antibody-antibiotic+conjugates%3A+a+novel+therapeutic+platform+against+bacterial+infections&doi=10.1016%2Fj.molmed.2016.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody-Antibiotic Conjugates: A Novel Therapeutic Platform against Bacterial Infections</span></div><div class="casAuthors">Mariathasan, Sanjeev; Tan, Man-Wah</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-149</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Antibodies are potent components of the immune repertoire and have been successfully exploited to treat bacterial infections.  Recently an antibody-antibiotic conjugate (AAC) that combines key attributes of an antibody and antibiotic has been shown to be efficacious against Staphylococcus aureus infection.  An AAC has three components: an antibiotic payload to kill bacteria, an antibody to target delivery of the payload to bacteria, and a linker attaching the payload to the antibody.  With increasing understanding of the biol. and pathophysiol. of S. aureus, this article highlights how this knowledge has led to the design principles of an efficacious AAC, and discusses how the AAC platform could be translationally applied to treat other perilous infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXJPXDVg4x6LVg90H21EOLACvtfcHk0ljW_WyuPO7WhQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvVWgtg%253D%253D&md5=a647ef11e4a702f356a617b94c9876b0</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2016.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2016.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DMariathasan%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DM.%2BW.%26atitle%3DAntibody-antibiotic%2520conjugates%253A%2520a%2520novel%2520therapeutic%2520platform%2520against%2520bacterial%2520infections%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2017%26volume%3D23%26spage%3D135%26epage%3D149%26doi%3D10.1016%2Fj.molmed.2016.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peoples, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spoering, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engels, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conlon, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaberle, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarides, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felix, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fetterman, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millett, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitti, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zullo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, K.</span></span> <span> </span><span class="NLM_article-title">A new antibiotic kills pathogens without detectable resistance</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>517</i></span>,  <span class="NLM_fpage">455</span>â <span class="NLM_lpage">459</span>, <span class="refDoi">Â DOI: 10.1038/nature14098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fnature14098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=25561178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOju7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=517&publication_year=2015&pages=455-459&author=L.+L.+Lingauthor=T.+Schneiderauthor=A.+J.+Peoplesauthor=A.+L.+Spoeringauthor=I.+Engelsauthor=B.+P.+Conlonauthor=A.+Muellerauthor=T.+F.+Schaberleauthor=D.+E.+Hughesauthor=S.+Epsteinauthor=M.+Jonesauthor=L.+Lazaridesauthor=V.+A.+Steadmanauthor=D.+R.+Cohenauthor=C.+R.+Felixauthor=K.+A.+Fettermanauthor=W.+P.+Millettauthor=A.+G.+Nittiauthor=A.+M.+Zulloauthor=C.+Chenauthor=K.+Lewis&title=A+new+antibiotic+kills+pathogens+without+detectable+resistance&doi=10.1038%2Fnature14098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">A new antibiotic kills pathogens without detectable resistance</span></div><div class="casAuthors">Ling, Losee L.; Schneider, Tanja; Peoples, Aaron J.; Spoering, Amy L.; Engels, Ina; Conlon, Brian P.; Mueller, Anna; Schaberle, Till F.; Hughes, Dallas E.; Epstein, Slava; Jones, Michael; Lazarides, Linos; Steadman, Victoria A.; Cohen, Douglas R.; Felix, Cintia R.; Fetterman, K. Ashley; Millett, William P.; Nitti, Anthony G.; Zullo, Ashley M.; Chen, Chao; Lewis, Kim</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">517</span>
        (<span class="NLM_cas:issue">7535</span>),
    <span class="NLM_cas:pages">455-459</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Antibiotic resistance is spreading faster than the introduction of new compds. into clin. practice, causing a public health crisis.  Most antibiotics were produced by screening soil microorganisms, but this limited resource of cultivable bacteria was overmined by the 1960s.  Synthetic approaches to produce antibiotics have been unable to replace this platform.  Uncultured bacteria make up approx. 99% of all species in external environments, and are an untapped source of new antibiotics.  We developed several methods to grow uncultured organisms by cultivation in situ or by using specific growth factors.  Here we report a new antibiotic that we term teixobactin, discovered in a screen of uncultured bacteria.  Teixobactin inhibits cell wall synthesis by binding to a highly conserved motif of lipid II (precursor of peptidoglycan) and lipid III (precursor of cell wall teichoic acid).  We did not obtain any mutants of Staphylococcus aureus or Mycobacterium tuberculosis resistant to teixobactin.  The properties of this compd. suggest a path towards developing antibiotics that are likely to avoid development of resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV0hZrSZheoLVg90H21EOLACvtfcHk0ljW_WyuPO7WhQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOju7w%253D&md5=27e302d7d44a549a91aa52113c3b4ad8</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1038%2Fnature14098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14098%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DL.%2BL.%26aulast%3DSchneider%26aufirst%3DT.%26aulast%3DPeoples%26aufirst%3DA.%2BJ.%26aulast%3DSpoering%26aufirst%3DA.%2BL.%26aulast%3DEngels%26aufirst%3DI.%26aulast%3DConlon%26aufirst%3DB.%2BP.%26aulast%3DMueller%26aufirst%3DA.%26aulast%3DSchaberle%26aufirst%3DT.%2BF.%26aulast%3DHughes%26aufirst%3DD.%2BE.%26aulast%3DEpstein%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DLazarides%26aufirst%3DL.%26aulast%3DSteadman%26aufirst%3DV.%2BA.%26aulast%3DCohen%26aufirst%3DD.%2BR.%26aulast%3DFelix%26aufirst%3DC.%2BR.%26aulast%3DFetterman%26aufirst%3DK.%2BA.%26aulast%3DMillett%26aufirst%3DW.%2BP.%26aulast%3DNitti%26aufirst%3DA.%2BG.%26aulast%3DZullo%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLewis%26aufirst%3DK.%26atitle%3DA%2520new%2520antibiotic%2520kills%2520pathogens%2520without%2520detectable%2520resistance%26jtitle%3DNature%26date%3D2015%26volume%3D517%26spage%3D455%26epage%3D459%26doi%3D10.1038%2Fnature14098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moraski, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanassi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podos, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pucci, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. J.</span></span> <span> </span><span class="NLM_article-title">One-step syntheses of nitrofuranyl benzimidazoles that are active against multidrug-resistant bacteria</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">667</span>â <span class="NLM_lpage">671</span>, <span class="refDoi">Â DOI: 10.1038/ja.2011.67</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fja.2011.67" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2011&pages=667-671&author=G.+C.+Moraskiauthor=J.+A.+Thanassiauthor=S.+D.+Podosauthor=M.+J.+Pucciauthor=M.+J.+Miller&title=One-step+syntheses+of+nitrofuranyl+benzimidazoles+that+are+active+against+multidrug-resistant+bacteria&doi=10.1038%2Fja.2011.67"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1038%2Fja.2011.67&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2011.67%26sid%3Dliteratum%253Aachs%26aulast%3DMoraski%26aufirst%3DG.%2BC.%26aulast%3DThanassi%26aufirst%3DJ.%2BA.%26aulast%3DPodos%26aufirst%3DS.%2BD.%26aulast%3DPucci%26aufirst%3DM.%2BJ.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26atitle%3DOne-step%2520syntheses%2520of%2520nitrofuranyl%2520benzimidazoles%2520that%2520are%2520active%2520against%2520multidrug-resistant%2520bacteria%26jtitle%3DJ.%2520Antibiot.%26date%3D2011%26volume%3D64%26spage%3D667%26epage%3D671%26doi%3D10.1038%2Fja.2011.67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fuda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heilmayer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vakulenko, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobashery, S.</span></span> <span> </span><span class="NLM_article-title">Mechanistic basis for the action of new cephalosporin antibiotics effective against methicillin- and vancomycin-resistant <i>Staphylococcus aureus</i></span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">10035</span>â <span class="NLM_lpage">10041</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M508846200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1074%2Fjbc.M508846200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=16459335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjt1KgtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=10035-10041&author=C.+Fudaauthor=D.+Hesekauthor=M.+Leeauthor=W.+Heilmayerauthor=R.+Novakauthor=S.+B.+Vakulenkoauthor=S.+Mobashery&title=Mechanistic+basis+for+the+action+of+new+cephalosporin+antibiotics+effective+against+methicillin-+and+vancomycin-resistant+Staphylococcus+aureus&doi=10.1074%2Fjbc.M508846200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic basis for the action of new cephalosporin antibiotics effective against methicillin- and vancomycin-resistant Staphylococcus aureus</span></div><div class="casAuthors">Fuda, Cosimo; Hesek, Dusan; Lee, Mijoon; Heilmayer, Werner; Novak, Rodger; Vakulenko, Sergei B.; Mobashery, Shahriar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">10035-10041</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Emergence of methicillin-resistant Staphylococcus aureus (MRSA) has created challenges in treatment of nosocomial infections.  The recent clin. emergence of vancomycin-resistant MRSA is a new disconcerting chapter in the evolution of these strains.  S. aureus normally produces four PBPs, which are susceptible to modification byÎ²-lactam antibiotics, an event that leads to bacterial death.  The gene product of mecA from MRSA is a penicillin-binding protein (PBP) designated PBP 2a.  PBP 2a is refractory to the action of all com. available Î²-lactam antibiotics.  Furthermore, PBP 2a is capable of taking over the functions of the other PBPs of S. aureus in the face of the challenge by Î²-lactam antibiotics.  Three cephalosporins (compds. 1-3) have been studied herein, which show antibacterial activities against MRSA, including the clin. important vancomycin-resistant strains.  These cephalosporins exhibit substantially smaller dissocn. consts. for the preacylation complex compared with the case of typical cephalosporins, but their pseudo-second-order rate consts. for encounter with PBP 2a (k2/Ks) are not very large (â¤200 M-1 s-1).  It is documented herein that these cephalosporins facilitate a conformational change in PBP 2a, a process that is enhanced in the presence of a synthetic surrogate for cell wall, resulting in increases in the k2/Ks parameter and in more facile enzyme inhibition.  These findings argue that the novel cephalosporins are able to co-opt interactions between PBP 2a and the cell wall in gaining access to the active site in the inhibition process, a set of events that leads to effective inhibition of PBP 2a and the attendant killing of the MRSA strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4U3-57JYP4bVg90H21EOLACvtfcHk0ljW_WyuPO7WhQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjt1KgtbY%253D&md5=a833e7fddfd2d920d10f14f49a4c3422</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M508846200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M508846200%26sid%3Dliteratum%253Aachs%26aulast%3DFuda%26aufirst%3DC.%26aulast%3DHesek%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DHeilmayer%26aufirst%3DW.%26aulast%3DNovak%26aufirst%3DR.%26aulast%3DVakulenko%26aufirst%3DS.%2BB.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DMechanistic%2520basis%2520for%2520the%2520action%2520of%2520new%2520cephalosporin%2520antibiotics%2520effective%2520against%2520methicillin-%2520and%2520vancomycin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D10035%26epage%3D10041%26doi%3D10.1074%2Fjbc.M508846200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janardhanan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobashery, S.</span></span> <span> </span><span class="NLM_article-title">The oxadiazole antibacterials</span>. <i>Curr. Opin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">13</span>â <span class="NLM_lpage">17</span>, <span class="refDoi">Â DOI: 10.1016/j.mib.2016.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.mib.2016.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=27239942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC28XoslWlur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=13-17&author=J.+Janardhananauthor=M.+Changauthor=S.+Mobashery&title=The+oxadiazole+antibacterials&doi=10.1016%2Fj.mib.2016.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">The oxadiazole antibacterials</span></div><div class="casAuthors">Janardhanan, Jeshina; Chang, Mayland; Mobashery, Shahriar</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Microbiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-17</span>CODEN:
                <span class="NLM_cas:coden">COMIF7</span>;
        ISSN:<span class="NLM_cas:issn">1369-5274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The oxadiazoles are a class of antibacterials discovered by in silico docking and scoring of compds. against the X-ray structure of a penicillin-binding protein.  These antibacterials exhibit activity against Gram-pos. bacteria, including against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).  They show in vivo efficacy in murine models of peritonitis/sepsis and neutropenic thigh MRSA infection.  They are bactericidal and orally bioavailable.  The oxadiazoles show promise in treatment of MRSA infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGkNPBwBHezbVg90H21EOLACvtfcHk0ljnTATNrEnkhw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XoslWlur0%253D&md5=b0a236214aa4f89149d7197e43c8d4e7</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.mib.2016.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mib.2016.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DJanardhanan%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DThe%2520oxadiazole%2520antibacterials%26jtitle%3DCurr.%2520Opin.%2520Microbiol.%26date%3D2016%26volume%3D33%26spage%3D13%26epage%3D17%26doi%3D10.1016%2Fj.mib.2016.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phumisantiphong, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siripanichgon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reamtong, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diraphat, P.</span></span> <span> </span><span class="NLM_article-title">A novel bacteriocin from <i>Enterococcus faecalis</i> 478 exhibits a potent activity against vancomycin-resistant enterococci</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0186415</span>, <span class="refDoi">Â DOI: 10.1371/journal.pone.0186415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1371%2Fjournal.pone.0186415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=29023515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFegur3O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0186415&author=U.+Phumisantiphongauthor=K.+Siripanichgonauthor=O.+Reamtongauthor=P.+Diraphat&title=A+novel+bacteriocin+from+Enterococcus+faecalis+478+exhibits+a+potent+activity+against+vancomycin-resistant+enterococci&doi=10.1371%2Fjournal.pone.0186415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">A novel bacteriocin from Enterococcus faecalis 478 exhibits a potent activity against vancomycin-resistant enterococci</span></div><div class="casAuthors">Phumisantiphong, Uraporn; Siripanichgon, Kanokrat; Reamtong, Onrapak; Diraphat, Pornphan</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e0186415/1-e0186415/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The emergence of multidrug-resistant enterococci (MDRE) and particularly vancomycin-resistant enterococci (VRE) is considered a serious health problem worldwide, causing the need for new antimicrobials.  The aim of this study was to discover and characterize bacteriocin against clin. isolates of MDRE and VRE.  Over 10,000 bacterial isolates from water, environment and clin. samples were screened.  E. faecalis strain 478 isolated from human feces produced the highest antibacterial activity against several MDRE and VRE strains.  The optimum condition for bacteriocin prodn. was cultivation in MRS broth at 37Â°C, pH 5-6 for 16 h.  The bacteriocin-like substance produced from E. faecalis strain EF478 was stable at 60Â°C for at least 1 h and retained its antimicrobial activity after storage at -20Â°C for 1 yr, at 4Â°C for 6 mo, and at 25Â°C for 2 mo.  A nano-HPLC electrospray ionization multi-stage tandem mass spectrometry (nLC-ESI-MS/MS) anal. showed that the amino acid sequences of the bacteriocin-like substance was similar to serine protease of E. faecalis, gi|488296663 (NCBI database), which has never been reported as a bacteriocin.  This study reported a novel bacteriocin with high antibacterial activity against VRE and MDRE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH32a9tPkHp7Vg90H21EOLACvtfcHk0ljnTATNrEnkhw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFegur3O&md5=f2f69b11797985e7d3d90346270204d2</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0186415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0186415%26sid%3Dliteratum%253Aachs%26aulast%3DPhumisantiphong%26aufirst%3DU.%26aulast%3DSiripanichgon%26aufirst%3DK.%26aulast%3DReamtong%26aufirst%3DO.%26aulast%3DDiraphat%26aufirst%3DP.%26atitle%3DA%2520novel%2520bacteriocin%2520from%2520Enterococcus%2520faecalis%2520478%2520exhibits%2520a%2520potent%2520activity%2520against%2520vancomycin-resistant%2520enterococci%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0186415%26doi%3D10.1371%2Fjournal.pone.0186415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zipperer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konnerth, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berscheid, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidenmaier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slavetinsky, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marschal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalbacher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schittek, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brotz-Oesterhelt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grond, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peschel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krismer, B.</span></span> <span> </span><span class="NLM_article-title">Human commensals producing a novel antibiotic impair pathogen colonization</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>535</i></span>,  <span class="NLM_fpage">511</span>â <span class="NLM_lpage">516</span>, <span class="refDoi">Â DOI: 10.1038/nature18634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fnature18634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=27466123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Ont73P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2016&pages=511-516&author=A.+Zippererauthor=M.+C.+Konnerthauthor=C.+Lauxauthor=A.+Berscheidauthor=D.+Janekauthor=C.+Weidenmaierauthor=M.+Burianauthor=N.+A.+Schillingauthor=C.+Slavetinskyauthor=M.+Marschalauthor=M.+Willmannauthor=H.+Kalbacherauthor=B.+Schittekauthor=H.+Brotz-Oesterheltauthor=S.+Grondauthor=A.+Peschelauthor=B.+Krismer&title=Human+commensals+producing+a+novel+antibiotic+impair+pathogen+colonization&doi=10.1038%2Fnature18634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Human commensals producing a novel antibiotic impair pathogen colonization</span></div><div class="casAuthors">Zipperer, Alexander; Konnerth, Martin C.; Laux, Claudia; Berscheid, Anne; Janek, Daniela; Weidenmaier, Christopher; Burian, Marc; Schilling, Nadine A.; Slavetinsky, Christoph; Marschal, Matthias; Willmann, Matthias; Kalbacher, Hubert; Schittek, Birgit; Broetz-Oesterhelt, Heike; Grond, Stephanie; Peschel, Andreas; Krismer, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">7613</span>),
    <span class="NLM_cas:pages">511-516</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nasal Staphylococcus lugdunensis strains produce lugdunin, a novel thiazolidine-contg. cyclic peptide antibiotic that prohibits colonization by Staphylococcus aureus, and a rare example of a non-ribosomally synthesized bioactive compd. from human-assocd. bacteria.  Lugdunin is bactericidal against major pathogens, effective in animal models, and not prone to causing development of resistance in S. aureus.  Notably, human nasal colonization by S. lugdunensis was assocd. with a significantly reduced S. aureus carriage rate, suggesting that lugdunin or lugdunin-producing commensal bacteria could be valuable for preventing staphylococcal infections.  Moreover, human microbiota should be considered as a source for new antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIXuvnunypn7Vg90H21EOLACvtfcHk0ljnTATNrEnkhw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Ont73P&md5=04c4e8b4dac5aa1c56edf164e8360a3d</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2Fnature18634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18634%26sid%3Dliteratum%253Aachs%26aulast%3DZipperer%26aufirst%3DA.%26aulast%3DKonnerth%26aufirst%3DM.%2BC.%26aulast%3DLaux%26aufirst%3DC.%26aulast%3DBerscheid%26aufirst%3DA.%26aulast%3DJanek%26aufirst%3DD.%26aulast%3DWeidenmaier%26aufirst%3DC.%26aulast%3DBurian%26aufirst%3DM.%26aulast%3DSchilling%26aufirst%3DN.%2BA.%26aulast%3DSlavetinsky%26aufirst%3DC.%26aulast%3DMarschal%26aufirst%3DM.%26aulast%3DWillmann%26aufirst%3DM.%26aulast%3DKalbacher%26aufirst%3DH.%26aulast%3DSchittek%26aufirst%3DB.%26aulast%3DBrotz-Oesterhelt%26aufirst%3DH.%26aulast%3DGrond%26aufirst%3DS.%26aulast%3DPeschel%26aufirst%3DA.%26aulast%3DKrismer%26aufirst%3DB.%26atitle%3DHuman%2520commensals%2520producing%2520a%2520novel%2520antibiotic%2520impair%2520pathogen%2520colonization%26jtitle%3DNature%26date%3D2016%26volume%3D535%26spage%3D511%26epage%3D516%26doi%3D10.1038%2Fnature18634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohamed, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelkhalek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seleem, M. N.</span></span> <span> </span><span class="NLM_article-title">Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular <i>Staphylococcus aureus</i></span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">29707</span>, <span class="refDoi">Â DOI: 10.1038/srep29707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1038%2Fsrep29707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=27405275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A280%3ADC%252BC2s7pslOqug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=29707&author=M.+F.+Mohamedauthor=A.+Abdelkhalekauthor=M.+N.+Seleem&title=Evaluation+of+short+synthetic+antimicrobial+peptides+for+treatment+of+drug-resistant+and+intracellular+Staphylococcus+aureus&doi=10.1038%2Fsrep29707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus</span></div><div class="casAuthors">Mohamed Mohamed F; Abdelkhalek Ahmed; Seleem Mohamed N; Seleem Mohamed N</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29707</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Methicillin-resistant Staphylococcus aureus (MRSA) infections present a serious challenge because of the emergence of resistance to numerous conventional antibiotics.  Due to their unique mode of action, antimicrobial peptides are novel alternatives to traditional antibiotics for tackling the issue of bacterial multidrug resistance.  Herein, we investigated the antibacterial activity of two short novel peptides (WR12, a 12 residue peptide composed exclusively of arginine and tryptophan, and D-IK8, an eight residue Î²-sheet peptide) against multidrug resistant staphylococci.  In vitro, both peptides exhibited good antibacterial activity against MRSA, vancomycin-resistant S. aureus, linezolid-resistant S. aureus, and methicillin-resistant S. epidermidis.  WR12 and D-IK8 were able to eradicate persisters, MRSA in stationary growth phase, and showed significant clearance of intracellular MRSA in comparison to both vancomycin and linezolid.  In vivo, topical WR12 and D-IK8 significantly reduced both the bacterial load and the levels of the pro-inflammatory cytokines including tumor necrosis factor-Î± (TNF-Î±) and interleukin-6 (IL-6) in MRSA-infected skin lesions.  Moreover, both peptides disrupted established in vitro biofilms of S. aureus and S. epidermidis significantly more so than traditional antimicrobials tested.  Taken together, these results support the potential of WR12 and D-IK8 to be used as a topical antimicrobial agent for the treatment of staphylococcal skin infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAE8XpIz_IilMGsG_HTXYFfW6udTcc2ebDE5slnbJER7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7pslOqug%253D%253D&md5=bb332990a7df476b0f93535713307e9a</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1038%2Fsrep29707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep29707%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DM.%2BF.%26aulast%3DAbdelkhalek%26aufirst%3DA.%26aulast%3DSeleem%26aufirst%3DM.%2BN.%26atitle%3DEvaluation%2520of%2520short%2520synthetic%2520antimicrobial%2520peptides%2520for%2520treatment%2520of%2520drug-resistant%2520and%2520intracellular%2520Staphylococcus%2520aureus%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D29707%26doi%3D10.1038%2Fsrep29707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoque, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uppu, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konai, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Small molecular antibacterial peptoid mimics: the simpler the better!</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1428</span>â <span class="NLM_lpage">1436</span>, <span class="refDoi">Â DOI: 10.1021/jm401680a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401680a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsF2mtrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1428-1436&author=C.+Ghoshauthor=G.+B.+Manjunathauthor=P.+Akkapeddiauthor=V.+Yarlagaddaauthor=J.+Hoqueauthor=D.+S.+Uppuauthor=M.+M.+Konaiauthor=J.+Haldar&title=Small+molecular+antibacterial+peptoid+mimics%3A+the+simpler+the+better%21&doi=10.1021%2Fjm401680a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecular antibacterial peptoid mimics: the simpler the better!</span></div><div class="casAuthors">Ghosh, Chandradhish; Manjunath, Goutham B.; Akkapeddi, Padma; Yarlagadda, Venkateswarlu; Hoque, Jiaul; Uppu, Divakara S. S. M.; Konai, Mohini M.; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1428-1436</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The emergence of multidrug-resistant bacteria compounded by the depleting arsenal of antibiotics has accelerated efforts toward development of antibiotics with novel mechanisms of action.  The authors present a series of small mol. antibacterial peptoid mimics which exhibit high in vitro potency against a variety of Gram-pos. and Gram-neg. bacteria, including drug-resistant species such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium.  The highlight of these compds. is their superior activity against the major nosocomial pathogen Pseudomonas aeruginosa.  Nontoxic toward mammalian cells, these rapidly bactericidal compds. primarily act by permeabilization and depolarization of bacterial membrane.  Synthetically simple and selectively antibacterial, these compds. can be developed into a newer class of therapeutic agents against multidrug resistant bacterial species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD3gv-iZUu8bVg90H21EOLACvtfcHk0ljajstivW3sgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsF2mtrs%253D&md5=5d047aae6b6218f01525953fdf452979</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1021%2Fjm401680a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401680a%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DC.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DAkkapeddi%26aufirst%3DP.%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DHoque%26aufirst%3DJ.%26aulast%3DUppu%26aufirst%3DD.%2BS.%26aulast%3DKonai%26aufirst%3DM.%2BM.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DSmall%2520molecular%2520antibacterial%2520peptoid%2520mimics%253A%2520the%2520simpler%2520the%2520better%2521%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1428%26epage%3D1436%26doi%3D10.1021%2Fjm401680a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uppu, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoque, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Polymers with tunable side-chain amphiphilicity as non-hemolytic antibacterial agents</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">9389</span>â <span class="NLM_lpage">9391</span>, <span class="refDoi">Â DOI: 10.1039/c3cc43751e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1039%2Fc3cc43751e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=23868724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2it7jL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=9389-9391&author=D.+S.+Uppuauthor=P.+Akkapeddiauthor=G.+B.+Manjunathauthor=V.+Yarlagaddaauthor=J.+Hoqueauthor=J.+Haldar&title=Polymers+with+tunable+side-chain+amphiphilicity+as+non-hemolytic+antibacterial+agents&doi=10.1039%2Fc3cc43751e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Polymers with tunable side-chain amphiphilicity as non-hemolytic antibacterial agents</span></div><div class="casAuthors">Uppu, Divakara S. S. M.; Akkapeddi, Padma; Manjunath, Goutham B.; Yarlagadda, Venkateswarlu; Hoque, Jiaul; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">82</span>),
    <span class="NLM_cas:pages">9389-9391</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Quaternized polymers mimicking the antimicrobial peptides were created by tuning the side-chain amphiphilicity using a first-time approach of post-functionalization.  They displayed excellent efficacy against pathogenic bacteria even in human plasma and membrane disruptive mode of action.  The optimized polymers and degraded products were non-hemolytic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0q4c7w8PIFrVg90H21EOLACvtfcHk0ljajstivW3sgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2it7jL&md5=c735f000f6202efb8780063c52fda9bf</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1039%2Fc3cc43751e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cc43751e%26sid%3Dliteratum%253Aachs%26aulast%3DUppu%26aufirst%3DD.%2BS.%26aulast%3DAkkapeddi%26aufirst%3DP.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DHoque%26aufirst%3DJ.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DPolymers%2520with%2520tunable%2520side-chain%2520amphiphilicity%2520as%2520non-hemolytic%2520antibacterial%2520agents%26jtitle%3DChem.%2520Commun.%26date%3D2013%26volume%3D49%26spage%3D9389%26epage%3D9391%26doi%3D10.1039%2Fc3cc43751e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoque, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konai, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonuguntla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Membrane active small molecules show selective broad spectrum antibacterial activity with no detectable resistance and eradicate biofilms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5486</span>â <span class="NLM_lpage">5500</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b00443</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00443" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKit7%252FM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5486-5500&author=J.+Hoqueauthor=M.+M.+Konaiauthor=S.+Gonuguntlaauthor=G.+B.+Manjunathauthor=S.+Samaddarauthor=V.+Yarlagaddaauthor=J.+Haldar&title=Membrane+active+small+molecules+show+selective+broad+spectrum+antibacterial+activity+with+no+detectable+resistance+and+eradicate+biofilms&doi=10.1021%2Facs.jmedchem.5b00443"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-active small molecules show selective broad spectrum antibacterial activity with no detectable resistance and eradicate biofilms</span></div><div class="casAuthors">Hoque, Jiaul; Konai, Mohini M.; Gonuguntla, Spandhana; Manjunath, Goutham B.; Samaddar, Sandip; Yarlagadda, Venkateswarlu; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5486-5500</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Treating bacterial biofilms with conventional antibiotics is limited due to ineffectiveness of the drugs and higher propensity to develop bacterial resistance.  Development of new classes of antibacterial therapeutics with alternative mechanisms of action has become imperative.  Here, the authors report the design, synthesis, and biol. evaluations of novel membrane-active small mols. featuring two pos. charges, four nonpeptidic amide groups, and variable hydrophobic/hydrophilic (amphiphilic) character.  The biocides synthesized via a facile methodol. not only displayed good antibacterial activity against wild-type bacteria but also showed high activity against various drug-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium (VRE), and Î²-lactam-resistant Klebsiella pneumoniae.  Further, these biocides not only inhibited the formation of biofilms but also disrupted the established S. aureus and E. coli biofilms.  The membrane-active biocides hindered the propensity to develop bacterial resistance.  Moreover, the biocides showed negligible toxicity against mammalian cells and thus bear potential to be used as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUd-NAG1Bl6rVg90H21EOLACvtfcHk0lhTZaeAa5Mm-g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKit7%252FM&md5=dae696b7992515ade5fcd9145594e0ee</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00443%26sid%3Dliteratum%253Aachs%26aulast%3DHoque%26aufirst%3DJ.%26aulast%3DKonai%26aufirst%3DM.%2BM.%26aulast%3DGonuguntla%26aufirst%3DS.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DMembrane%2520active%2520small%2520molecules%2520show%2520selective%2520broad%2520spectrum%2520antibacterial%2520activity%2520with%2520no%2520detectable%2520resistance%2520and%2520eradicate%2520biofilms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5486%26epage%3D5500%26doi%3D10.1021%2Facs.jmedchem.5b00443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konai, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adhikary, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of amino acid tunable lipidated norspermidine conjugates: disrupting biofilms with potent activity against bacterial persisters</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2442</span>â <span class="NLM_lpage">2453</span>, <span class="refDoi">Â DOI: 10.1021/acs.bioconjchem.5b00494</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.5b00494" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1ekurjL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=2442-2453&author=M.+M.+Konaiauthor=U.+Adhikaryauthor=S.+Samaddarauthor=C.+Ghoshauthor=J.+Haldar&title=Structure-activity+relationship+of+amino+acid+tunable+lipidated+norspermidine+conjugates%3A+disrupting+biofilms+with+potent+activity+against+bacterial+persisters&doi=10.1021%2Facs.bioconjchem.5b00494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship of Amino Acid Tunable Lipidated Norspermidine Conjugates: Disrupting Biofilms with Potent Activity against Bacterial Persisters</span></div><div class="casAuthors">Konai, Mohini M.; Adhikary, Utsarga; Samaddar, Sandip; Ghosh, Chandradhish; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2442-2453</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The emergence of bacterial resistance and biofilm assocd. infections has created a challenging situation in global health.  In this present state of affairs where conventional antibiotics are falling short of being able to provide a soln. to these problems, development of novel antibacterial compds. possessing the twin prowess of antibacterial and antibiofilm efficacy is imperative.  Herein, we report a library of amino acid tunable lipidated norspermidine conjugates that were prepd. by conjugating both amino acids and fatty acids with the amine functionalities of norspermidine through amide bond formation.  These lipidated conjugates displayed potent antibacterial activity against various planktonic Gram-pos. and Gram-neg. bacteria including drug-resistant superbugs such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and Î²-lactam-resistant Klebsiella pneumoniae.  This class of nontoxic and fast-acting antibacterial mols. (capable of killing bacteria within 15 min) did not allow bacteria to develop resistance against them after several passages.  Most importantly, an optimized compd. in the series was also capable of killing metabolically inactive persisters and stationary phase bacteria.  Addnl., this compd. was capable of disrupting the preformed biofilms of S. aureus and E. coli.  Therefore, this class of antibacterial conjugates have potential in tackling the challenging situation posed by both bacterial resistance as well as drug tolerance due to biofilm formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvjwlv1w8fLLVg90H21EOLACvtfcHk0lhTZaeAa5Mm-g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1ekurjL&md5=3a3cb9395e60476cf47b93555afed587</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.5b00494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.5b00494%26sid%3Dliteratum%253Aachs%26aulast%3DKonai%26aufirst%3DM.%2BM.%26aulast%3DAdhikary%26aufirst%3DU.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DC.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520of%2520amino%2520acid%2520tunable%2520lipidated%2520norspermidine%2520conjugates%253A%2520disrupting%2520biofilms%2520with%2520potent%2520activity%2520against%2520bacterial%2520persisters%26jtitle%3DBioconjugate%2520Chem.%26date%3D2015%26volume%3D26%26spage%3D2442%26epage%3D2453%26doi%3D10.1021%2Facs.bioconjchem.5b00494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmagadda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span> <span> </span><span class="NLM_article-title">Novel bis-cyclic guanidines as potent membrane-active antibacterial agents with therapeutic potential</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">11948</span>â <span class="NLM_lpage">11951</span>, <span class="refDoi">Â DOI: 10.1039/C7CC07285F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1039%2FC7CC07285F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=29052670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1GmurzE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=11948-11951&author=P.+Tengauthor=A.+Nimmagaddaauthor=M.+Suauthor=Y.+Hongauthor=N.+Shenauthor=C.+Liauthor=L.+Y.+Tsaiauthor=J.+Caoauthor=Q.+Liauthor=J.+Cai&title=Novel+bis-cyclic+guanidines+as+potent+membrane-active+antibacterial+agents+with+therapeutic+potential&doi=10.1039%2FC7CC07285F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Novel bis-cyclic guanidines as potent membrane-active antibacterial agents with therapeutic potential</span></div><div class="casAuthors">Teng, Peng; Nimmagadda, Alekhya; Su, Ma; Hong, Yuzhu; Shen, Ning; Li, Chunpu; Tsai, Ling-Yu; Cao, Jessica; Li, Qi; Cai, Jianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">87</span>),
    <span class="NLM_cas:pages">11948-11951</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We designed a class of small dimeric cyclic guanidine derivs. which display potent antibacterial activity against both multidrug-resistant Gram-neg. and Gram-pos. bacteria.  They could compromise bacterial membranes without developing resistance, inhibit biofilms formed by E. coli, and exhibit excellent in vivo activity in the MRSA-infected thigh burden mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovKB8nHZUHYrVg90H21EOLACvtfcHk0lhTZaeAa5Mm-g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1GmurzE&md5=b46b06f9e2545fbf0c94889a02e26596</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1039%2FC7CC07285F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC07285F%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DP.%26aulast%3DNimmagadda%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DTsai%26aufirst%3DL.%2BY.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DJ.%26atitle%3DNovel%2520bis-cyclic%2520guanidines%2520as%2520potent%2520membrane-active%2520antibacterial%2520agents%2520with%2520therapeutic%2520potential%26jtitle%3DChem.%2520Commun.%26date%3D2017%26volume%3D53%26spage%3D11948%26epage%3D11951%26doi%3D10.1039%2FC7CC07285F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmagadda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odom, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span> <span> </span><span class="NLM_article-title">Membrane-active hydantoin derivatives as antibiotic agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8456</span>â <span class="NLM_lpage">8465</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00847</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00847" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Sku7jK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8456-8465&author=M.+Suauthor=D.+Xiaauthor=P.+Tengauthor=A.+Nimmagaddaauthor=C.+Zhangauthor=T.+Odomauthor=A.+Caoauthor=Y.+Huauthor=J.+Cai&title=Membrane-active+hydantoin+derivatives+as+antibiotic+agents&doi=10.1021%2Facs.jmedchem.7b00847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-Active Hydantoin Derivatives as Antibiotic Agents</span></div><div class="casAuthors">Su, Ma; Xia, Donglin; Teng, Peng; Nimmagadda, Alekhya; Zhang, Chao; Odom, Timothy; Cao, Annie; Hu, Yong; Cai, Jianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8456-8465</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydantoin (imidazolidinedione) derivs. such as nitrofurantoin are small mols. that have aroused considerable interest recently due to their low rate of bacterial resistance.  However, their moderate antimicrobial activity may hamper their application combating antibiotic resistance in the long run.  Herein we report the design of bacterial membrane-active hydantoin derivs., from which we identified compds. that show much more potent antimicrobial activity against a panel of clin. relevant Gram-pos. and Gram-neg. bacterial strains than nitrofurantoin.  These compds. are able to act on bacterial membranes, analogous to natural host-defense peptides (HDPs).  Addnl., these hydantoin compds. could not only kill bacterial pathogens rapidly, but also prevent the development of methicillin-resistant Staphylococcus aureus (MRSA) bacterial resistance under the tested conditions.  More intriguingly, the lead compd. exhibited in vivo efficacy which is much superior to vancomycin by eradicating bacteria and suppressing inflammation caused by MRSA-induced pneumonia on a rat model, demonstrating their promising therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp48yfWduVgk7Vg90H21EOLACvtfcHk0lgAaDVjavaOgg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Sku7jK&md5=04a2e9ba317c8f7f444db7cdd6bffce7</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00847%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DM.%26aulast%3DXia%26aufirst%3DD.%26aulast%3DTeng%26aufirst%3DP.%26aulast%3DNimmagadda%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DOdom%26aufirst%3DT.%26aulast%3DCao%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DJ.%26atitle%3DMembrane-active%2520hydantoin%2520derivatives%2520as%2520antibiotic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8456%26epage%3D8465%26doi%3D10.1021%2Facs.jmedchem.7b00847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ichikawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsuan, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, A.</span></span> <span> </span><span class="NLM_article-title">Carbacaprazamycins: chemically stable analogues of the caprazamycin nucleoside antibiotics</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">151</span>â <span class="NLM_lpage">156</span>, <span class="refDoi">Â DOI: 10.1021/id5000376</span> </span><div class="citationLinks">[<a href="/doi/10.1021/id5000376" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVahsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=151-156&author=S.+Ichikawaauthor=M.+Yamaguchiauthor=L.+S.+Hsuanauthor=Y.+Katoauthor=A.+Matsuda&title=Carbacaprazamycins%3A+chemically+stable+analogues+of+the+caprazamycin+nucleoside+antibiotics&doi=10.1021%2Fid5000376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Carbacaprazamycins: Chemically Stable Analogues of the Caprazamycin Nucleoside Antibiotics</span></div><div class="casAuthors">Ichikawa, Satoshi; Yamaguchi, Mayumi; Hsuan, Lee Shang; Kato, Yuta; Matsuda, Akira</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">151-156</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Carbacaprazamycins, which are chem. stable analogs of caprazamycins, were designed and synthesized.  These analogs (I) were active against drug-resistant bacterial pathogens such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and their activities were comparable to those of the parent caprazamycins.  The effect of treatment with carbacaprazamycin on morphol. changes in S. aureus indicated that the mode of action was completely different from those of existing peptidoglycan inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8wPaC80lQfbVg90H21EOLACvtfcHk0lgAaDVjavaOgg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVahsbg%253D&md5=9caed0fec927f4f10a0e1435660eb746</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fid5000376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fid5000376%26sid%3Dliteratum%253Aachs%26aulast%3DIchikawa%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DHsuan%26aufirst%3DL.%2BS.%26aulast%3DKato%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DA.%26atitle%3DCarbacaprazamycins%253A%2520chemically%2520stable%2520analogues%2520of%2520the%2520caprazamycin%2520nucleoside%2520antibiotics%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2015%26volume%3D1%26spage%3D151%26epage%3D156%26doi%3D10.1021%2Fid5000376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitors of staphyloxanthin virulence factor in comparison with linezolid and vancomycin versus methicillin-resistant, linezolid-resistant, and vancomycin-intermediate <i>Staphylococcus aureus</i> infections in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8145</span>â <span class="NLM_lpage">8159</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00949</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00949" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKgs7vN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8145-8159&author=S.+Niauthor=H.+Weiauthor=B.+Liauthor=F.+Chenauthor=Y.+Liuauthor=W.+Chenauthor=Y.+Xuauthor=X.+Qiuauthor=X.+Liauthor=Y.+Luauthor=W.+Liuauthor=L.+Huauthor=D.+Linauthor=M.+Wangauthor=X.+Zhengauthor=F.+Maoauthor=J.+Zhuauthor=L.+Lanauthor=J.+Li&title=Novel+inhibitors+of+staphyloxanthin+virulence+factor+in+comparison+with+linezolid+and+vancomycin+versus+methicillin-resistant%2C+linezolid-resistant%2C+and+vancomycin-intermediate+Staphylococcus+aureus+infections+in+vivo&doi=10.1021%2Facs.jmedchem.7b00949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate Staphylococcus aureus Infections in Vivo</span></div><div class="casAuthors">Ni, Shuaishuai; Wei, Hanwen; Li, Baoli; Chen, Feifei; Liu, Yifu; Chen, Wenhua; Xu, Yixiang; Qiu, Xiaoxia; Li, Xiaokang; Lu, Yanli; Liu, Wenwen; Hu, Linhao; Lin, Dazheng; Wang, Manjiong; Zheng, Xinyu; Mao, Fei; Zhu, Jin; Lan, Lefu; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8145-8159</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors' previous work (Wang, et al. J. Med. Chem. 2016, 59, 4831-4848) revealed that effective benzocycloalkane-derived staphyloxanthin inhibitors against methicillin-resistant Staphylococcus aureus (S. aureus) infections were accompanied by poor water soly. and high hERG inhibition and dosages (pre-administration).  In this study, ninety-two chroman and coumaran derivs. as novel inhibitors have been addressed for overcoming deficiencies above.  Derivs. 69 ((E)-N-(coumaran-5-methyl)-N-methyl-3-(4-biphenyl)prop-2-en-1-amine hydrochloride) and 105 ((E,E)-N-(chroman-7-methyl)-N-methyl-5-(4-biphenyl)pent-2,4-dien-1-amine hydrochloride) displayed the excellent pigment inhibitory activities and low hERG inhibition, along with the improvement of soly. by salt type selection.  The broad and significantly potent antibacterial spectra of 69 and 105 were displayed firstly with normal administration in the livers and hearts in mice against pigmented S. aureus Newman, Mu50 (vancomycin-intermediate S. aureus) and NRS271 (linezolid-resistant S. aureus), compared with linezolid and vancomycin.  In summary, both 69 and 105 have the potential to be developed as good antibacterial candidates targeting virulence factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcybrWG0xXSLVg90H21EOLACvtfcHk0lgAaDVjavaOgg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKgs7vN&md5=c29f6cf0efd0584034f623d62222a943</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00949%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DNovel%2520inhibitors%2520of%2520staphyloxanthin%2520virulence%2520factor%2520in%2520comparison%2520with%2520linezolid%2520and%2520vancomycin%2520versus%2520methicillin-resistant%252C%2520linezolid-resistant%252C%2520and%2520vancomycin-intermediate%2520Staphylococcus%2520aureus%2520infections%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8145%26epage%3D8159%26doi%3D10.1021%2Facs.jmedchem.7b00949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clauditz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieland, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peschel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotz, F.</span></span> <span> </span><span class="NLM_article-title">Staphyloxanthin plays a role in the fitness of <i>Staphylococcus aureus</i> and its ability to cope with oxidative stress</span>. <i>Infection and immunity</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">4950</span>â <span class="NLM_lpage">4953</span>, <span class="refDoi">Â DOI: 10.1128/IAI.00204-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1128%2FIAI.00204-06" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2006&pages=4950-4953&author=A.+Clauditzauthor=A.+Reschauthor=K.+P.+Wielandauthor=A.+Peschelauthor=F.+Gotz&title=Staphyloxanthin+plays+a+role+in+the+fitness+of+Staphylococcus+aureus+and+its+ability+to+cope+with+oxidative+stress&doi=10.1128%2FIAI.00204-06"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1128%2FIAI.00204-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00204-06%26sid%3Dliteratum%253Aachs%26aulast%3DClauditz%26aufirst%3DA.%26aulast%3DResch%26aufirst%3DA.%26aulast%3DWieland%26aufirst%3DK.%2BP.%26aulast%3DPeschel%26aufirst%3DA.%26aulast%3DGotz%26aufirst%3DF.%26atitle%3DStaphyloxanthin%2520plays%2520a%2520role%2520in%2520the%2520fitness%2520of%2520Staphylococcus%2520aureus%2520and%2520its%2520ability%2520to%2520cope%2520with%2520oxidative%2520stress%26jtitle%3DInfection%2520and%2520immunity%26date%3D2006%26volume%3D74%26spage%3D4950%26epage%3D4953%26doi%3D10.1128%2FIAI.00204-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Essex, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastian, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fierer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizet, V.</span></span> <span> </span><span class="NLM_article-title"><i>Staphylococcus aureus</i> golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>202</i></span>,  <span class="NLM_fpage">209</span>â <span class="NLM_lpage">215</span>, <span class="refDoi">Â DOI: 10.1084/jem.20050846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1084%2Fjem.20050846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=16009720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVKht74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2005&pages=209-215&author=G.+Y.+Liuauthor=A.+Essexauthor=J.+T.+Buchananauthor=V.+Dattaauthor=H.+M.+Hoffmanauthor=J.+F.+Bastianauthor=J.+Fiererauthor=V.+Nizet&title=Staphylococcus+aureus+golden+pigment+impairs+neutrophil+killing+and+promotes+virulence+through+its+antioxidant+activity&doi=10.1084%2Fjem.20050846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity</span></div><div class="casAuthors">Liu, George Y.; Essex, Anthony; Buchanan, John T.; Datta, Vivekanand; Hoffman, Hal M.; Bastian, John F.; Fierer, Joshua; Nizet, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-215</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Golden color imparted by carotenoid pigments is the eponymous feature of the human pathogen Staphylococcus aureus.  Here the authors demonstrate a role of this hallmark phenotype in virulence.  Compared with the wild-type (WT) bacterium, a S. aureus mutant with disrupted carotenoid biosynthesis is more susceptible to oxidant killing, has impaired neutrophil survival, and is less pathogenic in a mouse s.c. abscess model.  The survival advantage of WT S. aureus over the carotenoid-deficient mutant is lost upon inhibition of neutrophil oxidative burst or in human or murine NADP oxidase-deficient hosts.  Conversely, heterologous expression of the S. aureus carotenoid in the nonpigmented Streptococcus pyogenes confers enhanced oxidant and neutrophil resistance and increased animal virulence.  Blocking S. aureus carotenogenesis increases oxidant sensitivity and decreases whole-blood survival, suggesting a novel target for antibiotic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO5jK5cytS-bVg90H21EOLACvtfcHk0lh3dZ2Qj9QCdg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVKht74%253D&md5=aaf85913e260d691a71f83d963d007c9</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1084%2Fjem.20050846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20050846%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%2BY.%26aulast%3DEssex%26aufirst%3DA.%26aulast%3DBuchanan%26aufirst%3DJ.%2BT.%26aulast%3DDatta%26aufirst%3DV.%26aulast%3DHoffman%26aufirst%3DH.%2BM.%26aulast%3DBastian%26aufirst%3DJ.%2BF.%26aulast%3DFierer%26aufirst%3DJ.%26aulast%3DNizet%26aufirst%3DV.%26atitle%3DStaphylococcus%2520aureus%2520golden%2520pigment%2520impairs%2520neutrophil%2520killing%2520and%2520promotes%2520virulence%2520through%2520its%2520antioxidant%2520activity%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2005%26volume%3D202%26spage%3D209%26epage%3D215%26doi%3D10.1084%2Fjem.20050846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oldfield, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span> <span> </span><span class="NLM_article-title">Resistance-resistant antibiotics</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">664</span>â <span class="NLM_lpage">674</span>, <span class="refDoi">Â DOI: 10.1016/j.tips.2014.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.tips.2014.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=25458541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWmtrzP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=664-674&author=E.+Oldfieldauthor=X.+Feng&title=Resistance-resistant+antibiotics&doi=10.1016%2Fj.tips.2014.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance-resistant antibiotics</span></div><div class="casAuthors">Oldfield, Eric; Feng, Xinxin</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">664-674</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">New antibiotics are needed because drug resistance is increasing while the introduction of new antibiotics is decreasing.  We discuss here six possible approaches to develop 'resistance-resistant' antibiotics.  First, multitarget inhibitors in which a single compd. inhibits more than one target may be easier to develop than conventional combination therapies with two new drugs.  Second, inhibiting multiple targets in the same metabolic pathway is expected to be an effective strategy owing to synergy.  Third, discovering multiple-target inhibitors should be possible by using sequential virtual screening.  Fourth, repurposing existing drugs can lead to combinations of multitarget therapeutics.  Fifth, targets need not be proteins.  Sixth, inhibiting virulence factor formation and boosting innate immunity may also lead to decreased susceptibility to resistance.  Although it is not possible to eliminate resistance, the approaches reviewed here offer several possibilities for reducing the effects of mutations and, in some cases, suggest that sensitivity to existing antibiotics may be restored in otherwise drug-resistant organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoFcN1H0q81rVg90H21EOLACvtfcHk0lh3dZ2Qj9QCdg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWmtrzP&md5=1fd8f53ba0e90abbc83a6616db24568a</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DOldfield%26aufirst%3DE.%26aulast%3DFeng%26aufirst%3DX.%26atitle%3DResistance-resistant%2520antibiotics%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26spage%3D664%26epage%3D674%26doi%3D10.1016%2Fj.tips.2014.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van Harten, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, R. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrickx, A. P. A.</span></span> <span> </span><span class="NLM_article-title">Multidrug-resistant enterococcal infections: new compounds, novel antimicrobial therapies?</span>. <i>Trends Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">467</span>â <span class="NLM_lpage">479</span>, <span class="refDoi">Â DOI: 10.1016/j.tim.2017.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.tim.2017.01.004" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=467-479&author=R.+M.+van+Hartenauthor=R.+J.+L.+Willemsauthor=N.+I.+Martinauthor=A.+P.+A.+Hendrickx&title=Multidrug-resistant+enterococcal+infections%3A+new+compounds%2C+novel+antimicrobial+therapies%3F&doi=10.1016%2Fj.tim.2017.01.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.tim.2017.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tim.2017.01.004%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHarten%26aufirst%3DR.%2BM.%26aulast%3DWillems%26aufirst%3DR.%2BJ.%2BL.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26aulast%3DHendrickx%26aufirst%3DA.%2BP.%2BA.%26atitle%3DMultidrug-resistant%2520enterococcal%2520infections%253A%2520new%2520compounds%252C%2520novel%2520antimicrobial%2520therapies%253F%26jtitle%3DTrends%2520Microbiol.%26date%3D2017%26volume%3D25%26spage%3D467%26epage%3D479%26doi%3D10.1016%2Fj.tim.2017.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koopmans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ât Hart, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleijn, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrickx, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breukink, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. I.</span></span> <span> </span><span class="NLM_article-title">Semisynthetic lipopeptides derived from nisin display antibacterial activity and lipid II binding on par with that of the parent compound</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">9382</span>â <span class="NLM_lpage">9389</span>, <span class="refDoi">Â DOI: 10.1021/jacs.5b04501</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b04501" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVyitb%252FO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=9382-9389&author=T.+Koopmansauthor=T.+M.+Woodauthor=P.+%E2%80%98t+Hartauthor=L.+H.+Kleijnauthor=A.+P.+Hendrickxauthor=R.+J.+Willemsauthor=E.+Breukinkauthor=N.+I.+Martin&title=Semisynthetic+lipopeptides+derived+from+nisin+display+antibacterial+activity+and+lipid+II+binding+on+par+with+that+of+the+parent+compound&doi=10.1021%2Fjacs.5b04501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Semisynthetic lipopeptides derived from nisin display antibacterial activity and lipid II binding on par with that of the parent compound</span></div><div class="casAuthors">Koopmans, Timo; Wood, Thomas M.; 't Hart, Peter; Kleijn, Laurens H. J.; Hendrickx, Antoni P. A.; Willems, Rob J. L.; Breukink, Eefjan; Martin, Nathaniel I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">9382-9389</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lipid II-binding N-terminus of nisin, comprising the so-called A/B ring system, was synthetically modified to provide antibacterially active and proteolytically stable derivs.  Various lipids were coupled to the C-terminus of the nisin A/B ring system to generate semisynthetic constructs that display potent inhibition of bacterial growth, with activities approaching that of nisin itself.  Most notable was the activity obsd. against clin. relevant bacterial strains including MRSA and VRE.  Expts. with membrane models indicate that these constructs operate via a lipid II-mediated mode of action without causing pore formation.  A lipid II-dependent mechanism of action is further supported by antagonization assays wherein the addn. of lipid II was found to effectively block the antibacterial activity of the nisin-derived lipopeptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTWVAfxVxlF7Vg90H21EOLACvtfcHk0ljkeZI28WdROg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVyitb%252FO&md5=f119eebfdd958cb5ae3aae7872746682</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b04501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b04501%26sid%3Dliteratum%253Aachs%26aulast%3DKoopmans%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DT.%2BM.%26aulast%3D%25E2%2580%2598t%2BHart%26aufirst%3DP.%26aulast%3DKleijn%26aufirst%3DL.%2BH.%26aulast%3DHendrickx%26aufirst%3DA.%2BP.%26aulast%3DWillems%26aufirst%3DR.%2BJ.%26aulast%3DBreukink%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26atitle%3DSemisynthetic%2520lipopeptides%2520derived%2520from%2520nisin%2520display%2520antibacterial%2520activity%2520and%2520lipid%2520II%2520binding%2520on%2520par%2520with%2520that%2520of%2520the%2520parent%2520compound%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D9382%26epage%3D9389%26doi%3D10.1021%2Fjacs.5b04501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castiglione, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciciliato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gastaldo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candiani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Losi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parenti, F.</span></span> <span> </span><span class="NLM_article-title">Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">22</span>â <span class="NLM_lpage">31</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2007.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=10.1016%2Fj.chembiol.2007.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=18215770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpt12qsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=22-31&author=F.+Castiglioneauthor=A.+Lazzariniauthor=L.+Carranoauthor=E.+Cortiauthor=I.+Ciciliatoauthor=L.+Gastaldoauthor=P.+Candianiauthor=D.+Losiauthor=F.+Marinelliauthor=E.+Selvaauthor=F.+Parenti&title=Determining+the+structure+and+mode+of+action+of+microbisporicin%2C+a+potent+lantibiotic+active+against+multiresistant+pathogens&doi=10.1016%2Fj.chembiol.2007.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Determining the Structure and Mode of Action of Microbisporicin, a Potent Lantibiotic Active Against Multiresistant Pathogens</span></div><div class="casAuthors">Castiglione, Franca; Lazzarini, Ameriga; Carrano, Lucia; Corti, Emiliana; Ciciliato, Ismaela; Gastaldo, Luciano; Candiani, Paolo; Losi, Daniele; Marinelli, Flavia; Selva, Enrico; Parenti, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-31</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Antibiotics blocking bacterial cell wall assembly (Î²-lactams and glycopeptides) are facing a challenge from the progressive spread of resistant pathogens.  Lantibiotics are promising candidates to alleviate this problem.  Microbisporicin, the most potent antibacterial among known comparable lantibiotics, was discovered during a screening applied to uncommon actinomycetes.  It is produced by Microbispora sp. as two similarly active and structurally related polypeptides (A1, 2246-Da and A2, 2230-Da) of 24 amino acids linked by 5 intramol. thioether bridges.  Microbisporicin contains two posttranslational modifications that have never been reported previously in lantibiotics: 5-chloro-trypthopan and mono- (in A2) or bis-hydroxylated (in A1) proline.  Consistent with screening criteria, microbisporicin selectively blocks peptidoglycan biosynthesis, causing cytoplasmic UDP-linked precursor accumulation.  Considering its spectrum of activity and its efficacy in vivo, microbisporicin represents a promising antibiotic to treat emerging infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5uYPrVWN1XLVg90H21EOLACvtfcHk0ljkeZI28WdROg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpt12qsw%253D%253D&md5=5d7230918250e8dd298bbb5a0027d594</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2007.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2007.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DCastiglione%26aufirst%3DF.%26aulast%3DLazzarini%26aufirst%3DA.%26aulast%3DCarrano%26aufirst%3DL.%26aulast%3DCorti%26aufirst%3DE.%26aulast%3DCiciliato%26aufirst%3DI.%26aulast%3DGastaldo%26aufirst%3DL.%26aulast%3DCandiani%26aufirst%3DP.%26aulast%3DLosi%26aufirst%3DD.%26aulast%3DMarinelli%26aufirst%3DF.%26aulast%3DSelva%26aufirst%3DE.%26aulast%3DParenti%26aufirst%3DF.%26atitle%3DDetermining%2520the%2520structure%2520and%2520mode%2520of%2520action%2520of%2520microbisporicin%252C%2520a%2520potent%2520lantibiotic%2520active%2520against%2520multiresistant%2520pathogens%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D22%26epage%3D31%26doi%3D10.1016%2Fj.chembiol.2007.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sinko, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feixas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldfield, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span> <span> </span><span class="NLM_article-title">Undecaprenyl diphosphate synthase inhibitors: antibacterial drug leads</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5693</span>â <span class="NLM_lpage">5701</span>, <span class="refDoi">Â DOI: 10.1021/jm5004649</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5004649" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5693-5701&author=W.+Sinkoauthor=Y.+Wangauthor=W.+Zhuauthor=Y.+Zhangauthor=F.+Feixasauthor=C.+L.+Coxauthor=D.+A.+Mitchellauthor=E.+Oldfieldauthor=J.+A.+McCammon&title=Undecaprenyl+diphosphate+synthase+inhibitors%3A+antibacterial+drug+leads&doi=10.1021%2Fjm5004649"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm5004649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5004649%26sid%3Dliteratum%253Aachs%26aulast%3DSinko%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFeixas%26aufirst%3DF.%26aulast%3DCox%26aufirst%3DC.%2BL.%26aulast%3DMitchell%26aufirst%3DD.%2BA.%26aulast%3DOldfield%26aufirst%3DE.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26atitle%3DUndecaprenyl%2520diphosphate%2520synthase%2520inhibitors%253A%2520antibacterial%2520drug%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5693%26epage%3D5701%26doi%3D10.1021%2Fjm5004649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01093&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01093%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-7%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01093" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                13MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a8ba678303ce8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
